name,genes,brief,full,GPT,ZulGene
BIOCARTA_FIBRINOLYSIS_PATHWAY,"['PLAU', 'PLG', 'FGB', 'F13A1', 'FGA', 'SERPINE1', 'F2R', 'PLAT', 'CPB2', 'SERPINB2', 'F2', 'FGG']",Fibrinolysis Pathway,"Clot formation and fibrinolysis is a balance of plasmin activation/inhibition and thrombin-thrombomodulin activity that regulates fibrin polymer formation and degradation. Active thrombin is produced by the cleavage of prothrombin in the intrinsic thrombin activation pathway or the extrinsic thrombin activation pathway. Cleavage of fibrinogen by thrombin releases the fibrin monomers that auto-polymerize within seconds into fibrin threads or fibers. The coagulation cascade has many feedback loops. One example is the binding of thrombin to the fibrin polymers resulting in a reduction in soluble thrombin. The fibers form a more stable clot as a result of the covalent bonds formed by activated factor XIII enzyme (also known as Fibrin stabilizing factor). These fibers form a mesh the traps platelets, blood cells and plasma to form a clot. The removal of the clot is caused by plasmin cleavage of the fibrin monomers into soluble fibrin degradation products. Plasmin is formed by the cleavage of plasminogen between Arg561 and Val562. Plasmin is a two-chain trypsin-like serine protease. Plasminogen activator inhibitor 1 (PAI1) and plasminogen activator inhibitor 2 (PAI2) inhibit cleavage of plasminogen by tissue-type plasminogen activator (tPA) or urokinase plasminogen activator (uPA). The presence of fibrin fibers and fibrin degradation products exert a two-fold stimulation of tPA and uPA. Plasmin activity is also inhibited by alpha2-antiplasmin. Thrombin activatable fibrinolysis inhibitor (TAFI) is a carboxy-peptidase B-like proenzyme activated by the thrombin-thrombomodulin dimer. TAFI cleaves (DD)E2 to separate DD and E fragments which do not enhance the activation of tPA or uPA and results in a reduced feedback signal. Disease Significance: Overabundance or increased activity of the plamsminogen activator inhibitors or reduced presence or function of tPA or uPA can result in atherosclerotic disease and venous thrombosis due to an increase in fibrin deposition or formation of a thrombus. Thrombosis can also result from plasminogen deficiency caused by a lack of protein or lack of functional protein. Reduced or depleted levels of alpha2-antiplamin can result in severe bleeding disorders.","The gene cluster provided consists of key components involved in the fibrinolytic and coagulation systems, which are critical for maintaining hemostasis, the process that prevents and stops bleeding. This cluster includes genes associated with fibrin clot formation, stabilization, and breakdown.\n\nSome genes in this cluster, such as PLAU (Plasminogen Activator, Urokinase) and PLAT (Plasminogen Activator, Tissue Type), convert plasminogen to plasmin, a serine protease involved in the degradation of fibrin clots. PLG (Plasminogen) codes for plasminogen, the precursor of plasmin that degrades fibrin polymers in blood clots. SERPINE1 (Plasminogen Activator Inhibitor-1) and SERPINB2 (Plasminogen Activator Inhibitor Type 2) act as serine protease inhibitors that regulate fibrinolysis by inhibiting tissue plasminogen activator (tPA) and urokinase (uPA).\n\nOther genes, such as F2 (Prothrombin), encode the precursor to thrombin, a central enzyme in blood coagulation that converts fibrinogen to fibrin. F2R (Coagulation Factor II Receptor, Thrombin Receptor) mediates cellular responses to thrombin, linking coagulation and cellular proliferation. FGA, FGB, and FGG (Fibrinogen Alpha, Beta, and Gamma Chains) form fibrinogen, which upon proteolytic cleavage by thrombin, polymerizes to form fibrin strands essential for clot formation. F13A1 (Coagulation Factor XIII, A1 Subunit) stabilizes blood clots by cross-linking fibrin molecules. CPB2 (Carboxypeptidase B2, Thrombin-Activatable Fibrinolysis Inhibitor) modulates fibrinolysis by removing C-terminal lysine residues from fibrin, reducing plasminogen binding.\n\nAdditionally, the interplay between coagulation and fibrinolysis is finely coordinated. Plasminogen activators and inhibitors regulate the conversion of plasminogen to plasmin, impacting fibrin degradation. The balance between PAIs (SERPINE1, SERPINB2) and plasminogen activators (PLAU, PLAT) is crucial for preventing excessive clot lysis. The expression of coagulation and fibrinolytic factors is tightly regulated at the transcriptional level and by post-translational modifications. Inflammatory cytokines can influence the expression of several of these genes, suggesting a link between coagulation, fibrinolysis, and immune response.\n\nAll in all, this gene cluster forms a crucial part of the hemostatic system, with implications for both normal physiology and pathological states. Dysregulation of this gene cluster can lead to pathological conditions such as thrombosis or bleeding disorders. Understanding these genes helps in diagnosing and treating conditions like deep vein thrombosis, pulmonary embolism, and hemophilia. Targeting specific components of this cluster is a therapeutic strategy for the management of clotting disorders. While well-studied, ongoing research is needed to fully elucidate the complex regulation and interactions of these genes in various physiological and pathological contexts.","The gene cluster involved in coagulation is a cascade of proteolytic enzymes that leads to the formation of a clot to seal wounds. Some genes in this cluster include tissue factor (TF), which initiates the clotting cascade by binding to factor VII in the blood. Other genes, such as those coding for factors X and IX, are activated by the TF-factor VII complex and subsequently activate prothrombin. Additionally, thrombin, the final enzyme in the cascade, cleaves fibrinogen to release fibrin, the units that form the clot, and the clot is stabilized by factor XIII, which cross-links the fibrin molecules. All in all, this gene cluster plays a crucial role in the formation and stabilization of blood clots during the coagulation process."
BIOCARTA_CTLA4_PATHWAY,"['CD80', 'CD3G', 'CD3E', 'ICOSLG', 'ICOS', 'IL2', 'PIK3R1', 'CD247', 'CD86', 'CTLA4', 'CD28', 'GRB2', 'LCK', 'CD3D', 'PTPN11', 'HLA-DRA', 'HLA-DRB5', 'PIK3CA', 'ITK', 'HLA-DRB1', 'HLA-DRB4', 'HLA-DRB3']",The Co-Stimulatory Signal During T-cell Activation,"For a T cell to be activated by a specific antigen, the T cell receptor must recognize complexes of MHCI with the antigen on the surface of an antigen-presenting cell. T cells and the T cell receptor complex do not respond to antigen in solution, but even for the specific antigen they only respond to antigen-MHC-1 complexes on the cell surface. This interaction is necessary for T cell activation, but it is not sufficient. T cell activation also requires a co-stimulatory signal involving interaction of CD28 on the T cell with CD80 or CD86 (B7 family genes) on the antigen-presenting cell. CD28 activates a signal transduction pathway acting through PI-3K, Lck and Grb-2/ITK to provide its co-stimulatory signal for T cell activation. Another means to control T cell activation is by expressing factors that down-regulate T cell activation. Signaling by activated T cell receptors induces expression of CTLA-4, a receptor that opposes T cell activation. CTLA-4 has a higher affinity than CD28 for B7 proteins, terminating T cell activation. ICOS is a protein related to CD28 that is only expressed on activated T cells, and that provides another important co-stimulatory signal. The requirement for co-stimulatory signals provides additional control mechanisms that prevent inappropriate and hazardous T cell activation.","The gene cluster provided is primarily associated with the immune response, particularly T-cell activation and antigen presentation, which are crucial for adaptive immunity.\n\n1. **Cluster Identification and Biological Function:**\n   The gene cluster includes genes involved in T-cell receptor (TCR) signaling, co-stimulatory and inhibitory signaling, and antigen presentation. These processes are essential for initiating and regulating immune responses, ensuring that T-cells can properly recognize and respond to antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs).\n\n2. **Key Genes and Functions:**\n   Some genes in this cluster, such as CD3G, CD3E, CD3D, and CD247, encode components of the CD3 complex, which associates with the TCR and is necessary for T-cell activation and signal transduction. CD80 and CD86 encode proteins expressed on the surface of APCs, providing co-stimulatory signals to T-cells by interacting with CD28 or CTLA4, thereby influencing T-cell activation and regulation. CD28 provides positive co-stimulation necessary for T-cell activation and survival, while CTLA4 delivers an inhibitory signal, acting as a crucial immune checkpoint. ICOS and ICOSLG are involved in T-cell proliferation and cytokine production, with ICOS being a co-stimulatory receptor on T-cells and ICOSLG its ligand on APCs. IL2 is a cytokine crucial for T-cell proliferation and differentiation, often produced following TCR and co-stimulatory signals.\n\n   Other genes, such as HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, and HLA-DRB5, encode human leukocyte antigen (HLA) class II molecules, essential for presenting exogenous antigens to CD4+ T-cells. PIK3R1 and PIK3CA encode components of the phosphoinositide 3-kinase (PI3K) pathway, which is activated following TCR engagement and is involved in T-cell growth, survival, and metabolism. LCK and ITK are tyrosine kinases involved in TCR signaling; LCK is a key kinase that initiates signaling, whereas ITK is involved in further propagating the signal. PTPN11 (SHP-2) and GRB2 are involved in downstream signaling; SHP-2 is a phosphatase that modulates signaling, while GRB2 acts as an adaptor protein, linking receptor activation to downstream pathways.\n\n3. **Relationships Between Genes:**\n   The interaction between CD3, CD28, CTLA4, ICOS, and their ligands on APCs (such as CD80, CD86, and ICOSLG), alongside TCR and HLA engagement, illustrates the complexity of the immune synapse. PI3K, LCK, ITK, and downstream signaling molecules like PTPN11 and GRB2 orchestrate signal transduction leading to T-cell responses.\n\n4. **Regulatory Elements and Patterns:**\n   The balance of co-stimulatory and inhibitory signals, particularly involving CD28, CTLA4, and their ligands, is crucial for maintaining immune homeostasis and preventing autoimmunity.\n\n5. **Biological Implications:**\n   Additionally, this gene cluster is critical in immune function, with implications for autoimmunity, infection, and cancer. Dysregulation can lead to conditions such as autoimmune diseases or impaired immune responses. CTLA4, for instance, is a therapeutic target in cancer immunotherapy due to its role as an immune checkpoint.\n\nAll in all, while considerable knowledge exists regarding these genes, further research is required to fully understand their regulatory networks and contributions to various immune-related diseases.","The gene cluster of T cells plays a crucial role in the immune system by identifying and destroying infected cells or those undergoing abnormal replication. Some genes in this cluster code for the T cell receptor (TCR) complex, which recognizes specific antigens presented by antigen-presenting cells (APCs) and triggers T cell activation. Other genes include those responsible for the CD3 complex, made up of four different polypeptides: epsilon, gamma, delta, and zeta. Additionally, the zeta subunit facilitates the dimerization of the other subunits and ensures the association between the CD3 complex and the TCR. The CD3 complex also associates the TCR with protein tyrosine kinases Lck and Fyn, which are critical for the phosphorylation of the TCR and other proteins involved in T cell activation. All in all, this gene cluster is essential for T cell activation and function within the immune response."
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,"['F2', 'F2R', 'VWF', 'KNG1', 'FGB', 'PLAT', 'SERPIND1', 'MBL2', 'F3', 'F5', 'SERPINA1', 'PLAUR', 'F7', 'PLAU', 'F10', 'F9', 'TFPI', 'F8', 'KLKB1', 'CR2', 'MASP1', 'C9', 'A2M', 'CR1', 'F12', 'F13A1', 'F11', 'C8A', 'F13B', 'C7', 'C8G', 'C8B', 'CD59', 'SERPINA5', 'FGG', 'CD55', 'C6', 'C5AR1', 'C5', 'BDKRB1', 'C4BPB', 'C4BPA', 'C4B', 'C4A', 'BDKRB2', 'CFH', 'CFB', 'CPB2', 'CD46', 'PROS1', 'SERPINF2', 'PROC', 'FGA', 'SERPINE1', 'PLG', 'C2', 'SERPINC1', 'C1S', 'C3AR1', 'C3', 'C1QB', 'CFD', 'C1QA', 'C1R', 'C1QC', 'CFI', 'SERPING1', 'MASP2', 'THBD']",Complement and coagulation cascades,"Blood coagulation is a series of coordinated and calcium-dependent proenzyme-to-serine protease conversions likely to be localized on the surfaces of activated cells in vivo. It culminates in the formation of thrombin, the enzyme responsible for the conversion of soluble fibrinogen to the insoluble fibrin clot. The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). Kinin peptides are implicated in many physiological and pathological processes including the regulation of blood pressure and sodium homeostasis, inflammatory processes, and the cardioprotective effects of preconditioning. Complement is a system of plasma proteins that is activated by the presence of pathogens. There are three pathways of complement activation: the classical pathway, the lectin pathway, and the alternative pathway. All of these pathways generate a crucial enzymatic activity that, intern, generates the effector molecules of complement. The three main consequences of complement activation are the opsonization of pathogens, the recruitment of inflammatory and immunocompetent cells, and the direct killing of pathogens.","The gene cluster provided is primarily involved in the complex biological processes of coagulation (blood clotting) and the complement system, which play critical roles in innate immunity. These systems are closely linked and involve a series of proteolytic cascades fundamental to hemostasis and immune responses.\n\nSome genes in this cluster are part of the coagulation pathway. For instance, **F2 (Prothrombin)** encodes thrombin, a key protease in blood coagulation, while **F2R** is a thrombin receptor involved in the cellular effects of thrombin. Genes such as **F5, F7, F8, F9, F10, F11, F12, F13A1,** and **F13B** encode factors crucial in the cascade leading to fibrin clot formation. **VWF (Von Willebrand Factor)** is important for platelet adhesion and acts as a carrier of Factor VIII. The genes **FGB, FGA,** and **FGG** encode fibrinogen subunits that form the core of a blood clot. **PLAUR** and **PLAU** are plasminogen activators involved in the breakdown of clots. Natural anticoagulants such as **SERPINC1 (Antithrombin III), PROS1 (Protein S),** and **PROC (Protein C)** regulate the coagulation cascade, while **SERPINA1 (Alpha-1-antitrypsin)** and **SERPIND1 (Heparin cofactor II)** inhibit proteases in coagulation. **PLG (Plasminogen)** is the precursor to plasmin, a major enzyme in clot breakdown.\n\nOther genes are involved in the complement system. **C1QA, C1QB, C1QC, C1R,** and **C1S** encode components of the C1 complex that initiates the classical pathway. **C2, C3, C4A, C4B,** and **C4BP (C4 binding protein)** are components involved in complement activation and regulation. **CFB** and **CFD** are alternative pathway components, while **CFH** and **CFI** are regulators that prevent complement activation on host cells. **C5, C6, C7, C8A, C8B, C8G,** and **C9** form the membrane attack complex. **CR1** and **CR2** are complement receptors involved in immune complex clearance, and **CD59** inhibits the formation of the membrane attack complex. **CD55 (DAF)** and **CD46 (MCP)** are complement regulatory proteins on cell surfaces, and **SERPING1** inhibits C1 complex formation, controlling complement pathway activation.\n\nAdditionally, the kinin-kallikrein system is represented by genes such as **KLKB1**, which encodes plasma kallikrein involved in kinin generation from kininogen, and **KNG1**, which encodes kininogen, a precursor to kinins affecting blood pressure and inflammation. **BDKRB1** and **BDKRB2** are kinin receptors that mediate inflammatory responses. Regulatory and interacting elements include **SERPINE1 (PAI-1)**, which inhibits tissue plasminogen activator and regulates clot breakdown, **THBD** (Thrombomodulin), a receptor that modifies thrombin\u2019s activity, and **CPB2**, a carboxypeptidase inhibitor that modulates fibrinolysis.\n\nAll in all, this gene cluster underscores its essential role in maintaining hemostasis, controlling inflammation, and defending against pathogens. Dysregulation can lead to conditions such as thrombosis, angioedema, and autoimmune diseases. Understanding these genes\u2019 interactions and regulation is critical for therapeutic targeting in disorders like hemophilia, sepsis, and hereditary angioedema. However, further research is needed to uncover more specific gene interaction details and their implications in disease contexts.","The gene cluster known as the complement system is a major component of the innate immune system and plays a crucial role in the immediate response to microbial infection. Some genes in this cluster are involved in the activation of the complement system, leading to the cleavage of various important plasma proteins. This process results in the opsonization of bacteria, enhanced phagocytosis, and the lysis of cells. \n\nOther genes contribute to the pathways of complement activation: the classical pathway is triggered by antibody binding to foreign antigens, followed by activation through the C1 complex. The alternative pathway is initiated by the spontaneous hydrolysis of C3, subsequently forming a C3 convertase that activates the entire cascade. The lectin-mediated pathway is activated when mannan-binding protein (MBP) recognizes carbohydrates on bacterial surfaces, subsequently activating the C3 convertase.\n\nAdditionally, Factor XII is activated through a sequence involving prekallikrein (PK) and high molecular weight kininogen (HK), which are also activated by MBP. The thrombin generated in this process cleaves the inactive precursor C3 into C3a and C3b. C3b plays a role in forming the C5 convertase, which subsequently cleaves C5 into C3a and the biologically active fragments C5a and C5b. The formation of C3a and C5a activates the anaphylatoxins C3a and C5a, which recruit phagocytes to the infection site and enhance their phagocytic activity. \n\nAll in all, this gene cluster facilitates the opsonization of bacteria by C3b and the formation of the membrane attack complex (MAC) using C5b, ultimately resulting in the lysis of bacteria."
BIOCARTA_IL10_PATHWAY,"['IL1A', 'IL10', 'JAK1', 'TNF', 'STAT5A', 'STAT3', 'BLVRA', 'IL10RA', 'BLVRB', 'HMOX1', 'IL6', 'IL10RB', 'STAT1']",IL-10 Anti-inflammatory Signaling Pathway,"IL-10 is a cytokine with potent anti-inflammatory properties, repressing the expression of inflammatory cytokines such as TNF-alpha, IL-6 and IL-1 by activated macrophages. The IL-10 receptor is in the JAK/STAT class of receptors but activation of the JAK/STAT pathways by IL-10 does not appear on its own to be responsible for the anti-inflammatory properties of this cytokine. The anti-inflammatory actions of IL-10 appear to require induction of the enzyme heme oxygenase-1 (HO-1) through a map kinase pathway involving the p38 kinases. HO-1 is involved in the biosynthesis of heme, and catalyzes a reaction producing carbon monoxide, free iron, and the heme precursor biliverdin. HO-1 is induced by IL-10 and is also induced by oxidative stress. Blocking HO-1 with inhibitors or antisense blocks the anti-inflammatory actions of IL-10. The anti-inflammatory actions of HO-1 appear to be the result of signaling by carbon monoxide it produces since removal of CO blocks the anti-inflammatory action of IL-10 and HO-1. The anti-inflammatory actions of IL-10 may be therapeutically useful either directly or through modulation of HO-1 activity.","The gene cluster provided includes several key components of the cytokine signaling pathway, particularly focusing on interleukins, their receptors, and transcription factors that mediate cytokine signal transduction. This cluster is crucial for regulating inflammatory responses, immune system function, and cell signaling.\n\nSome genes in this cluster, such as **IL1A (Interleukin 1 Alpha)**, encode a pro-inflammatory cytokine involved in cellular activities like cell proliferation, differentiation, and apoptosis, playing a critical role in inflammatory processes and the acute-phase response. **IL10 (Interleukin 10)** is known for its anti-inflammatory properties, essential for limiting immune responses and preventing host tissue damage by inhibiting the synthesis of pro-inflammatory cytokines.\n\nOther genes include **Cytokine Receptors (IL10RA and IL10RB)**, which encode receptors for interleukin 10. These form a receptor complex necessary for IL10-mediated signal transduction, activating intracellular pathways that lead to IL10's anti-inflammatory effects. **TNF (Tumor Necrosis Factor Alpha)** is a major pro-inflammatory cytokine involved in systemic inflammation and the acute phase reaction, with roles in cell proliferation, differentiation, and apoptosis, promoting inflammatory conditions. **JAK1 (Janus Kinase 1)** is an essential kinase in the cytokine receptor signaling pathway, associating with receptors like those for IL10 and phosphorylating STAT proteins to activate them for gene expression influence.\n\nAdditionally, **STAT Proteins (STAT1, STAT3, STAT5A)** are transcription factors activated via phosphorylation by JAK kinases. STAT1 and STAT3 mediate responses to various cytokines and growth factors, influencing immune response and cell growth, while STAT5A is involved in growth hormone and prolactin responses, playing a role in hematopoiesis. **HMOX1 (Heme Oxygenase 1) and BLVRs (BLVRA and BLVRB)** are involved in heme metabolism, with HMOX1 catalyzing heme degradation, which can have anti-inflammatory effects, and BLVRA and BLVRB converting biliverdin to bilirubin, which has antioxidant properties. **IL6 (Interleukin 6)** is a cytokine with both pro-inflammatory and anti-inflammatory roles, involved in the acute inflammatory response and systemic effects like fever induction.\n\nAll in all, this gene cluster outlines a framework essential for managing inflammation and immune responses, crucial for overall health and disease management. The JAK-STAT pathway, prominently featuring JAK1 and STAT proteins, is critical for transmitting signals from IL10 and similar cytokines. Regulatory elements such as cytokines (IL10, IL1A, IL6, TNF) and their receptors influence immune homeostasis, with STAT3 and STAT1 mediating signal transduction. Imbalances in these pathways can lead to autoimmune diseases, chronic inflammation, or unchecked cell proliferation, underscoring their biological significance. There is a complex interplay where pro-inflammatory cytokines (like IL1A and TNF) and anti-inflammatory factors (like IL10) together maintain immune equilibrium. Understanding such interactions offers potential therapeutic targets for inflammatory and autoimmune conditions, though gaps remain in precisely how these elements are fine-tuned in various pathologies, highlighting a need for further research.","The gene cluster under discussion involves Interleukin 10 (IL-10), an anti-inflammatory cytokine known for inhibiting the production of pro-inflammatory cytokines and other immune mediators. Some genes in this cluster signal through a receptor complex that includes a subunit called IL-10RA, which is shared with IL-1ra, another anti-inflammatory cytokine; however, IL-10RA is necessary for signaling by IL-10 but not by IL-1ra. Other genes in this cluster involve the IL-10RA subunit, which is essential for forming a high-affinity receptor complex for IL-10 that includes the IL-10RB subunit. Additionally, the IL-10RA subunit is required for signaling by IL-2, a cytokine that induces the production of inflammatory mediators. Mice with a disrupted IL-10RA gene develop an inflammatory bowel disease similar to human ulcerative colitis. The anti-inflammatory activity of IL-10 may be partly responsible for its capability to inhibit tumor development and prevent atherosclerosis. Furthermore, IL-10 can inhibit the development of arthritis and autoimmune diabetes, which may also relate to its anti-inflammatory activity. The ability of IL-10 to inhibit the development of pulmonary fibrosis, arthritis, and autoimmune diabetes is also attributed to its anti-inflammatory properties. All in all, this gene cluster highlights the pivotal role of IL-10 in modulating inflammatory responses and its therapeutic potential in preventing various inflammatory and autoimmune conditions."
KEGG_ENDOCYTOSIS,"['F2R', 'EPN3', 'IQSEC1', 'IQSEC3', 'GRK3', 'GRK2', 'ADRB3', 'ADRB2', 'EPN2', 'STAMBP', 'ADRB1', 'IGF1R', 'CLTCL1', 'HGS', 'VPS37C', 'MVB12B', 'PIP4K2B', 'RUFY1', 'SMAP2', 'HLA-G', 'FLT1', 'STAM', 'MDM2', 'PIKFYVE', 'VPS37D', 'PIP5K1A', 'VPS28', 'CHMP2B', 'MVB12A', 'PIP5K1B', 'RAB11FIP1', 'ACAP1', 'ARRB2', 'AP2A2', 'GRK7', 'ARRB1', 'AP2B1', 'AP2A1', 'EEA1', 'GRK1', 'CSF1R', 'SMURF1', 'SH3GLB1', 'VPS4A', 'ARFGAP3', 'DNM2', 'HSPA8', 'VPS36', 'PARD6B', 'RAB31', 'RAB11A', 'TRAF6', 'CHMP4A', 'PDCD6IP', 'LDLR', 'PIP5K1C', 'NEDD4L', 'ACAP3', 'CHMP5', 'ARAP2', 'IQSEC2', 'HLA-F', 'MET', 'HLA-E', 'ARAP3', 'ASAP2', 'RAB11B', 'RAB11FIP5', 'RBSN', 'PDGFRA', 'AGAP1', 'DNM3', 'AGAP2', 'ARFGAP1', 'ARAP1', 'CHMP4B', 'CBLC', 'ACAP2', 'VPS25', 'RAB22A', 'EHD1', 'PLD1', 'PLD2', 'ITCH', 'CDC42', 'SH3GLB2', 'PARD6A', 'CHMP6', 'VTA1', 'RNF41', 'DNAJC6', 'ARF6', 'CHMP1B', 'PSD2', 'USP8', 'PSD4', 'WWP1', 'HLA-C', 'CXCR4', 'HLA-B', 'PRKCI', 'CXCR2', 'SH3GL3', 'CXCR1', 'TSG101', 'HLA-A', 'ERBB4', 'HSPA1L', 'HSPA1B', 'ERBB3', 'HSPA2', 'RAB11FIP4', 'SH3GL1', 'EPS15', 'DNM1L', 'HSPA1A', 'TFRC', 'SH3GL2', 'SMAP1', 'RAB11FIP2', 'FGFR2', 'KDR', 'KIT', 'FGFR4', 'GIT2', 'DNM1', 'FGFR3', 'LDLRAP1', 'RET', 'CCR5', 'PRKCZ', 'PSD3', 'ASAP3', 'HSPA6', 'RAB5C', 'DAB2', 'SMURF2', 'HRAS', 'CHMP3', 'VPS37A', 'EGFR', 'IL2RG', 'VPS37B', 'IL2RB', 'CBLB', 'CBL', 'PSD', 'NEDD4', 'EGF', 'PARD6G', 'SH3KBP1', 'ARFGAP2', 'RAB5B', 'RAB4A', 'EHD4', 'RAB5A', 'AP2S1', 'EHD2', 'IL2RA', 'EHD3', 'AP2M1', 'SNF8', 'SRC', 'VPS4B', 'STAM2', 'CHMP2A', 'GIT1', 'GRK6', 'RABEP1', 'VPS45', 'RAB11FIP3', 'CLTA', 'CLTB', 'CLTC', 'CHMP4C', 'GRK4', 'PARD3', 'GRK5', 'ASAP1', 'NTRK1', 'EPN1']",Endocytosis,"Endocytosis is a mechanism for cells to remove ligands, nutrients, and plasma membrane (PM) proteins, and lipids from the cell surface, bringing them into the cell interior. Transmembrane proteins entering through clathrin-dependent endocytosis (CDE) have sequences in their cytoplasmic domains that bind to the APs (adaptor-related protein complexes) and enable their rapid removal from the PM. In addition to APs and clathrin, there are numerous accessory proteins including dynamin. Depending on the various proteins that enter the endosome membrane, these cargoes are sorted to distinct destinations. Some cargoes, such as nutrient receptors, are recycled back to the PM. Ubiquitylated membrane proteins, such as activated growth-factor receptors, are sorted into intraluminal vesicles and eventually end up in the lysosome lumen via multivesicular endosomes (MVEs). There are distinct mechanisms of clathrin-independent endocytosis (CIE) depending upon the cargo and the cell type.","The gene cluster provided is predominantly associated with intracellular trafficking, particularly focusing on endocytosis and vesicular transport. Some genes in this cluster play key roles in the coordinated process of vesicle formation, recycling, and signaling at the cellular membrane, which are important aspects of maintaining cellular homeostasis and responding to external stimuli. Other genes are involved in regulating the trafficking of specific endosomal and lysosomal compartments.\n\n### Biological Function:\nThe primary biological function of this gene cluster is to regulate and facilitate endocytosis, vesicular transport, and receptor-mediated signaling. These processes are essential for cell communication, nutrient uptake, and receptor recycling.\n\n### Key Genes and Functions:\n1. **EGFR (Epidermal Growth Factor Receptor)**: A critical receptor tyrosine kinase involved in cell growth and proliferation, which undergoes endocytosis upon ligand binding.\n2. **AP2 Complex (AP2A1, AP2A2, AP2B1, AP2M1, AP2S1)**: A heterotetrameric protein complex crucial for clathrin-mediated endocytosis by aiding in the recognition and internalization of cargo.\n3. **Clathrins (CLTA, CLTB, CLTC)**: Key structural proteins that form the clathrin coat around budding vesicles, essential for trafficking between intracellular compartments.\n4. **Rab Proteins (RAB4A, RAB5A, RAB11A, RAB5B, RAB5C, RAB22A, RAB31)**: Small GTPases that regulate various steps of vesicular transport and fusion within the endocytic pathway.\n5. **Caveolins and Endophilins (CAV1, CAV2, EPN1, EPN2, EPN3)**: Involved in caveolae formation and non-clathrin mediated endocytosis, impacting signal transduction and lipid regulation.\n6. **GRKs (G Protein-Coupled Receptor Kinases - GRK2, GRK3, etc.)**: Kinases involved in the desensitization and internalization of GPCRs (G Protein-Coupled Receptors).\n\n### Inter-gene Relationships:\n- **Rab and AP2 Interaction**: Rab proteins, such as RAB5 and RAB11, often act in concert with adaptor proteins like the AP2 complex to regulate vesicle budding and fusion with the target membrane.\n- **Clathrin and AP2 Complex**: The clathrin proteins directly interact with the AP2 complex to drive the formation of coated pits, emphasizing their synergy in endocytosis.\n- **SMURF1, SMURF2 (SMAD Specific E3 Ubiquitin Protein Ligases)**: These enzymes facilitate the ubiquitination and subsequent degradation of receptors, highlighting the link between signal propagation and vesicular trafficking.\n\n### Regulatory Elements and Patterns:\nSeveral of these genes are involved in feedback loops and regulatory pathways to ensure tight control over processes such as receptor recycling and degradation. For instance, ubiquitination patterns modulated by enzymes like SMURF1 and ITCH regulate receptor endocytosis.\n\n### Biological Implications:\nThis cluster's efficient functioning is crucial for maintaining cellular communication networks and adapting to environmental changes. Dysregulation in genes from this cluster could result in pathologies such as cancer (EGFR overactivity), metabolic disorders, and immune system dysregulation due to improper receptor turnover (e.g., integrins, cytokine receptors).\n\nAll in all, this gene cluster cohesively supports the fundamental process of endocytosis and vesicular trafficking, with far-reaching implications in cell signaling and homeostasis. Understanding these interactions provides insights into targeted therapeutic strategies, particularly in diseases where these processes are disrupted.","The gene cluster G-protein-coupled receptors (GPCRs) comprises a large family of cell surface receptors that respond to a diverse array of extracellular stimuli, including neurotransmitters, hormones, odorants, tastants, light, and lipids. Some genes in this cluster, upon agonist activation, catalyze the exchange of GDP for GTP on heterotrimeric G proteins, which in turn activate a variety of downstream effectors such as adenylyl cyclase and phospholipase C, generating second messengers like cAMP and IP3. Other genes are involved in terminating GPCR signaling through multiple mechanisms, including receptor desensitization mediated by G protein-coupled receptor kinases (GRKs) and arrestins. Additionally, GRKs and arrestins act as adaptor proteins to mediate the internalization of GPCRs. Once internalized, GPCRs can be either rapidly recycled to the plasma membrane or targeted to lysosomes for degradation. All in all, this gene cluster orchestrates complex signaling pathways and regulatory mechanisms essential for cellular responses to external signals."
BIOCARTA_BCR_PATHWAY,"['MAPK3', 'HRAS', 'NFATC4', 'CD79B', 'VAV1', 'MAPK8', 'MAP2K1', 'RAF1', 'BTK', 'ELK1', 'PLCG1', 'CALM1', 'NFATC2', 'SYK', 'RAC1', 'SHC1', 'PPP3CA', 'NFATC3', 'GRB2', 'PRKCB', 'CALM2', 'MAPK14', 'LYN', 'PPP3CB', 'CALM3', 'PRKCA', 'NFATC1', 'CD79A', 'MAP3K1', 'JUN', 'SOS1', 'FOS', 'PPP3CC']",BCR Signaling Pathway,"Significant progress has been made towards delineation of the intrinsic molecular processes that regulate B lymphocyte immune function. Recent observations have provided a clearer picture of the interactive signaling pathways that emanate from the mature B cell antigen receptor (BCR) complex and the different precursor complexes that are expressed during development. Studies have also revealed that the net functional response to a given antigenic challenge is affected by the combined action of BCR-dependent signaling pathways, as well as those originating from various coreceptors expressed by B cells (e.g. CD19, CD22, FcgRIIb and PIR-B). It is now well established that reversible tyrosine phosphorylation plays an important role in regulating B cell biology. In particular, binding of antigen to the BCR promotes the activation of several protein tyrosine kinases (PTK) that, in conjunction with protein tyrosine phosphatases (PTP), alter the homeostasis of reversible tyrosine phosphorylation in the resting B cell. The net effect is a transient increase in protein tyrosine phosphorylation that facilitates the phosphotyrosine dependent formation of effector protein complexes, promotes targeting of effector proteins to specific microenvironments within the B cell and initiates the catalytic activation of downstream effector proteins. Studies have demonstrated that Src family PTKs are activated initially and serve to phosphorylate CD79a and CD79b thereby creating phosphotyrosine motifs that recruit downstream signaling proteins. In particular, phosphorylation of the BCR complex leads to the recruitment and activation of the PTK Syk, which in turn promotes phosphorylation of PLCg, Shc and Vav. Additionally, the Tec family member Btk is recruited to the plasma membrane where it is involved in activation of PLCg. Initiation of B lymphocyte activation is dependent on the tyrosine phosphorylation-dependent formation of multi-molecular effector protein complexes that activate downstream signaling pathways. The formation of such complexes was initially hypothesized to occur primarily via effector protein binding to the BCR complex itself. However, recent studies have demonstrated that productive signaling via the BCR is in fact dependent on tyrosine phosphorylation of one or more adapter proteins that play a crucial role in recruitment and organization of effector proteins at the plasma membrane. The SLP-65/BLNK adapter protein has recently been shown to play a crucial role in recruitment and activation of key signal transducing effector proteins in the B cell. After the BCR has been engaged by antigen and the activation response has been initiated, numerous second messengers and intermediate signal transducing proteins are activated. These include the production of lipid second messengers by phosphatidylinositol 3-kinase, and the PLC-dependent hydrolysis of phosphatidylinositol 4,5-bisphosphate to yield diacylglycerol and 1,4,5-inositoltrisphosphate (IP3). DAG is important for activation of PKC whereas IP3 promote release of calcium from the endoplasmic reticulum and the subsequent influx Ca2+ from the extracellular space. Numerous intermediate signaling proteins are also activated including the Ras and Rap1, which are small molecular weight GTPases and these ultimately lead to the activation of MAP kinases including Erk, JNK and p38. The net effect of second messenger production and activation of intermediate signaling proteins is the concerted regulation of several transcription factors that mediate gene transcription in the B cell.","The gene cluster provided is involved in the MAPK/ERK pathway, which is crucial for transmitting signals from extracellular stimuli to the cell nucleus, ultimately influencing cell proliferation, differentiation, and survival. This cluster is essential in various cellular processes and is often linked to cancer, immune responses, and developmental signaling.\n\nSome genes in this cluster are key components of the MAPK pathway, including MAPK3 (ERK1), MAPK8 (JNK1), MAPK14, and MAP2K1 (MEK1), which are central to the MAPK signaling cascade, activating downstream effectors that drive transcriptional responses. RAF1 acts upstream as a serine/threonine kinase that activates MEK1/MEK2, leading to the activation of ERK1/ERK2, while MAP3K1 is an upstream kinase that can modulate different MAPK modules.\n\nOther genes serve as adaptor and regulatory proteins, such as GRB2 and SOS1, which facilitate signal transduction from receptor tyrosine kinases to Ras, thereby initiating the MAPK cascade. SHC1 and VAV1 act as scaffolding proteins to stabilize interactions between the receptors and downstream signaling molecules, and HRAS is a small GTPase central in coupling receptors to the RAF-MEK-ERK pathway.\n\nAdditionally, the cluster includes genes involved in phospholipase and calcium signaling, such as PLCG1, which catalyzes the generation of inositol trisphosphate, causing calcium release from the endoplasmic reticulum. CALM1, CALM2, and CALM3 (Calmodulin) are calcium-binding proteins that modulate various enzymes and signaling pathways. Transcription factors like ELK1, JUN, and FOS are immediate-early transcription factors activated by ERK, regulating genes involved in cell cycle progression and survival. The NFATC family (NFATC1, NFATC2, NFATC3, NFATC4) translocates to the nucleus upon dephosphorylation by calcineurin and regulates immune response genes.\n\nProteins in B-cell receptor signaling, such as CD79A, CD79B, and SYK, are part of the B-cell receptor complex and play key roles in B-cell activation and development. BTK and LYN are essential in the signaling pathways downstream of the B-cell receptor. Protein kinase C isoforms, including PRKCA and PRKCB, mediate various downstream effects of receptor-mediated signal transduction, including regulation of gene expression. Calcineurin subunits PPP3CA, PPP3CB, and PPP3CC are critical phosphatases involved in the activation of NFAT transcription factors.\n\nThe interplay among these gene products orchestrates a finely tuned response to external stimuli. The kinases (RAF, MEK, ERK) primarily propagate mitogenic signals, while the NFAT family integrates signals for immune response modulation. Calcium and phosphatidylinositol signaling, along with calmodulin and calcineurin, further refine these pathways by integrating various signals to fine-tune the cellular response. An important regulatory theme in this gene cluster is the feedback inhibition to prevent overactivation, which is often dysregulated in cancer and autoimmune diseases.\n\nAll in all, this gene cluster orchestrates complex signal transduction networks essential for critical cellular functions. Dysregulation of this cluster is implicated in various cancers due to its role in cell proliferation and survival. Furthermore, components like NFAT play critical roles in immune cell activation and differentiation, while the balance and timing of these signaling events are crucial for normal immune function and preventing disorders like autoimmunity. Future research into specific interactions and regulatory mechanisms within this cluster could unlock new therapeutic targets for cancers and immune-related diseases.","The gene cluster BCR-ABL encodes a chimeric protein known for its deregulated tyrosine kinase activity. Some genes in this cluster play a role as the causative agents in Philadelphia chromosome-positive (+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Other genes within this cluster are involved in transforming cells by stimulating proliferation and inhibiting apoptosis. Additionally, the activation of multiple signaling pathways, such as Ras, PI 3-kinase, and Stat5, contributes to BCR-ABL-mediated transformation. Lyn, a Src family kinase activated by BCR-ABL, also aids in transformation. The activation of Stat5 by BCR-ABL is essential for transformation, with Lyn and Stat5 further activating each other through a positive feedback loop. All in all, this gene cluster is critical in the transformation processes associated with certain leukemias due to its activation of key signaling pathways and interactions with proteins like Lyn and Stat5."
KEGG_CITRATE_CYCLE_TCA_CYCLE,"['IDH3B', 'DLST', 'PCK2', 'CS', 'PDHB', 'PCK1', 'PDHA1', 'PDHA2', 'SUCLG2P2', 'FH', 'SDHD', 'OGDH', 'SDHB', 'IDH3A', 'SDHC', 'IDH2', 'IDH1', 'ACO1', 'ACLY', 'MDH2', 'DLD', 'MDH1', 'DLAT', 'OGDHL', 'PC', 'SDHA', 'SUCLG1', 'SUCLA2', 'SUCLG2', 'IDH3G', 'ACO2']",Citrate cycle (TCA cycle),"The citrate cycle (TCA cycle, Krebs cycle) is an important aerobic pathway for the final steps of the oxidation of carbohydrates and fatty acids. The cycle starts with acetyl-CoA, the activated form of acetate, derived from glycolysis and pyruvate oxidation for carbohydrates and from beta oxidation of fatty acids. The two-carbon acetyl group in acetyl-CoA is transferred to the four-carbon compound of oxaloacetate to form the six-carbon compound of citrate. In a series of reactions two carbons in citrate are oxidized to CO2 and the reaction pathway supplies NADH for use in the oxidative phosphorylation and other metabolic processes. The pathway also supplies important precursor metabolites including 2-oxoglutarate. At the end of the cycle the remaining four-carbon part is transformed back to oxaloacetate. According to the genome sequence data, many organisms seem to lack genes for the full cycle , but contain genes for specific segments.","The gene cluster primarily involves the tricarboxylic acid (TCA) cycle, also known as the Krebs cycle or citric acid cycle. This metabolic pathway is crucial for cellular respiration in eukaryotic cells, where it oxidizes acetyl-CoA to carbon dioxide and generates energy-rich molecules such as NADH, FADH2, and ATP. These molecules are subsequently used in the electron transport chain to produce ATP, the primary energy currency of the cell.\n\nSome genes in this cluster include IDH1, IDH2, IDH3A, IDH3B, and IDH3G, which encode isocitrate dehydrogenases responsible for catalyzing the oxidative decarboxylation of isocitrate to alpha-ketoglutarate. IDH3 operates in an NAD+-dependent manner in the mitochondria, while IDH1 and IDH2 are NADP+-dependent and function in the cytosol and mitochondrial matrix, respectively. DLST and DLD are components of the 2-oxoglutarate dehydrogenase complex, critical for converting alpha-ketoglutarate into succinyl-CoA. ACO1 and ACO2 catalyze the isomerization of citrate to isocitrate via cis-aconitate. CS catalyzes the first step of the TCA cycle, converting oxaloacetate and acetyl-CoA to citrate. SDHA, SDHB, SDHC, and SDHD form the succinate dehydrogenase complex, involved in both the TCA cycle and the electron transport chain, converting succinate to fumarate and transferring electrons to coenzyme Q. MDH1 and MDH2 are responsible for the reversible oxidation of malate to oxaloacetate, utilizing NAD+. FH catalyzes the hydration of fumarate to malate. OGDH and OGDHL are isoforms converting alpha-ketoglutarate to succinyl-CoA. PDHA1, PDHA2, PDHB, and DLAT form the pyruvate dehydrogenase complex, converting pyruvate to acetyl-CoA, linking glycolysis and the TCA cycle. SUCLG1, SUCLA2, and SUCLG2 form succinyl-CoA synthetase, converting succinyl-CoA to succinate, generating GTP or ATP. PC catalyzes the carboxylation of pyruvate to oxaloacetate, an important anaplerotic reaction to replenish TCA cycle intermediates. PCK1 and PCK2 are involved in gluconeogenesis, converting oxaloacetate to phosphoenolpyruvate, with PCK2 localized to the mitochondrion.\n\nOther genes in the cluster are involved in the regulation and feedback mechanisms of the TCA cycle. The cycle is tightly regulated by substrate availability and feedback inhibition from its products, primarily ATP and NADH. Several key genes, including those encoding pyruvate dehydrogenase components, are subject to transcriptional regulation and allosteric feedback mechanisms to maintain metabolic balance. The SDH complex has dual roles in the TCA cycle and oxidative phosphorylation, linking metabolism to energy production.\n\nAdditionally, defects in genes of the TCA cycle are implicated in various metabolic disorders and cancers, highlighting their essential role in energy metabolism. The TCA cycle intermediates act as precursors for biosynthetic pathways, linking energy production to biosynthesis.\n\nAll in all, this gene cluster emphasizes its central role in cellular metabolism, particularly in energy generation and metabolic flux through the TCA cycle and related pathways. Understanding the regulation and interconnections of these genes provides significant insights into metabolic dysfunctions and potential therapeutic targets for disease intervention.","The gene cluster for the tricarboxylic acid (TCA) cycle represents a major pathway responsible for the oxidation of acetyl-CoA, which is derived from carbohydrates, fats, and proteins. Some genes in this cluster are involved in the initial step of the cycle, where oxaloacetate and acetyl-CoA condense to form citrate. Other genes facilitate the subsequent eight steps, leading to the production of succinyl-CoA, which combines with oxaloacetate to form succinate. Additionally, succinate is converted to fumarate, which is further processed to form malate and finally pyruvate. \n\nThe oxidation of pyruvate to acetyl-CoA completes the cycle, and this conversion is catalyzed by pyruvate dehydrogenase (PDH), whereas the conversion of pyruvate to acetyl-CoA is also catalyzed by pyruvate carboxylase (PC). The TCA cycle functions as a central metabolic pathway, oxidizing acetyl-CoA to carbon dioxide and water. It serves as the primary source of reducing equivalents, NADH and FADH2, which are essential for the electron transport chain and ATP synthesis. The cycle occurs in the mitochondrial matrix and is markedly compartmentalized, with the enzymes residing in distinct mitochondrial compartments.\n\nThese enzymes are organized into two main complexes: the alpha-ketoglutarate dehydrogenase (KGDHC) complex and the pyruvate dehydrogenase (PDH) complex. The KGDHC complex facilitates the conversion of alpha-ketoglutarate to succinyl-CoA, which is then converted to succinate by succinyl-CoA ligase. The activities of both the KGDHC and PDH complexes are regulated by various factors, including substrate and product concentrations, ATP and NADH levels, and the concentration of key metabolites like acetyl-CoA and Coenzyme A (CoA).\n\nAll in all, this gene cluster governs a pivotal metabolic pathway that efficiently oxidizes acetyl-CoA and produces essential reducing agents, demonstrating strong compartmentalization within the mitochondrial matrix for optimized functionality."
BIOCARTA_G2_PATHWAY,"['CDC25C', 'CCNB1', 'CHEK1', 'YWHAQ', 'GADD45A', 'RPS6KA1', 'CDC25B', 'BRCA1', 'YWHAH', 'WEE1', 'ATR', 'MYT1', 'CHEK2', 'ATM', 'CDKN1A', 'CDKN2D', 'TP53', 'CDC25A', 'MDM2', 'PRKDC', 'CDC34', 'EP300', 'PLK1', 'CDK1']",Cell Cycle: G2/M Checkpoint,"The G2/M DNA damage checkpoint prevents the cell from entering mitosis (M phase) if the genome is damaged. The Cdc2-cyclin B kinase is pivotal in regulating this transition. During G2 phase, Cdc2 is maintained in an inactive state by the kinases Wee1 and Mt1. As cells approach M phase, the phosphatase Cdc25 is activated, perhaps by the polo-kinase Pik1. Cdc25 then activates Cdc2, establishing a feedback amplification loop that efficiently drives the cell into mitosis. DNA damage activates the DNA-PK/ATM/ATR kinases, initiating two parallel cascades that inactivate Cdc2-cyclin B. The first cascade rapidly inhibits progression into mitosis: the CHK kinases phosphorylate and inactivate Cdc25, which can no longer activate Cdc2. The second cascade is slower. Phosphorylation of p53 dissociates it from MDM2, activating its DNA binding activity. Acetylation by p300/PCAF further activates its transcriptional activity. The genes that are turned on by p53 constitute effectors of this second cascade. They include 14-3-3s, which binds to the phosphorylated Cdc2-cyclin B kinase and exports it from the nucleus; GADD45, which apparently binds to and dissociates the Cdc2-cyclin B kinase; and p21Cip1, an inhibitor of a subset of the cyclin-dependent kinases including Cdc2 (CDK1).","The gene cluster presented encompasses a significant set of genes involved primarily in cell cycle regulation, DNA damage response, and cellular stress response, with a strong emphasis on the G2/M transition, checkpoint control, and subsequent DNA repair mechanisms.\n\nSome genes in this cluster are crucial for cell cycle regulation, particularly the G2/M transition. Cyclin B1 (CCNB1) and Cyclin-Dependent Kinase 1 (CDK1) are pivotal for this transition, forming a complex that triggers the onset of mitosis. The CDC25 family (CDC25A, CDC25B, CDC25C) includes phosphatases that activate CDK1 by removing inhibitory phosphates, effectively promoting cell cycle progression.\n\nOther genes are involved in checkpoint regulation and DNA damage response. Checkpoint kinases (CHEK1, CHEK2) are crucial components of the DNA damage response, with CHEK1 primarily involved in the ATR-mediated checkpoint and CHEK2 participating in ATM signaling. ATM and ATR are central to detecting DNA damage, with ATM responding mainly to double-strand breaks and ATR to replication stress. Tumor Protein p53 (TP53) acts as a critical transcription factor activated upon DNA damage, inducing cell cycle arrest or apoptosis. GADD45A is involved in p53-mediated DNA repair and cell cycle arrest. WEE1 and MYT1 are kinases that phosphorylate and inactivate CDK1, delaying cell cycle progression to allow DNA repair.\n\nAdditionally, gene regulation and apoptosis are influenced by MDM2, a negative regulator of p53 that ubiquitinates and promotes its degradation, modulating its activity in apoptosis and cell cycle regulation. E1A Binding Protein P300 (EP300) acts as a transcriptional co-activator with p53, modifying chromatin structure and facilitating the transcription of p53 target genes.\n\nDNA repair and maintenance are supported by BRCA1, essential for the repair of DNA double-strand breaks, aligning with checkpoint function, and PRKDC, which encodes the catalytic subunit of DNA-PK, essential for non-homologous end joining, another form of DNA repair.\n\nRegulatory and interaction patterns are evident with 14-3-3 proteins (YWHAQ, YWHAH), which bind to phosphorylated CDC25C, preventing its premature activation, showing a regulatory checkpoint mechanism. Cyclin-Dependent Kinase Inhibitors (CDKN1A/p21, CDKN2D/p19) play roles in halting the cell cycle in response to DNA damage, with p21 being a direct transcriptional target of p53.\n\nThe biological implications of this gene cluster ensure genomic integrity by either halting the cell cycle for repair or inducing apoptosis if the damage is irreparable. Disruptions in this cluster are commonly associated with cancer pathogenesis due to unchecked cellular proliferation and survival despite genomic insults. Understanding the intricate balance and regulation of this gene cluster further aids in developing therapeutic targets, especially in oncology, where restoring proper checkpoint function can enhance the efficacy of treatments like chemotherapy and radiation.\n\nAll in all, while substantial progress has been made in understanding individual roles of these genes, fully elucidating their interactions in a cellular context remains an area of ongoing research. Moreover, the impact of specific mutations or polymorphisms in these genes on disease susceptibility and treatment response warrants further investigation.","The gene cluster involved in the cell cycle is a highly conserved set of events that occur in a cell to create two daughter cells. Some genes in this cluster regulate a complex set of proteins that interact to create a cell that is either in the G1 phase, S phase, or G2/M phase. Other genes regulate the phases of the cell cycle: the G1 phase, where the cell is no longer able to repair DNA damage and prepares to enter the S phase; the S phase, where the cell completes DNA replication; and the G2/M phase, where the cell is no longer able to separate its chromosomes and divide. Additionally, checkpoint proteins regulate the cell cycle, providing time for DNA repair before progression. These checkpoint proteins include tumor suppressor proteins, such as p53 and BRCA1, which play roles in the G1/S and G2/M checkpoints. Checkpoint kinases, ATM, and ATR, also respond to DNA damage by halting the cell cycle. All in all, this gene cluster ensures proper cell cycle regulation, responding to DNA damage to maintain genomic integrity."
BIOCARTA_RAB_PATHWAY,"['ACTA1', 'RAB7A', 'RAB3A', 'RAB4A', 'RAB1A', 'RAB11A', 'RAB2A', 'RAB5A', 'RAB9A', 'RAB6A', 'RAB6C', 'RAB8A', 'RAB27A']",Rab GTPases Mark Targets In The Endocytotic Machinery,"The eukaryotic cell contains compartments with distinct functions bounded by lipid bilayer membranes. The movement of membrane vesicles between these compartments allows proteins in the secretory pathway to move outward from the endoplasmic reticulum (ER) to the Golgi, trans Golgi network (TGN), secretory vesicles, and the plasma membrane and to be secreted into the extracellular environment. The trafficking of membrane vesicles is also essential for endocytosis and the movement of material from the extracellular environment into the early endosome (EE), late endosome (LE) and lysosome. The movement of vesicles and their contents between these compartments and their secretion are essential for a host of cellular functions, including the release of neurotransmitters and hormones. The movement of membrane vesicles between all of these compartments is regulated by members of the Rab family of GTPases, part of the ras superfamily of genes, regulated through binding of GTP and hydrolysis of bound GTP to GDP. At least eleven yeast genes in this family have been identified as Ypts, yeast transport proteins, and over sixty mammalian Rab genes have been identified in this highly conserved gene family. The products of the Rab genes regulate specific steps in vesicle transport. Rab1 is involved in the movement of membranes from the ER through the Golgi. Rab3 regulates secretory vesicle release and Rab27 is also involved in regulated release of secreted proteins. Rab5, 7 and 9 contribute to endocytosis while Rab4 and Rab11 mediate recycling from the endosome back to the plasma membrane. Rab11 is involved in both endocytosis and exocytosis. As with other Ras family GTPases, the activity of Rabs is regulated by guanine-nucleotide exchange factors (GEFs) and GAPs (GTPase activating proteins). Downstream effectors must also interact with Rabs to transmit their signals regulating each step of the membrane trafficking pathways including vesicle formation, movement of vesicles between compartments, vesicle docking, fusion and membrane remodeling. Downstream effectors of the Rabs include Rabphilin-3 (vesicle movement effector for Rab3), Rabphilin-11 (vesicle formation effector for Rab11), and EEA1 (vesicle fusion and membrane remodeling). If Rabs are involved in more than one role and other components of Rab signaling also interact with more than one Rab this will further increase the complexity of the system. Elucidating the interaction of Rabs and regulation of vesicle trafficking by other signaling pathways will be a key area of research in the future.","The gene cluster primarily centers around the RAB protein family, which comprises small GTPases belonging to the Ras superfamily and is crucial for regulating intracellular vesicle trafficking. Some genes in this cluster, such as RAB7A, RAB3A, RAB4A, RAB5A, RAB11A, RAB1A, and RAB9A, encode proteins that regulate various aspects of endocytosis, exocytosis, and membrane trafficking within eukaryotic cells. Each RAB protein localizes to specific membrane compartments, directing vesicle transport and fusion events, which are essential for maintaining cellular organization and function. \n\nOther genes, like ACTA1, encode alpha-actin, which is central to muscle contraction but somewhat peripheral to the core RAB-centric functions. Additionally, RAB proteins typically act in concert with other accessory proteins and effector molecules, including GTPase-activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs), to finely tune their activity. The balance between their GTP-bound (active) and GDP-bound (inactive) forms is crucial for their function.\n\nAll in all, this gene cluster is critical for cellular homeostasis, with mutations or dysregulation in these RAB genes leading to a wide range of diseases. For instance, defects in RAB7A are linked to Charcot-Marie-Tooth disease type 2B, a neurological disorder. The overall integrity of vesicular trafficking pathways regulated by this RAB cluster has implications in fields such as neurobiology, cancer, and metabolic diseases. However, while the significance of individual RAB proteins is well-characterized, the coordinated regulation of multiple RAB proteins within this cluster, especially in a communal shared pathway or regulation, remains less understood. Further research is required to elucidate the interplay between these GTPases and identify potential comprehensive regulatory networks among them.","The gene cluster Rab GTPases is a family of small GTPases that regulate intracellular membrane traffic. Some genes in this cluster are localized to specific intracellular membranes and function as molecular switches, cycling between GTP- and GDP-bound states. Other genes within the cluster are associated with different membrane compartments in their GTP- and GDP-bound forms, with the conversion between these forms being regulated by GDP / GTP exchange factors (GEFs) and GTPase activating proteins (GAPs). Additionally, GEFs stimulate the release of GDP for the subsequent binding of GTP, while GAPs promote the hydrolysis of GTP to GDP. The activated Rab proteins then interact with various downstream effectors to control intracellular membrane traffic. The Rab GTPases are classified into four groups based on sequence homology: RAB1, RAB2, RAB3, and RAB5. Each group consists of several members, each localized to specific intracellular membranes. The RAB1 group includes RAB1B, RAB11B, RAB1A, and RAB1C, which are localized to the ER / Golgi intermediate compartment (ERGIC) and regulate ER to Golgi transport. The second group, RAB2, includes RAB2A, RAB2B, and RAB2C, and is localized to the Golgi, managing transport from the Golgi to the plasma membrane. The RAB3 group includes RAB3A, RAB3B, and RAB3D, found in synaptic vesicles, regulating exocytosis. Lastly, the RAB4 group includes RAB4A, RAB4B, RAB4B, and RAB4C, which are localized to early endosomes, facilitating early endosome to late endosome transport. All in all, this gene cluster plays a crucial role in the regulation of intracellular membrane traffic through various subcellular localizations and functions."
BIOCARTA_NKCELLS_PATHWAY,"['MAPK3', 'PTPN6', 'IL18', 'VAV1', 'PIK3R1', 'MAP2K1', 'HLA-A', 'SYK', 'RAC1', 'PAK1', 'PTK2B', 'KLRC1', 'B2M', 'PIK3CA', 'KLRD1', 'KLRC2', 'LAT', 'ITGB1', 'KLRC3', 'KLRC4']",Ras-Independent pathway in NK cell-mediated cytotoxicity,"NK (natural killer) cells are lymphocytes distinct from B and T cells that induce perforin-mediated lysis of tumor cells and virus-infected cells. NK cell-mediated cytotoxicity is activated by glycoproteins on the cell surface (activating receptors) and inhibited by MHC-1 with self-peptide bound. The MHC-1 inhibitory signal through Ig-family or lectin receptors prevents NK cells from killing normal cells. Abnormal MHC-1 expression in infected or tumor cells results in the release of perforin, the lysis of the abnormal cell and the release of cytokines that stimulate the immune response. MAP kinase inhibitors but not ras inhibitors are able to block NK cell cytotoxicity, indicating that the pathway can function by a ras-independent manner that involves the MAP kinase pathway. This pathway includes phosphoinositide-3-kinase (PI3K) as a key component, followed by Rac1 and the exchange factor Vav. The tyrosine kinase SYK and LAT may provide an additional pathway for activation of MAP kinases leading to NK cell activation, and also Pyk-2 activation by integrins. The protein tyrosine phosphatase SHP-1 appears to mediate the cytotoxicity inhibitory signal that blocks lysis of normal cells. The balance of these positive and negative signaling pathways regulates the role of NK cells in the immune response.","The gene cluster provided is primarily involved in immune signaling and cellular response pathways, with a significant focus on the regulation of immune cell activation and signal transduction. Some genes in this cluster are integral to the MAPK/ERK pathway, PI3K/AKT signaling, and immune cell receptor signaling, highlighting their roles in immune response modulation and cellular communication.\n\n### Key Genes and Functions:\n\n1. **MAPK3 (Mitogen-Activated Protein Kinase 3)** and **MAP2K1 (Mitogen-Activated Protein Kinase Kinase 1)**: These genes encode proteins that are part of the MAPK/ERK signaling pathway, crucial for transmitting signals from the cell surface to the DNA in the cell nucleus, affecting cell division, differentiation, and response to stress.\n\n2. **PTPN6 (Protein Tyrosine Phosphatase, Non-Receptor Type 6)**: Also known as SHP-1, this gene encodes a phosphatase that negatively regulates signaling pathways in hematopoietic cells, playing a critical role in immune cell signaling and homeostasis.\n\n3. **IL18 (Interleukin 18)**: This cytokine is involved in inducing cell-mediated immunity following infection, particularly by stimulating the production of interferon-gamma (IFN-\u03b3) in T cells and natural killer (NK) cells.\n\n4. **VAV1**: A guanine nucleotide exchange factor involved in transducing signals from the T-cell receptor (TCR) and B-cell receptor (BCR), crucial for lymphocyte development and activation.\n\n5. **PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1)** and **PIK3CA (Phosphoinositide-3-Kinase Catalytic Subunit Alpha)**: These genes are part of the PI3K/AKT signaling pathway, essential for cell growth, proliferation, and survival.\n\n6. **HLA-A** and **B2M (Beta-2-Microglobulin)**: These genes are involved in the presentation of peptide antigens to the immune system, playing a critical role in the adaptive immune response.\n\n7. **SYK (Spleen Associated Tyrosine Kinase)**: A key player in the signaling pathways of immune cells, particularly in B-cell receptor signaling and innate immune responses.\n\n8. **RAC1 (Ras-Related C3 Botulinum Toxin Substrate 1)** and **PAK1 (p21-Activated Kinase 1)**: These genes are involved in the regulation of the cytoskeleton, cell migration, and cell cycle progression.\n\n9. **PTK2B (Protein Tyrosine Kinase 2 Beta)**: Also known as PYK2, this gene is involved in signaling pathways that regulate cell adhesion and migration, particularly in immune cells.\n\n10. **KLRC1, KLRD1, KLRC2, KLRC3, KLRC4**: These genes encode killer cell lectin-like receptors, which are involved in the regulation of NK cell activity and play a role in the recognition of infected or transformed cells.\n\n11. **LAT (Linker for Activation of T cells)**: A critical adaptor protein in T-cell receptor signaling, essential for T-cell activation and function.\n\n12. **ITGB1 (Integrin Subunit Beta 1)**: This gene encodes a protein that is part of the integrin family, involved in cell adhesion and signal transduction.\n\n### Relationships and Regulatory Elements:\n\nAdditionally, the MAPK/ERK and PI3K/AKT pathways are interconnected, with cross-talk that modulates cell survival, proliferation, and differentiation. PTPN6 acts as a negative regulator, ensuring that immune responses are appropriately controlled to prevent overactivation. The HLA-A and B2M genes are crucial for antigen presentation, a fundamental process for adaptive immunity. The KLRC and KLRD genes are involved in the regulation of NK cell activity, highlighting their role in innate immunity.\n\n### Biological Implications:\n\nAll in all, this gene cluster is pivotal in orchestrating immune responses, from antigen presentation to the activation and regulation of immune cells. Dysregulation of these genes can lead to immune-related disorders, including autoimmune diseases, immunodeficiencies, and cancer. Understanding the interactions and regulatory mechanisms within this cluster is essential for developing targeted therapies for such conditions.","The gene cluster for Natural Killer (NK) cells is essential to the innate immune system, primarily participating in early viral infection responses and tumor surveillance. Some genes in this cluster encode activating receptors, such as Ig-like receptors, NKG2D, C-type lectin-like receptors, and integrins, which signal through adaptor proteins like DAP12, FcRgamma, and CD3zeta. Other genes produce inhibitory receptors, which include Ig-like receptors, MHC-I receptors, and leukocyte Ig-like receptors. These inhibitory receptors bind to MHC-I, thereby preventing activation by the activating receptors. Additionally, the activating receptors of NK cells engage various signaling pathways, including the MAP kinase pathway, the PI3 kinase pathway, and the p38 MAP kinase pathway. All in all, this gene cluster intricately manages the balance of inhibitory and activating signals crucial for NK cell function."
BIOCARTA_CLASSIC_PATHWAY,"['C1QB', 'C7', 'C8A', 'C2', 'C1S', 'C1QC', 'C6', 'C5', 'C1R', 'C3', 'C4B_2', 'C4A', 'C1QA', 'C9', 'C4B']",Classical Complement Pathway,"The complement system is part of the defense against invading cells and is composed of about twenty different proteins found in the plasma. When activated, complement proteins form a pathway of proteolytic reactions that culminates in the lysis of foreign cells. The complement system also stimulates phagocytosis of foreign cells and an inflammatory response. There are two different complement systems, the classical complement pathway initiated by antibody complexes on the cell surface, and an alternative complement pathway that is initiated without antibodies. The complement system proteins are named with a capital C followed by a number. A small letter after the number indicates that the protein is a smaller protein resulting from the cleavage of a larger precursor by a protease. In the classical pathway, the first step is the initiation of the pathway triggered by recognition by complement factor C1 of antigen-antibody complexes on the cell surface. When C1 complex interacts with aggregates of IgG with antigen on a cell's surface, two C1-associated proteases, C1r and C1s, are activated. Other factors like lipopolysaccharide also activate C1s. Once C1s is activated, it cleaves C4 to form C4b that then binds to the cell membrane of the cell being attacked. The proteolytic complement cascade is then amplified on the cell membrane through sequential cleavage of complement factors and recruitment of new factors until a cell surface complex containing C5b, C6, C7, and C8 is formed. The addition of a multiple C9 proteins creates the membrane attack complex results in a large pore that spans the membrane of the cell being attacked, allowing ions to flow freely between the cellular interior and exterior. Ions flow out, but large molecules stay in, causing water to flood into the cell and ultimately burst the cell from osmotic pressure.","The gene cluster provided consists of genes primarily involved in the complement system, a crucial component of the innate immune response. This system enhances the ability of antibodies and phagocytic cells to clear pathogens and damaged cells, promote inflammation, and attack the pathogen's cell membrane.\n\n1. **Cluster Identification and Biological Function:**\n   - The gene cluster is part of the complement cascade, which is divided into three pathways: classical, lectin, and alternative. These pathways converge at the formation of the C3 convertase, leading to a cascade of events resulting in pathogen opsonization, recruitment of inflammatory cells, and direct killing of pathogens through the formation of the membrane attack complex (MAC).\n\n2. **Key Genes and Their Functions:**\n   - Some genes in this cluster, such as **C1QA, C1QB, C1QC, C1R, and C1S**, encode components of the C1 complex, which initiates the classical pathway. C1q binds to antibodies attached to antigens, while C1r and C1s are serine proteases that activate downstream components.\n   - Other genes, including **C2 and C4A/C4B/C4B_2**, encode proteins that form the C3 convertase in the classical and lectin pathways. C4 is cleaved into C4a and C4b, with C4b binding to the pathogen surface and interacting with C2a to form the C3 convertase.\n   - Additionally, **C3** is central to the complement system, being cleaved into C3a and C3b. C3b opsonizes pathogens and forms part of the C5 convertase, while C3a acts as an anaphylatoxin, promoting inflammation.\n   - Furthermore, **C5, C6, C7, C8A, and C9** encode components of the MAC. C5 is cleaved into C5a, an anaphylatoxin, and C5b, which initiates the assembly of the MAC by sequentially binding C6, C7, C8, and multiple C9 molecules, forming a pore in the pathogen membrane leading to cell lysis.\n\n3. **Gene Interactions and Relationships:**\n   - The complement system is highly regulated, with precise interactions between its components. The activation of one component often leads to the activation of another, creating a cascade effect. For example, the binding of C1q to antibodies activates C1r and C1s, which then cleave C4 and C2 to form the C3 convertase.\n\n4. **Regulatory Elements and Patterns:**\n   - The complement system is tightly regulated to prevent damage to host tissues. Regulatory proteins such as factor H and decay-accelerating factor (DAF) ensure that complement activation is localized to pathogen surfaces. Deficiencies or dysregulation in these genes can lead to autoimmune diseases or increased susceptibility to infections.\n\n5. **Biological Implications:**\n   - Proper functioning of the complement system is essential for immune defense. Mutations or deficiencies in these genes can lead to a range of disorders, including hereditary angioedema (C1 inhibitor deficiency), systemic lupus erythematosus (associated with C1q, C2, and C4 deficiencies), and increased risk of infections (C3 deficiency). Understanding the roles and interactions of these genes is crucial for developing therapies for complement-related diseases.\n\nAll in all, this gene cluster is integral to the complement system, playing a vital role in immune surveillance and response. While much is known about the individual functions of these genes, ongoing research continues to uncover the complexities of their interactions and regulatory mechanisms.","The gene cluster known as the complement system is an essential part of the immune system, playing a crucial role in protecting the body against infection and injury. Some genes in this cluster encode over 30 proteins that are present in the blood either in a soluble form or bound to cell surfaces. These proteins can activate the immune system, alert it to infections, or aid in removing damaged cells upon activation.\n\nOther genes within this cluster outline the system's activation through three distinct pathways: the classical, alternative, and lectin-induced pathways. Each pathway is initiated by a pattern recognition molecule that binds to a specific molecular pattern linked to infection or injury, subsequently activating the complement system. These pathways lead to the activation of different proteins within the complement cascade which can destroy target cells or aid in the removal of damaged cells. Additionally, all three pathways converge at the C3 protein, which is crucial to all activation pathways. The classical pathway is triggered when C1q, a recognition molecule, binds to an antibody attached to a pathogen. The alternative pathway and the lectin-induced pathway are activated by different pattern recognition molecules, such as the mannose-binding protein, which recognizes carbohydrates on the surface of bacteria.\n\nAdditionally, the C3 protein is activated when cleaved by C3 convertase, an essential convergence point within the complement cascade. This convertase also activates the C5 convertase, which cleaves and activates the C5 protein. Subsequently, the C5 convertase triggers the activation of C6, C7, C8, and C9 proteins, forming the membrane attack complex (MAC), which lyses target cells.\n\nAll in all, this gene cluster describes a complex and highly coordinated system, with the classical and alternative pathways being antibody-independent. In contrast, the lectin-induced pathway depends on antibody interactions, being activated by binding of complement protein C1q to antibodies attached to pathogens. Despite these variations in activation, the pathways converge into a unified and effective immune response mechanism."
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,"['TRIP6', 'CASP8', 'CHUK', 'TAB3', 'CXCL1', 'RIPK2', 'TNF', 'BIRC3', 'CCL2', 'XIAP', 'CCL5', 'NOD1', 'CARD6', 'CCL13', 'CCL11', 'CCL8', 'CARD8', 'CCL7', 'MEFV', 'CXCL8', 'MAPK9', 'MAPK10', 'MAPK11', 'ERBIN', 'MAPK13', 'CASP5', 'IKBKB', 'NOD2', 'MAP3K7', 'CASP1', 'CARD18', 'TNFAIP3', 'SUGT1', 'MAPK3', 'PSTPIP1', 'NFKB1', 'NFKBIB', 'NFKBIA', 'MAPK1', 'IKBKG', 'CARD9', 'MAPK8', 'MAPK14', 'MAPK12', 'IL18', 'RELA', 'PYDC1', 'TRAF6', 'HSP90AA1', 'PYCARD', 'TAB2', 'NLRC4', 'IL1B', 'HSP90B1', 'NLRP3', 'NLRP1', 'NAIP', 'BIRC2', 'CXCL2', 'HSP90AB1', 'TAB1', 'IL6']",NOD-like receptor signaling pathway,"Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more than 20 members in mammals and plays a pivotal role in the recognition of intracellular ligands. NOD1 and NOD2, two prototypic NLRs, sense the cytosolic presence of the bacterial peptidoglycan fragments that escaped from endosomal compartments, driving the activation of NF-{kappa}B and MAPK, cytokine production and apoptosis. On the other hand, a different set of NLRs induces caspase-1 activation through the assembly of multiprotein complexes called inflammasomes. These NLRs include NALP1, NALP3 and Ipaf. The inflammasomes are critical for generating mature proinflammatory cytokines in concert with Toll-like receptor signaling pathway.","The gene cluster provided is primarily involved in the regulation of inflammatory responses, apoptosis, and immune signaling pathways. Some genes in this cluster encode proteins involved in the NF-\u03baB signaling pathway, MAPK signaling, cytokine production, and the regulation of apoptosis and inflammation.\n\n### Key Genes and Their Functions:\n\n1. **NF-\u03baB Pathway Components:**\n   - **NFKB1, NFKBIA, NFKBIB, RELA:** These genes encode components of the NF-\u03baB transcription factor complex, crucial for regulating immune response, inflammation, and cell survival.\n   - **IKBKB, IKBKG (NEMO):** These genes encode kinases that activate NF-\u03baB by phosphorylating inhibitors of NF-\u03baB, leading to their degradation and the release of active NF-\u03baB.\n   - **TNFAIP3 (A20):** A negative regulator of NF-\u03baB signaling, involved in terminating inflammatory responses.\n\n2. **MAPK Signaling Pathway:**\n   - **MAPK1, MAPK3, MAPK8, MAPK9, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14:** These genes encode various mitogen-activated protein kinases (MAPKs) involved in transducing extracellular signals into cellular responses, including inflammation and stress responses.\n\n3. **Cytokines and Chemokines:**\n   - **TNF, IL1B, IL6, IL18:** These cytokines are key mediators of inflammation and immune responses.\n   - **CXCL1, CXCL2, CXCL8, CCL2, CCL5, CCL7, CCL8, CCL11, CCL13:** These chemokines are involved in the recruitment of immune cells to sites of inflammation.\n\n4. **Apoptosis and Inflammation Regulators:**\n   - **CASP1, CASP5, CASP8:** These caspases are involved in the execution of apoptosis and the processing of pro-inflammatory cytokines.\n   - **BIRC2, BIRC3, XIAP:** These are inhibitors of apoptosis proteins (IAPs) that regulate cell death and survival.\n\n5. **NOD-like Receptors and Inflammasome Components:**\n   - **NOD1, NOD2, NLRC4, NLRP1, NLRP3:** These genes encode pattern recognition receptors that detect microbial components and activate inflammatory responses.\n   - **PYCARD (ASC):** An adaptor protein essential for the formation of inflammasomes, which are involved in the activation of inflammatory caspases.\n\n6. **Heat Shock Proteins:**\n   - **HSP90AA1, HSP90AB1, HSP90B1:** These chaperone proteins are involved in protein folding and stabilization, and they play roles in the regulation of signaling pathways.\n\nAdditionally, the NF-\u03baB and MAPK pathways are interconnected, with several genes in this cluster participating in both pathways, highlighting their roles in coordinating immune and inflammatory responses. The presence of multiple cytokines and chemokines suggests a robust system for modulating immune cell recruitment and activation. Regulatory proteins like TNFAIP3 and IAPs ensure that inflammatory responses are tightly controlled to prevent excessive tissue damage.\n\nAll in all, this gene cluster is critical for maintaining immune homeostasis and responding to infections and stress. Dysregulation of these genes can lead to chronic inflammatory diseases, autoimmune disorders, and cancer. Understanding the interactions and regulatory mechanisms within this cluster is essential for developing therapeutic strategies for inflammatory and immune-related diseases.","The gene cluster inflammasomes consists of large protein complexes that regulate the activation of caspase-1 in response to inflammatory stimuli. Some genes in this cluster involve the interaction between a sensor molecule, such as a NOD-like receptor, and the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD). This interaction recruits caspase-1 via CARD-CARD interaction. Other genes in the cluster are responsible for the conversion of pro-IL-1beta and pro-IL-18 to their active forms through caspase-1. Additionally, inflammasomes can be activated by a variety of stimuli, including bacterial components, ATP, uric acid crystals, amyloid-beta, and environmental toxins. All in all, this gene cluster plays a crucial role in the regulation of inflammatory responses by activating caspase-1 and processing proinflammatory cytokines."
BIOCARTA_PAR1_PATHWAY,"['PIK3CG', 'PIK3R1', 'F2RL3', 'ADCY1', 'RHOA', 'GNAQ', 'ROCK1', 'PLCB1', 'PPP1R12B', 'PRKCB', 'F2R', 'GNA12', 'PTK2B', 'GNA13', 'PRKCA', 'PIK3CA', 'MAP3K7', 'ARHGEF1', 'F2']",Thrombin signaling and protease-activated receptors,"Thrombin is an extracellular protease that is involved in the clotting of blood and inflammation through its action on platelets and endothelial cells in the vasculature and that plays a role in thrombosis and myocardial infarction. The protease activated receptors PAR1 and PAR4 are cellular targets of thrombin signaling and members of the G-protein coupled receptor gene family. Both of these receptors are cleaved in their N-terminus by thrombin, unmasking a portion of the receptor sequence that acts itself as a tethered peptide ligand that activates the receptor. The tethered ligand that activates PAR1 is SFLLRN and the tethered ligand that activates PAR4 is GYPGQV. Other members of the family include PAR2 which is activated by trypsin rather than thrombin and PAR3 which seems to play a role in the activation of other PARs but does not itself transduce a signal directly. Addition of peptide agonist exogenously in solution can also activate PAR1, PAR2 and PAR4. PAR1 activation may be involved in the dilation of arteries during inflammation through the action of thrombin on endothelial cells and in platelet activation by thrombin during clotting. PAR1 and PAR2 activation cause bronchodilation in airway and may protect against asthma. PAR 4 activation by thrombin activates platelets during clotting and mice lacking PAR4 have impaired clotting and platelets that do not respond to thrombin signaling. The action of thrombin on PAR1 and PAR4 on platelets and endothelial cells may also contribute to vascular permeability and inflammation. Activated PARs appear to couple primarily through Gq-mediated stimulation of inositol phosphate metabolism and intracellular calcium levels to activate platelets. PAR1 and PAR4 also appear to couple to multiple G-proteins and transduce signals through more than one G-protein mediated pathway in some circumstances. Signaling by PAR1 and PAR4 through Galpha12 pathways couples to Rho signaling and changes in cytoskeletal structure and cell shape. Gi activation does not appear necessary for platelet activation by PAR1 or PAR4, and platelet activation by these receptors requires an ADP signal perhaps acting through the platelet-associated purinergic receptor P2Y12. Gi-coupled signaling may play a role in mitogenic PAR signaling in some settings through Map kinase activation. Activation of Rho by PAR1 can induce cellular transformation through a Galpha12 mediated mechanism and sustained rho-dependent phosphorylation of the myosin light chain by PAR1 contributes to cytoskeletal changes and activation of platelets. Since the activation of PARs by protease cleavage is irreversible the primary mechanism for down-regulation of the PAR signaling cascade appears to be internalization and degradation of PAR receptors.","The gene cluster is primarily involved in signal transduction pathways, particularly those related to G-protein coupled receptor (GPCR) signaling, phosphoinositide 3-kinase (PI3K) signaling, and the regulation of cytoskeletal dynamics. This cluster plays a crucial role in cellular processes such as cell growth, survival, differentiation, and motility.\n\nSome genes in this cluster, such as **PIK3CG** and **PIK3CA**, encode catalytic subunits of phosphoinositide 3-kinases (PI3Ks), which are involved in the PI3K/AKT signaling pathway critical for cell growth, proliferation, and survival. **PIK3CG** is particularly important in immune cell signaling. **PIK3R1** encodes a regulatory subunit of PI3K, stabilizing and regulating the activity of catalytic subunits like PIK3CA and PIK3CG.\n\nOther genes, such as **F2RL3** and **F2R**, encode protease-activated receptors (PARs) activated by thrombin, playing roles in coagulation, inflammation, and cellular proliferation. **ADCY1** encodes adenylate cyclase 1, an enzyme converting ATP to cyclic AMP (cAMP), a secondary messenger involved in transmitting signals from GPCRs. **RHOA**, **GNAQ**, **GNA12**, and **GNA13** encode small GTPases and G-protein subunits involved in GPCR signaling, with **RHOA** being a key regulator of the actin cytoskeleton, while **GNAQ**, **GNA12**, and **GNA13** are involved in various signaling pathways regulating cell proliferation and movement. **ROCK1** encodes Rho-associated protein kinase 1, activated by RHOA and involved in regulating the cytoskeleton, cell shape, and motility. **PLCB1** encodes phospholipase C beta 1, generating inositol trisphosphate (IP3) and diacylglycerol (DAG) from phosphatidylinositol 4,5-bisphosphate, leading to calcium release and activation of protein kinase C (PKC). **PRKCB** and **PRKCA** encode protein kinase C beta and alpha, respectively, which are serine/threonine kinases activated by DAG and calcium, playing roles in cell proliferation, differentiation, and apoptosis. **PPP1R12B** encodes a regulatory subunit of protein phosphatase 1, involved in the dephosphorylation of myosin light chains, affecting muscle contraction and cell motility. **PTK2B** encodes protein tyrosine kinase 2 beta, involved in integrin signaling and cytoskeletal organization. **MAP3K7** encodes a mitogen-activated protein kinase kinase kinase, involved in the MAPK signaling pathway, which regulates gene expression, cell growth, and apoptosis. **ARHGEF1** encodes a Rho guanine nucleotide exchange factor, activating Rho GTPases, influencing cytoskeletal dynamics and cell movement.\n\nAdditionally, the interaction between PI3K components (PIK3CG, PIK3CA, and PIK3R1) and downstream effectors like PRKCB and PRKCA highlights the integration of lipid signaling with protein phosphorylation pathways. RHOA, ROCK1, and ARHGEF1 form a signaling axis that regulates cytoskeletal dynamics, crucial for cell motility and shape changes. The interplay between G-proteins (GNAQ, GNA12, GNA13) and their downstream effectors (PLCB1, ADCY1) illustrates the complexity of GPCR signaling pathways.\n\nAll in all, this gene cluster is integral to processes such as immune response, inflammation, coagulation, and cancer progression. Dysregulation of these genes can lead to pathological conditions, including cancer, cardiovascular diseases, and immune disorders. Understanding the interactions and regulatory mechanisms within this cluster can provide insights into therapeutic targets for these diseases. While the functions of individual genes are well-characterized, the precise interactions and regulatory networks within this cluster in specific cellular contexts remain to be fully elucidated. Further research is needed to understand the dynamic regulation and cross-talk between these pathways.","The gene cluster of protease-activated receptors consists of a family of G-protein coupled receptors activated by the protease thrombin. Some genes in this cluster are cleaved by proteases such as factor Xa and trypsin, leading to a new N-terminus of the PAR-1, which serves as a ligand for the thrombin receptor. Other genes encode the PAR-1 receptor, found in various tissues and cells, including platelets, neurons, endothelial cells, and keratinocytes. Additionally, the cleavage of PAR-1 by thrombin activates numerous signaling pathways, most prominently the MAP kinase pathway. This activation involves G alpha q and leads to downstream activation of the MAP kinase pathway. Furthermore, activation of PAR-1 triggers the small G protein Rho, which activates the kinase ROCK, resulting in the formation of stress fibers and focal adhesions. PAR-1 activation also prompts calcium signaling and PI3 kinase activation, which in turn activates the kinase Akt. This cascade involves phosphorylation by PDK-1, which activates Akt independently of PI3 kinase and is mediated by G alpha 13. Overall, the activation of Akt by PAR-1 plays a critical role in the anti-apoptotic effects of thrombin, highlighting the gene cluster's involvement in diverse cellular processes."
BIOCARTA_IGF1MTOR_PATHWAY,"['PPP2CA', 'PIK3R1', 'EIF2S1', 'IGF1', 'EIF4E', 'PDK2', 'EIF2B5', 'MTOR', 'EIF4EBP1', 'EIF2S2', 'GSK3B', 'PDPK1', 'RPS6KB1', 'PTEN', 'INPPL1', 'AKT1', 'EIF2S3', 'PIK3CA', 'IGF1R']",Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,"Skeletal muscle atrophies with disuse while with increased use and increased load skeletal muscle exhibits hypertrophy, with an increase in the size of existing muscle fibers. One signaling pathway involved in regulating skeletal muscle atrophy and hypertrophy is the AKT/mTOR pathway. The mTOR pathway activity increases in response to muscle activity during hypertrophy and decreases in activity during atrophy. Blocking this pathway genetically or with the mTOR inhibitor rapamycin blocks hypertrophy and genetic activation of the pathway induces hypertrophy. One agent that promotes muscle hypertrophy is the growth factor IGF-1. IGF-1 activates AKT, GSK-3beta and mTOR to promote hypertrophy. In contrast, the calcineurin pathway is not involved in hypertrophy and is down-regulated by agents such as IGF-1 that promote hypertrophy. Calcineurin may modulate other aspects of muscle function such as the development of slow muscle fibers through transcriptional regulation. These pathways lead to regulation of protein translation, with increased translation apparently acting as a key regulatory point in skeletal muscle hypertrophy. Agents such as IGF-1 that stimulate skeletal muscle hypertrophy may provide treatments for muscle atrophy and wasting.","The gene cluster provided is primarily involved in the regulation of cell growth, proliferation, and survival, with a significant focus on the PI3K/AKT/mTOR signaling pathway. This pathway is crucial for cellular responses to growth factors, such as insulin-like growth factor 1 (IGF1), and plays a pivotal role in various cellular processes, including protein synthesis, metabolism, and apoptosis.\n\nSome genes in this cluster include:\n\n1. **MTOR (Mechanistic Target of Rapamycin):** A central regulator of cell growth and metabolism, mTOR integrates signals from nutrients, growth factors, and energy status to control protein synthesis and autophagy.\n\n2. **PIK3CA and PIK3R1 (Phosphoinositide 3-Kinase Catalytic and Regulatory Subunits):** These genes encode components of the PI3K enzyme, which phosphorylates lipids in the cell membrane, initiating the AKT signaling cascade.\n\n3. **AKT1 (Protein Kinase B):** A serine/threonine kinase that is activated downstream of PI3K, AKT1 promotes cell survival and growth by phosphorylating a range of substrates involved in apoptosis, metabolism, and cell cycle progression.\n\n4. **PTEN (Phosphatase and Tensin Homolog):** A tumor suppressor gene that negatively regulates the PI3K/AKT pathway by dephosphorylating PIP3 back to PIP2, thus acting as a brake on cell proliferation and survival.\n\n5. **IGF1 and IGF1R (Insulin-like Growth Factor 1 and its Receptor):** IGF1 is a growth factor that binds to IGF1R, activating the PI3K/AKT pathway and promoting anabolic processes and cell growth.\n\nOther genes include:\n\n6. **EIF4E, EIF4EBP1, EIF2S1, EIF2S2, EIF2S3, EIF2B5 (Eukaryotic Translation Initiation Factors):** These genes are involved in the initiation of mRNA translation, a process tightly regulated by mTOR signaling. EIF4E is a cap-binding protein, while EIF4EBP1 is an inhibitor of EIF4E, modulated by mTOR activity.\n\n7. **RPS6KB1 (Ribosomal Protein S6 Kinase B1):** A downstream target of mTOR, RPS6KB1 phosphorylates ribosomal protein S6, enhancing protein synthesis.\n\n8. **GSK3B (Glycogen Synthase Kinase 3 Beta):** A kinase involved in glycogen metabolism, GSK3B is inhibited by AKT, linking the PI3K/AKT pathway to glucose homeostasis.\n\n9. **PDPK1 (3-Phosphoinositide Dependent Protein Kinase 1):** Activates AKT by phosphorylating it, serving as a critical node in the PI3K/AKT signaling pathway.\n\n10. **INPPL1 (Inositol Polyphosphate Phosphatase-Like 1):** Also known as SHIP2, it acts as a negative regulator of the PI3K pathway by dephosphorylating PIP3.\n\nAdditionally, the PI3K/AKT/mTOR pathway is a highly interconnected network where activation of PI3K leads to AKT activation, which in turn activates mTOR. mTOR then regulates protein synthesis through targets like EIF4E and RPS6KB1. PTEN and INPPL1 serve as critical negative regulators, ensuring that the pathway is tightly controlled to prevent unchecked cell growth, which is a hallmark of cancer. The balance between EIF4E and EIF4EBP1 is crucial for controlling translation initiation, with mTOR activity tipping the balance towards protein synthesis.\n\nAll in all, this gene cluster represents a critical axis in cellular signaling, with profound implications for understanding and treating diseases characterized by aberrant cell growth and metabolism. Dysregulation of this gene cluster, particularly through mutations or altered expression of PTEN, PIK3CA, or AKT1, is implicated in various cancers due to its role in promoting cell survival and growth. Therapeutic targeting of mTOR and PI3K/AKT components is a major focus in cancer treatment, aiming to restore normal regulatory control over cell proliferation and survival pathways.","The gene cluster Insulin-like growth factor 1 (IGF-1) serves as a potent mitogen and survival factor for many cell types. Some genes in this cluster signal through the type 1 IGF receptor (IGF-1R), a receptor tyrosine kinase closely related in structure to the insulin receptor. Other genes stimulated by IGF-1 contribute to the proliferation of various cell types, including those of neural origin, and provide protection against a variety of apoptotic stimuli. Additionally, the IGF-1 / IGF-1R system is implicated in numerous pathological conditions, such as cancer and neurodegenerative diseases, and is widely expressed in the developing and adult nervous system. IGF-1 promotes neuronal survival and differentiation, functions as a neurotrophic factor in the brain, stimulates neurite outgrowth and axonal regeneration, and may play a role in learning and memory. Notably, IGF-1 expression is reduced in the aged brain, but IGF-1 treatment has been shown to reverse age-related learning deficits in rodents. The neuroprotective effects of IGF-1 may also be mediated through the inhibition of apoptosis. All in all, this gene cluster plays a crucial role in cell survival, proliferation, neuronal development, and potentially in cognitive functions such as learning and memory, with significant implications for both normal physiology and pathological conditions."
BIOCARTA_IL17_PATHWAY,"['CXCL8', 'IL3', 'KITLG', 'CSF3', 'CD3G', 'CD3E', 'CD58', 'IL17A', 'CD8A', 'CD247', 'CD34', 'CD3D', 'CD2', 'CD4', 'IL6']",IL 17 Signaling Pathway,"Inflammation is a complex response involving many different cells and signaling molecules, including the secretion of the cytokine IL-17 by activated T cells. IL-17 secretion is restricted to specific subsets of T cells but the receptor for IL-17 is widely expressed throughout the body, including fibroblasts and epithelial cells. Inflammatory responses involving IL-17 probably contribute to arthritis, asthma, skin immune reactions and autoimmune disorders. Fibroblasts and other cells stimulated by IL-17 are induced themselves to secrete inflammatory and hematopoietic cytokines, including IL-6, IL-8, G-CSF and Stem Cell Factor (SCF). These cytokines in turn provoke a range of activities, including the stimulation of neutrophil proliferation and differentiation.","The gene cluster provided consists of a combination of cytokines, growth factors, and cell surface markers that play crucial roles in the immune system and hematopoiesis. Some genes in this cluster, such as CXCL8, IL3, and KITLG, are primarily involved in immune response modulation, hematopoietic cell differentiation, and signaling pathways critical for immune cell function. Other genes, including CSF3, the CD3 complex, and CD58, contribute to granulocyte production, T-cell activation, and cell adhesion. Additionally, genes like IL17A, CD8A, CD34, CD2, CD4, and IL6 are involved in pro-inflammatory responses, cytotoxic T-cell function, stem cell marker expression, and immune response regulation. All in all, this gene cluster is central to immune system function and hematopoiesis, with implications for understanding immune disorders, inflammatory diseases, and potential therapeutic targets for modulating immune responses.","The gene cluster consists of two major classes of cells: lymphocytes and cells of the monocyte-macrophage series. Some genes in this cluster are involved in initiating the immune response through the interaction of antigen-presenting cells (APCs) like macrophages, B cells, and dendritic cells with specific receptors on T cells. Other genes are engaged in the interaction between the T cell receptor (TCR) and the MHC-peptide complex on the APC cell surface, which is crucial for T cell activation. Additionally, the APC cell surface expresses various costimulatory molecules necessary for T cell activation, such as the interaction of CD28 on T cells with its ligand on the APC cell surface, and the interaction of the CD4 coreceptor on T cells with the MHC-peptide complex. Moreover, the CD52 coreceptor on the APC cell surface interacts with the CTLA-4 coreceptor on the T cell to provide further costimulatory signals. The activation of T cells results in cytokine production, T cell proliferation, and differentiation into Th or cytotoxic T cells. It can also induce apoptosis in T cells that do not interact with the APC; however, the interaction of CD28 with its ligand delivers a costimulatory signal that inhibits T cell apoptosis. All in all, this gene cluster orchestrates the activation, proliferation, differentiation, and survival of T cells within the immune response."
BIOCARTA_ALK_PATHWAY,"['NKX2-5', 'BMP4', 'BMP2', 'MYL2', 'NPPA', 'SMAD4', 'TGFBR2', 'FZD1', 'TGFB2', 'SMAD6', 'BMP10', 'APC', 'CHRD', 'SMAD5', 'NPPB', 'GATA4', 'WNT1', 'NOG', 'BMP5', 'GSK3B', 'ACVR1', 'BMPR2', 'BMP7', 'CTNNB1', 'TGFBR3', 'TGFBR1', 'RFC1', 'BMPR1A', 'AXIN1', 'TGFB3', 'ATF2', 'MAP3K7', 'SMAD1', 'TGFB1', 'MEF2C', 'HNF1A', 'DVL1']",ALK in cardiac myocytes,"Heart formation is cued by a combination of positive and negative signals from surrounding tissues. Inhibitory signals that block heart formation in anterior paraxial mesoderm include Wnt family members expressed in dorsal neural tube and anti-BMPs expressed in the axial tissues (i.e., noggin in the notochord). Wnt signalling pathway, which is essential for setting up the entire body pattern during embryonic development involves glycogen synthase kinase-3 (GSK3). In the absence of Wnt signaling, GSK3 is active and phosphorylates b-catenin resulting in its degradation by ubiquitin-mediated proteolysis. Activation of Wnt signaling inhibits GSK3, thereby preventing phosphorylation of b-catenin, which is then able to move to the nucleus. There it associates with members of the LEF-1/TCF family of transcription factors, which activate the transcription of genes like cyclin-D1, myc, and MMPs. The Wnt signaling pathway is blocked by a family of secreted proteins such as crescent and Dkk-1 sufficient for induction of heart formation in posterior mesoderm. BMP signaling can also be blocked by the BMP antagonists noggin and chordin, which are secreted from the notochord and cooperate with Wnts to prevent cardiogenesis. Receptors for BMPs, members of the transforming growth factor-beta (TGFb) superfamily, are persistently expressed during cardiac development, yet mice lacking type II or type IA BMP receptors die at gastrulation and cannot be used to assess potential later roles in creation of the heart. Activin receptor-like kinase 3 (ALK3) is specifically required at mid-gestation for normal development of the trabeculae, compact myocardium, interventricular septum, and endocardial cushion. Cardiac muscle lacking ALK3 is specifically deficient in expressing TGFb2, an established paracrine mediator of cushion morphogenesis. In humans, congenital heart defects occur with a prevalence of at least 1% in newborns, and are even more common in death before term. Most frequent are defects in septation and the cardiac valves, and few single gene etiologies are known. The invariable defects in myocardium and AV cushion resulting from congenital deletion of ALK3 provide strong support for its assessment as a candidate gene in human congenital heart disease.","The gene cluster provided is primarily involved in the regulation of cardiac development and function, as well as bone morphogenetic protein (BMP) and transforming growth factor-beta (TGF-\u03b2) signaling pathways. These pathways are crucial for embryonic development, cell differentiation, and tissue homeostasis.\n\nSome genes in this cluster include **NKX2-5**, a homeobox gene critical for heart development, where mutations can lead to congenital heart defects. The **BMP family** (BMP2, BMP4, BMP5, BMP7, BMP10) encodes proteins that are part of the TGF-\u03b2 superfamily, playing significant roles in cardiac development, bone formation, and embryogenesis, signaling through receptors such as BMPR1A and BMPR2. The **SMAD family** (SMAD1, SMAD4, SMAD5, SMAD6) consists of intracellular proteins that transduce extracellular signals from TGF-\u03b2 ligands to the nucleus, activating downstream gene expression, with SMAD4 as a common mediator and SMAD6 as an inhibitory SMAD. The **TGF-\u03b2 family** (TGFB1, TGFB2, TGFB3) involves cytokines that regulate cell growth, proliferation, differentiation, and apoptosis, signaling through receptors TGFBR1, TGFBR2, and TGFBR3. **GATA4** is a transcription factor essential for cardiac development and function, interacting with other cardiac-specific genes to regulate heart formation. **MYL2** encodes a myosin light chain involved in cardiac muscle contraction. **NPPA and NPPB** encode atrial and brain natriuretic peptides, respectively, which are involved in cardiovascular homeostasis.\n\nOther genes include those in the **WNT pathway** (WNT1, FZD1, DVL1, CTNNB1, AXIN1), which are crucial for cell fate determination, cell migration, and organogenesis. **APC and GSK3B** are involved in the regulation of the Wnt signaling pathway and play roles in cell cycle regulation and apoptosis. **NOG (Noggin) and CHRD (Chordin)** are BMP antagonists that regulate BMP activity during development. **ACVR1** is a receptor for activin, part of the TGF-\u03b2 superfamily, involved in various developmental processes. **MEF2C** is a transcription factor involved in muscle development, including cardiac muscle. **HNF1A** is a transcription factor involved in the regulation of gene expression in the liver and pancreas. **RFC1** is involved in DNA replication and repair. **ATF2 and MAP3K7** are part of the MAP kinase signaling pathway, involved in stress response and apoptosis.\n\nAdditionally, the relationships and regulatory elements include the interconnected BMP and TGF-\u03b2 signaling pathways, with SMAD proteins acting as common mediators. BMPs and TGF-\u03b2s can have overlapping and distinct roles in development and disease. The Wnt signaling pathway interacts with BMP and TGF-\u03b2 pathways, influencing cell fate and patterning during development. Regulatory interactions involve GATA4, NKX2-5, and MEF2C forming a network of transcription factors that regulate cardiac gene expression.\n\nAll in all, this gene cluster highlights the complexity and interconnectivity of signaling pathways essential for development and homeostasis, with significant implications for understanding congenital disorders and potential therapeutic targets. It is crucial for cardiac development, bone and tissue development, and is implicated in cancer and disease due to its roles in cell proliferation and differentiation. Dysregulation can lead to congenital heart defects, other cardiovascular diseases, and various cancers and fibrotic diseases.","The gene cluster known as the transforming growth factor-beta (TGF-beta) family consists of secreted growth factors that regulate a broad spectrum of cellular responses, including proliferation, differentiation, apoptosis, migration, and extracellular matrix production. Some genes in this cluster function by signaling through serine/threonine kinase receptors and intracellular SMAD proteins. The TGF-beta receptor complex includes type II and type I receptors; TGF-beta ligands bind to the type II receptor, which recruits and phosphorylates the type I receptor. Other genes play a role where the type I receptor phosphorylates receptor-activated SMADs (R-SMADs), such as SMAD2 and SMAD3. R-SMADs then associate with the co-SMAD SMAD4, and the complex translocates to the nucleus. Additionally, in the nucleus, the SMADs combine with DNA-binding proteins to regulate gene expression. TGF-beta signaling can be inhibited by SMAD6 and SMAD7, which interact with the type I receptor and block R-SMAD phosphorylation and activation. All in all, this gene cluster plays a crucial role in various cellular processes through its intricate signaling pathways and regulatory mechanisms."
BIOCARTA_DREAM_PATHWAY,"['MAPK3', 'OPRK1', 'PRKACG', 'CREM', 'PRKAR1A', 'PRKAR2B', 'KCNIP3', 'PRKACB', 'CREB1', 'PRKAR1B', 'PRKAR2A', 'JUN', 'FOS']",Repression of Pain Sensation by the Transcriptional Regulator DREAM,"The molecular events that lead to the perception of pain are a key research field in medicine and drug discovery. The opioid receptors modulate pain signaling in response to endogenous peptide ligands and opiate drugs such as morphine. The kappa opioid receptor plays a key role in the profound analgesia of opiates and is activated by the endogenous peptide ligand dynorphin, encoded by the prodynorphin gene. Production of prodynorphin is transcriptionally regulated by a downstream regulatory element (DRE) in the prodynorphin gene. A transcription factor called DREAM (DRE antagonistic modulator) binds to the DRE and represses prodynorphin transcription when bound. DREAM binds calcium with 4 EF-hand motifs and the binding of DREAM to DNA is repressed in the presence of calcium. Many transcription factors are regulated by calcium indirectly through calcium sensitive kinases and phosphatases, but DREAM is unique to date in being a transcription factor that directly binds calcium and is regulated by calcium binding. DREAM may also regulate other genes such as c-fos. DREAM is expressed in spinal cord neurons in regions involved in pain signaling. The regulation of prodynorphin expression by DREAM also leads to the hypothesis that DREAM is involved in pain signaling. Transgenic mice lacking the DREAM gene were unusually pain insensitive and had elevated spinal levels of dynorphin and tonic activation of the kappa opioid receptor, supporting this hypothesis. Other functions of DREAM may exist such as regulation of presenilins and potassium channel activity in the heart. DREAM is also known as calsenilin and KChIP3 through its association with these other proteins. These processes were not affected in mice lacking the DREAM gene however.","The gene cluster provided includes a set of genes primarily involved in signal transduction pathways, particularly those related to the MAPK/ERK and cAMP signaling pathways. These pathways play crucial roles in cellular processes such as growth, differentiation, and response to external stimuli.\n\nSome genes in this cluster, such as **MAPK3 (Mitogen-Activated Protein Kinase 3)**, also known as ERK1, encode a protein kinase that is part of the MAPK/ERK pathway. It is involved in the regulation of meiosis, mitosis, and postmitotic functions in differentiated cells. **OPRK1 (Opioid Receptor Kappa 1)** encodes a receptor that binds to opioid ligands and is involved in modulating pain perception, mood, and stress responses. **PRKACG (Protein Kinase cAMP-Activated Catalytic Subunit Gamma)** encodes a catalytic subunit of protein kinase A (PKA), which is activated by cyclic AMP (cAMP) and plays a role in regulating metabolism, gene expression, and the cell cycle. **CREM (cAMP Responsive Element Modulator)** encodes a transcription factor that binds to cAMP response elements in DNA, modulating the transcription of target genes in response to cAMP levels.\n\nOther genes, such as **PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B (Protein Kinase cAMP-Dependent Regulatory Subunits 1A, 1B, 2A, 2B)**, encode regulatory subunits of PKA. They are responsible for modulating the activity of the catalytic subunits in response to cAMP, thus playing a critical role in the cAMP signaling pathway. **PRKACB (Protein Kinase cAMP-Activated Catalytic Subunit Beta)**, similar to PRKACG, encodes another catalytic subunit of PKA, contributing to the regulation of various cellular processes through cAMP signaling. **CREB1 (cAMP Responsive Element Binding Protein 1)** encodes a transcription factor that is activated by phosphorylation through PKA. It binds to cAMP response elements and regulates the expression of genes involved in neuronal plasticity, survival, and metabolism. **KCNIP3 (Kv Channel Interacting Protein 3)** encodes a protein that interacts with voltage-gated potassium channels and is involved in regulating neuronal excitability and apoptosis. **JUN and FOS** encode components of the AP-1 transcription factor complex. JUN and FOS proteins dimerize to form AP-1, which regulates gene expression in response to a variety of stimuli, including cytokines, growth factors, and stress.\n\nAdditionally, the relationships between these genes highlight a complex network of interactions where MAPK3 and the cAMP signaling components (PRKACG, PRKACB, CREM, CREB1, and the PRKAR subunits) converge to regulate transcription factors like JUN and FOS. This integration allows cells to respond dynamically to external signals, influencing processes such as cell growth, differentiation, and survival. Regulatory elements such as cAMP response elements (CRE) are crucial for the transcriptional regulation mediated by CREB1 and CREM. The presence of these elements in target gene promoters allows for precise control of gene expression in response to fluctuating cAMP levels.\n\nAll in all, this gene cluster is significant in contexts such as neuronal function, where cAMP signaling and MAPK pathways are critical for synaptic plasticity and memory formation. Dysregulation of these pathways can lead to various diseases, including cancer, neurodegenerative disorders, and mood disorders. Understanding the interactions and regulatory mechanisms within this cluster can provide insights into therapeutic targets for these conditions.","The gene cluster includes the opioid peptides met-enkephalin and leu-enkephalin, which are widely distributed in the central nervous system (CNS) and act as neurotransmitters or neuromodulators. Some genes in this cluster encode for three distinct opioid receptors: mu, delta, and kappa. The mu receptor, targeted by morphine and other opiates, mediates analgesic and other physiological actions and is coupled to the inhibition of adenylyl cyclase and the stimulation of K+ channel activity. Other genes encode receptors like the delta receptor, which is the target of endogenous peptides and similarly coupled to adenylyl cyclase inhibition and K+ channel activity, though less efficacious in the latter. The delta receptor also stimulates phospholipase C (PLC), leading to intracellular calcium release, although this pathway's physiological significance is unclear. The kappa receptor, targeted by belladonna alkaloids such as naloxone, is associated with dysphoric and other effects, and similarly inhibits adenylyl cyclase and stimulates K+ channel activity. Additionally, all three opioid receptors interact with other signaling systems. The mu receptor activates the MAP kinase pathway, involving Erk-1, Erk-2, and p38 kinases, mediated by Gi/o and betagamma subunits, and may influence some physiological processes. The delta receptor also stimulates MAP kinase pathways and the p38 pathway, involving Gs, betagamma subunits from Gi/o, and the alpha subunit of Gs, impacting physiological responses. The kappa receptor activates the MAP kinase pathway via Gi/o and betagamma, with p38 pathway activation influencing physiological responses. All in all, this gene cluster suggests complex roles in mediating a variety of physiological responses through its interaction with different signaling systems and pathways."
BIOCARTA_PS1_PATHWAY,"['PSEN1', 'FZD1', 'APC', 'WNT1', 'DLL1', 'ADAM17', 'GSK3B', 'CTNNB1', 'RBPJ', 'NOTCH1', 'AXIN1', 'BTRC', 'HNF1A', 'DVL1']",Presenilin action in Notch and Wnt signaling,"Presenilin-1 (PS1) is associated with gamma secretase activity that cleaves amyloid precursor protein (APP) and is implicated in Alzheimer's disease. Presenilin-1 is also a component in gamma-secretase activity involved in signaling by the transmembrane protein Notch. Active gamma secretase requires PS-1 N-terminal fragment and a C-terminal fragment and is unique in catalyzing proteolysis within the transmembrane region of proteins. Other proteins such as nicastrin may also be components of the gamma-secretase. Binding of the ligand Delta by Notch appears to trigger two proteolytic cleavages of Notch. The first step cleaves an extracellular domain and is catalyzed by a metalloprotease termed alpha-secretase or TACE. The second cleavage step appears to occur within the transmembrane domain of Notch, and releases a Notch intracellular doman (NICD). Once released, NICD moves into the nucleus where it is involved in transcriptional regulation through CSL family transcription factors (CBF1, Su(H), Lag-1) or other transcriptional regulators such as LEF-1. Presenilin is also involved in the Wnt/frizzled signaling pathway through beta-catenin. Beta-catenin is a cytoskeletal component that enters the nucleus to act as a transcriptional cofactor. Binding of WNT to Frizzled causes disheveled (DSH) to inhibit Glycogen synthase kinase 3 beta (GSK-3b) activity. Phosphorylation of Beta-catenin induces the ubiquitination and proteolytic degradation of beta-catenin by the proteasome. Non-phosphorylated beta-catenin is stable and enters the nucleus to regulate transcription with TCF. The beta-catenin/TCF complex activates genes that promote cellular survival, proliferation and differentiation during development. Presenilin stimulates beta-catenin turnover, reducing its transcriptional activation.","The gene cluster provided is primarily involved in the Wnt signaling pathway and the Notch signaling pathway, both of which are crucial for cell communication, development, and differentiation processes.\n\nSome genes in this cluster are part of the Wnt signaling pathway:\n- **WNT1** encodes a protein that is a member of the Wnt family, playing a critical role in embryonic development and cell signaling.\n- **FZD1** encodes a Frizzled receptor that binds to Wnt proteins, initiating the Wnt signaling cascade.\n- **DVL1** acts as a key mediator in the Wnt signaling pathway, transmitting signals from the Frizzled receptors to downstream effectors.\n- **CTNNB1 (\u03b2-catenin)** is central to the canonical Wnt pathway, translocating to the nucleus to activate transcription of Wnt target genes when stabilized.\n- **GSK3B** is a kinase that phosphorylates \u03b2-catenin, marking it for degradation in the absence of Wnt signaling.\n- **APC** is part of the destruction complex that targets \u03b2-catenin for degradation, thus acting as a negative regulator of the Wnt pathway.\n- **AXIN1** is another component of the \u03b2-catenin destruction complex, facilitating its degradation.\n- **BTRC** encodes a protein that is part of the ubiquitin ligase complex, targeting phosphorylated \u03b2-catenin for proteasomal degradation.\n\nOther genes are involved in the Notch signaling pathway:\n- **NOTCH1** encodes a receptor that, upon binding to its ligand, undergoes proteolytic cleavage to release the Notch intracellular domain (NICD), which translocates to the nucleus.\n- **DLL1** is a ligand for Notch receptors, playing a role in activating Notch signaling.\n- **RBPJ** is a transcription factor that associates with NICD to regulate the expression of Notch target genes.\n\nAdditionally, there are genes involved in cross-talk and regulation between these pathways:\n- **ADAM17** is a metalloprotease involved in the cleavage of membrane-bound precursors, including Notch ligands, thus modulating Notch signaling.\n- **PSEN1** is part of the \u03b3-secretase complex that cleaves the Notch receptor, releasing NICD, and is also involved in the processing of other proteins like APP.\n- **HNF1A**, while primarily known for its role in regulating liver-specific genes, may have indirect interactions with these pathways through metabolic regulation.\n\nThe biological implications of these pathways are significant:\n- The Wnt and Notch pathways are critical for embryonic development, stem cell maintenance, and tissue homeostasis. Dysregulation of these pathways is implicated in various diseases, including cancer, neurodegenerative disorders, and congenital anomalies.\n- The interplay between Wnt and Notch signaling can influence cell fate decisions, with potential implications in regenerative medicine and cancer therapy.\n\nRegulatory elements and patterns include:\n- The balance between the stabilization and degradation of \u03b2-catenin is a key regulatory mechanism in the Wnt pathway.\n- The proteolytic processing of Notch receptors and ligands is crucial for the activation of Notch signaling.\n\nAll in all, this gene cluster highlights the intricate network of interactions within the Wnt and Notch signaling pathways, emphasizing their roles in development and disease. Further research is needed to fully elucidate the complex regulatory mechanisms and interactions between these pathways.","The gene cluster known as the Notch signaling pathway is an evolutionarily conserved intercellular communication mechanism essential for proper embryonic development across various species. Some genes in this cluster are responsible for encoding the Notch receptor, a single-pass transmembrane protein activated through interaction with a Delta or Jagged ligand present on an adjacent cell. Other genes are involved in the process where the Notch receptor is cleaved by a protease, Presenilin, leading to the release and nuclear translocation of the Notch intracellular domain (NICD). Additionally, within the nucleus, NICD interacts with the DNA-binding protein CSL (CBF-1, Su (H), Lag1) and the coactivator MAML to activate transcription of Notch target genes. Furthermore, the Notch pathway plays a role in cell-fate decisions during nervous system development and in various adult tissues. Notch signaling is also implicated in the pathogenesis of several human cancers. All in all, this gene cluster is integral to developmental processes and cellular decision-making, and its dysregulation can contribute to oncogenesis."
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,"['PIGP', 'PIGW', 'PIGM', 'PIGN', 'PIGS', 'PIGF', 'DPM2', 'PIGQ', 'PIGH', 'PIGO', 'PIGG', 'PIGZ', 'GPAA1', 'PIGU', 'PGAP1', 'PIGT', 'PIGK', 'PIGY', 'PIGL', 'PIGV', 'PIGB', 'PIGX', 'PIGA', 'GPLD1', 'PIGC']",Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,"Cell surface proteins can be attached to the cell membrane via the glycolipid structure called glycosylphosphatidylinositol (GPI) anchor. Hundreds of GPI-anchored proteins have been identified in many eukaryotes ranging from protozoa and fungi to mammals. All protein-linked GPI anchors share a common core structure, characterized by the substructure Man (a14) GlcN (a1-6) myo-inositol-1P-lipid. Biosynthesis of GPI anchors proceeds in three stages: (i) preassembly of a GPI precursor in the ER membrane, (ii) attachment of the GPI to the C-terminus of a newly synthesized protein in the lumen of the ER, and (iii) lipid remodeling and/or carbohydrate side-chain modifications in the ER and the Golgi. Defects of GPI anchor biosynthesis gene result in a genetic disorder, paroxysmal nocturnal hemoglobinuria.","The gene cluster is primarily involved in the biosynthesis and remodeling of glycosylphosphatidylinositol (GPI) anchors, which are critical for attaching certain proteins to the cell membrane. GPI anchors are glycolipids that tether proteins to the extracellular surface of eukaryotic cell membranes, playing essential roles in various biological processes, including signal transduction, cell adhesion, and immune response.\n\nSome genes in this cluster, such as **PIGA, PIGC, PIGH, PIGP, PIGQ, PIGY, PIGL, PIGM, PIGX, PIGW, PIGB, PIGF, PIGG, PIGS, PIGT, PIGU, PIGZ, PIGK, PIGV, PIGN,** and **PIGO**, encode enzymes and proteins that participate in the stepwise synthesis of the GPI anchor. Each gene product is responsible for adding specific sugar residues, phosphoethanolamine, or other components to the growing GPI precursor.\n\nOther genes, such as **DPM2**, encode a regulatory subunit of the dolichol-phosphate-mannose (DPM) synthase complex, which is crucial for providing mannose residues during GPI anchor synthesis. **GPAA1** encodes a protein that is part of the GPI transamidase complex, which attaches the preassembled GPI anchor to proteins. **PGAP1** is involved in the remodeling of GPI anchors after their attachment to proteins, ensuring proper function and stability. **GPLD1** encodes a GPI-specific phospholipase D, which can cleave GPI anchors, releasing proteins from the cell surface, a process important for regulating the availability and activity of GPI-anchored proteins.\n\nAdditionally, the genes in this cluster are functionally interconnected, with each gene product contributing to different stages of GPI anchor biosynthesis and attachment. The process is highly coordinated, and disruptions in any of these genes can lead to defects in GPI anchor formation, affecting the localization and function of GPI-anchored proteins. Regulatory elements controlling the expression of these genes are crucial for maintaining the balance of GPI anchor synthesis, especially in tissues where GPI-anchored proteins play significant roles.\n\nAll in all, this gene cluster is essential for the biosynthesis and function of GPI anchors, with significant implications for cell biology and human health. Mutations in genes involved in GPI anchor biosynthesis can lead to a group of disorders known as GPI-anchor deficiencies, characterized by developmental delays, intellectual disabilities, and other systemic abnormalities. Understanding the function and regulation of this gene cluster is vital for developing therapeutic strategies for diseases associated with GPI anchor deficiencies. The study of GPI anchor biosynthesis also provides insights into fundamental cellular processes, such as protein sorting and membrane dynamics. While much is known about the individual roles of these genes, ongoing research continues to uncover the complexities of their regulation and interaction.","The gene cluster involved in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors is a complex series of enzymatic steps. Some genes in this cluster, like PIG-N (also known as PIG-A), initiate the process by catalyzing the addition of N-acetylglucosamine (GlcNAc) to phosphatidylinositol (PI). Other genes, such as PIG-P (also known as PIG-C), catalyze the subsequent addition of a phosphoethanolamine (EthN) group to the GlcNAc-PI, which is the second step in the pathway. Additionally, ethanolamine represents the third of the six conserved monosaccharides present in all GPI precursors, and the third EthN is deacetylated to generate the first mannose in the GPI precursor. Notably, the fourth component of the GPI precursor is identified as methionine, rather than EthN, and later steps involve the acylation of methionine components. The key committed step in this biosynthetic pathway is the addition of the first mannose by MPIase (also known as PIGM), followed by deacylation and transport of the GPI precursor from the ER to the Golgi by p2 4 proteins. In the Golgi, further modification of the mannose includes the addition of a phosphoethanolamine group, followed by deacetylation, and additional modifications by xylose and glucose through enzymes like B4GalT1 and B3GalT1, respectively. The last steps in GPI precursor biosynthesis are conserved from yeast to mammals, involving the further addition of EthN by PIG-P, followed by xylose and glucose modifications. Although the addition of the third EthN is catalyzed by PIG-N (PIG-A), there are enzymes yet to be identified, responsible for the remaining steps of GPI precursor biosynthesis. All in all, this gene cluster encapsulates the intricate process of GPI anchor biosynthesis, with several key enzymatic modifications crucial across different species."
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,"['CD80', 'CD86', 'H2BC26', 'CD28', 'MACROH2A1', 'H3Y2', 'H2AC1', 'H2AC7', 'H2AC25', 'H2AC8', 'FCGR1A', 'H2AC21', 'H3C14', 'H2AC19', 'C9', 'CTSG', 'H3Y1', 'H4C9', 'FCGR3B', 'FCGR2A', 'C8A', 'H3-4', 'C7', 'FCGR3A', 'C8G', 'FCGR2B', 'C8B', 'HLA-DRB4', 'HLA-DRB5', 'HLA-DRB3', 'C6', 'C5', 'ELANE', 'H4C16', 'C4B', 'C4A', 'H4C15', 'HLA-DPA1', 'H2AB3', 'HLA-DPB1', 'HLA-DQA1', 'HLA-DQA2', 'HLA-DQB1', 'H4C14', 'H2BC3', 'H2AX', 'H2AZ1', 'H2BC5', 'C2', 'H3-3B', 'C1S', 'C3', 'C1QB', 'H2AC12', 'C1QA', 'H3-3A', 'C1R', 'C1QC', 'H2BC12', 'ACTN2', 'HLA-DRB1', 'ACTN3', 'HLA-DRA', 'H2AC11', 'HLA-DOA', 'HLA-DOB', 'H3C7', 'TNF', 'H4C4', 'FCGR2C', 'H4C12', 'MACROH2A2', 'H4C6', 'H2AZ2', 'H4C3', 'H4C11', 'H4C2', 'HLA-DMB', 'H4C8', 'HLA-DMA', 'ACTN4', 'H4C13', 'H2BC11', 'ACTN1', 'H4C5', 'H4C7', 'H2BW1', 'H2BC21', 'GRIN2A', 'GRIN2B', 'RO60', 'TRIM21', 'H3C4', 'H3C1', 'H2BC18', 'H3C8', 'H3C11', 'H3C6', 'H3C3', 'H4C1', 'IL10', 'H3C2', 'SSB', 'H3C10', 'H3C15', 'H3C12', 'H2BW2', 'H2AB1', 'H3-5', 'H2AC20', 'H2BC8', 'H2AB2', 'H2AJ', 'SNRPD3', 'H2ACP1', 'IFNG', 'H2BC13', 'H2BC10', 'H2BC9', 'H2BC17', 'H2BC4', 'H2BC14', 'H2BC15', 'H2BC6', 'H2BC7', 'CD40LG', 'CD40', 'SNRPB', 'H2AC13', 'H3C13', 'H2AC18', 'H2AC17', 'SNRPD1', 'H2AC4', 'H2AC6', 'H2AC16', 'H2AC14', 'H2BC1', 'H2AC15']",Systemic lupus erythematosus,"Systemic lupus erythematosus (SLE) is characterized by circulating IgG autoantibodies that are specific for self-antigens, such as DNA, nuclear proteins and certain cytoplasmic components. Immune complexes comprising autoantibody and self-antigen is deposited particulary in the renal glomeruli and mediate a systemic inflammatory response by activating complement or via Fc-gamma-R-mediated neutrophil and macrophage activation. Activation of complement leads to injury both through formation of the membrane attack complex (C5b-9) or by generation of the anaphylatoxin and cell activator C5a. Neutrophils and macrophages cause tissue injury by the release of oxidants and proteases.","The gene cluster provided is a complex assembly of genes involved in immune response, histone modification, and structural proteins. This cluster can be broadly categorized into three main functional groups: immune system components, histone proteins, and structural proteins.\n\n### Immune System Components\n\n1. **Major Histocompatibility Complex (MHC) Genes**: \n   - **HLA Genes**: This includes genes such as HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DMA, HLA-DMB, HLA-DOA, and HLA-DOB. These genes encode proteins that are critical for antigen presentation and immune recognition, playing a pivotal role in adaptive immunity.\n\n2. **Complement System Genes**:\n   - **C1, C2, C3, C4, C5, C6, C7, C8, C9**: These genes encode components of the complement system, which is essential for innate immunity, facilitating opsonization, inflammation, and cell lysis.\n\n3. **Fc Gamma Receptors**:\n   - **FCGR1A, FCGR2A, FCGR2B, FCGR2C, FCGR3A, FCGR3B**: These receptors bind to the Fc region of IgG antibodies, mediating various immune responses such as phagocytosis and antibody-dependent cellular cytotoxicity.\n\n4. **Cytokines and Receptors**:\n   - **TNF (Tumor Necrosis Factor)** and **IFNG (Interferon Gamma)**: These cytokines are crucial for inflammatory responses and activation of immune cells.\n   - **CD40 and CD40LG**: These molecules are involved in B-cell activation and are important for adaptive immunity.\n\n5. **Other Immune Genes**:\n   - **CD80 and CD86**: These are co-stimulatory molecules that interact with CD28 on T-cells to enhance immune responses.\n   - **CTSG (Cathepsin G)** and **ELANE (Elastase, Neutrophil Expressed)**: These are serine proteases involved in the degradation of proteins during immune responses.\n\n### Histone Proteins\n\nThis cluster includes a large number of histone genes, which are critical for DNA packaging and regulation of gene expression:\n\n- **H2A, H2B, H3, and H4 Variants**: These include genes such as H2AX, H2AZ1, H2AZ2, H3-3A, H3-3B, H3C1, H3C2, H3C3, H3C4, H3C6, H3C7, H3C8, H3C10, H3C11, H3C12, H3C13, H3C14, H3C15, H4C1, H4C2, H4C3, H4C4, H4C5, H4C6, H4C7, H4C8, H4C9, H4C11, H4C12, H4C13, H4C14, H4C15, H4C16, and others. These histones are involved in the formation of nucleosomes, the basic unit of chromatin, and play roles in epigenetic regulation.\n\n### Structural Proteins\n\n- **ACTN1, ACTN2, ACTN3, ACTN4**: These genes encode actin-binding proteins that are important for maintaining the cytoskeleton and cellular integrity.\n\n### Regulatory Elements and Patterns\n\nThe presence of multiple histone variants suggests a complex regulatory network for chromatin remodeling and gene expression. The MHC genes are known for their high polymorphism, which is crucial for immune diversity. The interaction between co-stimulatory molecules (CD80/CD86) and their receptors (CD28) highlights the importance of cell signaling in immune responses.\n\n### Biological Implications\n\nThis gene cluster is integral to both innate and adaptive immunity, with implications for understanding autoimmune diseases, transplant rejection, and immune system disorders. The histone genes suggest roles in epigenetic regulation, which could impact gene expression patterns in various physiological and pathological contexts.\n\nAll in all, this gene cluster represents a multifaceted network of genes with critical roles in immune function, chromatin structure, and cellular architecture. Further research is needed to elucidate the precise interactions and regulatory mechanisms within this cluster.","The gene cluster consists of histones, which are basic proteins that are highly conserved through evolution. Some genes in this cluster are involved in forming the core histone complex, combining with DNA to form nucleosomes, the fundamental structural units of chromatin. Other genes classify histones into two types: core histones (H2A, H2B, H3, and H4) and linker histones (H1). Additionally, core histones create a stable histone octamer around which DNA is wound in a left-handed superhelix, while linker histones bind to nucleosomes to stabilize higher-order chromatin structures. Histones are manufactured in the cytoplasm and later moved into the nucleus. In addition to histones, cells also contain proteins known as histone chaperones, which assist in histone assembly, disassembly, and nucleosome stabilization. All in all, this gene cluster plays a critical role in maintaining chromatin structure and function."
BIOCARTA_BARR_MAPK_PATHWAY,"['MAPK3', 'GRK2', 'GNAS', 'MAP2K1', 'RAF1', 'KCNA3', 'ADCY1', 'KCNA2', 'KCNA1', 'PLCB1', 'MAPK1', 'MAP2K2', 'ARRB1', 'DNM1']",Role of b-arrestins in the activation and targeting of MAP kinases,"The binding of -arrestins to agonist-occupied GPCRs triggers the assembly of a MAP kinase activation complex using -arrestin as a scaffold, with subsequent activation of a -arrestin-bound pool of ERK1/2. The receptor-arrestinERK complexes are localized to endosomal vesicles, and their formation does not result in nuclear translocation of activated ERK1/2 or stimulation of cell proliferation. The function of -arrestin-bound ERK1/2 is presently unknown. Activation of ERK1/2 by -arrestin scaffolds may favor the phosphorylation of plasma membrane, cytosolic, or cytoskeletal ERK1/2 substrates, or it may lead to transcriptional activation through the ERK-dependent activation of other kinases. The model depicts -arrestin scaffolding of the ERK1/2 MAP kinase cascade, based upon data obtained with the protease-activated PAR2 and angiotensin AT1a receptors. A similar mechanism has been proposed for regulation of the JNK3 MAP kinase cascade by AT1a receptors.","The gene cluster provided is primarily involved in signal transduction pathways, particularly those related to the MAPK/ERK pathway and G protein-coupled receptor (GPCR) signaling. This cluster plays a crucial role in cellular processes such as growth, differentiation, and response to external stimuli.\n\nSome genes in this cluster are key components of the MAPK/ERK pathway. **MAPK3 (ERK1)** and **MAPK1 (ERK2)** are critical for transmitting signals from the cell surface to the nucleus, influencing cell division and differentiation. **MAP2K1 (MEK1)** and **MAP2K2 (MEK2)** are upstream kinases that activate ERK1/2 through phosphorylation. **RAF1** is a serine/threonine kinase that acts upstream of MEK1/2, initiating the MAPK/ERK cascade in response to growth factors.\n\nOther genes are involved in GPCR signaling. **GRK2** (G protein-coupled receptor kinase 2) regulates GPCR activity by phosphorylating activated receptors, leading to desensitization. **GNAS** encodes the G\u03b1s subunit of heterotrimeric G proteins, which activates adenylate cyclase, increasing cAMP levels and influencing various downstream effects. **ADCY1** encodes adenylate cyclase 1, an enzyme that converts ATP to cAMP, a secondary messenger involved in many signaling pathways.\n\nAdditionally, the cluster includes genes related to ion channels and the phospholipase C pathway. **KCNA1, KCNA2, and KCNA3** encode voltage-gated potassium channels (Kv1.1, Kv1.2, and Kv1.3, respectively), which are crucial for maintaining the membrane potential and regulating neuronal excitability. **PLCB1** encodes phospholipase C beta 1, which hydrolyzes phosphatidylinositol 4,5-bisphosphate to generate inositol trisphosphate and diacylglycerol, leading to calcium release and protein kinase C activation.\n\nThe cluster also includes genes involved in endocytosis and signal termination. **ARRB1** (\u03b2-arrestin 1) is involved in the desensitization and internalization of GPCRs, as well as in signaling pathways independent of G proteins. **DNM1** (dynamin 1) is a GTPase involved in the scission of clathrin-coated vesicles during endocytosis, playing a role in receptor internalization and recycling.\n\nThe MAPK/ERK pathway is tightly regulated by feedback loops and cross-talk with other signaling pathways, ensuring precise control of cellular responses. GPCR signaling is modulated by GRKs and \u03b2-arrestins, which provide a mechanism for signal attenuation and receptor recycling.\n\nAll in all, this gene cluster represents a complex network of signaling pathways that are essential for normal cellular function and response to environmental changes. Dysregulation of these pathways is implicated in various diseases, including cancer, cardiovascular disorders, and neurological conditions. Understanding the interactions and regulation within this gene cluster can provide insights into therapeutic targets for modulating these pathways in disease contexts. Further research is needed to fully elucidate the interactions and regulatory mechanisms within this cluster.","The gene cluster G-protein-coupled receptor kinase 2 (GRK2) plays a key role in the desensitization and internalization of G-protein-coupled receptors (GPCRs). Some genes in this cluster are involved in other cellular processes such as cell cycle control and apoptosis. Other genes interact specifically with the small GTPase RhoA, where this interaction is involved in the regulation of RhoA-mediated signaling. GRK2 interacts with the active form of RhoA, but not with its inactive form, leading to inhibition of RhoA-mediated signaling pathways such as stress fiber formation and SRF activation. Additionally, GRK2 is found to phosphorylate RhoA in vitro. All in all, this gene cluster suggests that GRK2 regulates RhoA-mediated signaling pathways through interaction and phosphorylation of RhoA."
BIOCARTA_IL2RB_PATHWAY,"['IL2RG', 'MAPK3', 'FASLG', 'CRKL', 'PIK3CG', 'HRAS', 'SOCS1', 'NMI', 'PTPN6', 'PIK3R1', 'BCL2', 'RAF1', 'MYC', 'JAK1', 'IL2RA', 'FAS', 'PPIA', 'BAD', 'IKZF3', 'SYK', 'CFLAR', 'MAPK1', 'SHC1', 'STAT5A', 'GRB2', 'RPS6KB1', 'IRS1', 'IL2RB', 'CBL', 'JAK3', 'AKT1', 'SOCS3', 'PIK3CA', 'STAT5B', 'E2F1', 'SOS1', 'FOS']",IL-2 Receptor Beta Chain in T cell Activation,"The IL-2 receptor is a key component of immune signaling and is required for the activation, proliferation, and survival of T cells. This receptor is composed of three polypeptide chains, the alpha, beta and gamma chains. The IL-2 receptor gamma chain is a common component for several other cytokine receptors, including IL-4, IL-7, IL-9 and IL-15. The IL-2 receptor beta chain is essential for IL-2 signaling and is also a component of the IL-15 receptor complex. The polypeptides of the IL-2 receptor do not themselves have intrinsic catalytic activity, but interact with cytoplasmic signaling proteins to transduce signals. br>Different regions of the cytoplasmic domain of the IL-2 receptor beta chain interact and couple with distinct signaling pathways and cellular responses. JAK1 associates with the beta chain, and JAK3 with the gamma chain. Binding of IL-2 induces heterodimerization of receptor subunits, and activation of JAK kinase activity. Tyrosine residues in the beta chain cytoplasmic domain are phosphorylated during activation, recruiting other factors to the phosphorylated tyrosine residues through src homology 2 (SH2) domains. The adaptor protein Shc binds to phosphorylated tyrosine 338 of the beta chain. When bound, Shc is phosphorylated and couples through Grb2 and Sos-1 to activate Ras and stimulate T cell proliferation. Another key proliferative pathway activated by IL-2 is phosphorylation of STAT-5 by JAK kinases. STAT-5 is recruited to IL-2 beta phosphorylated tyrosines at multiple positions, including Y338, Y392 and Y510. Once phosphorylated, STAT-5 enters the nucleus to regulate the transcription of several genes, some proliferative such as cyclin genes and others that are involved in T cell immune function such as cytokine genes. The suppressors of cytokine activation, SOCS-3 and SOCS-1, oppose phosphorylation and activation of STAT-5 and JAK1 caused by IL-2. PI3 kinase is another protein recruited to IL-2 receptor beta chain tyrosines when phosphorylated. Activation of PI3 Kinase also contributes to the proliferative activity of IL-2 in T cells. The role of other tyrosines in the IL-2 receptor beta chain, Y355, Y358 and Y361, is not yet clear, but may be involved in signaling by the protein kinase p56lck. In addition to stimulating T cell activation and proliferation, IL-2 activation blocks T cell apoptosis through multiple pathways. Among the genes activated by STAT-5 are BCL-xL, an inhibitor of apoptosis, and fas-ligand, an activator of apoptosis in cells expressed the fas receptor. PI3 kinase also contributes to anti-apoptotic activity of IL-2 through AKT activation. T cell responses to IL-2 must be coordinated in part in the complex protein-protein interactions with the IL-2 receptor beta chain.","The gene cluster provided is primarily involved in the regulation of immune responses, cell growth, apoptosis, and signal transduction pathways. Some genes in this cluster are integral to the JAK-STAT signaling pathway, PI3K-AKT signaling pathway, and MAPK signaling pathway, which are crucial for cellular responses to external stimuli, including cytokines and growth factors.\n\n### Key Genes and Their Functions:\n\n1. **IL2RG, IL2RA, IL2RB**: These genes encode components of the interleukin-2 receptor, essential for T-cell proliferation and immune response regulation. IL2RG is the common gamma chain shared by several interleukin receptors, playing a critical role in immune system signaling.\n\n2. **JAK1, JAK3, STAT5A, STAT5B**: These genes are part of the JAK-STAT signaling pathway. JAK1 and JAK3 are tyrosine kinases that, upon activation by cytokine receptors, phosphorylate STAT5A and STAT5B, which then translocate to the nucleus to regulate gene expression.\n\n3. **PIK3CA, PIK3CG, PIK3R1, AKT1**: These genes are involved in the PI3K-AKT signaling pathway, crucial for cell survival, growth, and metabolism. PIK3CA and PIK3CG encode catalytic subunits of phosphoinositide 3-kinases, while PIK3R1 encodes a regulatory subunit. AKT1 is a serine/threonine kinase that mediates downstream effects of PI3K activation.\n\n4. **MAPK1, MAPK3, RAF1**: These genes are part of the MAPK signaling pathway, involved in cell proliferation, differentiation, and stress responses. RAF1 is a kinase that activates MAPK/ERK kinases, leading to the activation of MAPK1 and MAPK3.\n\n5. **FAS, FASLG, CFLAR**: These genes are involved in the regulation of apoptosis. FAS and its ligand FASLG are critical for the induction of programmed cell death, while CFLAR (c-FLIP) can inhibit this process, providing a balance between cell survival and apoptosis.\n\n6. **BCL2, BAD**: These genes are key regulators of apoptosis. BCL2 is an anti-apoptotic protein, while BAD promotes apoptosis by antagonizing BCL2.\n\n7. **MYC, E2F1, FOS**: These transcription factors are involved in cell cycle regulation and proliferation. MYC and E2F1 promote cell cycle progression, while FOS is part of the AP-1 complex that regulates gene expression in response to growth signals.\n\n8. **SOCS1, SOCS3**: These genes encode suppressors of cytokine signaling, which are negative regulators of the JAK-STAT pathway, providing feedback inhibition to prevent excessive signaling.\n\n9. **CRKL, GRB2, SHC1, SOS1**: These adaptor proteins are involved in linking receptor tyrosine kinases to downstream signaling pathways, including the RAS-MAPK pathway.\n\n10. **HRAS, CBL**: HRAS is a small GTPase involved in signal transduction, while CBL is an E3 ubiquitin ligase that regulates receptor tyrosine kinase degradation.\n\n### Relationships and Regulatory Elements:\n\n- The JAK-STAT, PI3K-AKT, and MAPK pathways are interconnected, with cross-talk between them influencing cellular outcomes such as proliferation, survival, and differentiation.\n- Regulatory elements such as SOCS proteins provide feedback inhibition to prevent overactivation of cytokine signaling.\n- The balance between pro-apoptotic and anti-apoptotic signals (e.g., BAD vs. BCL2) is crucial for cell fate decisions.\n\n### Biological Implications:\n\n- Dysregulation of these pathways can lead to immune disorders, cancer, and other diseases. For example, mutations in JAK or STAT genes are associated with various hematological malignancies.\n- Understanding the interactions and regulation within this gene cluster can provide insights into therapeutic targets for modulating immune responses and treating cancers.\n\nAll in all, this gene cluster represents a complex network of signaling pathways that are essential for maintaining cellular homeostasis and responding to external stimuli. Further research is needed to fully elucidate the interactions and regulatory mechanisms within this cluster.","The gene cluster for Interleukin-2 (IL-2) includes components essential for stimulating the growth and proliferation of T cells. Some genes in this cluster encode the IL-2 receptor, a heterodimer consisting of an alpha subunit, which is responsible for high-affinity ligand binding, and a beta subunit, which is responsible for signal transduction. Other genes in this cluster are involved in the activation processes that follow IL-2 binding. Specifically, the binding of IL-2 to its receptor activates the JAK family of tyrosine kinases, which phosphorylate the receptor and other substrates. Additionally, phosphorylated substrates trigger the MAP kinase pathway and activate the STAT transcription factors. The MAP kinase pathway leads to the activation of transcription factors such as ELK-1 and SRF, while STAT factors promote the transcription of various genes involved in proliferation and differentiation. All in all, this gene cluster plays a vital role in modulating cellular responses that facilitate immune cell growth and specialization."
BIOCARTA_FAS_PATHWAY,"['FASLG', 'CASP10', 'CASP7', 'FADD', 'LMNB1', 'RIPK2', 'DFFB', 'MAPK8', 'CASP3', 'PARP1', 'FAS', 'DAXX', 'SPTAN1', 'CFLAR', 'RB1', 'PAK1', 'PTPN13', 'DFFA', 'PRKDC', 'ARHGDIB', 'MAP2K4', 'PAK2', 'FAF1', 'LMNB2', 'LMNA', 'MAP3K7', 'CASP8', 'MAP3K1', 'CASP6', 'JUN']",FAS signaling pathway ( CD95 ),"Receptors in the TNF receptor family are associated with the induction of apoptosis, as well as inflammatory signaling. The Fas receptor (CD95) mediates apoptotic signaling by Fas-ligand expressed on the surface of other cells. The Fas-FasL interaction plays an important role in the immune system and lack of this system leads to autoimmunity, indicating that Fas-mediated apoptosis removes self-reactive lymphocytes. Fas signaling is also involved in immune surveillance to remove transformed cells and virus infected cells. Binding of FAS to oligimerized FasL on another cell activates apoptotic signaling through a cytoplasmic domain termed the death domain that interacts with signaling adaptors including FAF, FADD and DAX to activate the caspase proteolytic cascade. Caspase-8 and caspase-10 are first activated, to then cleave and activate downstream caspases, and a variety of cellular substrates that lead to cell death. Caspases cleave nuclear lamins, causing the nucleus to break down and lose its normal structure and another caspase substrate is DFF, inducing cleavage and degradation of the genome. Other caspase substrates are involved in cytoskeletal structure, cell cycle regulation and signaling pathways. Activation of JNK kinase, activation of Jun, and production of ceramide may also play roles in Fas-mediated apoptosis. Activation of fas-mediated apoptosis is opposed by I-FLICE and FAP. Viruses and tumors may escape immune surveillance in part through suppression of fas-mediated apoptosis using similar mechanisms.","The gene cluster is primarily associated with the regulation of apoptosis, a form of programmed cell death crucial for maintaining cellular homeostasis and development. Some genes in this cluster are involved in both the intrinsic and extrinsic apoptotic pathways, as well as in cell signaling, structural integrity, and stress responses.\n\n### Key Genes and Their Functions:\n\n1. **FASLG and FAS**: These genes encode the Fas ligand and its receptor, respectively, which are critical components of the extrinsic apoptotic pathway. Binding of FASLG to FAS triggers a cascade leading to cell death.\n\n2. **CASP8, CASP10, CASP7, CASP3, CASP6**: These caspases are proteolytic enzymes that execute apoptosis. CASP8 and CASP10 are initiator caspases in the extrinsic pathway, while CASP3, CASP6, and CASP7 are effector caspases that dismantle cellular components.\n\n3. **FADD**: This adaptor protein is essential for transmitting apoptotic signals from the FAS receptor to initiator caspases.\n\n4. **DAXX**: Functions as a signaling adaptor that can modulate apoptosis and transcriptional regulation.\n\n5. **CFLAR**: Also known as c-FLIP, this protein inhibits caspase-8 activation, thus acting as a regulator of apoptosis.\n\n6. **PARP1**: Involved in DNA repair and apoptosis; it is cleaved by caspases during apoptosis, which facilitates cellular disassembly.\n\n7. **DFFB and DFFA**: These genes encode components of the DNA fragmentation factor, which is activated by caspases to degrade DNA during apoptosis.\n\n8. **MAPK8 (JNK1), MAP2K4, MAP3K1, MAP3K7**: These kinases are part of the MAPK signaling pathway, which can influence apoptosis, stress responses, and cellular proliferation.\n\n9. **RIPK2**: Involved in immune signaling and can modulate apoptotic pathways.\n\n10. **FAF1**: A Fas-associated factor that can promote apoptosis.\n\n11. **PTPN13**: A phosphatase that can negatively regulate apoptotic signaling pathways.\n\n12. **PRKDC**: Involved in DNA repair and can influence cell survival and apoptosis.\n\n13. **RB1**: The retinoblastoma protein, a key regulator of the cell cycle, which can also influence apoptosis.\n\n14. **JUN**: A component of the AP-1 transcription factor, involved in regulating gene expression in response to stress and apoptotic signals.\n\n15. **PAK1 and PAK2**: These kinases are involved in cytoskeletal reorganization and can influence cell survival and apoptosis.\n\n16. **ARHGDIB**: Involved in the regulation of the cytoskeleton and cell migration, with potential roles in apoptosis.\n\n17. **LMNA, LMNB1, LMNB2**: These genes encode nuclear lamins, which are structural components of the nuclear envelope and can be cleaved during apoptosis.\n\n18. **SPTAN1**: Encodes spectrin, a cytoskeletal protein that can be cleaved during apoptosis, contributing to cell disassembly.\n\n### Relationships and Regulatory Elements:\n\n- The interaction between FASLG and FAS initiates the extrinsic apoptotic pathway, with FADD recruiting and activating CASP8 and CASP10.\n- CFLAR acts as a regulatory checkpoint by inhibiting CASP8, thus modulating the sensitivity of cells to apoptotic signals.\n- The MAPK pathway, involving MAPK8, MAP2K4, MAP3K1, and MAP3K7, integrates stress signals and can either promote or inhibit apoptosis depending on the context.\n- PARP1 and the DFF complex are downstream targets of caspases, facilitating the execution phase of apoptosis.\n\nAdditionally, this gene cluster highlights the complexity of apoptotic regulation, with multiple checks and balances to ensure appropriate cell death. Dysregulation of these genes can lead to pathological conditions such as cancer, autoimmune diseases, and neurodegenerative disorders. Understanding the interactions and regulatory mechanisms within this cluster is crucial for developing therapeutic strategies targeting apoptosis-related diseases.\n\nAll in all, this gene cluster is integral to the regulation of apoptosis, ensuring cellular homeostasis and development, and its dysregulation can have significant pathological implications.","The gene cluster encompassing the Fas / APO-1 receptor is a part of the TNF receptor gene family. Some genes in this cluster are responsible for the binding of Fas-ligand (FasL) to the Fas-receptor, which induces apoptosis in sensitive cells. Other genes within this cluster are involved in regulating immune responses and may play a role in the development of autoimmune diseases and certain forms of cancer, as the Fas-induced apoptotic pathway resembles that induced by the TNF receptor. Additionally, the binding of the Fas-ligand triggers receptor aggregation and the recruitment of the Fas-associated death domain (FADD) protein, which subsequently recruits pro-caspase-8 to the receptor complex. Caspase-8 activation leads to the cleavage and activation of downstream caspases and the conversion of Bid to tBid, which translocates to the mitochondria to promote apoptosis. All in all, this gene cluster is integral to apoptosis and the regulation of immune responses, with implications in autoimmune diseases and cancer."
BIOCARTA_CARM_ER_PATHWAY,"['HDAC2', 'HDAC6', 'HDAC4', 'HDAC1', 'NCOR2', 'NRIP1', 'BRCA1', 'ESR1', 'NR0B1', 'CARM1', 'HDAC5', 'CREBBP', 'PHB2', 'GRIP1', 'EP300', 'HDAC3', 'CCND1', 'PPARGC1A', 'SPEN', 'TBP', 'GTF2A1', 'MED1', 'H3C14', 'MEF2C', 'SRA1', 'PELP1']",CARM1 and Regulation of the Estrogen Receptor,"Several forms of post-translational modification regulate protein activities. Recently, protein methylation by CARM1 (coactivator-associated arginine methyltransferase 1) has been observed to play a key role in transcriptional regulation. CARM1 associates with the p160 class of transcriptional coactivators involved in gene activation by steroid hormone family receptors. CARM1 also interacts with CBP/p300 transcriptional coactivators involved in gene activation by a large variety of transcription factors, including steroid hormone receptors and CEBP. One target of CARM1 is the core histones H3 and H4, which are also targets of the histone acetylase activity of CBP/p300 coactivators. Recruitment of CARM1 to the promoter region by binding to coactivators increases histone methylation and makes promoter regions more accessible for transcription. Another target of CARM1 methylation is a coactivator it interacts with, CBP. Methylation of CBP by CARM1 blocks CBP from acting as a coactivator for CREB and redirects the limited CBP pool in the cell to be available for steroid hormone receptors. Other forms of post-translational protein modification such as phosphorylation are reversible in nature, but as of yet a protein demethylase is not known. The methylation activity of CARM1 modulates the activity of specific transcriptional regulators. CARM1 acts as a coactivator for the myogenic transcription factor Mef2c, and is necessary for normal muscle cell differentiation. The estrogen receptor is another transcription factor that uses CARM1 as one of several coactivators, acting synergistically with CBP through the Grip1 member of the p160 family of coactivators. The interaction of estrogen receptor with various ligand-dependent coactivators may produce the tissue selective response of some estrogen receptor ligands like tamoxifen.","The gene cluster provided is primarily involved in the regulation of gene expression through chromatin remodeling and transcriptional regulation. Some genes in this cluster include a variety of histone deacetylases (HDACs), nuclear receptor co-regulators, and transcription factors, which together play crucial roles in modulating chromatin structure and influencing transcriptional activity.\n\n### Key Genes and Their Functions:\n\n1. **Histone Deacetylases (HDACs)**: \n   - **HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6**: These enzymes remove acetyl groups from histone proteins, leading to chromatin condensation and transcriptional repression. They are involved in various cellular processes, including cell cycle regulation and differentiation.\n\n2. **Nuclear Receptor Co-regulators**:\n   - **NCOR2 (Nuclear Receptor Co-repressor 2)**: Acts as a transcriptional co-repressor by recruiting HDACs to nuclear receptors, thereby repressing gene expression.\n   - **NRIP1 (Nuclear Receptor Interacting Protein 1)**: Functions as a co-regulator for nuclear receptors, modulating their transcriptional activity.\n   - **CARM1 (Coactivator-Associated Arginine Methyltransferase 1)**: Methylates histones and other proteins, influencing transcriptional activation.\n   - **GRIP1 (Glucocorticoid Receptor Interacting Protein 1)**: Serves as a coactivator for nuclear receptors, enhancing transcriptional activity.\n\n3. **Transcription Factors and Coactivators**:\n   - **BRCA1 (Breast Cancer 1)**: Involved in DNA repair and transcriptional regulation, playing a critical role in maintaining genomic stability.\n   - **ESR1 (Estrogen Receptor 1)**: A nuclear hormone receptor that regulates gene expression in response to estrogen.\n   - **CREBBP (CREB Binding Protein) and EP300 (E1A Binding Protein p300)**: These are transcriptional coactivators with histone acetyltransferase activity, facilitating transcriptional activation by acetylating histones.\n   - **TBP (TATA-Box Binding Protein) and GTF2A1 (General Transcription Factor IIA Subunit 1)**: Essential components of the transcription initiation complex.\n   - **MED1 (Mediator Complex Subunit 1)**: Part of the mediator complex, which bridges transcription factors and RNA polymerase II.\n\n4. **Other Notable Genes**:\n   - **PPARGC1A (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha)**: Involved in energy metabolism and mitochondrial biogenesis.\n   - **SPEN (Spen Family Transcriptional Repressor)**: Functions as a transcriptional repressor.\n   - **MEF2C (Myocyte Enhancer Factor 2C)**: A transcription factor involved in muscle development and differentiation.\n   - **SRA1 (Steroid Receptor RNA Activator 1)**: Functions as a coactivator for steroid hormone receptors.\n   - **PELP1 (Proline, Glutamic Acid, and Leucine Rich Protein 1)**: Acts as a co-regulator for nuclear receptors and is involved in chromatin remodeling.\n\nAdditionally, the HDACs in this cluster are often recruited by co-repressors like NCOR2 to deacetylate histones, leading to transcriptional repression. Conversely, coactivators such as CREBBP and EP300 acetylate histones, promoting transcriptional activation. The interaction between nuclear receptors (e.g., ESR1) and their co-regulators (e.g., NRIP1, CARM1) is crucial for the fine-tuning of gene expression in response to hormonal signals. The presence of transcription factors like TBP and components of the mediator complex (e.g., MED1) highlights the importance of this cluster in the initiation and regulation of transcription.\n\nAll in all, this gene cluster is integral to the regulation of gene expression, impacting processes such as cell cycle progression, differentiation, and response to hormonal signals. Dysregulation of these genes can lead to various pathologies, including cancer, metabolic disorders, and developmental abnormalities. Understanding the interactions and regulatory mechanisms within this cluster is essential for developing targeted therapies for diseases associated with aberrant gene expression.","The gene cluster known as the estrogen receptor (ER) is a member of the nuclear receptor gene family. Some genes in this cluster function as ligand-dependent transcription factors. In the absence of a ligand, the ER is associated with a corepressor complex containing N-CoR and SMRT. Other genes are involved in the binding process, whereby upon estrogen binding, the ER undergoes a conformational change and dissociates from the corepressor complex. Additionally, the dissociated ER forms a heterodimer with the 90-kDa heat shock protein (hsp-90) and is recruited to the estrogen response element (ERE) in the promoter region of target genes. The activated ER complex interacts with other transcription factors, such as Sp1 and the p65 subunit of RNA polymerase II, to activate transcription. The activity of ER can also be regulated by phosphorylation; phosphorylation by protein kinase A (PKA) and protein kinase C (PKC) increases the transcriptional activity of ER. Phosphorylation by CDKs and p34cdc2 similarly enhances its transcriptional activity. The phosphorylation of ER by CDKs may play a role in the cell cycle-dependent regulation of its activity. All in all, this gene cluster demonstrates complex regulatory mechanisms crucial for proper genetic transcription in response to estrogen."
KEGG_ERBB_SIGNALING_PATHWAY,"['JUN', 'SOS2', 'PAK3', 'RAF1', 'PRKCB', 'BTC', 'SHC1', 'PRKCA', 'ELK1', 'NRG1', 'PAK2', 'MTOR', 'PAK4', 'MAP2K4', 'EIF4EBP1', 'BAD', 'PRKCG', 'NRG3', 'MAPK9', 'ERBB4', 'MAPK10', 'PTK2', 'ERBB2', 'ERBB3', 'MAP2K2', 'TGFA', 'BRAF', 'MAP2K1', 'MAP2K7', 'ABL1', 'NRG2', 'AKT1', 'ABL2', 'AKT2', 'SHC4', 'RPS6KB1', 'RPS6KB2', 'AKT3', 'NRAS', 'GRB2', 'AREG', 'STAT5B', 'MAPK3', 'STAT5A', 'PAK6', 'SOS1', 'MYC', 'MAPK1', 'NCK1', 'PIK3R5', 'NRG4', 'HRAS', 'MAPK8', 'EGFR', 'GSK3B', 'CBLB', 'KRAS', 'CBL', 'SHC3', 'CDKN1B', 'CDKN1A', 'EGF', 'EREG', 'ARAF', 'NCK2', 'PAK5', 'SRC', 'PIK3R3', 'CAMK2A', 'CAMK2B', 'CAMK2D', 'CAMK2G', 'PAK1', 'CBLC', 'CRK', 'PIK3CA', 'PIK3CB', 'CRKL', 'PIK3CD', 'GAB1', 'PLCG1', 'PLCG2', 'SHC2', 'HBEGF', 'PIK3CG', 'PIK3R1', 'PIK3R2']",ErbB signaling pathway,"The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, differentiation, cell motility, and survival. Ligand binding to the four closely related members of this RTK family -epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4)-induces the formation of receptor homo- and heterodimers and the activation of the intrinsic kinase domain, resulting in phosphorylation on specific tyrosine residues (pY) within the cytoplasmic tail. Signaling effectors containing binding pockets for pY-containing peptides are recruited to activated receptors and induce the various signaling pathways. The Shc- and/or Grb2-activated mitogen-activated protein kinase (MAPK) pathway is a common target downstream of all ErbB receptors. Similarly, the phosphatidylinositol-3-kinase (PI-3K) pathway is directly or indirectly activated by most ErbBs. Several cytoplasmic docking proteins appear to be recruited by specific ErbB receptors and less exploited by others. These include the adaptors Crk, Nck, the phospholipase C gamma (PLCgamma), the intracellular tyrosine kinase Src, or the Cbl E3 ubiquitin protein ligase.","The gene cluster is primarily involved in receptor tyrosine kinase (RTK) signaling pathways, particularly the Epidermal Growth Factor Receptor (EGFR) pathway and its downstream signaling cascades. This cluster plays a crucial role in regulating cell proliferation, differentiation, survival, and metabolism, which are fundamental processes in both normal cellular function and oncogenesis.\n\nSome genes in this cluster include the **EGFR and ERBB Family (ERBB2, ERBB3, ERBB4)**, which encode members of the EGFR family of receptor tyrosine kinases. Upon ligand binding (e.g., EGF, TGFA, NRG1-4), these receptors dimerize and autophosphorylate, initiating downstream signaling. The **RAS Family (HRAS, KRAS, NRAS)** consists of small GTPases that act as molecular switches, transmitting signals from activated RTKs to downstream effectors like RAF kinases. The **RAF Family (RAF1, BRAF, ARAF)** includes serine/threonine kinases that are part of the MAPK/ERK pathway, critical for cell division and differentiation.\n\nOther genes include the **MAPK Cascade (MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1, MAPK9/JNK2, MAPK10/JNK3)**, which propagate signals from the cell surface to the nucleus, affecting gene expression and cellular responses. The **PI3K/AKT Pathway (PIK3CA, PIK3CB, PIK3CD, PIK3CG, AKT1, AKT2, AKT3)** is vital for cell survival and metabolism, where PI3Ks phosphorylate PIP2 to PIP3, leading to AKT activation, promoting cell survival and growth. **mTOR (MTOR)** is a central regulator of cell growth and metabolism, integrating signals from the PI3K/AKT pathway and other inputs to control protein synthesis and autophagy. **JUN and MYC** are transcription factors that are downstream targets of MAPK signaling, regulating genes involved in cell proliferation and survival. **STAT5A/B** are transcription factors activated by cytokine signaling and can be involved in cell growth and differentiation. **SOS1/2 and GRB2** are adaptor proteins that facilitate the activation of RAS by linking RTKs to RAS-GEFs (guanine nucleotide exchange factors). The **PAK Family (PAK1-6)** consists of serine/threonine kinases that are effectors of the Rho family of GTPases and are involved in cytoskeletal reorganization and cell motility. **CDKN1A (p21) and CDKN1B (p27)** are cyclin-dependent kinase inhibitors that regulate cell cycle progression, acting as tumor suppressors.\n\nAdditionally, the relationships and interactions within this cluster include RTK activation, where ligand binding to EGFR and ERBB receptors leads to dimerization and autophosphorylation, creating docking sites for adaptor proteins like GRB2 and SHC1-4, which recruit SOS1/2 to activate RAS. The MAPK/ERK pathway involves activated RAS recruiting RAF kinases, which phosphorylate and activate MEK1/2 (MAP2K1/2), leading to ERK1/2 activation and nuclear translocation. The PI3K/AKT/mTOR pathway involves activated RTKs recruiting and activating PI3K, leading to AKT activation and subsequent mTOR signaling, promoting cell growth and survival. There is significant cross-talk and feedback between the MAPK and PI3K/AKT pathways, with feedback loops that fine-tune cellular responses.\n\nRegulatory elements and patterns include feedback inhibition, where negative feedback loops, such as those involving SPRY proteins, modulate pathway activity to prevent overactivation. Oncogenic mutations in genes like EGFR, KRAS, BRAF, and PI3KCA are common in cancers, leading to constitutive pathway activation.\n\nAll in all, this gene cluster represents a complex network of signaling pathways that are crucial for cellular communication and function. Dysregulation of this signaling network is implicated in various cancers, making these pathways targets for therapeutic intervention. These pathways are also essential for normal development and tissue homeostasis, with roles in cell fate decisions and organogenesis. While much is known about these pathways, ongoing research continues to uncover new regulatory mechanisms and therapeutic targets.","The gene cluster of ErbB receptors is activated by members of the EGF family of growth factors. Some genes in this cluster encode ligands such as EGF, TGF-alpha, amphiregulin, betacellulin, and epiregulin. These ligands are initially synthesized as transmembrane precursors, which are then proteolytically cleaved to release the soluble growth factor. Other genes encode parts of the ErbB receptors, which consist of an extracellular ligand-binding domain, a single transmembrane region, and an intracellular domain endowed with tyrosine kinase activity.\n\nAdditionally, the receptors typically organize as dimers, except for ErbB-3, which exists as a monomer. The ErbB receptors are capable of forming both homodimers and heterodimers, with preferred dimerization partners determined by the specific ErbB receptor involved. Receptor activation occurs through ligand-induced dimerization, bringing intracellular kinase domains into proximity and allowing for transphosphorylation. Phosphorylated tyrosine residues consequently serve as docking sites for other signaling molecules. Regulation of these receptors involves the protein tyrosine phosphatase PTP1B and Cbl-mediated ubiquitination and degradation of activated receptors.\n\nAll in all, this gene cluster engages in the activation of several signaling cascades, including the Ras/Raf/MEK/MAPK and PI3K/AKT pathways, which are crucial for processes such as cell proliferation, differentiation, and apoptosis."
BIOCARTA_LEPTIN_PATHWAY,"['PRKAA1', 'PRKAB2', 'ACACA', 'LEP', 'PRKAA2', 'CPT1A', 'PRKAG1', 'PRKAG3', 'PRKAG2', 'LEPR', 'PRKAB1']",Reversal of Insulin Resistance by Leptin,"The insulin resistance of type II diabetes appears to be caused in part by the presence of high levels of lipids in cells such as skeletal muscle where this would not normally be found. The presence of excess lipid stores in skeletal muscle cells interferes with energy metabolism, impairing glucose oxidation and insulin response. Skeletal muscle is one of the primary glucose-consuming tissues, giving it a central role in insulin resistance. The increased risk of diabetes associated with obesity may be caused by increased lipid deposits in skeletal muscle and liver, creating insulin resistance. Leptin is a peptide hormone secreted by adipose tissue that has been associated with many processes. One of the target tissues of leptin is the hypothalamus where it can act to regulate feeding behavior and metabolism. Another leptin target is skeletal muscle. Activation of leptin signaling in skeletal muscle activates the AMP-activated protein kinase (AMP-kinase), known to play a key role in signaling in response to nutrients throughout evolution. AMPK phosphorylates and inactivates the enzyme ACC, acetyl-CoA carboxylase. ACC catalyzes the production of malonyl-CoA from acetyl-CoA. Malonyl-CoA in turn is an inhibitor of the import of fatty acids into mitochondria by carnitine palmitoyl-transferase I for oxidation and energy production. In the presence of leptin, AMPK is activated, ACC is inhibited, and malonyl-CoA levels fall, increasing the oxidation of fatty acids and reducing the lipid content of cells. The reduced lipid content in skeletal muscle allows insulin signaling and glucose consumption to return to their normal levels, reducing insulin resistance.","The gene cluster provided is primarily associated with the regulation of energy metabolism, particularly focusing on the AMP-activated protein kinase (AMPK) pathway and its interactions with lipid metabolism and energy homeostasis.\n\n### Cluster Identification and Biological Function\n\nThe gene cluster centers around the AMPK complex, a critical energy sensor in cells that maintains energy balance. AMPK is a heterotrimeric enzyme composed of a catalytic \u03b1 subunit (encoded by genes such as **PRKAA1** and **PRKAA2**) and regulatory \u03b2 and \u03b3 subunits (encoded by genes like **PRKAB1**, **PRKAB2**, **PRKAG1**, **PRKAG2**, and **PRKAG3**). The AMPK complex is activated in response to low energy states, such as increased AMP/ATP ratios, and it functions to restore energy balance by activating catabolic pathways and inhibiting anabolic processes.\n\n### Key Genes and Their Functions\n\nSome genes in this cluster, such as **PRKAA1** and **PRKAA2**, encode the catalytic \u03b1 subunits of AMPK, responsible for the kinase activity of the complex, phosphorylating various downstream targets to regulate energy homeostasis. Other genes, like **PRKAB1** and **PRKAB2**, encode the \u03b2 subunits, which play a role in stabilizing the AMPK complex and facilitating its activation. Additionally, **PRKAG1**, **PRKAG2**, and **PRKAG3** encode the \u03b3 subunits, which contain binding sites for AMP and ATP, thus acting as sensors for the energy status of the cell.\n\nAdditionally, **ACACA (Acetyl-CoA carboxylase alpha)** encodes an enzyme that is a key regulator of fatty acid synthesis. AMPK phosphorylates and inhibits ACACA, thereby reducing lipid synthesis when energy is low. **CPT1A (Carnitine palmitoyltransferase 1A)** encodes an enzyme involved in the transport of fatty acids into mitochondria for \u03b2-oxidation, and AMPK activation enhances CPT1A activity, promoting fatty acid oxidation. **LEP (Leptin)** and **LEPR (Leptin receptor)** are involved in regulating energy balance by inhibiting hunger, which in turn diminishes fat storage in adipocytes. LEPR is the receptor for leptin, and its interaction with leptin is crucial for the regulation of appetite and energy expenditure.\n\n### Relationships and Regulatory Elements\n\nThe AMPK complex acts as a central regulator, integrating signals from various pathways to maintain energy homeostasis. It directly interacts with metabolic enzymes like ACACA and CPT1A to modulate lipid metabolism. The leptin signaling pathway, through LEP and LEPR, provides additional regulatory input, linking energy status to appetite control and energy expenditure.\n\n### Biological Implications\n\nAll in all, this gene cluster is vital for maintaining cellular and systemic energy balance. Dysregulation of this cluster can lead to metabolic disorders such as obesity, type 2 diabetes, and cardiovascular diseases. Understanding the interactions within this cluster can provide insights into therapeutic targets for metabolic diseases.\n\n### Gaps in Knowledge\n\nWhile the roles of individual genes in this cluster are well-characterized, the precise mechanisms of their interactions and regulation in different tissues and under various physiological conditions remain areas of active research. Further studies are needed to elucidate these complex interactions and their implications for metabolic health.","The gene cluster associated with leptin involves its role as an adipocyte-derived hormone that regulates energy homeostasis by acting on the brain and other peripheral tissues. Some genes in this cluster function by allowing leptin to bind to the Ob-Rb receptor, which is coupled to the JAK/STAT signaling pathway. Other genes facilitate leptin's role as a metabolic regulator, where leptin stimulates fatty acid oxidation in skeletal muscle by activating AMP-activated protein kinase (AMPK), which is a metabolic stress-sensing enzyme activated by increases in AMP: ATP and/or ADP: ATP ratios. Additionally, leptin stimulates fatty acid oxidation in the liver by influencing AMPK in the hypothalamus. The activation of AMPK by leptin in both skeletal muscle and liver is independent of the JAK/STAT pathway and is mediated by the protein kinase LKB1, a tumor suppressor that activates AMPK through phosphorylation. Leptin also promotes glucose uptake and utilization in skeletal muscle via AMPK activation. All in all, this gene cluster highlights leptin's ability to stimulate fatty acid oxidation and glucose uptake in skeletal muscle, which may contribute to its weight-reducing and anti-diabetic effects."
KEGG_GLIOMA,"['SOS2', 'CALM2', 'E2F1', 'PRKCB', 'RAF1', 'SHC1', 'PRKCA', 'CALM1', 'IGF1', 'MTOR', 'IGF1R', 'PRKCG', 'PDGFRB', 'MAP2K2', 'TGFA', 'BRAF', 'MAP2K1', 'MDM2', 'RB1', 'AKT1', 'SHC4', 'AKT2', 'NRAS', 'AKT3', 'GRB2', 'MAPK3', 'SOS1', 'MAPK1', 'PIK3R5', 'HRAS', 'EGFR', 'KRAS', 'CDKN2A', 'SHC3', 'CDKN1A', 'EGF', 'ARAF', 'CALML5', 'CCND1', 'PTEN', 'PIK3R3', 'PDGFA', 'CAMK2A', 'PDGFB', 'CAMK2B', 'PDGFRA', 'CAMK2D', 'CAMK2G', 'CDK4', 'TP53', 'E2F3', 'CALML3', 'E2F2', 'PIK3CA', 'PIK3CB', 'CDK6', 'PIK3CD', 'PLCG1', 'SHC2', 'PLCG2', 'CALM3', 'PIK3CG', 'PIK3R1', 'PIK3R2', 'CALML6']",Glioma,"Glioblastoma multiforme (GBM) formation is either de novo (primary GBMs) or due to the progression of a lower grade glioma to a higher grade one through the acquisition of additional mutations (secondary GBMs). In primary GBM, disruption of the p53 pathway often occurs through loss of ARF, or less frequently through amplification of MDM2. Disruption of the RB pathway occurs through loss of INK4A. Amplification and/or mutation of the epidermal growth factor receptor (EGFR) is the most frequently detected genetic defect that is associated with primary GBM. In secondary GBM, loss of p53 and activation of the growth-factorreceptor-tyrosine-kinase signalling pathway (such as through overexpression of PDGF/PDGFR ) initiates tumour formation,whereas disruption of the retinoblastoma (RB) pathway contributes to the progression of tumour development. Loss of PTEN has been implicated in both pathways, although it is much more common in the pathogenesis of primary GBM.","The gene cluster provided is primarily involved in the regulation of cell growth, proliferation, survival, and differentiation, with a significant focus on the PI3K/AKT/mTOR and MAPK/ERK signaling pathways. These pathways are critical for transmitting signals from growth factors and other extracellular stimuli to the cell's interior, influencing various cellular processes.\n\nSome genes in this cluster are part of the PI3K/AKT/mTOR pathway. These include:\n\n- **PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5:** These genes encode subunits of phosphoinositide 3-kinases (PI3Ks), which are involved in the activation of AKT signaling.\n- **AKT1, AKT2, AKT3:** These serine/threonine kinases are central to the PI3K pathway, promoting cell survival and growth.\n- **MTOR:** A key regulator of cell growth and metabolism, mTOR integrates signals from nutrients and growth factors.\n- **PTEN:** A tumor suppressor that negatively regulates the PI3K/AKT pathway by dephosphorylating PIP3 back to PIP2.\n\nOther genes are involved in the MAPK/ERK pathway, including:\n\n- **RAF1, BRAF, ARAF:** These kinases are part of the RAF family, which activates the MEK/ERK cascade.\n- **MAP2K1 (MEK1), MAP2K2 (MEK2):** These kinases activate ERK1/2.\n- **MAPK1 (ERK2), MAPK3 (ERK1):** These are the terminal kinases in the MAPK pathway, regulating gene expression and cell cycle progression.\n\nAdditionally, the cluster includes genes related to growth factor receptors and ligands, such as:\n\n- **EGFR, IGF1R, PDGFRA, PDGFRB:** Receptors that initiate signaling cascades upon binding their respective ligands (EGF, IGF1, PDGFA, PDGFB).\n- **TGFA, EGF, PDGFA, PDGFB:** Growth factors that activate their corresponding receptors.\n\nThe cluster also encompasses genes involved in cell cycle regulation:\n\n- **CDK4, CDK6, CCND1 (Cyclin D1):** These proteins form complexes that drive the cell cycle from G1 to S phase.\n- **RB1:** A tumor suppressor that regulates the cell cycle by controlling E2F transcription factors.\n- **CDKN2A, CDKN1A (p21):** Cyclin-dependent kinase inhibitors that regulate cell cycle progression.\n\nTranscription factors and regulators in this cluster include:\n\n- **E2F1, E2F2, E2F3:** Transcription factors that regulate genes essential for cell cycle progression.\n- **TP53:** A crucial tumor suppressor involved in DNA repair, apoptosis, and cell cycle arrest.\n- **MDM2:** A negative regulator of TP53, controlling its degradation.\n\nThe cluster also contains adaptor proteins and other signaling molecules:\n\n- **SOS1, SOS2:** Guanine nucleotide exchange factors that activate RAS proteins.\n- **GRB2, SHC1, SHC2, SHC3, SHC4:** Adaptor proteins that link receptor tyrosine kinases to downstream signaling pathways.\n- **NRAS, HRAS, KRAS:** Small GTPases that act as molecular switches in signaling pathways.\n\nCalcium signaling is represented by:\n\n- **CALM1, CALM2, CALM3, CALML3, CALML5, CALML6:** Calmodulin and calmodulin-like proteins that mediate calcium-dependent signaling.\n- **CAMK2A, CAMK2B, CAMK2D, CAMK2G:** Calcium/calmodulin-dependent protein kinases involved in various cellular processes.\n\nThe PI3K/AKT and MAPK/ERK pathways are interconnected, with cross-talk influencing cellular outcomes. Growth factor receptors like EGFR and IGF1R initiate these pathways, leading to diverse cellular responses. Tumor suppressors such as PTEN and TP53 play critical roles in maintaining cellular homeostasis by counteracting oncogenic signals. Cyclins and CDKs, regulated by inhibitors like CDKN2A, ensure proper cell cycle progression.\n\nAll in all, this gene cluster represents a complex network of signaling pathways essential for normal cellular function and growth, with significant implications in cancer biology. Dysregulation of these pathways is implicated in various cancers, as they control critical processes like cell proliferation and survival. Understanding these gene interactions provides insights into potential therapeutic targets for cancer treatment. The balance between oncogenes and tumor suppressors within this cluster is crucial for preventing uncontrolled cell growth. Further research is needed to fully elucidate the interactions and regulatory mechanisms within this cluster.","The gene cluster is the epidermal growth factor receptor (EGFR), which is a member of the ErbB family of receptor tyrosine kinases. Some genes in this cluster can be activated by ligand-induced dimerization with other members of the ErbB family of receptors, including EGFR / HER1, HER2 / neu, HER3, and HER4, or by homodimerization with itself. Other genes are involved in receptor dimerization upon ligand binding to the extracellular domain, activating the intracellular tyrosine kinase domain, leading to the phosphorylation of intracellular substrates. Additionally, the phosphorylation of ErbB-3 and ErbB-4 by the EGFR is less significant in the mitogenic signaling pathway compared to other substrates. All in all, this gene cluster recruits signaling molecules that activate two major signaling cascades: the Ras-Raf-mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3'-kinase (PI3-kinase)-Akt pathway, ultimately resulting in cellular proliferation, differentiation, and/or migration."
KEGG_MELANOGENESIS,"['CALM2', 'CALM1', 'TYR', 'CREB3L1', 'FZD1', 'FZD4', 'FZD6', 'FZD7', 'LEF1', 'CREBBP', 'CREB3', 'FZD8', 'FZD9', 'POMC', 'WNT9B', 'WNT9A', 'CREB1', 'WNT2B', 'WNT11', 'EDN1', 'WNT10B', 'NRAS', 'EDNRB', 'KRAS', 'PRKX', 'GNAI1', 'GNAI2', 'CALML5', 'ADCY3', 'ADCY2', 'ADCY1', 'CREB3L3', 'WNT5B', 'CAMK2A', 'CAMK2B', 'CAMK2D', 'CAMK2G', 'PRKACA', 'GNAQ', 'PRKACB', 'PRKACG', 'GNAS', 'GNAI3', 'WNT16', 'GNAO1', 'CALML3', 'DCT', 'CALM3', 'PLCB2', 'ADCY8', 'ADCY9', 'PLCB1', 'ADCY6', 'ADCY7', 'PRKCB', 'RAF1', 'PLCB3', 'PRKCA', 'PLCB4', 'ADCY5', 'CREB3L4', 'ASIP', 'KITLG', 'PRKCG', 'MC1R', 'WNT3A', 'DVL3', 'DVL2', 'MAP2K2', 'MAP2K1', 'KIT', 'FZD3', 'DVL1', 'ADCY4', 'TYRP1', 'WNT4', 'WNT10A', 'MAPK3', 'TCF7', 'MAPK1', 'TCF7L2', 'HRAS', 'WNT1', 'EP300', 'GSK3B', 'WNT7A', 'WNT7B', 'WNT8A', 'WNT8B', 'WNT2', 'WNT3', 'WNT5A', 'CTNNB1', 'WNT6', 'FZD10', 'CREB3L2', 'FZD5', 'TCF7L1', 'MITF', 'FZD2', 'CALML6']",Melanogenesis,"Cutaneous melanin pigment plays a critical role in camouflage, mimicry, social communication, and protection against harmful effects of solar radiation. Melanogenesis is under complex regulatory control by multiple agents. The most important positive regulator of melanogenesis is the MC1 receptor with its ligands melanocortic peptides. MC1R activates the cyclic AMP (cAMP) response-element binding protein (CREB). Increased expression of MITF and its activation by phosphorylation (P) stimulate the transcription of tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), and dopachrome tautomerase (DCT), which produce melanin. Melanin synthesis takes place within specialized intracellular organelles named melanosomes. Melanin-containing melanosomes then move from the perinuclear region to the dendrite tips and are transferred to keratinocytes by a still not well-characterized mechanism.","The gene cluster provided is primarily involved in the Wnt signaling pathway, a crucial pathway for regulating cell fate, proliferation, migration, and polarity during embryonic development and in adult tissues. This pathway is highly conserved across species and plays a significant role in various biological processes, including stem cell maintenance and differentiation, as well as in the pathogenesis of diseases such as cancer.\n\nSome genes in this cluster include Wnt ligands and Frizzled receptors. The WNT genes (e.g., WNT1, WNT2, WNT3A, WNT5A, etc.) encode secreted glycoproteins that initiate the Wnt signaling cascade by binding to Frizzled receptors. The Frizzled receptors (FZD1, FZD2, FZD3, etc.) are G protein-coupled receptors that interact with Wnt ligands to activate downstream signaling pathways.\n\nOther genes in the cluster are involved in downstream signaling. CTNNB1 (\u03b2-catenin) is a central player in the canonical Wnt pathway, where its stabilization and translocation to the nucleus lead to the activation of Wnt target genes. DVL (Dishevelled) proteins (DVL1, DVL2, DVL3) act as key mediators that transduce signals from Frizzled receptors to downstream effectors.\n\nAdditionally, transcription factors such as LEF1, TCF7, TCF7L1, and TCF7L2 form complexes with \u03b2-catenin to regulate the expression of Wnt target genes. Regulatory proteins like GSK3B (Glycogen Synthase Kinase 3 Beta) are involved in the degradation of \u03b2-catenin in the absence of Wnt signaling. CREB and CREBBP/EP300 are involved in the transcriptional regulation of genes and can interact with \u03b2-catenin to modulate gene expression.\n\nCalcium/calmodulin and protein kinases also play a role. CALM genes (CALM1, CALM2, CALM3, etc.) encode calmodulin, a calcium-binding messenger protein that can influence various signaling pathways, including Wnt. CAMK2 and PRK genes (e.g., CAMK2A, PRKACA) encode kinases that can modulate Wnt signaling through phosphorylation events.\n\nG proteins and adenylyl cyclases are part of this cluster as well. GNAI, GNAQ, and GNAS encode G proteins that can modulate signaling pathways, including those initiated by Frizzled receptors. ADCY genes (ADCY1, ADCY2, etc.) encode adenylyl cyclases that produce cAMP, a secondary messenger involved in various signaling pathways.\n\nAll in all, this gene cluster is critical for normal development and tissue homeostasis. Dysregulation of this pathway is implicated in numerous diseases, particularly cancer, where aberrant activation can lead to uncontrolled cell proliferation and survival. The presence of multiple Wnt ligands and Frizzled receptors in this cluster suggests a complex regulatory network that allows for fine-tuned control of cellular responses. While the core components and interactions of the Wnt signaling pathway are well-characterized, the specific roles and interactions of some genes in this cluster, such as the various CREB and CAMK2 isoforms, in the context of Wnt signaling remain less understood. Further research is needed to elucidate these interactions and their implications in health and disease.","The gene cluster involved in melanocyte development is regulated by a network of transcription factors. Some genes in this cluster, such as the basic helix-loop-helix (bHLH) -Zip transcription factors MITF, TFAP2A, TFAP2B, and USF, serve as important regulators in this process. Other genes, including the transcription factor PAX3, are also essential for the development of the melanocyte lineage. Additionally, mutations in the PAX3 gene are associated with the human disease Splendore-Hoorn (or lozartan hair), characterized by a tuft of thin, redundant, coarse, and curly hair. The agouti gene encodes a 132 amino acid protein secreted by the hair follicle into the hair bulb, thought to act as an inverse agonist of the melanocortin-1 receptor (MC1R). The binding of alpha-melanocyte stimulating hormone (alpha-MSH) to MC1R stimulates the synthesis of cAMP, activating MITF and the transcription of genes involved in melanin production, while the agouti protein antagonizes this effect by binding to MC1R and inhibiting cAMP production. All in all, this gene cluster plays a crucial role in regulating melanocyte development and pigmentation processes."
BIOCARTA_NFKB_PATHWAY,"['IL1A', 'IKBKG', 'NFKBIA', 'MYD88', 'FADD', 'CHUK', 'TNFAIP3', 'TNF', 'TNFRSF1B', 'TNFRSF1A', 'MAP3K14', 'TRAF6', 'TRADD', 'RELA', 'TAB1', 'RIPK1', 'MAP3K7', 'IKBKB', 'NFKB1', 'MAP3K1', 'IL1R1']",NF-kB Signaling Pathway,"Nuclear factor kB (NF-kB) is a nuclear transcription factor that regulates expression of a large number of genes that are critical for the regulation of apoptosis, viral replication, tumorigenesis, inflammation, and various autoimmune diseases. The activation of NF-kB is thought to be part of a stress response as it is activated by a variety of stimuli that include growth factors, cytokines, lymphokines, UV, pharmacological agents, and stress. In its inactive form, NF-kB is sequestered in the cytoplasm, bound by members of the IkB family of inhibitor proteins, which include IkBa, IkBb, IkBg, and IkBe. The various stimuli that activate NF-kB cause phosphorylation of IkB, which is followed by its ubiquitination and subsequent degradation. This results in the exposure of the nuclear localization signals (NLS) on NF-kB subunits and the subsequent translocation of the molecule to the nucleus. In the nucleus, NF-kB binds with a consensus sequence (5'GGGACTTTCC-3') of various genes and thus activates their transcription. IkB proteins are phosphorylated by IkB kinase complex consisting of at least three proteins; IKK1/IKKa, IKK2/IKKb, and IKK3/IKKg. These enzymes phosphorylate IkB leading to its ubiquitination and degradation. Tumor necrosis factor (TNF) which is the best-studied activator binds to its receptor and recruits a protein called TNF receptor death domain (TRADD). TRADD binds to the TNF receptor-associated factor 2 (TRAF-2) that recruits NF-kB-inducible kinase (NIK). Both IKK1 and IKK2 have canonical sequences that can be phosphorylated by the MAP kinase NIK/MEKK1 and both kinases can independently phosphorylate IkBa or IkBb. TRAF-2 also interacts with A20, a zinc finger protein whose expression is induced by agents that activate NF-kB. A20 functions to block TRAF2-mediated NF-kB activation. A20 also inhibits TNF and IL-1 induced activation of NF-kB suggesting that it may act as a general inhibitor of NF-kB activation.","The gene cluster provided is primarily involved in the regulation of the NF-\u03baB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway, which is crucial for immune response, inflammation, and cell survival. This pathway is activated by various stimuli, including cytokines, stress, and microbial antigens, and plays a pivotal role in regulating genes involved in immune and inflammatory responses.\n\nSome genes in this cluster include:\n\n1. **IL1A (Interleukin 1 Alpha)**: A pro-inflammatory cytokine that activates the NF-\u03baB pathway by binding to its receptor, IL1R1.\n2. **IKBKG (Inhibitor of Nuclear Factor Kappa B Kinase Subunit Gamma)**: Also known as NEMO, essential for activating the IKK complex, which phosphorylates I\u03baB proteins, leading to the release and nuclear translocation of NF-\u03baB.\n3. **NFKBIA (Nuclear Factor of Kappa Light Polypeptide Gene Enhancer in B-cells Inhibitor, Alpha)**: Encodes I\u03baB\u03b1, an inhibitor that binds NF-\u03baB, sequestering it in the cytoplasm. Phosphorylation leads to its degradation, allowing NF-\u03baB to enter the nucleus.\n4. **MYD88 (Myeloid Differentiation Primary Response 88)**: An adaptor protein that mediates signaling from IL1R1 and Toll-like receptors, leading to NF-\u03baB activation.\n5. **FADD (Fas-Associated Protein with Death Domain)**: Involved in apoptotic signaling and can interact with TNF receptor pathways.\n6. **CHUK (Conserved Helix-Loop-Helix Ubiquitous Kinase)**: Also known as IKK\u03b1, part of the IKK complex that phosphorylates I\u03baB proteins.\n7. **TNFAIP3 (TNF Alpha Induced Protein 3)**: Also known as A20, a ubiquitin-editing enzyme that negatively regulates NF-\u03baB signaling, providing a feedback mechanism to dampen inflammation.\n8. **TNF (Tumor Necrosis Factor)**: A cytokine that binds to TNFRSF1A and TNFRSF1B, initiating signaling cascades that activate NF-\u03baB.\n9. **TNFRSF1A and TNFRSF1B (TNF Receptor Superfamily Members 1A and 1B)**: Receptors for TNF, initiating downstream signaling that includes NF-\u03baB activation.\n10. **MAP3K14 (Mitogen-Activated Protein Kinase Kinase Kinase 14)**: Also known as NIK, involved in the non-canonical NF-\u03baB pathway.\n11. **TRAF6 (TNF Receptor Associated Factor 6)**: An E3 ubiquitin ligase that mediates signaling from IL1R1 and TNF receptors to activate NF-\u03baB.\n12. **TRADD (TNFRSF1A-Associated Via Death Domain)**: An adaptor protein that links TNFRSF1A to downstream signaling pathways, including NF-\u03baB.\n13. **RELA (v-rel Avian Reticuloendotheliosis Viral Oncogene Homolog A)**: A subunit of the NF-\u03baB transcription factor complex.\n14. **TAB1 (TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 1)**: Works with TAK1 (MAP3K7) to activate the IKK complex.\n15. **RIPK1 (Receptor Interacting Serine/Threonine Kinase 1)**: Involved in TNF receptor signaling, leading to NF-\u03baB activation and cell survival.\n16. **MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7)**: Also known as TAK1, a key kinase in the activation of the IKK complex.\n17. **IKBKB (Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta)**: Part of the IKK complex, phosphorylates I\u03baB proteins.\n18. **NFKB1 (Nuclear Factor Kappa B Subunit 1)**: Encodes the p105 precursor, which is processed to p50, a component of the NF-\u03baB complex.\n19. **MAP3K1 (Mitogen-Activated Protein Kinase Kinase Kinase 1)**: Involved in various signaling pathways, including NF-\u03baB.\n20. **IL1R1 (Interleukin 1 Receptor Type 1)**: The receptor for IL1A, initiating signaling cascades that activate NF-\u03baB.\n\nAdditionally, the NF-\u03baB pathway is tightly regulated by a balance of activating and inhibitory signals. Key regulatory elements include the IKK complex (CHUK, IKBKB, IKBKG) and inhibitors like NFKBIA and TNFAIP3. The pathway involves a complex network of interactions, with adaptor proteins like MYD88, TRADD, and FADD linking receptors to downstream kinases and transcription factors. Feedback mechanisms, such as the induction of TNFAIP3, help to prevent excessive inflammation.\n\nAll in all, this gene cluster represents a critical component of the immune response, with intricate regulatory mechanisms ensuring balanced activation and inhibition of NF-\u03baB signaling. Dysregulation of the NF-\u03baB pathway is implicated in various diseases, including chronic inflammatory conditions, autoimmune diseases, and cancer. Understanding the interactions and regulatory mechanisms within this gene cluster is crucial for developing therapeutic strategies targeting NF-\u03baB signaling in disease contexts.","The gene cluster associated with Interleukin 1 (IL-1) is a pro-inflammatory cytokine signaling through the IL-1 receptor. Some genes in this cluster are responsible for the production of IL-1 by macrophages in response to infection, stimulating the production of other cytokines, such as TNF, across various cell types. Other genes, like those involved in TNF production, carry out functions including the induction of fever and other responses to infection. Additionally, IL-1 and TNF can serve as inflammatory agents even in the absence of infection. All in all, this gene cluster is critical for signaling through the IL-1 receptor, which is part of the TNF receptor family and uses the TRAF family of proteins to activate NF-kB and other transcription factors."
BIOCARTA_BLYMPHOCYTE_PATHWAY,"['CD80', 'ITGAL', 'CR1', 'ITGB2', 'CR2', 'CD40', 'HLA-DRA', 'HLA-DRB5', 'ICAM1', 'FCGR2B', 'PTPRC', 'HLA-DRB1', 'HLA-DRB4', 'HLA-DRB3']",B Lymphocyte Cell Surface Molecules,"B cells must communicate with their environment to participate in the immune system as the source of antigen-specific immunoglobulins. Cell surface proteins on B cells receive signals from the exterior, adhere to other cells, and transmit signals to other cells. Antigen recognized by a B cell's immunoglobulin is presented in MHC Class II to T cells during B cell activation. Cell surface immunoglobulins are a key to B cell function, assisting in the response of B cells to specific antigen recognized by that cell's immunoglobulin. CD54 (ICAM-1) is an adhesion molecule involved in the binding of B cells to other cell types and LFA-1 is an integrin adhesion protein with two subunits that binds to ICAM. CD35 and CD21 are receptors for complement factors that stimulate the B cell response when complement is activated. CD80 and CD40 bind to T cell proteins (CD28 and CD40L, respectively) to provide costimulatory signals in the B cell-T cell interaction required for B cell activation. CD45 is a protein tyrosine phosphatase that regulates activation of B cells and T cells through dephosphorylation of signaling factors. CD32 is a receptor for IgG Fc, and is also called FcgammaRII. The number of proteins on the surface of B cell proteins indicates the complexity of regulation of B cell activation.","The gene cluster is primarily associated with immune system function, particularly in antigen presentation, cell adhesion, and immune cell signaling. Some genes in this cluster encode proteins involved in the adaptive immune response, highlighting their roles in immune cell communication and activation.\n\n1. **Major Histocompatibility Complex (MHC) Class II Genes**: \n   - **HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5**: These genes encode the alpha and beta chains of MHC class II molecules, crucial for presenting extracellular antigens to CD4+ T helper cells. The diversity in the HLA-DRB genes allows for a wide range of antigen presentation, critical for adaptive immunity.\n\n2. **Costimulatory and Adhesion Molecules**:\n   - **CD80**: Encodes a protein that provides a costimulatory signal necessary for T cell activation and survival, interacting with CD28 and CTLA-4 on T cells.\n   - **CD40**: Encodes a receptor on antigen-presenting cells that, upon binding with CD40 ligand on T cells, enhances the immune response by promoting B cell proliferation, antibody class switching, and memory B cell development.\n   - **ICAM1 (Intercellular Adhesion Molecule 1)**: Encodes a cell surface glycoprotein involved in stabilizing cell-cell interactions and facilitating leukocyte endothelial transmigration.\n\n3. **Integrins and Complement Receptors**:\n   - **ITGAL (Integrin Alpha L) and ITGB2 (Integrin Beta 2)**: These genes encode components of the LFA-1 integrin, important for leukocyte adhesion and migration.\n   - **CR1 (Complement Receptor 1) and CR2 (Complement Receptor 2)**: These genes encode receptors that play roles in the complement system, aiding in the clearance of immune complexes and enhancing B cell activation.\n\n4. **Fc Receptor and Phosphatase**:\n   - **FCGR2B (Fc Fragment of IgG Receptor IIb)**: Encodes a receptor that binds the Fc region of IgG antibodies, providing inhibitory signals to B cells and other immune cells to prevent overactivation.\n   - **PTPRC (Protein Tyrosine Phosphatase, Receptor Type C, also known as CD45)**: Encodes a protein tyrosine phosphatase essential for T and B cell receptor signaling.\n\nAdditionally, the genes in this cluster are often regulated by cytokines and other immune signals, which modulate their expression during immune responses. The MHC class II genes, in particular, are tightly regulated by transcription factors such as CIITA (Class II Transactivator).\n\nAll in all, this gene cluster is critical for effective immune surveillance and response. Dysregulation or genetic variation in these genes can lead to immune-related disorders, including autoimmune diseases, immunodeficiencies, and increased susceptibility to infections. Understanding the interactions and regulation of these genes is vital for developing therapeutic strategies for immune modulation. Overall, this gene cluster represents a fundamental component of the immune system, with each gene contributing to the complex network of immune regulation and response. Further research is needed to fully elucidate the interactions and regulatory mechanisms governing these genes.","The gene cluster associated with B cells interacting with antigen-presenting cells (APCs) is crucial for generating an effective immune response. Some genes in this cluster are involved with the B cell receptor (BCR), which is responsible for recognizing antigens and initiating B cell activation. The BCR is a heterodimer, consisting of immunoglobulin (Ig) heavy and light chains alongside the signaling subunits Ig-alpha (CD79a) and Ig-beta (CD79b). \n\nOther genes facilitate the interaction between B cells and APCs, which is important for the immune response. This interaction is mediated by various cell surface molecules, such as the integrins LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18), the Ig-alpha/Ig-beta heterodimer, and CD40. \n\nAdditionally, the binding of an antigen to the BCR triggers a signaling cascade, resulting in the proliferation and differentiation of the B cell. \n\nAll in all, this gene cluster is integral to the immune response by mediating B cell interactions with both antigens and APCs, leading to B cell activation and function."
BIOCARTA_ASBCELL_PATHWAY,"['CD80', 'FASLG', 'IL4', 'IL2', 'IL10', 'FAS', 'CD28', 'CD40', 'HLA-DRA', 'HLA-DRB5', 'CD40LG', 'CD4', 'HLA-DRB1', 'HLA-DRB4', 'HLA-DRB3']",Antigen Dependent B Cell Activation,"A key part of the immune system is the production of immunoglobulins (antibodies) by B cells to bind and inactivate specific foreign antigens. The body produces B cells with a wide range of antigen specificities in the immunoglobulin B cell receptor, one antigen specificity per cell. When the B cell receptor immunoglobulin binds antigen, that cell is activated to proliferate and create plasma cells secreting immunoglobulins to bind that specific antigen. B cell activation also creates memory cells with the same antigen specificity that do not actively secrete immunoglobulin but provide for rapid future immune responses to the same antigen. B cells are not activated by antigen on their own, but require interaction with helper CD4+ T cells to become activated and proliferate. The B cell first expresses immunoglobulin on the cell surface as the B cell receptor. If the B cell receptor immunoglobulin binds specific antigen, then the cell internalizes the antigen and presents it to T cells in MHC II, where it is recognized by the T cell receptor. In addition to the interaction between the T cell receptor and the B cell MHC-antigen, T cell interaction with the B cell involves additional positive and negative regulatory signals. CD40 interaction with CD40L and CD28 interaction with CD80 provide positive costimulatory signals that stimulate B cell activation and proliferation. T cell receptor activation induces expression of molecules like the CD40 ligand that modulate the B cell-T cell interaction. The CD40-CD40L interaction induces cytokine production and expression of other genes and alters the fate of the B cell involved in the interaction. If the interaction between CD40 and CD40L is prolonged, the B cell can be induced to become a memory cell rather than a plasma cell. Fas ligand binding to Fas between B and T cells may negatively modulate B cell activation, inducing apoptosis that limits B cell proliferation and activation. Cytokines like IL-2, IL-4 and IL-10 also play an important role in B cell activation.","The gene cluster provided is primarily involved in immune system regulation and function, particularly in the context of T-cell activation, antigen presentation, and immune response modulation. Some genes in this cluster encode cytokines, receptors, and major histocompatibility complex (MHC) molecules, which are crucial for adaptive immunity.\n\n### Key Genes and Their Functions:\n\n1. **CD80 and CD28**: CD80 is a costimulatory molecule expressed on antigen-presenting cells (APCs) that binds to CD28 on T-cells, providing necessary signals for T-cell activation and survival. This interaction is critical for initiating immune responses.\n\n2. **FAS and FASLG**: FAS (also known as CD95) and its ligand FASLG (Fas Ligand) are involved in the regulation of programmed cell death (apoptosis). This pathway is essential for maintaining immune homeostasis and preventing autoimmunity by eliminating activated T-cells.\n\n3. **IL2, IL4, and IL10**: These interleukins are cytokines with distinct roles in immune modulation. IL2 is crucial for T-cell proliferation, IL4 is involved in the differentiation of naive T-cells into Th2 cells, and IL10 is an anti-inflammatory cytokine that helps regulate immune responses to prevent excessive inflammation.\n\n4. **CD40 and CD40LG**: CD40 is a receptor on APCs, and its ligand CD40LG (CD40 Ligand) is expressed on activated T-cells. Their interaction is vital for B-cell activation, differentiation, and isotype switching, as well as for enhancing APC function.\n\n5. **HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5**: These genes encode for MHC class II molecules, which are essential for presenting extracellular antigens to CD4+ T-helper cells. This antigen presentation is crucial for the activation of adaptive immune responses.\n\n6. **CD4**: CD4 is a co-receptor that assists in the recognition of MHC class II molecules by T-helper cells, facilitating their activation and function.\n\n### Relationships and Regulatory Elements:\n\n- The interaction between CD80/CD28 and CD40/CD40LG is pivotal for T-cell and B-cell collaboration, enhancing immune responses.\n- The balance between pro-inflammatory cytokines (IL2, IL4) and anti-inflammatory cytokines (IL10) is crucial for immune regulation and preventing pathological conditions such as autoimmunity or chronic inflammation.\n- The FAS/FASLG pathway is a key regulatory mechanism for controlling immune cell lifespan and preventing overactivation of the immune system.\n\n### Biological Implications:\n\nAdditionally, this gene cluster plays a fundamental role in orchestrating immune responses, ensuring effective defense against pathogens while maintaining self-tolerance. Dysregulation of these genes can lead to immune-related disorders, including autoimmune diseases, immunodeficiencies, and lymphoproliferative disorders. Understanding the interactions and regulatory mechanisms within this cluster is essential for developing therapeutic strategies for immune-mediated diseases.\n\nAll in all, this gene cluster is integral to the regulation and function of the immune system, with significant implications for health and disease.","The gene cluster consists of the CD40 ligand (CD154), which is expressed on activated T cells. Some genes in this cluster interact with CD40, which is a member of the tumor necrosis factor receptor (TNFR) gene family. Other genes in this cluster facilitate the binding of CD154 to CD40, leading to biological outcomes. Additionally, this interaction induces B cell proliferation and differentiation as well as T cell activation. All in all, this gene cluster plays a crucial role in immune response modulation through its interactions and induced cellular processes."
BIOCARTA_CYTOKINE_PATHWAY,"['CXCL8', 'IL3', 'IL13', 'IFNG', 'IL9', 'IL1A', 'IL5', 'TXLNA', 'IFNA1', 'IL17A', 'IL4', 'IL18', 'IL2', 'IFNB1', 'IL15', 'IL10', 'TNF', 'IL16', 'IL6']",Cytokine Network,"Several different cell types coordinate their efforts as part of the immune system, including B cells, T cells, macrophages, neutrophils, basophils and eosinophils. Each of these cell types has a distinct role in the immune system, and communicates with other immune cells using secreted factors called cytokines, including interleukins, TNF, and the interferons. Macrophages phagocytose foreign bodies and are antigen-presenting cells, using cytokines to stimulate specific antigen dependent responses by B and T cells and non-specific responses by other cell types. T cells secrete a variety of factors to coordinate and stimulate immune responses to specific antigen, such as the role of helper T cells in B cell activation in response to antigen. The proliferation and activation of eosinophils, neutrophils and basophils respond to cytokines as well. Cytokine communication is often local, within a tissue or between cells in close proximity. Each of the cytokines is secreted by one set of cells and provokes a response in another target set of cells, often including the cell that secretes the cytokine. Some cytokines, like IL-1, interferons and TNF, stimulate a broad inflammatory response in response to infection or injury. Other cytokines have more specific functions such the following examples. IL-2 stimulates the proliferation and activation of B and T cells. IL-4 plays a role in the differentiation of Th2 cells, in allergic responses, and in the switching of antibody types. IL-5 stimulates the production and maturation of eosinophils during inflammation. IL-8 is a chemokine, a chemotactic factor that attracts neutrophils, basophils and T cells to sites of inflammation. IL-12 and IL-18 are involved in helper T cell differentiation. IL-10 apparently acts to repress secretion of proinflammatory cytokines. The complex interplay of these different cytokine functions with immune cells is essential for correct immune function.","The gene cluster provided consists predominantly of cytokines and interleukins, which are critical components of the immune system. This cluster plays a significant role in mediating and regulating immune responses, inflammation, and hematopoiesis.\n\n1. **Cluster Identification and Biological Function:**\n   - The gene cluster is primarily involved in immune signaling and inflammatory responses. The genes encode cytokines and interleukins that are crucial for communication between immune cells, facilitating both innate and adaptive immune responses.\n\n2. **Key Genes and Their Functions:**\n   - Some genes in this cluster include:\n     - **CXCL8 (IL-8):** A chemokine that attracts neutrophils to sites of infection, playing a key role in acute inflammation.\n     - **IL3:** Supports the growth and differentiation of hematopoietic stem cells into various blood cells, including myeloid lineage cells.\n     - **IL13:** Involved in the regulation of inflammatory responses, particularly in allergic reactions and asthma.\n     - **IFNG (Interferon gamma):** A critical cytokine for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control.\n     - **IL9:** Promotes the growth and function of T cells and mast cells, with implications in allergic responses.\n     - **IL1A:** A pro-inflammatory cytokine that plays a role in the regulation of immune and inflammatory responses.\n     - **IL5:** Stimulates the growth and differentiation of eosinophils, important in allergic reactions and asthma.\n     - **TXLNA (Taxilin alpha):** Although not a cytokine, it is involved in intracellular vesicle trafficking, which may influence cytokine secretion.\n     - **IFNA1 (Interferon alpha 1):** Part of the type I interferon family, crucial for antiviral defense.\n     - **IL17A:** A pro-inflammatory cytokine that plays a role in autoimmune diseases and is involved in the defense against extracellular pathogens.\n     - **IL4:** Induces differentiation of naive helper T cells to Th2 cells, important in humoral immunity and allergic responses.\n     - **IL18:** Enhances the activity of natural killer cells and T cells, promoting the production of IFN-gamma.\n     - **IL2:** Essential for T cell proliferation and survival, playing a central role in the immune response.\n     - **IFNB1 (Interferon beta 1):** Involved in antiviral responses and modulation of the immune system.\n     - **IL15:** Similar to IL2, it is important for the development and function of natural killer cells and memory T cells.\n     - **IL10:** An anti-inflammatory cytokine that regulates immune responses to prevent damage to the host.\n     - **TNF (Tumor Necrosis Factor):** A key regulator of inflammation, involved in systemic inflammation and acute phase reactions.\n     - **IL16:** Functions as a chemoattractant for CD4+ T cells and modulates T cell activation.\n     - **IL6:** A multifunctional cytokine that plays roles in inflammation, immune response, and hematopoiesis.\n\n3. **Relationships Between Genes:**\n   - Other genes in this cluster work synergistically to modulate immune responses. For example, IL-4 and IL-13 are both involved in promoting Th2 cell responses, while IL-2 and IL-15 share roles in T cell proliferation and survival.\n\n4. **Regulatory Elements and Patterns:**\n   - Additionally, the expression of these genes is tightly regulated by various transcription factors and signaling pathways, such as NF-kB and JAK-STAT pathways, which are activated in response to immune challenges.\n\n5. **Biological Implications:**\n   - Dysregulation of these cytokines can lead to various pathological conditions, including autoimmune diseases, chronic inflammatory conditions, and allergies. Understanding the interactions and regulation of this gene cluster is crucial for developing therapeutic strategies for these conditions.\n\nAll in all, this gene cluster is integral to the immune system's ability to respond to pathogens and maintain homeostasis, with each gene contributing to a complex network of immune regulation.","The gene cluster responsible for the innate immune response serves as the first line of defense against invading microorganisms, activating within a few hours of infection. Some genes in this cluster lead to the activation of macrophages and neutrophils by microbial components such as lipopolysaccharide (LPS). Macrophages and neutrophils respond by secreting cytokines such as TNF-alpha, IL-1, IL-6, and IL-8, which further activate the innate and adaptive immune responses mediated by T cells and antibodies. \n\nOther genes, like those associated with Toll-like receptor 4 (TLR4), recognize bacterial LPS and play a critical role in activating the innate immune response. An important transcription factor in this process, NF-kappaB, is initially inhibited by I-kappaB in the absence of LPS. However, upon LPS stimulation, I-kappaB is phosphorylated, ubiquitinated, and ultimately degraded, liberating NF-kappaB to translocate into the nucleus and activate genes that contain NF-kappaB binding sites. This activation is facilitated by IRAK-1 and the adapter protein MyD88, with subsequent activation of NIK and phosphorylation-induced degradation of I-kappaB.\n\nAdditionally, the activation of NF-kappaB by LPS is a transient response, quickly attenuated by the induction of I-kappaB and feedback inhibition from cytokines IL-1 and IL-4, mediated by transcription factor STAT3. This transient nature is crucial for rapidly activating and then attenuating the immune response, preventing potential problems like septic shock caused by an over-exuberant inflammatory response.\n\nAll in all, this gene cluster orchestrates a complex but regulated innate immune response, ensuring a rapid but controlled reaction to pathogenic threats while preventing excessive inflammation and collateral tissue damage."
BIOCARTA_RARRXR_PATHWAY,"['NCOR2', 'KAT2B', 'TBP', 'RXRA', 'GTF2A1', 'NCOA1', 'RARA']",Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,RXR and RAR are nuclear receptors that bind either all trans retinoic (tRA) or 9cis retinoic acid (9cisRA). In the absence of ligand corepressors with histone deacetylase activity are bound to the RAR/RXR hetrodimer and suppress transcription. Once they bind retinoic acid a conformational change in the receptors cause the dissociation of the corepressors and the binding of coactivators with histone acetylase activity (1). Following ligand binding by the hetrodimer the receptors and proteins in the basal transcription machinery (like TBP and TAF135) are degraded by the proteasome (2).,"The gene cluster comprising 'NCOR2', 'KAT2B', 'TBP', 'RXRA', 'GTF2A1', 'NCOA1', and 'RARA' is primarily involved in the regulation of transcription, particularly in the context of nuclear receptor signaling pathways. Some genes in this cluster, such as NCOR2 and NCOA1, play opposing roles in transcriptional regulation, with NCOR2 acting as a corepressor that interacts with nuclear hormone receptors to repress transcription, and NCOA1 serving as a coactivator that enhances transcription through its intrinsic histone acetyltransferase activity. Other genes, like KAT2B, function as histone acetyltransferases, facilitating transcriptional activation and playing roles in chromatin remodeling and various cellular processes. Additionally, TBP and GTF2A1 are critical components of the transcription initiation complex, with TBP binding to the TATA box and GTF2A1 stabilizing this interaction to facilitate the recruitment of other transcription factors. RXRA and RARA form a functional heterodimer central to retinoic acid signaling, regulating gene expression patterns crucial for development and homeostasis. All in all, this gene cluster is pivotal in processes such as development, differentiation, and metabolism, with dysregulation potentially leading to pathologies like cancer, metabolic disorders, and developmental abnormalities. Understanding the interactions and regulatory mechanisms within this cluster is crucial for developing therapeutic strategies targeting nuclear receptor signaling pathways.","The gene cluster for the retinoic acid receptor (RAR) is part of the steroid hormone receptor gene family. It is activated by the vitamin A derivative retinoic acid (RA) and is instrumental in various developmental processes. Some genes in this cluster include the RAR alpha form, which is present in most adult tissues and is crucial for the development of the central nervous system. Other genes include the RAR beta form, which is located in the lung, skin, and male germ cells, and is vital for the development of the lung and male germ cells. Additionally, RAR functions as a ligand-activated transcription factor. Upon binding RA, it forms a heterodimer with the retinoid X receptor (RXR), another member of the steroid hormone receptor family. This RAR/RXR heterodimer binds to DNA at a retinoic acid response element (RARE) and recruits coactivators that possess histone acetyltransferase activity, necessary for transcriptional activation. Corepressors also bind to the RAR/RXR heterodimer, but upon RA binding, they are released, and coactivators are recruited. Coactivators, containing histone acetyltransferase and Bromo domains, are crucial for transcriptional activation and may aid in chromatin remodeling. Corepressors have a repression domain interacting with the RAR/RXR heterodimer and are released upon RA binding. Coactivators then recruit corepressors to the promoter region of RA-responsive genes. These corepressors have a deacetylase domain that might be involved in chromatin remodeling. The binding of coactivators and corepressors to the RAR/RXR heterodimer depends on the DNA sequence of the RARE, which can be in various forms such as direct repeats and inverted repeats with specific spacing. The RAR/RXR heterodimer can also bind to negative response elements (NREs) in the promoters of RA-responsive genes, which have a lower affinity than RAREs. These NREs can be formatted as direct or inverted repeats and have the unique ability to repress transcription in the presence of RA, yet activate it in its absence. All in all, this gene cluster, through its ability to bind to different response elements, enables RA to regulate a diverse array of genes."
BIOCARTA_MTA3_PATHWAY,"['SNAI1', 'TUBA4A', 'HDAC1', 'MBD3', 'ESR1', 'TUBA3C', 'SNAI2', 'MTA3', 'PDZK1', 'CDH1', 'GREB1', 'ALDOA', 'HSPB1', 'MTA1', 'GAPDH', 'TUBA1A', 'CTSD', 'HSPB2']",Downregulated of MTA-3 in ER-negative Breast Tumors,"Approximately 30% of breast carcinomas lack ER expression. Presumably, these breast cancers become estrogen independent through genetic alterations that bypass the requirement for ER-dependent stimulation of cell proliferation. As such estrogen receptor is a key regulator of proliferation and differentiation in mammary epithelia and represents a crucial prognostic indicator and therapeutic target in breast cancer. Mechanistically, estrogen receptor induces changes in gene expression through direct gene activation of a number of genes (cathepsin D, HSP27 (heat shock protein 27,000 kDa, aldolase A, dehydrogenase, alpha-tubulin, and glyceraldehyde-3-phosphat, Pdzk1, Greb ets) and also through the biological functions of target loci. The product of human MTA3 has been identified as an estrogen-dependent component of the Mi-2/NuRD transcriptional corepressor in breast epithelial cells and demonstrate that MTA3 constitutes a key component of an estrogen-dependent pathway regulating growth and differentiation. The absence of estrogen receptor or of MTA3 leads to aberrant expression of the transcriptional repressor Snail, a master regulator of epithelial to mesenchymal transitions. Aberrant Snail expression results in loss of expression of the cell adhesion molecule E-cadherin, an event associated with changes in epithelial architecture and invasive growth. MTA3 is the mechanistic link between estrogen receptor status and invasive growth of breast cancers.","The gene cluster provided includes a diverse set of genes involved in various cellular processes, with a notable emphasis on epithelial-mesenchymal transition (EMT), cytoskeletal dynamics, and transcriptional regulation. This cluster is significant in the context of cancer biology, particularly in processes like metastasis and hormone response.\n\n1. **EMT and Transcriptional Regulation:**\n   - Some genes in this cluster, such as **SNAI1 and SNAI2 (Snail Family Transcriptional Repressors)**, encode transcription factors that play crucial roles in EMT. This process involves epithelial cells losing their polarity and adhesion, gaining migratory and invasive properties. SNAI1 and SNAI2 repress E-cadherin (CDH1) expression, facilitating EMT and contributing to cancer metastasis.\n   - **CDH1 (E-cadherin)** is a key cell-cell adhesion molecule, and its downregulation is a hallmark of EMT. Loss of E-cadherin disrupts cell adhesion, promoting metastasis.\n   - **MTA1 and MTA3 (Metastasis-Associated Proteins)** are part of the nucleosome remodeling and deacetylase (NuRD) complex, involved in chromatin remodeling and transcriptional repression. MTA3 is known to regulate SNAI1, linking it to EMT processes.\n\n2. **Cytoskeletal Dynamics:**\n   - Other genes, such as **TUBA1A, TUBA3C, and TUBA4A (Tubulin Alpha Chains)**, encode components of microtubules, essential for maintaining cell structure, intracellular transport, and cell division. Alterations in tubulin expression can affect cell motility and stability, relevant in cancer progression.\n\n3. **Hormone Response and Metabolism:**\n   - Additionally, **ESR1 (Estrogen Receptor 1)** is a nuclear hormone receptor that mediates the effects of estrogen, playing a critical role in breast cancer development and progression. It regulates genes involved in cell proliferation and survival.\n   - **GREB1 (Growth Regulation by Estrogen in Breast Cancer 1)** is an estrogen-responsive gene that acts as a coactivator of ESR1, involved in the proliferation of hormone-responsive tissues.\n   - **PDZK1** is a scaffold protein that interacts with ESR1, influencing estrogen signaling pathways.\n\n4. **Metabolic and Stress Response:**\n   - **ALDOA (Aldolase A)** is an enzyme involved in glycolysis, its expression is often upregulated in cancer cells to meet increased energy demands.\n   - **GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase)** is another glycolytic enzyme, frequently used as a housekeeping gene in studies, but also implicated in apoptosis and transcriptional regulation.\n   - **HSPB1 and HSPB2 (Heat Shock Proteins)** are small heat shock proteins functioning as molecular chaperones, protecting cells from stress-induced damage. They are involved in protein folding and can influence cancer cell survival.\n\n5. **Epigenetic Regulation:**\n   - **HDAC1 (Histone Deacetylase 1)** is a component of the NuRD complex, involved in chromatin remodeling and transcriptional repression, influencing gene expression patterns critical for cell cycle regulation and differentiation.\n   - **MBD3 (Methyl-CpG Binding Domain Protein 3)** is part of the NuRD complex, binding methylated DNA and playing a role in transcriptional repression and epigenetic regulation.\n\n6. **Proteolysis:**\n   - **CTSD (Cathepsin D)** is a lysosomal protease involved in protein degradation, implicated in cancer progression through its role in apoptosis and tissue remodeling.\n\nAll in all, this gene cluster highlights the interplay between transcriptional regulation, cytoskeletal dynamics, and metabolic pathways in cancer biology. The presence of EMT-related genes (SNAI1, SNAI2, CDH1) alongside those involved in hormone response (ESR1, GREB1) and stress response (HSPB1, HSPB2) underscores the complexity of cancer progression and metastasis. Understanding the interactions and regulatory mechanisms within this cluster could provide insights into therapeutic targets for cancer treatment, particularly in hormone-responsive and metastatic cancers. However, further research is needed to elucidate the precise interactions and regulatory networks among these genes.","The gene cluster involved in the epithelial-mesenchymal transition (EMT) plays a crucial role in both developmental processes and tumor progression by facilitating invasion and metastasis. Some genes in this cluster include transcription factors such as the zinc finger proteins Snail and ZEB, and the basic helix-loop-helix protein Twist, which regulate the repression of E-cadherin, a vital component of epithelial cell-cell adhesion. Additionally, the induction of EMT results in the expression of mesenchymal genes, such as vimentin and N-cadherin. Other genes participate in the regulation of EMT through secreted factors like TGF-beta, which activate receptor tyrosine kinases and various signaling pathways, including MAP kinase and PI3 kinase. Secreted factors also stimulate the expression of transcription factors like Snail and ZEB\u2014repressing epithelial genes while activating mesenchymal ones. The transcription factors Snail, Twist, and ZEB suppress E-cadherin by binding to E-box elements in its promoter; Snail recruits histone deacetylases and DNA methyltransferases, while Twist engages mSin3A and histone deacetylase 1 (HDAC1). The forkhead transcription factor FOXC2 further represses E-cadherin by activating Snail. Additionally, TGF-beta induction leads to expression of SIP1/ZEB2 and deltaEF1/ZEB1 transcription factors, with deltaEF1/ZEB1 recruiting repressors to the E-cadherin promoter. Ras signaling induces EMT by activating transcription factors such as NF-kappaB, Twist, and FOXC2; Twist facilitates E-cadherin repression by promoting Snail expression. All in all, this gene cluster orchestrates the loss of epithelial characteristics and acquisition of a mesenchymal phenotype through intricate regulatory mechanisms involving a multitude of transcription factors and signaling pathways."
KEGG_CELL_ADHESION_MOLECULES_CAMS,"['CDH5', 'JAM3', 'CDH3', 'NLGN3', 'CDH4', 'CD80', 'NLGN1', 'CD86', 'CD28', 'CD274', 'PDCD1LG2', 'ITGA9', 'ITGAL', 'NRCAM', 'ITGAM', 'CD34', 'CD276', 'ICOSLG', 'CADM3', 'ITGA4', 'ICOS', 'SIGLEC1', 'CADM1', 'HLA-G', 'CLDN20', 'PECAM1', 'CD22', 'ITGB7', 'SELL', 'VCAM1', 'ITGAV', 'SELP', 'SPN', 'ITGB1', 'SELPLG', 'ITGB2', 'CDH2', 'JAM2', 'CTLA4', 'HLA-DRB4', 'CLDN18', 'CD4', 'HLA-DRB5', 'CNTN1', 'NLGN2', 'HLA-DRB3', 'NRXN3', 'ALCAM', 'SELE', 'CD8A', 'CD8B', 'CD6', 'CLDN17', 'L1CAM', 'ITGB8', 'MAG', 'VCAN', 'HLA-F', 'NFASC', 'HLA-E', 'NRXN1', 'HLA-DPA1', 'HLA-DPB1', 'HLA-DQA1', 'HLA-DQA2', 'HLA-DQB1', 'NRXN2', 'CD2', 'CLDN16', 'CLDN23', 'MADCAM1', 'SDC2', 'SDC4', 'SDC1', 'OCLN', 'PVR', 'HLA-DRB1', 'NECTIN2', 'CDH1', 'HLA-DRA', 'NECTIN1', 'HLA-DOA', 'HLA-DOB', 'CLDN10', 'ICAM2', 'ICAM3', 'CLDN8', 'CLDN2', 'CLDN6', 'CLDN5', 'CLDN1', 'ICAM1', 'NEO1', 'HLA-C', 'HLA-B', 'ESAM', 'HLA-DMB', 'HLA-DMA', 'HLA-A', 'F11R', 'PDCD1', 'CLDN19', 'PTPRF', 'CLDN15', 'CD226', 'CD99', 'CLDN22', 'CNTNAP2', 'MPZ', 'MPZL1', 'PTPRC', 'NECTIN3', 'ITGA8', 'NCAM2', 'NCAM1', 'CD58', 'NEGR1', 'CLDN11', 'SDC3', 'CLDN7', 'CLDN4', 'PTPRM', 'CLDN3', 'ITGA6', 'CNTN2', 'CD40LG', 'CNTNAP1', 'CD40', 'GLG1', 'CDH15', 'CLDN14', 'NLGN4X', 'CLDN9']",Cell adhesion molecules (CAMs),"Cell adhesion molecules are (glyco)proteins expressed on the cell surface and play a critical role in a wide array of biologic processes that include hemostasis, the immune response, inflammation, embryogenesis, and development of neuronal tissue. There are four main groups: the integrin family, the immunoglobulin superfamily, selectins, and cadherins. Membrane proteins that mediate immune cellcell interactions fall into different categories, namely those involved in antigen recognition, costimulation and cellular adhesion. Furthermore cell-cell adhesions are important for brain morphology and highly coordinated brain functions such as memory and learning. During early development of the nervous system, neurons elongate their axons towards their targets and establish and maintain synapses through formation of cell-cell adhesions. Cell-cell adhesions also underpin axon-axon contacts and link neurons with supporting schwann cells and oligodendrocytes.","The gene cluster provided is primarily associated with cell adhesion, immune response, and intercellular communication. Some genes in this cluster encode cadherins, integrins, immunoglobulin superfamily members, claudins, and major histocompatibility complex (MHC) molecules, among others. These genes play crucial roles in maintaining tissue integrity, facilitating immune cell interactions, and mediating signaling pathways essential for immune surveillance and response.\n\n### Key Genes and Their Functions:\n\n1. **Cadherins (CDH1, CDH2, CDH3, CDH4, CDH5, CDH15):** These are calcium-dependent adhesion molecules critical for cell-cell adhesion, maintaining epithelial cell integrity, and tissue morphogenesis.\n\n2. **Integrins (ITGA4, ITGA6, ITGA8, ITGA9, ITGAL, ITGAM, ITGAV, ITGB1, ITGB2, ITGB7, ITGB8):** These transmembrane receptors facilitate cell-extracellular matrix adhesion and signal transduction, influencing cell migration, proliferation, and survival.\n\n3. **Immunoglobulin Superfamily (ICAM1, ICAM2, ICAM3, PECAM1, ALCAM, NCAM1, NCAM2, L1CAM, NRCAM, NEGR1):** These molecules are involved in immune cell interactions, leukocyte trafficking, and synaptic connections in the nervous system.\n\n4. **Claudins (CLDN1, CLDN2, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9, CLDN10, CLDN11, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN20, CLDN22, CLDN23):** Essential components of tight junctions, claudins regulate paracellular transport and maintain the selective permeability barrier of epithelial and endothelial layers.\n\n5. **MHC Molecules (HLA-A, HLA-B, HLA-C, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DPA1, HLA-DPB1, HLA-DOA, HLA-DOB, HLA-DMA, HLA-DMB, HLA-E, HLA-F, HLA-G):** These genes encode proteins critical for antigen presentation and immune recognition, playing a pivotal role in adaptive immunity.\n\n6. **Checkpoint Molecules (CD274, PDCD1, PDCD1LG2, CTLA4, CD80, CD86, ICOS, ICOSLG):** These are involved in immune checkpoint pathways that regulate T-cell activation and tolerance, crucial for preventing autoimmunity and modulating immune responses.\n\n### Relationships and Interactions:\n\n- **Cell Adhesion and Immune Response:** Cadherins and integrins work together to maintain tissue architecture and facilitate immune cell migration. Integrins also interact with immunoglobulin superfamily members to mediate leukocyte adhesion and transmigration.\n\n- **Tight Junctions and Barrier Function:** Claudins form tight junction strands that regulate paracellular permeability, crucial for maintaining tissue homeostasis and barrier function against pathogens.\n\n- **Immune Modulation:** MHC molecules present antigens to T-cells, while checkpoint molecules modulate T-cell responses, balancing immune activation and tolerance.\n\n### Regulatory Elements and Patterns:\n\n- **Gene Expression Regulation:** Many of these genes are regulated by cytokines and growth factors, which modulate their expression in response to inflammation, infection, or tissue injury.\n\n- **Epigenetic Modifications:** Histone modifications and DNA methylation patterns can influence the expression of these genes, impacting immune responses and cell adhesion properties.\n\n### Biological Implications:\n\n- **Disease Associations:** Dysregulation of these genes is implicated in various diseases, including cancer, autoimmune disorders, and infectious diseases. For example, altered expression of MHC molecules and checkpoint proteins can lead to immune evasion by tumors.\n\n- **Therapeutic Targets:** Checkpoint inhibitors targeting PD-1/PD-L1 and CTLA-4 pathways are already in use for cancer immunotherapy, highlighting the clinical significance of this gene cluster.\n\nAll in all, this gene cluster encompasses a diverse array of genes integral to cell adhesion, immune function, and intercellular communication, with significant implications for health and disease. Further research is needed to fully elucidate the complex interactions and regulatory mechanisms governing these genes.","The gene cluster responsible for the immune system encompasses a complex network of cells that protect against infectious agents and repair damaged tissues. Some genes in this cluster pertain to the innate immune system, which includes natural killer (NK) cells, macrophages, and dendritic cells (DCs) that serve as the first line of defense against pathogens by initiating early inflammatory responses. Other genes facilitate the adaptive immune system, comprising B cells, T cells, and antibodies. In this system, upon activation, T cells differentiate into effector cells capable of destroying infected cells and triggering the maturation of antigen-presenting cells (APCs). Additionally, these APCs activate B cells to produce specific antibodies. All in all, this gene cluster underpins the multifaceted operations of the immune system, which involves both immediate and adaptive mechanisms to defend and repair the body."
BIOCARTA_EPHA4_PATHWAY,"['ACTA1', 'SELP', 'EPHB1', 'RAP1B', 'EPHA4', 'FYN', 'LYN', 'ITGB1']",Eph Kinases and ephrins support platelet aggregation,"Eph kinases are a family of receptor tyrosine kinases with an extracellular domain that binds their ligand, the ephrins, and an intracellular kinase domain. The ephrins are also expressed on the cell surface, so that interaction between Eph kinases and ephrins occurs at the interface between neighboring cells. Binding of ephrins to Eph kinases stimulates signaling in both directions across the interface between cells, in both the receptor expressing and the ligand expressing cells. Eph kinases and ephrins are involved in several biological processes, and their role in neuronal development has been extensively examined. Both Eph kinases (EphA4 and EphB1) and ephrins (ephrinB1) are expressed on platelets, suggesting activation of eph kinases by ephrins may play a role in clotting when platelets are brought into close proximity in the developing clot. Platelet activation progresses in stages with an early stage that is stimulated by soluble factors like ADP acting through GPCRs and is reversible and later stages with stronger interaction between platelets that may require interact between Eph kinases and ephrins. One of the molecular targets of signaling by Eph kinases and ephrins is the actin cytoskeleton, which also plays a role in platelet activation. Clustering Eph kinases or ephrins in platelets stimulated cytoskeletal changes as well as other markers of platelet activation during clotting such as secretion of alpha-granules to release clotting factors. Clustering ephrins together activated Rap1b, a ras gene family member that may regulate integrins. Platelet activation caused Eph kinases to bind to src family members Fyn and Lyn and also with the cell adhesion molecule L1. Failure of the ephrins/Eph kinase pathway to function normally in platelets may result in loosely associated platelets and improper clot formation. Eph kinases and ephrins are also expressed on the vascular wall by endothelial cells, suggesting that signaling by these proteins may also play a role in the interaction of platelets with the vascular wall and clot formation in the vasculature.","The gene cluster comprising 'ACTA1', 'SELP', 'EPHB1', 'RAP1B', 'EPHA4', 'FYN', 'LYN', and 'ITGB1' is primarily involved in cellular signaling, adhesion, and cytoskeletal dynamics, which are crucial for various physiological processes, including cell movement, immune response, and tissue development.\n\nSome genes in this cluster, such as **ACTA1 (Actin, Alpha 1, Skeletal Muscle)**, encode a major component of the cytoskeleton, actin, which is essential for muscle contraction and cellular structure. Mutations in ACTA1 are associated with muscle diseases such as nemaline myopathy. **SELP (Selectin P)** encodes P-selectin, a cell adhesion molecule expressed on activated endothelial cells and platelets, playing a critical role in the inflammatory response by mediating the interaction between leukocytes and the endothelium.\n\nOther genes, like **EPHB1 and EPHA4 (Ephrin Receptors B1 and A4)**, encode members of the Eph receptor family involved in developmental processes, particularly in the nervous system. They mediate cell-cell communication and are crucial for axon guidance and synaptic plasticity. **RAP1B (RAP1B, Member of RAS Oncogene Family)** is a small GTPase that regulates integrin-mediated cell adhesion and cell junction formation, involved in controlling cell proliferation and differentiation. **FYN and LYN (Src Family Tyrosine Kinases)** encode tyrosine kinases that are part of the Src family, involved in signaling pathways that regulate cell growth, differentiation, and survival, playing roles in immune cell signaling and neuronal development. **ITGB1 (Integrin Subunit Beta 1)** encodes a component of integrin receptors, which are transmembrane receptors that facilitate cell-extracellular matrix adhesion, critical for cell migration, proliferation, and survival.\n\nAdditionally, the interaction between integrins (ITGB1) and actin (ACTA1) is fundamental for cell adhesion and movement, linking the extracellular matrix to the cytoskeleton. Eph receptors (EPHB1, EPHA4) interact with their ephrin ligands to mediate cell positioning and boundary formation, often involving actin cytoskeletal rearrangements. RAP1B modulates integrin activity, influencing cell adhesion and migration, which can be further regulated by signals from FYN and LYN kinases. SELP's role in leukocyte adhesion and migration is complemented by integrin-mediated signaling, highlighting a coordinated response in immune surveillance and inflammation.\n\nThe expression of these genes is tightly regulated by various signaling pathways, including those mediated by growth factors and cytokines. Post-translational modifications, such as phosphorylation by kinases like FYN and LYN, are crucial for the activation and function of these proteins.\n\nAll in all, this gene cluster represents a network of proteins that coordinate to maintain cellular integrity and communication, with significant implications for health and disease. Dysregulation of this gene cluster can lead to pathological conditions such as cancer, where altered cell adhesion and migration contribute to metastasis. Understanding the interactions within this cluster can provide insights into therapeutic targets for diseases involving immune dysfunction, neurodevelopmental disorders, and muscle pathologies.","The gene cluster involved in thrombus formation at the site of vascular injury is a complex system that includes platelets, the coagulation cascade, and endothelial interactions. Some genes in this cluster are responsible for the interaction of platelets with the damaged vessel wall, which leads to the exposure of subendothelial matrix proteins and stimulates the binding of von Willebrand factor (vWF) to the platelet glycoprotein Ib-IX-V complex. Other genes facilitate the activation of integrin alpha IIb beta 3 (GPIIb-IIIa) by vWF binding, which is essential for platelet aggregation. Additionally, vWF binding induces fibrinogen binding to alpha IIb beta 3, crucial for stable platelet aggregation. Furthermore, vWF binding enhances phospholipase A2 activation, freeing arachidonic acid from membrane phospholipids, with subsequent conversion of arachidonic acid to thromboxane A2 (TXA2) by thromboxane synthase, amplifying further thromboxane A2 production. The additional binding of fibrinogen, supported by activated GPIb-IX-V, strengthens platelet aggregation and initiates further phospholipase A2 activation, which is vital not only for further TXA2 formation but also for generating other platelet agonists like ADP and serotonin. This pathway also activates the protein kinase C pathway, influencing phosphorylation of proteins such as myosin light chains, which regulate platelet shape change and aggregation. Finally, thrombin binding to its receptor on the platelet surface activates the protease-activated receptor PAR4 and the glycoprotein Ib-IX-V complex, contributing to platelet activation. All in all, this gene cluster intricately regulates the thrombus formation process, ensuring effective platelet activation and aggregation during vascular injury."
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,"['JUN', 'ZAP70', 'MALT1', 'CD28', 'PDPK1', 'PPP3R2', 'PPP3CC', 'PPP3R1', 'PAK4', 'ICOS', 'VAV1', 'IKBKB', 'MAP3K8', 'MAP3K7', 'AKT1', 'AKT2', 'NRAS', 'AKT3', 'VAV2', 'CHP2', 'NFAT5', 'NFKB1', 'NFKBIB', 'NFKBIA', 'PAK6', 'NFKBIE', 'NCK1', 'CTLA4', 'CSF2', 'PIK3R5', 'CD4', 'NFATC4', 'MAPK14', 'MAPK12', 'NFATC3', 'RELA', 'KRAS', 'CD8A', 'CD8B', 'CD247', 'NCK2', 'MAP3K14', 'PAK5', 'CD3D', 'CD3E', 'PAK1', 'CD3G', 'CBLC', 'LCP2', 'PLCG1', 'NFATC2', 'NFATC1', 'LCK', 'CDC42', 'RASGRP1', 'SOS2', 'PAK3', 'CHUK', 'RAF1', 'TNF', 'CARD11', 'PAK2', 'RHOA', 'PTPN6', 'PDCD1', 'MAPK9', 'MAPK11', 'MAP2K2', 'PRKCQ', 'MAPK13', 'MAP2K1', 'MAP2K7', 'GRAP2', 'GRB2', 'MAPK3', 'IL10', 'PTPRC', 'SOS1', 'MAPK1', 'HRAS', 'IKBKG', 'TEC', 'GSK3B', 'CBLB', 'CBL', 'ITK', 'LAT', 'IFNG', 'IL2', 'CD40LG', 'PIK3R3', 'CDK4', 'PPP3CB', 'DLG1', 'PPP3CA', 'PIK3CA', 'PIK3CB', 'PIK3CD', 'BCL10', 'IL4', 'FYN', 'IL5', 'FOS', 'PIK3CG', 'VAV3', 'PIK3R1', 'PIK3R2', 'CHP1']",T cell receptor signaling pathway,"Activation of T lymphocytes is a key event for an efficient response of the immune system. It requires the involvement of the T-cell receptor (TCR) as well as costimulatory molecules such as CD28. Engagement of these receptors through the interaction with a foreign antigen associated with major histocompatibility complex molecules and CD28 counter-receptors B7.1/B7.2, respectively, results in a series of signaling cascades. These cascades comprise an array of protein-tyrosine kinases, phosphatases, GTP-binding proteins and adaptor proteins that regulate generic and specialised functions, leading to T-cell proliferation, cytokine production and differentiation into effector cells.","The gene cluster provided is primarily involved in T-cell receptor (TCR) signaling, a critical pathway in the adaptive immune response. Some genes in this cluster encode proteins involved in the activation, differentiation, and function of T-cells, which are essential for recognizing and responding to antigens.\n\n### Key Genes and Their Functions:\n\n1. **TCR Complex Components**: \n   - **CD3D, CD3E, CD3G, CD247**: These genes encode components of the CD3 complex, crucial for TCR signaling. They associate with the TCR to form the TCR-CD3 complex, essential for signal transduction upon antigen recognition.\n   - **CD4, CD8A, CD8B**: These co-receptors assist in TCR signaling by stabilizing the interaction between T-cells and antigen-presenting cells.\n\n2. **Signal Transduction Molecules**:\n   - **ZAP70**: A tyrosine kinase activated upon TCR engagement, phosphorylating downstream signaling proteins.\n   - **LCK**: A Src family kinase that phosphorylates ITAMs on the CD3 complex, initiating TCR signaling.\n   - **LAT**: A transmembrane adaptor protein acting as a scaffold for assembling signaling complexes.\n   - **VAV1, VAV2, VAV3**: Guanine nucleotide exchange factors that activate Rho family GTPases, influencing cytoskeletal reorganization.\n\n3. **Downstream Signaling Pathways**:\n   - **MAPK Pathway**: Includes genes like MAPK1, MAPK3, MAPK14, and MAP2K1, involved in the MAP kinase signaling cascade, leading to cellular responses such as proliferation and differentiation.\n   - **PI3K/AKT Pathway**: Genes such as PIK3CA, PIK3CB, PIK3CD, and AKT1/2/3 are involved in the PI3K/AKT pathway, regulating cell survival and metabolism.\n   - **NF-\u03baB Pathway**: Includes NFKB1, NFKBIA, and IKBKB, critical for the activation of NF-\u03baB, a transcription factor that regulates immune response genes.\n\n4. **Transcription Factors**:\n   - **NFATC1, NFATC2, NFATC3, NFATC4**: Members of the NFAT family, these transcription factors are activated by calcium signaling and regulate the expression of cytokines.\n   - **JUN, FOS**: Components of the AP-1 transcription factor complex, activated downstream of MAPK signaling.\n\n5. **Cytokines and Receptors**:\n   - **IL2, IL4, IL5, IFNG, TNF**: Cytokines crucial for T-cell proliferation, differentiation, and effector functions.\n   - **CD28, ICOS, CTLA4, PDCD1**: Co-stimulatory and inhibitory receptors that modulate T-cell activation and tolerance.\n\n### Regulatory Elements and Patterns:\n\nAdditionally, calcium signaling involves genes like PPP3CA, PPP3CB, and PPP3CC, which encode calcineurin subunits activated by calcium and dephosphorylate NFAT, allowing its translocation to the nucleus. Ras/MAPK activation involves genes such as KRAS, HRAS, and NRAS, crucial for T-cell activation and proliferation.\n\n### Biological Implications:\n\nAll in all, this gene cluster is essential for the proper functioning of T-cells, pivotal in the immune response against pathogens and in maintaining immune homeostasis. Dysregulation of these genes can lead to immune deficiencies, autoimmunity, or cancer. Understanding the interactions and regulation within this cluster can provide insights into therapeutic targets for immunological diseases and cancer immunotherapy.\n\n### Gaps in Knowledge:\n\nWhile the functions of many genes in this cluster are well-characterized, the precise interactions and regulatory mechanisms in different contexts (e.g., different T-cell subsets or disease states) remain areas of active research. Further studies are needed to elucidate these complex networks fully.","The gene cluster involved in T cell activation requires two distinct signals. Some genes in this cluster are activated by the first signal, which is provided by the T cell receptor (TCR) interacting with the MHC-peptide complex. Other genes are influenced by the second signal, which is delivered through costimulatory signals either from the costimulatory receptor CD28 or from the TCR's interaction with costimulatory ligands such as B7.\n\nAdditionally, the TCR triggers multiple signaling pathways: the calcium-calcineurin pathway, the protein kinase C (PKC) pathway, and the Ras-Raf-mitogen-activated protein kinase (MAPK) pathway. The calcium-calcineurin pathway facilitates the dephosphorylation and activation of the transcription factor NFAT, which subsequently induces the expression of interleukin 2 (IL-2) and other genes essential for T cell activation. The PKC pathway activates transcription factors NF-AT and NF-kB, which are pivotal in expressing additional genes needed for T cell activation. The Ras-Raf-MAPK pathway leads to the activation of the transcription factor ELK-1, promoting the expression of further genes implicated in T cell activation.\n\nMoreover, the interaction between the TCR and the costimulatory receptor CD28, or with its ligands, provides an essential positive costimulatory signal necessary for T cell activation. The p21-activated kinase (PAK), a downstream target of the small GTPases Rac and Cdc42, is activated by the guanine nucleotide exchange factor vav, and this activation by Rac and Cdc42 is also crucial for T cell activation.\n\nAll in all, this gene cluster orchestrates a comprehensive network of signals and pathways vital for the successful activation of T cells."
KEGG_BASE_EXCISION_REPAIR,"['NEIL2', 'MPG', 'SMUG1', 'XRCC1', 'POLE4', 'HMGB1', 'POLE3', 'POLD4', 'MBD4', 'OGG1', 'UNG', 'POLD3', 'PCNA', 'NEIL1', 'POLE2', 'PARP4', 'PARP3', 'PARP2', 'POLB', 'APEX1', 'POLL', 'POLD1', 'POLD2', 'POLE', 'NEIL3', 'TDG', 'APEX2', 'LIG3', 'HMGB1P1', 'NTHL1', 'HMGB1P40', 'FEN1', 'LIG1', 'MUTYH', 'PARP1']",Base excision repair,"Base excision repair (BER) is the predominant DNA damage repair pathway for the processing of small base lesions, derived from oxidation and alkylation damages. BER is normally defined as DNA repair initiated by lesion-specific DNA glycosylases and completed by either of the two sub-pathways: short-patch BER where only one nucleotide is replaced and long-patch BER where 2-13 nucleotides are replaced. Each sub-pathway of BER relies on the formation of protein complexes that assemble at the site of the DNA lesion and facilitate repair in a coordinated fashion. This process of complex formation appears to provide an increase in specificity and efficiency to the BER pathway, thereby facilitating the maintenance of genome integrity by preventing the accumulation of highly toxic repair intermediates.","The gene cluster provided is primarily involved in the Base Excision Repair (BER) pathway, a critical cellular mechanism for repairing small base lesions in DNA that result from oxidation, alkylation, deamination, or spontaneous loss of a base. This pathway is essential for maintaining genomic stability and preventing mutations that could lead to cancer and other diseases.\n\nSome genes in this cluster encode DNA glycosylases, such as NEIL1, NEIL2, and NEIL3, which recognize and remove oxidized bases, initiating the BER process. OGG1 specifically excises 8-oxoguanine, a common oxidative lesion, while MUTYH removes adenines misincorporated opposite 8-oxoguanine. UNG and SMUG1 are involved in uracil removal, with UNG excising uracil from DNA arising from cytosine deamination. TDG excises thymine and uracil from G:T and G:U mismatches, respectively, and MBD4 recognizes and removes T from G:T mismatches.\n\nOther genes include endonucleases and lyases such as APEX1 and APEX2, which are apurinic/apyrimidinic (AP) endonucleases that cleave the DNA backbone at abasic sites created by glycosylases. NTHL1 functions similarly to NEIL glycosylases, with lyase activity to cleave DNA at damaged sites. DNA polymerases like POLB (DNA Polymerase Beta) fill in the single nucleotide gap left after lesion removal, while POLL is another polymerase involved in gap-filling during BER. The subunits of DNA polymerase epsilon (POLE, POLE2, POLE3, POLE4) and delta (POLD1, POLD2, POLD3, POLD4) are also involved in DNA repair and replication. Ligases such as LIG1 and LIG3 seal the nicks in the DNA backbone after repair synthesis.\n\nAdditionally, accessory proteins like XRCC1 act as a scaffold protein, coordinating the activities of various BER enzymes, and PCNA (Proliferating Cell Nuclear Antigen) enhances the processivity of DNA polymerases during repair. FEN1 removes flap structures that can form during long-patch BER. The PARP family, including PARP1, PARP2, PARP3, and PARP4, consists of poly(ADP-ribose) polymerases that detect DNA strand breaks and signal for repair, recruiting other repair proteins to the site of damage. HMGB1 facilitates DNA bending and repair complex assembly, while HMGB1P1 and HMGB1P40 are pseudogenes related to HMGB1, with unclear roles in BER.\n\nThe BER pathway is highly coordinated, with glycosylases recognizing specific lesions and initiating repair, followed by endonucleases and lyases processing the DNA, and polymerases and ligases completing the repair. XRCC1 serves as a central hub, interacting with multiple proteins to ensure efficient repair. PARP proteins play a crucial role in detecting DNA damage and recruiting repair machinery, highlighting their importance in the initial response to DNA damage.\n\nAll in all, this gene cluster represents a comprehensive network of proteins that work together to maintain DNA integrity, highlighting the complexity and importance of the BER pathway in cellular homeostasis. Defects in BER genes can lead to the accumulation of DNA damage, contributing to carcinogenesis and other age-related diseases. Understanding the interactions and regulation of these genes is crucial for developing therapeutic strategies targeting DNA repair pathways in cancer treatment.","The gene cluster Base Excision Repair (BER) represents the major pathway for rectifying small DNA lesions, specifically alkylated or oxidized bases. Some genes in this cluster encode DNA glycosylases that initiate the repair process by recognizing damaged bases, cleaving the bond between the base and the deoxyribose phosphate, and releasing both the damaged base and an apurinic/apyrimidinic (AP) site. Other genes contribute to processing the AP site, which is incised by an AP endonuclease, followed by filling the resulting single-stranded DNA (ss-DNA) gap with a DNA polymerase and sealing it with a DNA ligase. Additionally, DNA glycosylases in the BER pathway are categorized into monofunctional DNA glycosylases, which remove only damaged bases and are found in bacteria and some lower eukaryotes, and bifunctional DNA glycosylases, which remove both damaged bases and the deoxyribose phosphate (dRP) group and are present in higher eukaryotes. These bifunctional enzymes contain an N-terminal glycosylase domain and a C-terminal AP lyase domain; the glycosylase domain releases the damaged base, and the AP lyase domain cleaves the DNA strand at the AP site, producing a 3'-phospho-alpha, beta-unsaturated aldehyde (PUA) residue and a 5'-phosphate. The removal of the dRP group is carried out by the 5'-phosphodiesterase activity of pol beta or the 3'-phosphodiesterase activity of APE1, and DNA ligase I or III (or potentially IV) completes the sealing of the DNA strand. All in all, the gene cluster includes enzymes like nth-like DNA glycosylase 1 (NEIL1) and NEIL2, identified as bifunctional DNA glycosylases distinct from E. coli Fpg and Nei proteins. These enzymes, which share similar structural domains (a glycosylase domain and an AP lyase domain), play a crucial role in the repair of oxidative DNA damage and are localized in the nucleus."
BIOCARTA_P53_PATHWAY,"['CDK2', 'GADD45A', 'CDK4', 'PCNA', 'BCL2', 'CCNE1', 'ATM', 'CDKN1A', 'RB1', 'TP53', 'MDM2', 'CCND1', 'APAF1', 'BAX', 'TIMP3', 'E2F1']",p53 Signaling Pathway,p53 is a transcription factor who's activity is regulated by phosphorylation. The function is p53 is to keep the cell from progressing through the cell cycle if there is damage to DNA present. It may do this in multiple ways from holding the cell at a checkpoint until repairs can be made to causing the cell to enter apoptosis if the damage cannot be repaired. The critical role of p53 is evidenced by the fact that it is mutated in a very large fraction of tumors from nearly all sources.,"The gene cluster provided is primarily involved in the regulation of the cell cycle, DNA repair, and apoptosis, which are critical processes for maintaining cellular homeostasis and preventing tumorigenesis. This cluster includes key regulators of cell cycle progression, DNA damage response, and apoptotic pathways.\n\n1. **Cell Cycle Regulation**: \n   - Some genes in this cluster, such as **CDK2** and **CDK4**, are cyclin-dependent kinases (CDKs) that play crucial roles in cell cycle progression. CDK2 is involved in the transition from G1 to S phase, while CDK4 is important for the G1 phase progression.\n   - Other genes like **CCNE1 (Cyclin E1)** and **CCND1 (Cyclin D1)** are cyclins that activate CDK2 and CDK4, respectively, facilitating cell cycle transitions.\n   - Additionally, **RB1 (Retinoblastoma protein)** acts as a tumor suppressor that regulates the cell cycle by inhibiting E2F transcription factors, preventing uncontrolled cell proliferation.\n   - **E2F1** is a transcription factor that promotes the expression of genes required for S phase entry and DNA replication.\n\n2. **DNA Damage Response and Repair**:\n   - Some genes, such as **ATM (Ataxia Telangiectasia Mutated)**, are key kinases activated by DNA double-strand breaks, initiating DNA repair and cell cycle arrest.\n   - Other genes like **TP53 (Tumor Protein p53)** are critical tumor suppressors that respond to DNA damage by inducing cell cycle arrest, DNA repair, or apoptosis.\n   - Additionally, **GADD45A (Growth Arrest and DNA Damage Inducible Alpha)** is involved in DNA repair and cell cycle arrest in response to stress signals.\n   - **PCNA (Proliferating Cell Nuclear Antigen)** functions as a processivity factor for DNA polymerase in DNA replication and repair.\n\n3. **Apoptosis Regulation**:\n   - Some genes, such as **BCL2 (B-cell Lymphoma 2)**, are anti-apoptotic proteins that prevent cell death by inhibiting pro-apoptotic factors.\n   - Other genes like **BAX (Bcl-2-associated X protein)** are pro-apoptotic members of the Bcl-2 family that promote apoptosis by permeabilizing the mitochondrial membrane.\n   - Additionally, **APAF1 (Apoptotic Peptidase Activating Factor 1)** is a key component of the apoptosome, which activates caspases leading to apoptosis.\n\n4. **Regulatory Interactions**:\n   - Some interactions involve **TP53 and MDM2**, where TP53 activity is tightly regulated by MDM2, an E3 ubiquitin ligase that targets TP53 for degradation, forming a feedback loop.\n   - Additionally, **CDKN1A (p21, Cip1/Waf1)** is a cyclin-dependent kinase inhibitor regulated by TP53, which inhibits CDK activity, leading to cell cycle arrest.\n\n5. **Additional Elements**:\n   - **TIMP3 (Tissue Inhibitor of Metalloproteinases 3)** is involved in extracellular matrix remodeling and may influence cell proliferation and apoptosis indirectly.\n\nAll in all, this gene cluster is integral to maintaining genomic stability and preventing cancer. Dysregulation of these genes can lead to uncontrolled cell proliferation, impaired DNA repair, and evasion of apoptosis, contributing to oncogenesis. Understanding the interactions and regulatory mechanisms within this cluster is crucial for developing targeted cancer therapies. Despite extensive research, some interactions and regulatory mechanisms remain incompletely understood, highlighting the need for further investigation.","The gene cluster revolves around the tumor suppressor gene p53, which is often mutated in a variety of human cancers. Some genes in this cluster include the oncogene MDM2 and the tumor suppressor genes p21 and p27, which interact with the p53 gene product to regulate key cellular processes such as the cell cycle and apoptosis. Other genes that are affected by or interact with p53 include those that respond to DNA damage, thereby influencing cell growth and apoptosis. Additionally, the p21 gene product is specifically activated by DNA damage and works alongside p53 to induce apoptosis, while the p21 and p27 gene products also interact with each other to regulate cell growth. All in all, this gene cluster plays a crucial role in maintaining cellular homeostasis by regulating cell cycle, apoptosis, and overall cell growth in response to DNA damage."
BIOCARTA_CK1_PATHWAY,"['DRD1', 'GRM1', 'DRD2', 'PPP2CA', 'PRKACG', 'PRKAR1A', 'PPP1R1B', 'PLCB1', 'PRKAR2B', 'PPP3CA', 'PRKACB', 'CDK5R1', 'PRKAR1B', 'CSNK1D', 'PRKAR2A', 'CDK5']",Regulation of ck1/cdk5 by type 1 glutamate receptors,"Cdk5 is a cyclin dependent protein kinase involved in dopaminergic signaling in the neostriatal region of the brain. The role of cdk5 in dopamine responses occurs through phosphorylation of DARPP-32. Caseine kinase 1 (CK1) also regulates DARPP-32 phosphorylation and dopamine signaling. The phosphorylation of DARPP-32 by cdk5 reduced dopamine signaling. Depending on its phosphorylation state, DARPP-32 inhibits either protein phosphatase 1 (PP1) or PKA. The role of mGLUR1 in this process is supported by the induction of cdk5 and CK1 activity by the mGLUR1 agonist DHPG and the subsequent phosphorylation of DARPP-32 associated with DHPG treatment of nigrostriatal neurons. CK-1 and Ckd5 inhibitors block the DHPG induced DARPP-32 phosphorylation. Dopamine exerts a positive signal that increases dopamine response by reversing phosphorylation of DARPP-32 at threonine-75. Dopamine initiates this pathway through activation of the D1 dopamine receptor, a Gs coupled GPCR, elevating cAMP and activating PKA. PKA activates protein phosphatase 2A (PP2A) which dephosphorylates DARPP-32 and increases dopamine responsiveness. This also removes the inhibition of PKA by DARPP-32, forming a positive feedback loop for further DARPP-32 inactivation by PKA. Activation of the D2 dopamine receptor has the opposite effect, shifting the DARPP-32 population toward the threonine-75 phosphorylated form.","The gene cluster provided is primarily involved in the regulation of neurotransmission and signal transduction pathways in the brain, particularly those related to dopamine and glutamate signaling. This cluster plays a crucial role in modulating synaptic plasticity, learning, memory, and various neuropsychiatric processes.\n\n1. **Cluster Identification and Biological Function:**\n   - The gene cluster includes genes encoding dopamine receptors (DRD1, DRD2), a glutamate receptor (GRM1), and several components of the protein kinase A (PKA) signaling pathway (PRKACG, PRKAR1A, PRKAR2B, PRKACB, PRKAR1B, PRKAR2A). It also includes genes involved in phosphatase activity (PPP2CA, PPP3CA, PPP1R1B) and other kinases (CDK5, CDK5R1, CSNK1D, PLCB1).\n   - This cluster is integral to the regulation of dopaminergic and glutamatergic signaling, which are critical for cognitive functions and motor control.\n\n2. **Key Genes and Their Functions:**\n   - **DRD1 and DRD2:** These genes encode dopamine receptors D1 and D2, which are involved in modulating neurotransmission and are critical for reward and motivation pathways.\n   - **GRM1:** Encodes the metabotropic glutamate receptor 1, which is involved in modulating synaptic plasticity and neuronal excitability.\n   - **PPP2CA and PPP3CA:** Encode catalytic subunits of protein phosphatases 2A and 3 (calcineurin), respectively, which are involved in dephosphorylation processes that counterbalance kinase activity.\n   - **PRKACG, PRKACB, PRKAR1A, PRKAR2B, PRKAR1B, PRKAR2A:** These genes encode various subunits of the PKA complex, which is a key regulator of many cellular processes, including metabolism, gene expression, and synaptic plasticity.\n   - **CDK5 and CDK5R1:** Encode cyclin-dependent kinase 5 and its regulatory subunit p35, which are involved in neuronal development and synaptic function.\n   - **CSNK1D:** Encodes casein kinase 1 delta, which is involved in various cellular processes, including circadian rhythm regulation.\n   - **PLCB1:** Encodes phospholipase C beta 1, which is involved in the phosphoinositide signaling pathway, crucial for intracellular calcium release.\n\n3. **Gene Interactions and Relationships:**\n   - The dopamine receptors (DRD1, DRD2) and glutamate receptor (GRM1) interact with downstream signaling pathways involving PKA and phosphatases (PPP2CA, PPP3CA) to modulate neuronal activity.\n   - PKA subunits (PRKACG, PRKACB, PRKAR1A, PRKAR2B, PRKAR1B, PRKAR2A) are regulated by cyclic AMP (cAMP) levels, which are influenced by neurotransmitter signaling.\n   - CDK5 and its activator CDK5R1 are involved in the phosphorylation of various substrates, affecting neuronal structure and function.\n\n4. **Regulatory Elements and Patterns:**\n   - The activity of PKA is tightly regulated by cAMP levels, which are modulated by neurotransmitter binding to receptors such as DRD1, DRD2, and GRM1.\n   - Phosphatases like PPP2CA and PPP3CA provide a counterbalance to kinase activity, ensuring precise control of phosphorylation states.\n\n5. **Biological Implications:**\n   - Dysregulation of this gene cluster can lead to various neurological and psychiatric disorders, including schizophrenia, Parkinson's disease, and depression.\n   - Understanding the interactions and regulation within this cluster can provide insights into therapeutic targets for modulating neurotransmission and treating related disorders.\n\nOverall, this gene cluster represents a complex network of signaling pathways that are essential for proper brain function and behavior. Further research is needed to fully elucidate the intricate interactions and regulatory mechanisms within this cluster.","The gene cluster consists of five different dopamine receptor subtypes (D1-5). Some genes in this cluster, specifically the D1-like receptors (D1 and D5), are coupled to the Golf heterotrimer and stimulate cAMP formation through the activation of adenylate cyclase. Other genes, the D2-like receptors (D2, D3, and D4), are coupled to the Gi protein and inhibit cAMP formation. Additionally, the actions of dopamine are mediated by a variety of signal transduction systems, including ion channels, protein kinases, phosphatases, and gene transcription. All in all, this gene cluster mediates the physiological effects of dopamine through different mechanisms involving various receptors and signal pathways."
BIOCARTA_IGF1R_PATHWAY,"['MAPK3', 'HRAS', 'PIK3R1', 'MAP2K1', 'RPS6KA1', 'PRKACG', 'RAF1', 'ADCY1', 'YWHAH', 'PRKAR1A', 'BAD', 'MAPK1', 'PRKAR2B', 'SHC1', 'GRB2', 'IRS1', 'PRKACB', 'PRKAR1B', 'AKT1', 'PIK3CA', 'PRKAR2A', 'IGF1R', 'SOS1']",Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,"IGF-1R, the type 1 receptor for insulin-like growth factor, mediates cell survival and growth in response to its ligands IGF-1 and IGF-2. This tyrosine kinase receptor is widely expressed in many cell types and is a key mediator of growth. Overexpression or activation of IGF-1R may be involved in the proliferation of transformed cells, making inhibition of IGF-1R signaling a strategy for the development of cancer drugs. IGF-1R activates three signaling pathways that converge to phosphorylate BAD protein and block apoptosis. The first pathway activated by IGF-1R stimulates PI3-kinase and the AKT pathway to phosphorylate BAD and block apoptosis. A second pathway activated by IGF-1R involves ras mediated activation of the map kinase pathway to block apoptosis. A third pathway involves interaction of raf with mitochondria in response to IGF-1R activation. The convergence of these pathways to block apoptosis may enhance the IGF-1R response.","The gene cluster provided is primarily involved in the MAPK/ERK signaling pathway, a critical pathway for regulating various cellular processes, including growth, proliferation, differentiation, and survival. This pathway is often implicated in cancer and other diseases due to its role in cell cycle regulation and apoptosis.\n\nSome genes in this cluster, such as **MAPK3 (ERK1)** and **MAPK1 (ERK2)**, are central components of the MAPK/ERK pathway. They are serine/threonine kinases that, when activated, translocate to the nucleus to regulate gene expression. **RAF1** encodes a protein kinase that is part of the MAPK/ERK pathway, activated by RAS proteins and subsequently activates MEK1/2 (MAP2K1/2). **MAP2K1 (MEK1)** is activated by RAF1 and, in turn, activates ERK1/2 (MAPK3/1) through phosphorylation. **HRAS**, a member of the RAS family of GTPases, is a key upstream regulator of the MAPK/ERK pathway, activating RAF1 upon binding GTP.\n\nOther genes, such as **PIK3R1** and **PIK3CA**, encode components of the PI3K complex, which is involved in the PI3K/AKT signaling pathway, often interacting with the MAPK/ERK pathway to regulate cell survival and growth. **AKT1** is a serine/threonine kinase that is a central node in the PI3K/AKT pathway, promoting cell survival and growth. **IGF1R**, the insulin-like growth factor 1 receptor, is a receptor tyrosine kinase that activates both the MAPK/ERK and PI3K/AKT pathways upon ligand binding. **SOS1** is a guanine nucleotide exchange factor that facilitates the activation of RAS proteins, linking receptor tyrosine kinases to the MAPK/ERK pathway. **GRB2** and **SHC1** are adaptor proteins that link activated receptor tyrosine kinases to SOS1, facilitating RAS activation. **RPS6KA1 (RSK1)** is a downstream effector of ERK1/2, involved in the regulation of protein synthesis and cell growth. **PRKACG, PRKACB, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B** encode components of the protein kinase A (PKA) complex, which can intersect with the MAPK/ERK pathway, influencing cellular responses to hormonal signals. **BAD** is a pro-apoptotic member of the Bcl-2 family, regulated by phosphorylation through the PI3K/AKT pathway, linking survival signals to apoptotic pathways. **ADCY1**, adenylate cyclase 1, is involved in the production of cAMP, which can modulate PKA activity and intersect with MAPK/ERK signaling. **YWHAH** encodes 14-3-3 eta, a protein that interacts with phosphorylated proteins, including those in the MAPK/ERK pathway, to regulate their activity and localization.\n\nAdditionally, the MAPK/ERK pathway is initiated by growth factors binding to receptor tyrosine kinases like IGF1R, leading to the activation of RAS (HRAS), which then activates RAF1. RAF1 phosphorylates and activates MEK1 (MAP2K1), which in turn activates ERK1/2 (MAPK3/1). The PI3K/AKT pathway, involving PIK3R1, PIK3CA, and AKT1, often works in parallel with the MAPK/ERK pathway, providing a survival signal that can counteract apoptotic signals. Cross-talk between these pathways is facilitated by shared components and regulatory proteins, such as BAD and 14-3-3 proteins (YWHAH).\n\nAll in all, this gene cluster represents a complex network of signaling pathways that are crucial for normal cellular function and are often hijacked in disease states. Dysregulation of the MAPK/ERK and PI3K/AKT pathways is a hallmark of many cancers, as these pathways control critical aspects of cell proliferation and survival. Understanding the interactions and regulatory mechanisms within this gene cluster can provide insights into therapeutic targets for cancer and other diseases involving aberrant cell signaling. Further research is needed to fully elucidate the intricate regulatory mechanisms and potential therapeutic interventions.","The gene cluster is involved in insulin binding to its receptor, which activates the receptor tyrosine kinase and initiates a signaling cascade that facilitates glucose uptake into the cell. Some genes in this cluster include those responsible for the binding of insulin to the receptor and the subsequent activation of PI3-kinase, which phosphorylates membrane lipids to produce PIP3. Other genes are involved in recruiting AKT to the membrane, where it is phosphorylated and activated by PDK1 and p38. Additionally, AKT then phosphorylates and activates mTOR, resulting in the translocation of GLUT4 to the plasma membrane and the stimulation of glucose uptake. All in all, this gene cluster plays a crucial role in regulating glucose uptake through the insulin signaling pathway."
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,"['CDC16', 'ADCY8', 'ADCY9', 'ADCY6', 'RAF1', 'ADCY7', 'ADCY5', 'SPDYA', 'IGF1', 'RPS6KA6', 'CDK1', 'ANAPC10', 'IGF1R', 'ANAPC1', 'INS', 'ANAPC11', 'SPDYC', 'MAPK9', 'MAPK10', 'MAPK11', 'BRAF', 'MAPK13', 'MAP2K1', 'ADCY4', 'AKT1', 'AKT2', 'RPS6KA2', 'RPS6KA3', 'AKT3', 'CPEB1', 'MAPK3', 'ANAPC7', 'ANAPC5', 'ANAPC2', 'ANAPC4', 'MAD2L1', 'RPS6KA1', 'MAPK1', 'PIK3R5', 'PDE3B', 'MAPK8', 'CDC23', 'MAPK14', 'MAPK12', 'KRAS', 'PRKX', 'GNAI1', 'CCNA1', 'GNAI2', 'FZR1', 'ADCY3', 'HSP90AA1', 'ARAF', 'ADCY2', 'PLK1', 'ADCY1', 'PDE3A', 'ANAPC13', 'MOS', 'PIK3R3', 'PGR', 'CCNA2', 'BUB1', 'PKMYT1', 'PRKACA', 'CDK2', 'PRKACB', 'PRKACG', 'CDC26', 'GNAI3', 'HSP90AB1', 'CDC27', 'PIK3CA', 'PIK3CB', 'CDC25B', 'CDC25C', 'CCNB2', 'PIK3CD', 'CDC25A', 'MAD2L2', 'CCNB1', 'PIK3CG', 'PIK3R1', 'CCNB3', 'PIK3R2']",Progesterone-mediated oocyte maturation,"Xenopus oocytes are naturally arrested at G2 of meiosis I. Exposure to either insulin/IGF-1 or the steroid hormone progesterone breaks this arrest and induces resumption of the two meiotic division cycles and maturation of the oocyte into a mature, fertilizable egg. This process is termed oocyte maturation. The transition is accompanied by an increase in maturation promoting factor (MPF or Cdc2/cyclin B) which precedes germinal vesicle breakdown (GVBD). Most reports point towards the Mos-MEK1-ERK2 pathway and the polo-like kinase/CDC25 pathway as responsible for the activation of MPF in meiosis, most likely triggered by a decrease in cAMP.","The gene cluster provided is a complex network of genes involved in several critical cellular processes, primarily focusing on cell cycle regulation, signal transduction, and metabolic pathways. Some genes in this cluster encode proteins that are key players in the regulation of the cell cycle, including cyclins and cyclin-dependent kinases (CDKs) such as **CCNA1, CCNA2, CCNB1, CCNB2, CCNB3, CDK1,** and **CDK2**, which are crucial for cell cycle progression. Additionally, genes like **ANAPC1, ANAPC2, ANAPC4, ANAPC5, ANAPC7, ANAPC10, ANAPC11,** and **ANAPC13** encode components of the anaphase-promoting complex (APC/C), a key E3 ubiquitin ligase regulating the transition from metaphase to anaphase. The CDC genes, including **CDC16, CDC23, CDC25A, CDC25B, CDC25C, CDC26,** and **CDC27**, are involved in various stages of cell cycle control.\n\nOther genes in this cluster are involved in signal transduction pathways. The MAPK pathway includes genes such as **MAPK1, MAPK3, MAPK8, MAPK9, MAPK10, MAPK11, MAPK12, MAPK13,** and **MAPK14**, which encode MAP kinases involved in transmitting signals from the cell surface to the DNA in the nucleus. **RAF1** and **BRAF** are part of the MAPK/ERK pathway, while the PI3K pathway involves genes like **PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2,** and **PIK3R3**. The AKT genes, **AKT1, AKT2,** and **AKT3**, mediate downstream effects of PI3K signaling.\n\nAdditionally, the cluster includes genes encoding adenylate cyclases, such as **ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8,** and **ADCY9**, which convert ATP to cyclic AMP (cAMP). Insulin and growth factor signaling is represented by genes like **INS, IGF1,** and **IGF1R**. Regulatory elements include **MAD2L1, MAD2L2, HSP90AA1, HSP90AB1, PDE3A,** and **PDE3B**.\n\nAll in all, this gene cluster is integral to maintaining cellular homeostasis and responding to external stimuli. Dysregulation of these genes can lead to various diseases, including cancer, due to their roles in cell proliferation, apoptosis, and metabolism. Understanding the interactions and regulatory mechanisms within this cluster is crucial for developing targeted therapies for conditions like cancer, diabetes, and cardiovascular diseases. While many functions of these genes are well-characterized, further studies are needed to elucidate their complex interactions and regulatory networks in different tissue types and physiological conditions.","The gene cluster responsible for the cell cycle is a vital, highly conserved biological process in which eukaryotic cells replicate and distribute their chromosomes to two daughter cells. Some genes in this cluster include cyclin-dependent kinases (CDKs), a family of serine/threonine protein kinases activated by binding to regulatory cyclin subunits. These CDKs are essential for advancing through each phase of the cell cycle. Other genes in this cluster regulate CDK activity through the availability of cyclin subunits, phosphorylation of specific threonine and tyrosine residues, and binding of inhibitory proteins.\n\nAdditionally, the progression of various cell cycle phases involves specific cyclin-CDK complexes: the G1-S transition is facilitated by cyclin E-CDK2 and cyclin A-CDK2 activation, while cyclin D-CDK4/6 and cyclin E-CDK2 activation prompts overall G1-S progression; cyclin A-CDK2 targets the S-phase transition; and cyclin B-CDK1 is crucial for the G2-M transition and mitotic progression. The G2-M checkpoint activation ensures repair of damaged DNA before proceeding through mitosis. Moreover, the spindle assembly checkpoint (SAC) serves as a surveillance mechanism to ensure chromosome segregation fidelity by delaying anaphase onset until all kinetochores are firmly attached to microtubules from opposite poles. Unattached kinetochores activate the SAC, which subsequently inhibits the anaphase-promoting complex (APC), a ubiquitin ligase responsible for the proteolytic degradation of cyclin B and other mitotic regulators.\n\nAll in all, this gene cluster comprises a tightly regulated network that ensures accurate cell division and genome integrity through diverse regulatory mechanisms and checkpoints."
BIOCARTA_LAIR_PATHWAY,"['CXCL8', 'IL1A', 'SELP', 'KNG1', 'C7', 'VCAM1', 'ITGAL', 'TNF', 'ITGB2', 'ITGA4', 'C6', 'C5', 'C3', 'SELPLG', 'ICAM1', 'ITGB1', 'IL6']",Cells and Molecules involved in local acute inflammatory response,"Inflammation has several distinct components, including the localized response at the site of tissue injury or infection. Tissue injury stimulates the release of inflammatory signaling molecules such as bradykinin. Bacterial infection stimulates an immune response in several ways. Bacteria that are phagocytosed can activate macrophages, causing the release of inflammatory cytokines such as IL-1, TNF, and IL-6. Bacteria can also activate the complement cascade through either the antibody-mediated pathway (classical pathway) or the alternative complement pathway. In extravascular tissues, cells that respond to infection or injury include macrophages and mast cells. Macrophages and other immune cells secrete chemokines that recruit leukocytes from the circulation to the site of inflammation. Mast cells release histamine, prostaglandins, and leukotrienes that act as chemokines, increase vascular permeability, and act on the vascular endothelium to increase tissue recruitment of leukocytes. Chemokines can recruit leukocytes or lymphocytes out of the blood stream into tissues and make blood vessels more permeable. Leukocytes are activated by inflammatory signals to express adhesion molecules that cause them to interact with the vascular endothelium, penetrate the endothelial wall and migrate into the extracellular space of tissues. The combined response of immune cells and signaling molecules at the site of inflammation induces swelling, activation of immune cells, and clearance of potential infectious agents. Chronic inflammation can however also lead to tissue damage in conditions such as arthritis, in which anti-inflammatory drugs act on various steps in inflammation to prevent disease.","The gene cluster provided is primarily involved in the inflammatory response and immune system regulation. Some genes in this cluster encode cytokines, adhesion molecules, and components of the complement system, which collectively play crucial roles in mediating inflammation, immune cell recruitment, and pathogen clearance.\n\n1. **Cytokines and Chemokines:**\n   - **CXCL8 (Interleukin-8):** A chemokine that attracts neutrophils to sites of infection or injury, playing a pivotal role in the acute inflammatory response.\n   - **IL1A (Interleukin-1 alpha):** A pro-inflammatory cytokine involved in various cellular activities, including cell proliferation, differentiation, and apoptosis. It is a key mediator of the inflammatory response.\n   - **IL6 (Interleukin-6):** A multifunctional cytokine that influences immune response, inflammation, and hematopoiesis. It is involved in the acute phase response and can stimulate the production of acute-phase proteins.\n\n2. **Adhesion Molecules:**\n   - **SELP (Selectin P):** An adhesion molecule that mediates the interaction of leukocytes with endothelial cells, facilitating their migration to sites of inflammation.\n   - **VCAM1 (Vascular Cell Adhesion Molecule 1):** Expressed on endothelial cells, it binds to integrins on leukocytes, aiding in their adhesion and transmigration.\n   - **ICAM1 (Intercellular Adhesion Molecule 1):** Facilitates leukocyte endothelial transmigration and is upregulated in response to inflammatory cytokines.\n   - **SELPLG (Selectin P Ligand):** Binds to selectins, playing a role in leukocyte rolling and migration.\n\n3. **Integrins:**\n   - **ITGAL (Integrin Subunit Alpha L), ITGB2 (Integrin Subunit Beta 2), ITGA4 (Integrin Subunit Alpha 4), ITGB1 (Integrin Subunit Beta 1):** These integrins are involved in cell adhesion and signal transduction, crucial for leukocyte trafficking and immune response modulation.\n\n4. **Complement System Components:**\n   - **C3, C5, C6, C7:** These genes encode proteins that are part of the complement cascade, a critical component of innate immunity. They facilitate opsonization, cell lysis, and inflammation.\n\nOther genes in this cluster include:\n\n- **TNF (Tumor Necrosis Factor):** A major pro-inflammatory cytokine that regulates immune cells, induces fever, and can lead to apoptotic cell death.\n- **KNG1 (Kininogen 1):** Involved in the kinin-kallikrein system, which regulates blood pressure, inflammation, and coagulation.\n\nAdditionally, the genes in this cluster interact to coordinate the body's response to injury and infection. Cytokines like IL1A, IL6, and TNF initiate and propagate inflammatory signals, while chemokines such as CXCL8 recruit immune cells to the site of inflammation. Adhesion molecules and integrins facilitate the migration and adhesion of these cells to the endothelium. The complement system components enhance pathogen clearance and inflammation. Many of these genes are regulated by transcription factors such as NF-\u03baB, which is activated in response to inflammatory stimuli. Dysregulation of these genes can lead to chronic inflammatory diseases, autoimmune disorders, or impaired immune responses.\n\nAll in all, this gene cluster is crucial for developing therapeutic strategies for inflammatory and autoimmune diseases, as well as for modulating immune responses in various clinical settings. Further research is needed to elucidate the precise regulatory mechanisms and interactions within this cluster.","The gene cluster involved in the adhesion of leukocytes to the endothelium plays a key role in the inflammatory response. Some genes in this cluster encode integrins, a family of adhesion molecules that mediate the interaction between leukocytes and the endothelium. Other genes in this cluster code for the leukocyte integrin Mac-1 (CD11b/CD18), which binds to its endothelial counter receptors ICAM-1 (CD54) and ICAM-2 (CD31). The interaction of Mac-1 with ICAM-1 is crucial for the firm adhesion of leukocytes to the endothelium and their subsequent migration into tissues, while interaction with ICAM-2 is involved in the regulation of leukocyte activation. Additionally, the interaction of Mac-1 with its endothelial ligands is regulated in part by the leukocyte protease elastase, and Mac-1 also serves as the receptor for the complement fragment iC3b. The interaction of Mac-1 with iC3b is important for the phagocytosis of opsonized bacteria by macrophages. This interaction, as well as the interaction of Mac-1 with its endothelial ligands, is inhibited by the serum protein alpha 1-antichymotrypsin. All in all, this gene cluster coordinates critical pathways in inflammation and immune response mechanisms."
BIOCARTA_RHO_PATHWAY,"['ARHGEF5', 'MYL2', 'BAIAP2', 'OPHN1', 'ARHGAP1', 'RHOA', 'ROCK1', 'ARHGAP6', 'PPP1R12B', 'TLN1', 'PFN1', 'ARHGEF11', 'GSN', 'DIAPH1', 'PIP5K1B', 'ARHGAP5', 'ARHGEF1', 'VCL', 'LIMK1', 'PIP5K1A', 'ARHGAP4']",Rho cell motility signaling pathway,"RhoA is a small G-protein in the Rho family that regulates cell morphology via actin cytoskeleton reorganization in response to extracellular signals. The majority of RhoA activations is due to disruption of intramolecular autoinhibitory interactions. Changes in cytoskeletal structure and other aspects of cell structure are involved in cell morphology. RhoA is activated by GEF factors, and repressed by GAPs. GEFs are guanine nucleotide exchange factors. GAPs are GTPase-activating proteins. The RhoGAP ARHGAP1 also acts as a GAP for Rac and CDC42. Active RhoA increases the stability of actin-based structures such as stress fibers and focal adhesions. Several different factors downstream of RhoA act on cytoskeletal structures to affect stability of these structures. Rock1 provides a direct link from RhoA to cell morphology through phosphorylation of the myosin light chain. Rock1 also phosphorylates and activates LIM kinase, which phosphorylates cofilin. Cofilin stimulates actin depolymerization and changes in cell structure, and phosphorylation of cofilin by LIM kinase represses this activity. According to Nimnual et al. Rho activity is reduced as a result of Rac-induced redox-dependent inhibition. Related Disease: Non-syndromic deafness appears to be the result of amino acid substitutions in the 52-amino acid C-terminal end of Dia 1. This modification creates a constituatively active Dia 1 protein. A mutation in the RhoGAP Oligophrenin-1 is thought to contribute to a form of mental retardation due to loss of Rho inhibition in neuronal development.","The gene cluster provided is primarily involved in the regulation of the Rho GTPase signaling pathway, which plays a crucial role in cytoskeletal dynamics, cell movement, and various cellular processes. Some genes in this cluster encode guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), which interact with or regulate the Rho family of GTPases.\n\n### Key Genes and Their Functions:\n\n1. **ARHGEF5, ARHGEF11, ARHGEF1**: These genes encode Rho guanine nucleotide exchange factors (GEFs), which activate Rho GTPases by facilitating the exchange of GDP for GTP. This activation is crucial for initiating downstream signaling pathways that regulate actin cytoskeleton organization.\n\n2. **ARHGAP1, ARHGAP6, ARHGAP5, ARHGAP4**: These genes encode Rho GTPase-activating proteins (GAPs), which inactivate Rho GTPases by stimulating their intrinsic GTPase activity, converting GTP to GDP. This inactivation is essential for turning off Rho GTPase signaling and ensuring proper cellular responses.\n\nOther genes in the cluster include:\n\n3. **RHOA**: A member of the Rho family of GTPases, RHOA is a central regulator of the actin cytoskeleton, influencing cell shape, motility, and division.\n\n4. **ROCK1**: Rho-associated coiled-coil containing protein kinase 1 (ROCK1) is a downstream effector of RHOA, mediating various cellular processes such as contraction, adhesion, and motility through phosphorylation of target proteins.\n\n5. **MYL2**: Encodes myosin light chain 2, which is involved in muscle contraction and is regulated by phosphorylation, a process influenced by Rho/ROCK signaling.\n\n6. **BAIAP2 (IRSp53)**: This gene encodes a protein that links Rho GTPase signaling to actin cytoskeleton remodeling, playing a role in filopodia formation and cell motility.\n\n7. **OPHN1**: Encodes oligophrenin 1, a RhoGAP involved in synaptic function and neuronal development, highlighting the role of Rho signaling in the nervous system.\n\n8. **PPP1R12B**: Encodes a regulatory subunit of protein phosphatase 1, which is involved in the dephosphorylation of myosin light chains, thus influencing muscle contraction and cell motility.\n\n9. **TLN1 (Talin 1)**: A cytoskeletal protein that links integrins to the actin cytoskeleton, playing a critical role in cell adhesion and migration.\n\n10. **PFN1 (Profilin 1)**: Binds actin monomers and regulates actin polymerization, essential for cell movement and structure.\n\n11. **GSN (Gelsolin)**: An actin-binding protein that severs and caps actin filaments, regulating actin dynamics.\n\n12. **DIAPH1**: A formin protein that nucleates actin filaments, promoting their elongation and playing a role in cytokinesis and cell polarity.\n\n13. **PIP5K1A, PIP5K1B**: Encode phosphatidylinositol-4-phosphate 5-kinases, which produce phosphatidylinositol (4,5)-bisphosphate, a lipid that regulates actin dynamics and is involved in signal transduction.\n\n14. **VCL (Vinculin)**: A cytoskeletal protein involved in cell-cell and cell-matrix junctions, crucial for maintaining cell integrity and transmitting mechanical signals.\n\n15. **LIMK1**: A kinase that phosphorylates and inactivates cofilin, a protein that disassembles actin filaments, thus regulating actin dynamics.\n\nAdditionally, the interplay between GEFs and GAPs in this cluster highlights the dynamic regulation of Rho GTPase activity, ensuring precise control over actin cytoskeleton remodeling. ROCK1, as a downstream effector of RHOA, links Rho GTPase activation to changes in cell contractility and motility. The presence of actin-binding proteins like PFN1, GSN, and DIAPH1 underscores the cluster's role in actin filament dynamics, essential for cellular processes such as migration and division.\n\n### Biological Implications:\n\n- Dysregulation of Rho GTPase signaling is implicated in various diseases, including cancer metastasis, cardiovascular diseases, and neurological disorders.\n- Understanding the interactions within this gene cluster can provide insights into therapeutic targets for modulating cell movement and invasion in pathological conditions.\n\nAll in all, this gene cluster represents a critical network for regulating the actin cytoskeleton and cellular dynamics, with significant implications for health and disease.","The gene cluster known as the Rho family of GTPases, which includes RhoA, Rac1, and Cdc42, functions as molecular switches that alternate between an inactive GDP-bound state and an active GTP-bound state. Some genes in this cluster are activated by guanine nucleotide exchange factors (GEFs), which facilitate the release of bound GDP and the binding of GTP, thus transitioning the molecules into their active form. Other genes are influenced by GTPase-activating proteins (GAPs), which enhance the intrinsic GTPase activity of Rho-GTPases; this action encourages the conversion from the active GTP-bound state back to the inactive GDP-bound state. Additionally, guanine nucleotide dissociation inhibitors (GDIs) bind to Rho-GTPases, maintaining them in the inactive state in the cytosol by attaching to the isoprenyl group of Rho-GTPases and inhibiting interaction with other regulators and effectors. Guanine nucleotide exchange factors (GEFs) are the only known regulators of Rho-GTPases and are classified into four subfamilies based on sequence homology: the Dbl-homology (DH) domain family, the Vav family, the Map kinase kinase family, and the PSD-95/discs large/ZO-1 (PDZ) domain family. GEFs are activated by upstream signals and are regulated through mechanisms like the release of inhibitory interactions, protein-protein interactions, and phosphorylation, allowing them to facilitate GDP release and GTP binding on Rho-GTPases. Activated Rho-GTPases engage with various downstream targets to convey signals leading to multiple cellular responses. Specific effectors link Rho-GTPases to certain cellular actions. For instance, RhoA promotes the formation of stress fibers and focal adhesions via the Rho-associated coiled-coil containing protein kinase 1 (ROCK1) and p160ROCK. Rac1 is involved in lamellopodial extension through the activation of the kinase Pak1, which phosphorylates the regulatory light chain of myosin II. The function of Cdc42 in cellular responses is less clear, but it is believed to regulate the formation of filopodia through phosphorylation of the Wiskott-Aldrich syndrome protein (WASP) and the Arp2/3 complex. All in all, this gene cluster plays a crucial role in regulating cellular dynamics and responses through intricate regulatory mechanisms and interactions."
BIOCARTA_SODD_PATHWAY,"['FADD', 'BIRC3', 'BAG4', 'TNF', 'TNFRSF1B', 'TNFRSF1A', 'TRADD', 'RIPK1', 'TRAF2', 'CASP8']",SODD/TNFR1 Signaling Pathway,"The tumor necrosis factor (TNF) receptor superfamily contains several members with homologous cytoplasmic domains known as death domains (DD). The intracellular DD are important in initiating apoptosis and other signaling pathways following ligand binding by the receptors.1 In the absence of ligand, DD-containing receptors are maintained in an inactive state. TNF RI contains a cytoplasmic DD required for signaling pathways associated with apoptosis and NF-kB activation.2,3 Jiang et al.4 identified a widely expressed 60 kDa protein, named SODD (silencer of death domains), associated with the DD of TNF RI and DR3. Overexpression of SODD suppresses TNF-induced cell death and NF-kB activation demonstrating its role as a negative regulatory protein for these signaling pathways. TNF-induced receptor trimerization aggregates the DD of TNF RI and recruits the adapter protein TRADD.3,5 This in turn promotes the recruitment of the DD-containing cytoplasmic proteins FADD, TRAF2 and RIP to form an active TNF RI signaling complex (Figure 1A).6-9 In contrast, SODD acts as a silencer of TNF RI signaling and does not interact with TRADD, FADD, or RIP (Figure 1B).4 It is associated with the DD of TNF RI and maintains TNF RI in an inactive, monomeric state. TNF-induced aggregation of TNF RI promotes the disruption of the SODD-TNF RI complex. SODD does not interact with the DD of other TNF receptor superfamily members such as Fas, DR4, DR5, or TNF RII. SODD association with TNF RI may represent a general model for the prevention of spontaneous TNF signaling by other DD-containing receptors.","The gene cluster is primarily involved in the regulation of apoptosis and the inflammatory response, with a central focus on the tumor necrosis factor (TNF) signaling pathway. This cluster plays a critical role in cell death, survival, and immune system regulation.\n\nSome genes in this cluster include TNF and its receptors, TNFRSF1A and TNFRSF1B. TNF is a cytokine that binds to these receptors, initiating a cascade of signaling events. TNFRSF1A is primarily involved in apoptosis and inflammation, while TNFRSF1B is more associated with cell survival and immune regulation.\n\nOther genes include adaptor proteins such as TRADD and FADD. Upon TNF binding, TRADD (TNF receptor-associated death domain) is recruited to TNFRSF1A, serving as a platform for further signaling. FADD (Fas-associated death domain) interacts with TRADD to propagate apoptotic signals, particularly through the extrinsic apoptosis pathway.\n\nAdditionally, kinases and ubiquitin ligases like RIPK1 and TRAF2 play a role. RIPK1 (receptor-interacting serine/threonine-protein kinase 1) is a key mediator that can lead to either cell survival or death, depending on the context. It interacts with TRADD and TRAF2 (TNF receptor-associated factor 2), an E3 ubiquitin ligase that facilitates the activation of NF-\u03baB, a transcription factor promoting cell survival and inflammation.\n\nInhibitors of apoptosis such as BIRC3 and BAG4 are also part of this cluster. BIRC3 (baculoviral IAP repeat-containing protein 3), also known as cIAP2, inhibits caspases and promotes cell survival by ubiquitinating RIPK1. BAG4 (BCL2-associated athanogene 4), also known as SODD, negatively regulates TNFR1 signaling by preventing spontaneous receptor activation.\n\nCaspases, particularly CASP8, are crucial in this cluster. CASP8 (caspase 8) is a crucial initiator caspase in the extrinsic apoptosis pathway. It is activated upon recruitment to the death-inducing signaling complex (DISC) formed by FADD and TRADD, leading to the execution of apoptosis.\n\nThe balance between pro-apoptotic and pro-survival signals in this cluster is tightly regulated. The ubiquitination of RIPK1 by TRAF2 and BIRC3 is a critical control point, determining whether the cell undergoes apoptosis or survives. Additionally, the activation of NF-\u03baB by TRAF2 promotes the expression of anti-apoptotic genes, further influencing cell fate.\n\nDysregulation of this gene cluster can lead to various diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. Overactive TNF signaling is implicated in inflammatory diseases, while impaired apoptosis can contribute to cancer progression. Understanding the interactions within this cluster is crucial for developing targeted therapies for these conditions.\n\nAll in all, this gene cluster orchestrates a complex network of signals that determine cell fate, balancing apoptosis and survival, with significant implications for health and disease.","The gene cluster known as the TNF receptor superfamily consists of cell-surface receptors that induce apoptosis upon binding with their respective ligands. Some genes in this cluster include the Fas receptor (also referred to as APO1, CD95, and TNFRSF6), which is activated by the Fas ligand (also known as APO1L, CD95L, and TNFSF6) to trigger apoptosis in various cell types. Other genes in this cluster participate in a signaling cascade where the binding of Fas ligand to the Fas receptor causes the receptor to aggregate and recruit the Fas-associated death domain (FADD). FADD subsequently recruits caspase-8 (also referred to as MACH and Mch5), a protease that ordinarily remains inactive in the cytosol. Additionally, once FADD and caspase-8 associate at the receptor, they form the death-inducing signaling complex (DISC), leading to the activation of caspase-8. This activation results in the stimulation of downstream caspases like caspase-3, -6, and -7. The Bcl-2 family of proteins further regulates apoptosis by managing the mitochondrial pathway of apoptosis. Bcl-2 and Bcl-xL specifically inhibit the release of mitochondrial factors, such as cytochrome c, that would otherwise activate the caspase cascade. The interaction of the Bcl-2 family protein Bid with Bax causes Bax to relocate to the mitochondria, prompting the release of cytochrome c. Cytochrome c then interacts with Apaf-1 to activate caspase-9, initiating a caspase cascade that leads to apoptosis. Bcl-2 and Bcl-xL mitigate this mitochondrial pathway by preventing the release of cytochrome c. All in all, this gene cluster orchestrates a complex pathway that controls the induction of apoptosis through both extracellular and mitochondrial signals."
KEGG_RNA_DEGRADATION,"['LSM5', 'MPHOSPH6', 'MTREX', 'PATL1', 'EXOSC4', 'PNPT1', 'EXOSC2', 'SKIC2', 'XRN2', 'EXOSC5', 'SKIC3', 'LSM6', 'EXOSC3', 'EXOSC1', 'EDC4', 'CNOT3', 'CNOT2', 'XRN1', 'PARN', 'C1D', 'PAPOLA', 'DDX6', 'DCP1A', 'ZCCHC7', 'ENO1', 'CNOT4', 'CNOT7', 'TENT4A', 'EXOSC8', 'C1DP3', 'HSPA9', 'LSM1', 'CNOT6L', 'EXOSC6', 'LSM7', 'LSM8', 'CNOT9', 'LSM4', 'CNOT1', 'CNOT10', 'EXOSC7', 'LSM3', 'DIS3', 'ENO3', 'ENO2', 'CNOT6', 'C1DP2', 'LSM2', 'DCP2', 'HSPD1', 'EXOSC9', 'EXOSC10', 'EDC3', 'DCPS', 'PAPOLB', 'DCP1B', 'SKIC8', 'CNOT8', 'PAPOLG']",RNA degradation,"The correct processing, quality control and turnover of cellular RNA molecules are critical to many aspects in the expression of genetic information. In eukaryotes, two major pathways of mRNA decay exist and both pathways are initiated by poly(A) shortening of the mRNA. In the 5' to 3' pathway, this is followed by decapping which then permits the 5' to 3' exonucleolytic degradation of transcripts. In the 3' to 5' pathway, the exosome, a large multisubunit complex, plays a key role. The exosome exists in archaeal cells, too. In bacteria, endoribonuclease E, a key enzyme involved in RNA decay and processing, organizes a protein complex called degradosome. RNase E or R interacts with the phosphate-dependent exoribonuclease polynucleotide phosphorylase, DEAD-box helicases, and additional factors in the RNA-degrading complex.","The gene cluster provided is primarily associated with RNA processing and degradation, involving components of the exosome complex, the Lsm complex, the CCR4-NOT complex, and other related factors. Some genes in this cluster play crucial roles in RNA metabolism, including RNA decay, surveillance, and processing, which are essential for maintaining cellular RNA homeostasis.\n\n### Key Components and Functions:\n\n1. **Exosome Complex (EXOSC1-10, DIS3, RRP6/EXOSC10):**\n   - The exosome is a multi-protein complex essential for the degradation of various RNA species. It is involved in the 3' to 5' exonucleolytic decay of RNA and is crucial for RNA quality control and processing. **DIS3** and **EXOSC10 (RRP6)** are catalytic subunits providing exonuclease activity.\n\n2. **Lsm Complex (LSM1-8):**\n   - The Lsm proteins form a heptameric ring that binds to RNA, playing a role in mRNA decay and splicing. Lsm1-7 is involved in mRNA decapping and decay, while Lsm2-8 is associated with U6 snRNA in splicing.\n\n3. **CCR4-NOT Complex (CNOT1-10):**\n   - This complex is a major regulator of mRNA deadenylation, a critical step in mRNA decay. It also influences transcription and translation. **CNOT1** serves as a scaffold, while other subunits like **CNOT6** and **CNOT7** have deadenylase activity.\n\n4. **Decapping Enzymes (DCP1A, DCP1B, DCP2, DCPS):**\n   - These enzymes remove the 5' cap from mRNA, a key step in mRNA decay. **DCP2** is the catalytic subunit, while **DCP1A** and **DCP1B** act as regulatory factors.\n\n5. **XRN1 and XRN2:**\n   - These are 5' to 3' exonucleases involved in degrading uncapped RNA. **XRN1** functions in the cytoplasm, while **XRN2** is nuclear.\n\n6. **SKI Complex (SKIC2, SKIC3, SKIC8):**\n   - Works with the exosome to degrade RNA. It is involved in the cytoplasmic 3' to 5' decay pathway.\n\n7. **PARN:**\n   - A poly(A)-specific ribonuclease involved in mRNA deadenylation, working in concert with the CCR4-NOT complex.\n\n8. **DDX6 and EDC3/EDC4:**\n   - DDX6 is an RNA helicase involved in mRNA decapping and decay. EDC3 and EDC4 are enhancers of decapping.\n\n9. **PAPOLA, PAPOLB, PAPOLG:**\n   - These are poly(A) polymerases involved in the polyadenylation of mRNA, a process that can influence mRNA stability and translation.\n\n10. **HSPA9 and HSPD1:**\n    - These are heat shock proteins involved in protein folding and stress responses, indirectly affecting RNA metabolism by maintaining protein homeostasis.\n\n### Relationships and Regulatory Elements:\n\n- The interplay between the exosome, Lsm, and CCR4-NOT complexes is crucial for the regulation of mRNA stability and decay.\n- Decapping and deadenylation are tightly coordinated processes that precede RNA decay, with the CCR4-NOT complex often initiating deadenylation.\n- The exosome and SKI complex collaborate for efficient RNA degradation, particularly in the cytoplasm.\n\n### Biological Implications:\n\n- Proper functioning of these complexes is vital for gene expression regulation, cellular stress responses, and the prevention of aberrant RNA accumulation.\n- Dysregulation can lead to diseases, including cancer and neurodegenerative disorders, due to the accumulation of faulty or excess RNA.\n\nAll in all, this gene cluster highlights the complexity and interconnectivity of RNA processing pathways, emphasizing the importance of coordinated regulation for cellular homeostasis. Further research is needed to fully elucidate the specific interactions and regulatory mechanisms within this cluster.","The gene cluster known as the CCR4-NOT complex is a highly conserved multi-subunit complex that spans from yeast to humans and plays a crucial role in post-transcriptional regulation of gene expression. Some genes in this cluster contribute to functions such as deadenylation, histone modification, and mRNA decay. Other genes form at least two functional subcomplexes within the CCR4-NOT complex: a core complex comprising nine subunits (NOT1-9) and a regulatory complex consisting of CAF1/2, BTG1/2, and CNOT1-3. Additionally, the core complex is known to have deadenylase activity, which is stimulated by CAF1/2, and histone acetyltransferase activity, which is stimulated by BTG/BTG2. The CCR4-NOT complex also interacts with transcription factors and coactivators to regulate gene expression at the transcriptional level. All in all, this gene cluster is integral to multiple aspects of gene expression regulation."
BIOCARTA_PDGF_PATHWAY,"['MAPK3', 'PIK3CG', 'HRAS', 'PDGFRA', 'PIK3R1', 'MAPK8', 'MAP2K1', 'RAF1', 'ELK1', 'JAK1', 'PLCG1', 'SHC1', 'STAT5A', 'GRB2', 'PRKCB', 'STAT3', 'MAP2K4', 'SRF', 'PRKCA', 'PDGFA', 'PIK3CA', 'CSNK2A1', 'MAP3K1', 'RASA1', 'JUN', 'SOS1', 'FOS', 'STAT1']",PDGF Signaling Pathway,"Platelet Derived Growth Factor (PDGF) plays a critical role in cellular proliferation and development. The biologically active form is a dimer formed from the A and B chains. PDGF is active to a differing degree depending on which dimer is formed (AA, AB, or BB). The PDGF Receptor (PDGFR) is also a dimer and can form from the combination of the alpha and beta chains in any order (alpha-alpha, alpha-beta, beta-beta). The PDGFR dimer is only formed after ligand binding so the alpha/beta composition of the receptor can be influenced by the form of PDGF that is present. Upon binding of ligand the PDGFR is tyrosine phosphorylated and leads to the phosphorylation of several other cellular proteins.","The gene cluster provided is primarily involved in the MAPK/ERK signaling pathway, a critical pathway for regulating various cellular processes, including growth, proliferation, differentiation, and survival. This pathway is highly conserved across species and plays a pivotal role in transmitting signals from the cell surface to the nucleus in response to extracellular stimuli.\n\nSome genes in this cluster, such as **MAPK3 (ERK1)** and **MAPK8 (JNK1)**, are mitogen-activated protein kinases (MAPKs) that play crucial roles in the MAPK/ERK and JNK signaling pathways, respectively. They are involved in the regulation of gene expression, cellular growth, and apoptosis. **PIK3CG, PIK3R1, and PIK3CA** encode components of the phosphoinositide 3-kinase (PI3K) complex, which is involved in the PI3K/AKT signaling pathway, important for cell growth, survival, and metabolism. **HRAS**, a member of the RAS family of GTPases, is a key regulator of the MAPK/ERK pathway, acting as a molecular switch to transmit signals from growth factor receptors to downstream effectors. **PDGFRA and PDGFA** encode the platelet-derived growth factor receptor alpha and its ligand, respectively, and are involved in cell proliferation and development, particularly in mesenchymal cells. **RAF1** encodes a serine/threonine kinase that is part of the MAPK/ERK pathway, activated by RAS and subsequently activating MEK1/2 (MAP2K1/2), leading to the activation of ERK1/2 (MAPK3/1).\n\nOther genes, such as **MAP2K1 (MEK1)** and **MAP2K4 (MEK4)**, are dual-specificity kinases that activate MAPKs through phosphorylation. MEK1 is specifically involved in the MAPK/ERK pathway, while MEK4 is part of the JNK and p38 MAPK pathways. **ELK1, JUN, and FOS** are transcription factors activated by MAPKs, regulating the expression of genes involved in cell proliferation and differentiation. **JAK1 and STAT proteins (STAT1, STAT3, STAT5A)** are components of the JAK/STAT signaling pathway, activated by cytokines and growth factors, crucial for immune function and cell growth. **GRB2, SHC1, and SOS1** are adaptor proteins that facilitate the activation of RAS by linking receptor tyrosine kinases to the RAS signaling pathway. **PRKCB and PRKCA** encode protein kinase C (PKC) isoforms involved in various signaling pathways, including those regulating cell proliferation and survival. **CSNK2A1** encodes casein kinase 2, a serine/threonine-selective enzyme regulating various cellular processes, including cell cycle progression and apoptosis. **RASA1** encodes a RAS GTPase-activating protein that helps in the inactivation of RAS, serving as a negative regulator of the RAS/MAPK pathway. **SRF** is a transcription factor that binds to the serum response element in the promoter region of target genes, regulating their expression in response to growth factors.\n\nAdditionally, the MAPK/ERK pathway is initiated by the binding of growth factors to receptor tyrosine kinases (e.g., PDGFRA), leading to the activation of RAS (HRAS), which then activates RAF1. RAF1 phosphorylates and activates MEK1 (MAP2K1), which in turn activates ERK1/2 (MAPK3/1). Activated ERK translocates to the nucleus to regulate gene expression by phosphorylating transcription factors such as ELK1, JUN, and FOS. The PI3K/AKT pathway, involving PIK3CG, PIK3R1, and PIK3CA, is often activated in parallel with the MAPK/ERK pathway, providing a robust mechanism for promoting cell survival and growth. The JAK/STAT pathway, involving JAK1 and STAT proteins, can be activated by cytokines and growth factors, leading to the transcription of genes involved in immune response and cell proliferation.\n\nAll in all, this gene cluster represents a complex network of signaling pathways that are essential for normal cellular function and are frequently altered in disease states. Dysregulation of these pathways is implicated in various diseases, including cancer, due to their roles in controlling cell proliferation and survival. Mutations in genes such as HRAS, PIK3CA, and RAF1 are commonly associated with oncogenesis. Understanding the interactions and regulatory mechanisms within this gene cluster is crucial for developing targeted therapies for diseases resulting from pathway dysregulation. Further research is needed to fully elucidate the intricate regulatory mechanisms and interactions within this cluster.","The gene cluster associated with PDGF acts as a potent mitogen, stimulating the proliferation of various cell types. Some genes in this cluster are mediated by two receptor tyrosine kinases, namely PDGFR-alpha and PDGFR-beta, which have structural similarities but differ in their expression patterns and downstream signaling pathways. Other genes reveal that the primary distinction between these receptors is that PDGFR-beta signals through the Ras-Map kinase pathway, whereas PDGFR-alpha signals via the p130 pathway. Additionally, the Ras-Map kinase pathway results in the phosphorylation and activation of the transcription factor ELK-1, subsequently activating the transcription of genes responsible for cell proliferation and transformation. All in all, this gene cluster highlights the intricate roles of PDGFR-alpha and PDGFR-beta in cellular signaling and proliferation."
BIOCARTA_DEATH_PATHWAY,"['CASP10', 'CASP7', 'NFKBIA', 'FADD', 'BIRC3', 'DFFB', 'CASP3', 'BCL2', 'CHUK', 'CASP9', 'XIAP', 'SPTAN1', 'CFLAR', 'MAP3K14', 'TRADD', 'TNFRSF25', 'TNFSF10', 'DFFA', 'RELA', 'RIPK1', 'TRAF2', 'APAF1', 'BID', 'LMNA', 'CASP8', 'NFKB1', 'CASP6', 'BIRC2', 'GAS2']",Induction of apoptosis through DR3 and DR4/5 Death Receptors,"Apoptosis is specifically induced via signaling through a family of receptors known collectively as 'death receptors' including Fas, TNFR, DR3, -4 and -5. Death receptor ligands characteristically initiate signaling via receptor oligomerization, recruitment of specialized adaptor proteins and activation of caspase cascades. Apo3L recruits initiator caspase 8 via the adapter protein FADD. Caspase 8 then oligomerizes and is activated via autocatalysis. Activated caspase 8 stimulates apoptosis via two parallel cascades: it directly cleaves and activates caspase-3, and it cleaves Bid (a Bcl-2 family protein). Truncated Bid (tBid) translocates to mitochondria, inducing cytochrome C release, which sequentially activates caspases 9 and 3. DR-3L can deliver pro- or anti-apoptotic signals. DR-3 promote apoptosis via the adaptor proteins TRADD/FADD and the activation of caspase 8. Alternatively, apoptosis inhibited via an adaptor protein complex including RIP which activates NF-kB and induces survival genes including IAP. Induction of apoptosis via Apo2L requires caspase activity, but the adaptor requirement is unclear.","The gene cluster provided is primarily involved in the regulation of apoptosis, a form of programmed cell death, and the modulation of inflammatory responses. Some genes in this cluster encode caspases, Bcl-2 family proteins, inhibitors of apoptosis, and components of the NF-\u03baB signaling pathway, all of which play critical roles in maintaining cellular homeostasis and responding to cellular stress.\n\n### Key Genes and Their Functions:\n\n1. **Caspases (CASP3, CASP6, CASP7, CASP8, CASP9, CASP10):** These cysteine-aspartic proteases are essential in the execution phase of cell apoptosis. CASP8 and CASP10 are initiator caspases that activate downstream effector caspases like CASP3, CASP6, and CASP7, leading to the cleavage of cellular substrates and eventual cell death.\n\n2. **BCL2:** This gene encodes an anti-apoptotic protein that prevents the release of cytochrome c from mitochondria, thereby inhibiting the apoptotic process. It is a key regulator of the intrinsic apoptosis pathway.\n\n3. **Inhibitors of Apoptosis (BIRC2, BIRC3, XIAP):** These proteins inhibit caspases and prevent apoptosis, thus promoting cell survival. XIAP is particularly potent in directly binding and inhibiting CASP3, CASP7, and CASP9.\n\n4. **NF-\u03baB Pathway Components (NFKBIA, RELA, NFKB1, CHUK):** These genes are involved in the NF-\u03baB signaling pathway, which regulates immune response, inflammation, and cell survival. NFKBIA encodes I\u03baB\u03b1, an inhibitor that sequesters NF-\u03baB in the cytoplasm. CHUK (IKK\u03b1) is part of the IKK complex that phosphorylates I\u03baB\u03b1, leading to its degradation and the release of NF-\u03baB to the nucleus.\n\nOther genes include:\n\n5. **FADD and TRADD:** These adaptor proteins are involved in death receptor signaling, particularly in the extrinsic apoptosis pathway. They facilitate the formation of the death-inducing signaling complex (DISC) upon ligand binding to death receptors like TNFRSF25.\n\n6. **TNFSF10 (TRAIL) and TNFRSF25:** These are part of the tumor necrosis factor (TNF) superfamily, involved in inducing apoptosis through death receptor pathways.\n\n7. **APAF1:** This gene encodes a key component of the apoptosome, which activates CASP9 in the intrinsic apoptosis pathway.\n\n8. **RIPK1 and TRAF2:** These proteins are involved in signaling pathways that can lead to either cell survival or cell death, depending on the cellular context and additional signals.\n\n9. **BID and DFFA/DFFB:** BID is a pro-apoptotic Bcl-2 family member that links extrinsic and intrinsic apoptosis pathways. DFFA and DFFB are involved in DNA fragmentation during apoptosis.\n\n10. **MAP3K14 (NIK):** This kinase is involved in the non-canonical NF-\u03baB signaling pathway, which is important for immune response regulation.\n\nAdditionally, the interplay between pro-apoptotic and anti-apoptotic members of the Bcl-2 family, along with the regulation of caspase activity by IAPs, determines the cell's fate towards survival or apoptosis. The NF-\u03baB pathway components interact with apoptotic regulators to modulate inflammation and cell survival, highlighting the crosstalk between apoptosis and inflammatory signaling. Regulatory elements such as I\u03baB\u03b1 and the IKK complex are crucial for controlling NF-\u03baB activity, which in turn influences the expression of genes involved in cell survival and apoptosis.\n\nAll in all, this gene cluster is critical for maintaining cellular homeostasis and responding to stress signals. Dysregulation of these genes can lead to various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Understanding the interactions and regulatory mechanisms within this cluster is essential for developing therapeutic strategies targeting apoptosis and inflammation-related pathologies. Despite extensive research, some interactions and regulatory mechanisms remain incompletely understood, warranting further investigation.","The gene cluster controlling apoptosis, or programmed cell death, is integral to the development and homeostasis of multicellular organisms. Some genes in this cluster are involved in chromatin condensation, the fragmentation of chromatin into nucleosomal ladders, and membrane blebbing. Other genes encode for caspases, a family of cysteine proteases that play a central role in apoptosis. These caspases are synthesized as inactive precursors and are activated through proteolytic cleavage, subsequently activating other proteases responsible for cellular disassembly. \n\nAdditionally, caspases-8 and caspase-3 are activated by the Fas receptor and other members of the TNF receptor family. Caspase-8 functions as an upstream protease, cleaving caspase-3 and other caspases. In contrast, caspase-3 is an effector protease that directly cleaves cellular substrates, such as nuclear lamins that maintain the cell's structural integrity. Caspase-6 and caspase-7, also effector caspases, become activated by caspase-3. Other essential components in this pathway include the Bcl-2 family of proteins and the DNA fragmentation factor (DFF), while caspases are inhibited by the IAP family of proteins, including XIAP, NAIP, and survivin. Bcl-2 and Bax play opposing roles by inhibiting and promoting apoptosis, respectively. The IAP proteins directly bind and inhibit caspase activity and interact with TNF receptor-associated factors such as TRAF2 and FADD to regulate apoptosis induced by the TNF receptor family.\n\nAll in all, this gene cluster orchestrates a complex network of interactions that regulate apoptosis through a series of activations and inhibitions, ensuring the proper balance and function of multicellular organisms."
BIOCARTA_STATHMIN_PATHWAY,"['CD3G', 'CD3E', 'CCNB1', 'UHMK1', 'CD247', 'PRKACG', 'MAPK13', 'RB1CC1', 'STMN1', 'PRKAR1A', 'PRKAR2B', 'PRKACB', 'CD3D', 'PRKAR1B', 'CD2', 'TSG101', 'CAMK4', 'PRKAR2A', 'CDK1', 'HSPA5']",Stathmin and breast cancer resistance to antimicrotubule agents,"Stathmin is a ubiquitous, cytosolic 19-kDa protein, which is phosphorylated on up to four sites in response to many regulatory signals within cells. Its molecular characterization indicates a functional organization including an N-terminal regulatory domain that bears the phosphorylation sites, linked to a putative alpha-helical binding domain predicted to participate in coiled-coil, protein-protein interactions. In addtion to the protein kinases that phospjhorylate Stathmin such as CaMK, MAPK, p34cdc2, PKA, a few other proteins have been suggested to interact with stathmin in vivo. One of them was identified as BiP, a member of the hsp70 heat-shock protein family. Another is a previously unidentified, putative serine/threonine kinase, KIS, which might be regulated by stathmin or, more likely, be part of the kinases controlling its phosphorylation state. Finally, two proteins, CC1 and CC2, predicted to form alpha-helices participating in coiled-coil interacting structures. It has been also suggest that the action of antimicrotubule drugs can be affected by stathmin in at least two ways: (a) altered drug binding; and (b) growth arrest at the G2 to M boundary. Mutant p53 breast cancers exhibiting high levels of stathmin may be resistant to antimicrotubule agents.","The gene cluster provided includes a diverse set of genes involved in various cellular processes, primarily focusing on immune response, cell cycle regulation, and signal transduction. This cluster does not form a single, well-defined biological pathway but rather represents a collection of genes with distinct yet sometimes overlapping functions.\n\n1. **Immune Response and T-Cell Activation:**\n   Some genes in this cluster, such as **CD3G, CD3E, CD3D, CD247, and CD2**, are integral components of the T-cell receptor (TCR) complex. CD3G, CD3E, and CD3D encode for the CD3 gamma, epsilon, and delta chains, respectively, which are essential for TCR signaling. CD247 encodes the CD3 zeta chain, crucial for signal transduction upon antigen recognition. CD2 is a surface protein that enhances T-cell adhesion and activation. Together, these genes play a pivotal role in T-cell development and activation, critical for adaptive immunity.\n\n2. **Cell Cycle Regulation:**\n   Other genes, such as **CCNB1 and CDK1**, are involved in cell cycle regulation. CCNB1 encodes Cyclin B1, which, in complex with CDK1 (Cyclin-Dependent Kinase 1), regulates the G2/M transition in the cell cycle. This complex is essential for the initiation of mitosis, ensuring proper cell division and proliferation.\n\n3. **Signal Transduction and Kinase Activity:**\n   Additionally, genes like **PRKACG, PRKACB, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B** encode various subunits of the protein kinase A (PKA) complex, which is involved in numerous cellular processes, including metabolism, gene expression, and cell growth. PRKACG and PRKACB encode catalytic subunits, while PRKAR1A, PRKAR1B, PRKAR2A, and PRKAR2B encode regulatory subunits, highlighting the complexity and versatility of PKA signaling. **MAPK13** encodes a member of the p38 MAP kinase family, involved in cellular responses to stress and inflammation. **CAMK4** encodes Calcium/Calmodulin-dependent protein kinase IV, which is involved in transcriptional regulation in response to calcium signaling.\n\n4. **Cellular Stress Response and Protein Folding:**\n   **HSPA5**, also known as BiP or GRP78, encodes a heat shock protein that functions as a chaperone in the endoplasmic reticulum, assisting in protein folding and the stress response.\n\n5. **Cellular Structure and Dynamics:**\n   **STMN1** encodes Stathmin, a protein that regulates microtubule dynamics, crucial for cell division and intracellular transport.\n\n6. **Tumor Suppression and Cellular Regulation:**\n   **RB1CC1** is involved in the regulation of the RB1 pathway, playing a role in cell cycle control and tumor suppression. **TSG101** encodes a protein involved in endosomal sorting and is implicated in the regulation of cell growth and proliferation.\n\n**Regulatory Elements and Patterns:**\nThe genes in this cluster are regulated by various signaling pathways, including those mediated by kinases and phosphatases. The interplay between these genes, particularly those involved in immune response and cell cycle regulation, highlights the complexity of cellular signaling networks.\n\n**Biological Implications:**\nAll in all, this gene cluster is critical for maintaining cellular homeostasis, immune function, and proper cell division. Dysregulation of these genes can lead to immune disorders, cancer, and other diseases. Understanding their interactions and regulatory mechanisms is essential for developing therapeutic strategies targeting these pathways.","The gene cluster responsible for recognizing foreign antigens within the context of MHC II and triggering T cell activation is the T cell receptor (TCR) complex. Some genes in this cluster include a heterodimer of alpha and beta chains associated with the CD3 complex (comprising the gamma, delta, epsilon, and zeta subunits) and the CD4 or CD8 T cell coreceptor. Other genes in this cluster involve the CD3 complex, which transduces the activation signal from the TCR to the cytoplasm through its four subunits (gamma, delta, epsilon, and zeta), and the CD4 coreceptor, which binds to the MHC II molecule and aids in recognizing the antigen-MHC II complex. Additionally, T cell activation is marked by cell entry into the cell cycle and the expression of the cyclin-dependent kinase (cdk) activating kinase (p34 cdc2). The activity of p34 cdc2, essential for the G1 to S phase transition, is regulated by phosphorylation, dephosphorylation, association with cdk inhibitors (p16in4 and p19Ink4d), and cyclin subunits. These cyclin subunits are constitutively expressed throughout the cell cycle and are crucial for p34 cdc2 activity. The cyclin subunits' activity is controlled through association with the cdk inhibitors and phosphorylation. Similarly, the activity of the cdk inhibitors themselves is regulated by phosphorylation and association with the cyclin subunits. All in all, this gene cluster plays a vital role in T cell activation and regulation through complex interactions and signaling pathways among its components."
BIOCARTA_BARRESTIN_PATHWAY,"['GRK2', 'PPARA', 'GNAS', 'KCNA3', 'ADCY1', 'KCNA2', 'KCNA1', 'PLCB1', 'AP2A1', 'ARRB1', 'AP2M1', 'DNM1']",b-arrestins in GPCR Desensitization,"Role of -arrestins in the desensitization, sequestration and intracellular trafficking of GPCRs. Homologous desensitization of GPCRs (1) results from the binding of -arrestins (-arr) to agonist -occupied receptors following phosphorylation of the receptor by GRKs. -arrestin binding sterically precludes coupling between the receptor and heterotrimeric G proteins, leading to termination of signaling by G proteins effectors. Receptor-bound -arrestins also act as adapter proteins, binding to components of the clathrin endocytic machinery including clathrin, 2-adaptin (AP-2). Receptor sequestration (2) reflects the dynamin (Dyn)-dependent endocytosis of GPCRs via clathrin-coated pits. Once internalized, GPCRs exhibit two distinct patterns of -arrestin interaction. `Class A' GPCRs, for example the 2 adrenergic receptor, rapidly dissociate from -arrestin upon internalization. These receptors are trafficked to an acidified endosomal compartment, wherein the ligand is dissociated and the receptor dephosphorylated by a GPCR-specific protein phosphatase PP2A isoform, and are subsequently recycled to the plasma membrane (3). `Class B' receptors, for example the angiotensin II AT1a receptor, form stable receptor--arrestin complexes. These receptors accumulate in endocytic vesicles and are either targeted for degradation or slowly recycled to the membrane via as yet poorly defined routes.","The gene cluster provided includes a set of genes primarily involved in signal transduction, particularly in G protein-coupled receptor (GPCR) signaling pathways, and ion channel regulation. This cluster plays a crucial role in cellular communication, metabolism, and neuronal signaling.\n\nSome genes in this cluster include:\n\n1. **GRK2 (G protein-coupled receptor kinase 2)**: GRK2 is a key regulator of GPCR signaling. It phosphorylates activated receptors, leading to their desensitization and internalization, thus modulating receptor sensitivity and cellular responses.\n\n2. **PPARA (Peroxisome proliferator-activated receptor alpha)**: PPARA is a nuclear receptor that regulates lipid metabolism and energy homeostasis. It is activated by fatty acids and controls the expression of genes involved in fatty acid oxidation.\n\n3. **GNAS (GNAS complex locus)**: This gene encodes the G\u03b1s subunit of heterotrimeric G proteins, which activates adenylate cyclase, leading to increased cyclic AMP (cAMP) levels and subsequent activation of cAMP-dependent pathways.\n\n4. **KCNA1, KCNA2, KCNA3 (Potassium voltage-gated channel subfamily A members 1, 2, and 3)**: These genes encode voltage-gated potassium channels that are critical for maintaining the resting membrane potential and repolarizing the membrane during action potentials in neurons.\n\nOther genes include:\n\n5. **ADCY1 (Adenylate cyclase 1)**: ADCY1 is an enzyme that converts ATP to cAMP, a second messenger involved in transmitting signals from GPCRs and other receptors to intracellular targets.\n\n6. **PLCB1 (Phospholipase C beta 1)**: PLCB1 is involved in the phosphoinositide signaling pathway. It hydrolyzes phosphatidylinositol 4,5-bisphosphate to generate inositol trisphosphate and diacylglycerol, which act as secondary messengers in various signaling pathways.\n\n7. **AP2A1 and AP2M1 (Adaptor-related protein complex 2 subunit alpha 1 and mu 1)**: These genes encode components of the adaptor protein complex 2, which is involved in clathrin-mediated endocytosis, a process crucial for receptor internalization and recycling.\n\n8. **ARRB1 (Arrestin beta 1)**: ARRB1 is involved in the desensitization of GPCRs. It binds to phosphorylated receptors, preventing further signaling and targeting them for internalization.\n\n9. **DNM1 (Dynamin 1)**: DNM1 is a GTPase involved in the scission of clathrin-coated vesicles during endocytosis, playing a critical role in synaptic vesicle recycling.\n\nAdditionally, the genes in this cluster are interconnected through their roles in GPCR signaling and ion channel regulation. GRK2, ARRB1, and DNM1 are directly involved in receptor desensitization and endocytosis. GNAS and ADCY1 are part of the cAMP signaling pathway, while PLCB1 participates in phosphoinositide signaling. The KCNA genes contribute to neuronal excitability, which can be modulated by signaling pathways involving these other genes.\n\nThis cluster is characterized by the integration of signaling pathways that regulate cellular responses to external stimuli. The interplay between phosphorylation (GRK2, ARRB1), second messenger systems (GNAS, ADCY1, PLCB1), and ion channel activity (KCNA1, KCNA2, KCNA3) highlights a complex regulatory network.\n\nAll in all, this gene cluster exemplifies the intricate network of signaling pathways that maintain cellular homeostasis and respond to environmental changes. Dysregulation of these genes can lead to various disorders, including metabolic syndromes (PPARA), neurological diseases (KCNA genes, DNM1), and cardiovascular dysfunctions (GRK2, GNAS). Understanding this cluster's function is crucial for developing therapeutic strategies targeting these pathways in related diseases. Further research is needed to fully elucidate the interactions and regulatory mechanisms within this cluster.","The gene cluster related to the G-protein coupled receptor (GPCR) signaling pathway is a critical mechanism for cellular communication. Some genes in this cluster are responsible for encoding GPCRs, which are cell surface receptors that respond to a variety of extracellular stimuli such as neurotransmitters, hormones, odorants, taste ligands, light, and lipids. Other genes encode the components of intracellular G proteins, which comprise alpha, beta, and gamma subunits and facilitate signal transmission from GPCRs to downstream effectors, leading to cellular responses. The alpha subunit is particularly crucial as it is regulated by GPCRs and activates downstream effectors, while the beta and gamma subunits play roles in the regulation of G proteins and GPCR signaling. Additionally, the regulation of GPCR signaling involves several layers, including receptor regulation through phosphorylation, desensitization, and internalization. G protein regulation is also managed by regulator of G protein signaling (RGS) proteins, which are GTPase-activating proteins that stimulate the inactivation of G protein signaling. The beta and gamma subunits can further regulate G protein signaling. The downstream effectors include ion channels and second messenger systems, such as the cAMP/PKA pathway and the calcium pathway, which are involved in the regulation of ion channels and various cellular processes, respectively. All in all, this gene cluster governs a versatile signaling pathway crucial for numerous cellular functions."
BIOCARTA_AKAP95_PATHWAY,"['NCAPD2', 'CCNB1', 'PPP2CA', 'PRKACG', 'DDX5', 'PRKAR2B', 'PRKACB', 'PRKAG1', 'PRKAR2A', 'CDK1', 'AKAP8']",AKAP95 role in mitosis and chromosome dynamics,"The chromatin packaging of the genome is dynamic, changing with the cell cycle and with transcriptional regulation. During mitosis, chromatin is condensed for segregation of chromosomes, while for transcription chromatin is more open. The nuclear matrix, or scaffold, is a protein network in the nucleus providing structure and regulating chromatin condensation. Regulated interactions of matrix proteins with each other, DNA and other factors in different phases of the cell cycle alter the structure and function of chromatin. AKAP95 (A-kinase anchoring protein) is a nuclear matrix associated protein that also binds DNA and different proteins during different phases of the cell cycle. The interaction of AKAP95 with DNA and proteins alters the condensation and transcription of chromatin. A specific domain of AKAP95 regulates its interaction with the nuclear matrix and another regulates its association with DNA. One key protein that AKAP95 interacts with is the cAMP-dependent protein kinase, PKA. AKAP95 binds to PKA through a PKA RII regulatory subunit, an interaction that requires PKA phosphorylation by Cdk1. PKA activity and cAMP are reduced during entry into mitosis, but PKA recruited by AKAP95 to condensed chromosomes is essential to maintain the condensed state. Another protein recruited by AKAP95 is Eg7, a 150 kD protein recruited during mitotic chromatin condensation. Eg7 is a part of a multiprotein condensin complex, recruiting another key component of mitotic chromatin condensation. Modification of the core histones through phosphorylation regulates chromatin condensation. Histone H3 interacts with the condensin complex, and is phosphorylated during mitosis. Histone H3 phosphorylation by Aurora-2 induces chromatin condensation, and dephosphorylation by PP1 promotes chromatin decondensation for reentry into interphase. AKAP95 may play a role during the regulation of chromatin structure for transcription during interphase as well. The interaction of AKAP95 with the p68 RNA helicase recruits this enzyme to the nuclear matrix during interphase. Other nuclear RNA helicases interact with transcription factors and cofactors, suggesting that the p68 RNA helicase also may regulate interactions of transcription complexes.","The gene cluster provided includes a set of genes primarily involved in cell cycle regulation, signal transduction, and cellular structural organization. This cluster plays a crucial role in cell division, particularly during mitosis, and in the regulation of cellular responses to various signals.\n\nSome genes in this cluster include:\n\n1. **NCAPD2 (Non-SMC Condensin I Complex Subunit D2):** This gene encodes a component of the condensin complex, which is essential for chromosome condensation and stabilization during mitosis. It ensures proper segregation of chromosomes, thereby maintaining genomic stability.\n\n2. **CCNB1 (Cyclin B1):** Cyclin B1 is a regulatory protein involved in the cell cycle. It forms a complex with CDK1 (Cyclin-Dependent Kinase 1), which is critical for the transition from the G2 phase to the M phase of the cell cycle. This complex is a key driver of mitotic entry.\n\n3. **PPP2CA (Protein Phosphatase 2 Catalytic Subunit Alpha):** This gene encodes the catalytic subunit of protein phosphatase 2A (PP2A), a major serine/threonine phosphatase. PP2A is involved in the negative control of cell growth and division, and it regulates various signaling pathways by dephosphorylating key proteins.\n\n4. **PRKACG (Protein Kinase cAMP-Activated Catalytic Subunit Gamma):** This gene is part of the protein kinase A (PKA) family, which is activated by cyclic AMP (cAMP). PKA plays a significant role in regulating metabolism, cell division, and gene expression.\n\n5. **DDX5 (DEAD-Box Helicase 5):** DDX5 is an RNA helicase involved in various aspects of RNA metabolism, including transcription, splicing, and ribosome biogenesis. It also plays a role in the regulation of gene expression and cell proliferation.\n\nOther genes include:\n\n6. **PRKAR2B and PRKAR2A (Protein Kinase cAMP-Dependent Type II Regulatory Subunits Beta and Alpha):** These genes encode regulatory subunits of PKA. They modulate the activity of the catalytic subunits (such as PRKACG and PRKACB) by binding cAMP, which leads to the dissociation and activation of the catalytic subunits.\n\n7. **PRKACB (Protein Kinase cAMP-Activated Catalytic Subunit Beta):** Similar to PRKACG, this gene encodes another catalytic subunit of PKA, contributing to the regulation of various cellular processes through phosphorylation of target proteins.\n\n8. **PRKAG1 (Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 1):** This gene is part of the AMP-activated protein kinase (AMPK) complex, which is a key energy sensor in cells. It regulates energy balance and is involved in metabolic stress responses.\n\n9. **CDK1 (Cyclin-Dependent Kinase 1):** CDK1 is a pivotal kinase in cell cycle regulation, particularly in the control of the G2/M transition. It partners with cyclins, such as Cyclin B1, to drive the cell into mitosis.\n\n10. **AKAP8 (A-Kinase Anchoring Protein 8):** AKAP8 is involved in anchoring PKA to specific subcellular locations, thereby targeting the kinase activity to particular substrates and cellular compartments. It plays a role in chromatin remodeling and gene expression regulation.\n\nAdditionally, the relationships and regulatory elements within this cluster include:\n\n- The interaction between CCNB1 and CDK1 is a well-characterized regulatory mechanism for mitotic entry.\n- The PKA components (PRKACG, PRKACB, PRKAR2A, PRKAR2B) and AKAP8 highlight the importance of spatial and temporal regulation of kinase activity in cellular signaling.\n- PPP2CA acts as a counterbalance to kinases by dephosphorylating substrates, thus providing a regulatory check on cell cycle progression and signal transduction pathways.\n\nBiological implications of this cluster include:\n\n- Dysregulation of these genes can lead to aberrant cell cycle progression, contributing to oncogenesis and tumor progression.\n- Understanding the interactions and regulatory mechanisms within this cluster can provide insights into potential therapeutic targets for cancer and other diseases involving cell cycle and signaling dysregulation.\n\nAll in all, this gene cluster is integral to maintaining cellular homeostasis through precise control of cell division and response to signaling cues. Further research is needed to elucidate the full spectrum of interactions and regulatory networks involving these genes.","The gene cluster Cyclin B / CDK1 (CDC2) is a key regulator of the cell cycle, and its activation is essential for the G2/M transition. Some genes in this cluster, like CDC2, have their activity regulated by their association with cyclin B. The activity of CDC2/cyclin B is inhibited by phosphorylation at specific sites on CDC2: threonine-14 and tyrosine-15 by Myt1, and threonine-5 by p27. Other genes, such as CDC25C, are implicated in the dephosphorylation of these residues, facilitating the activation of CDC2/cyclin B. Additionally, CDC25C's localization is influenced by phosphorylation at multiple sites, with phosphorylation on serine-21 creating a binding site for 14-3-3 proteins that retain CDC25C in the cytoplasm. The dephosphorylation of serine-21 allows CDC25C to move into the nucleus and activate CDC2/cyclin B. \n\nThe activation of CDC2/cyclin B is opposed by Wee-1 kinase and p27 inhibitor proteins. Wee-1's activation is associated with the dephosphorylation of tyrosine-123, while p27's activation involves the dephosphorylation of threonine-14 and tyrosine-15. Additionally, p27 inhibits CDC2/cyclin B by blocking CDC2 activation. The activation of p27 is counteracted by the KAP phosphatase, which dephosphorylates threonine-14 and tyrosine-15, and protein phosphatase 2C, which dephosphorylates threonine-14, tyrosine-15, serine-19, and threonine-5 of p27. KAP phosphatase is activated by the phosphorylation of serine-8 and serine-20, and further phosphorylation of threonine-5 and serine-20 activates KAP. KAP is inhibited by the p90 protein kinase.\n\nAll in all, this gene cluster involves a complex regulatory network responsible for the precise control of the cell cycle through the activation and inhibition of CDC2/cyclin B, moderated by various phosphorylation and dephosphorylation events."
BIOCARTA_BARRESTIN_SRC_PATHWAY,"['MAPK3', 'FGR', 'HRAS', 'GRK2', 'GNAS', 'MAP2K1', 'RAF1', 'KCNA3', 'ADCY1', 'KCNA2', 'KCNA1', 'PLCB1', 'MAPK1', 'MAP2K2', 'ARRB1', 'DNM1', 'HCK']",Roles of b-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,"The binding of -arrestins to agonist-occupied GPCRs coincides with the recruitment of Src family tyrosine kinases, including c-Src, Hck and c-Fgr (Src-TK), to the receptor-arrestin complex. Several signaling events have been reported to involve -arrestin-dependent Src recruitment. These include the regulation of clathrin-dependent 2-adrenergic receptor endocytosis by tyrosine phosphorylation of dynamin, Ras-dependent activation of the ERK1/2 MAP kinase cascade and stimulation of cell proliferation by 2-adrenergic and neurokinin NK1 receptors, and stimulation of chemokine CXCR1 receptor-mediated neutrophil degranulation","The gene cluster provided is primarily involved in signal transduction pathways, particularly those related to the MAPK/ERK pathway and G-protein coupled receptor (GPCR) signaling. This cluster plays a crucial role in cellular processes such as proliferation, differentiation, and response to external stimuli.\n\nSome genes in this cluster, such as **MAPK3 (ERK1)** and **MAPK1 (ERK2)**, encode proteins that are part of the MAPK/ERK pathway, which is critical for transmitting signals from the cell surface to the nucleus. They are involved in regulating cell division, differentiation, and development. **MAP2K1 (MEK1)** and **MAP2K2 (MEK2)** are upstream kinases that activate MAPK3 and MAPK1 through phosphorylation, serving as key regulatory nodes in the MAPK/ERK signaling cascade. **RAF1** encodes a serine/threonine kinase that acts upstream of MEK1/2, playing a pivotal role in the activation of the MAPK/ERK pathway and is involved in cell growth and survival. **HRAS**, a member of the RAS family of GTPases, is involved in transmitting signals from growth factor receptors to the MAPK/ERK pathway, with mutations associated with various cancers.\n\nOther genes, such as **GNAS**, encode the G-protein alpha subunit involved in GPCR signaling, playing a role in activating adenylate cyclase and leading to the production of cAMP, a secondary messenger. **GRK2** is a G-protein-coupled receptor kinase involved in the desensitization of GPCRs, regulating their activity and ensuring proper signal termination. **ADCY1** encodes adenylate cyclase 1, an enzyme that converts ATP to cAMP, a crucial secondary messenger in many signaling pathways. **PLCB1** is involved in the hydrolysis of phosphatidylinositol 4,5-bisphosphate, generating inositol trisphosphate and diacylglycerol, important for calcium signaling and activation of protein kinase C. **ARRB1** is involved in the regulation and desensitization of GPCRs, playing a role in receptor internalization and signaling. **FGR** and **HCK** encode Src family tyrosine kinases involved in signaling pathways that regulate immune responses, cell growth, and differentiation. **KCNA1, KCNA2, KCNA3** encode voltage-gated potassium channels, important for maintaining the membrane potential and regulating neuronal excitability. **DNM1** is involved in endocytosis and membrane trafficking, playing a role in synaptic vesicle recycling.\n\nAdditionally, the MAPK/ERK pathway is tightly regulated by a series of phosphorylation events, with RAF1, MEK1/2, and ERK1/2 forming a sequential activation cascade. GPCR signaling is modulated by GRK2 and ARRB1, which ensure proper receptor desensitization and internalization. Cross-talk between the MAPK/ERK pathway and GPCR signaling is facilitated by shared components such as GNAS and ADCY1, linking receptor activation to downstream signaling events.\n\nAll in all, this gene cluster represents a complex network of signaling pathways essential for maintaining cellular homeostasis and responding to external signals. Dysregulation of the MAPK/ERK pathway is implicated in various cancers, making components like HRAS, RAF1, and MEK1/2 potential targets for therapeutic intervention. The involvement of GNAS and ADCY1 in cAMP production highlights their role in metabolic regulation and potential implications in metabolic disorders. The presence of voltage-gated potassium channels (KCNA1, KCNA2, KCNA3) suggests a role in neuronal signaling and potential implications in neurological disorders. Further research is needed to fully elucidate the interactions and regulatory mechanisms within this cluster.","The gene cluster known as the G-protein-coupled receptor (GPCR) superfamily encompasses receptors that respond to a wide array of extracellular stimuli, including hormones, neurotransmitters, light, odorants, and pheromones. Some genes in this cluster are responsible for the coupling of these receptors to intracellular heterotrimeric G proteins, composed of alpha, beta, and gamma subunits. The alpha subunit can interact with and regulate downstream effectors such as adenylyl cyclase, phospholipase C, and ion channels. Other genes focus on the roles of the beta gamma subunits, which are capable of interacting with and activating the MAP kinase cascade. Additionally, the family of four proteins known as beta-arrestins binds to agonist-activated GPCRs, blocking further receptor-G-protein coupling. They also couple receptors to the activation of the MAP kinase cascade and participate in receptor internalization and downregulation. The second messenger pathways and the MAP kinase cascade are crucial for regulating cellular proliferation and differentiation. The regulation of many GPCR activities involves receptor kinases (GRKs), which phosphorylate the receptor to create a binding site for beta-arrestins. All in all, this gene cluster provides a rapid mechanism for controlling the activity of GPCRs through the regulation by GRKs and beta-arrestins."
KEGG_STEROID_HORMONE_BIOSYNTHESIS,"['SRD5A3', 'AKR1C4', 'CYP3A5', 'HSD3B2', 'UGT2B28', 'HSD3B1', 'COMT', 'SULT2B1', 'CYP3A4', 'CYP7A1', 'CYP11A1', 'AKR1C3', 'HSD11B2', 'SULT1E1', 'HSD11B1', 'HSD17B2', 'HSD17B3', 'CYP21A2', 'HSD17B1', 'CYP19A1', 'CYP17A1', 'CYP11B2', 'CYP11B1', 'HSD17B6', 'HSD17B7', 'UGT2B11', 'UGT2A3', 'UGT1A4', 'CYP3A7', 'UGT1A1', 'UGT1A3', 'UGT1A10', 'UGT1A8', 'UGT1A7', 'UGT1A6', 'UGT1A5', 'HSD17B8', 'AKR1C2', 'AKR1C1', 'CYP1A1', 'CYP1B1', 'STS', 'UGT2A1', 'SRD5A2', 'SRD5A1', 'CYP3A43', 'CYP7B1', 'UGT1A9', 'AKR1D1', 'HSD17B12', 'UGT2B10', 'UGT2B7', 'UGT2B4', 'UGT2B17', 'UGT2B15']",Steroid hormone biosynthesis,"Steroid hormones derived from cholesterol are a class of biologically active compounds in vertebrates. The cholesterol side-chain cleavage enzyme CYP11A1 catalyzes conversion of cholesterol, a C27 compound, to the first C21 steroid, pregnenolone, which is converted by a bifunctional enzyme complex to the gestagen hormone, progesterone. Pregnenolone and progesterone are the starting materials for the three groups of steroids: C21 steroids of glucocorticoids and mineralocorticoids, C19 steroids of androgens, and C18 steroids of estrogens. (i) Progesterone is converted by hydroxylations at carbons 21 and 11 to corticosterone, which is further modified by hydroxylation and oxydoreduction at carbon 18 to yield aldosterone, a mineralcorticoid. Cortisol, the main glucocorticoid, is formed from 17alpha-hydroxyprogesterone with 11-deoxycortisol as an intermediate. (ii) Male hormone testosterone is formed from pregnenolone by two pathways, delta5 pathway via dehydroepiandrosterone and delta4 pathway via androstenedione. The enzyme CYP17A1 is responsible for the 17,20 lyase and 17alpha-hydroxylase activities in respective pathways. (iii) Female hormones estrone and estradiol are formed from testosterone and 4-androstene-3,17-dione by oxidative removal of the C19 methyl group and subsequent aromatization of ring A. In addition to these three groups, recent studies show that there is another group, termed neurosteroids, synthesized in the brain rather than the peripheral endocrine gland.","The gene cluster is primarily involved in steroid metabolism, drug metabolism, and detoxification processes. Some genes in this cluster encode enzymes that participate in the biosynthesis and metabolism of steroids, as well as the conjugation and elimination of various endogenous and exogenous compounds.\n\n### Key Genes and Their Functions:\n\n1. **Cytochrome P450 Family (CYPs):**\n   - **CYP3A4, CYP3A5, CYP3A7, CYP3A43:** These enzymes are involved in the metabolism of a wide range of drugs and endogenous steroids, with CYP3A4 being particularly notable for its role in drug metabolism.\n   - **CYP11A1, CYP11B1, CYP11B2:** Crucial in steroidogenesis, CYP11A1 catalyzes the conversion of cholesterol to pregnenolone, the first step in steroid hormone biosynthesis.\n   - **CYP17A1, CYP19A1 (Aromatase):** Involved in the biosynthesis of androgens and estrogens, respectively.\n   - **CYP21A2:** Catalyzes the 21-hydroxylation of steroids, a critical step in cortisol and aldosterone synthesis.\n   - **CYP1A1, CYP1B1:** Involved in the metabolism of xenobiotics and the bioactivation of procarcinogens.\n\n2. **Hydroxysteroid Dehydrogenases (HSDs):**\n   - **HSD3B1, HSD3B2:** Convert pregnenolone to progesterone, a key step in steroid hormone biosynthesis.\n   - **HSD11B1, HSD11B2:** Regulate the conversion between active and inactive forms of glucocorticoids.\n   - **HSD17B1, HSD17B2, HSD17B3, HSD17B6, HSD17B7, HSD17B8, HSD17B12:** Involved in the interconversion of active and inactive forms of sex steroids.\n\n3. **Aldo-Keto Reductases (AKRs):**\n   - **AKR1C1, AKR1C2, AKR1C3, AKR1C4, AKR1D1:** These enzymes are involved in the reduction of ketosteroids and the metabolism of prostaglandins and other carbonyl-containing compounds.\n\n4. **UDP-Glucuronosyltransferases (UGTs):**\n   - **UGT1A and UGT2B families:** Catalyze the glucuronidation of steroids, drugs, and other xenobiotics, facilitating their excretion.\n\n5. **Sulfotransferases (SULTs):**\n   - **SULT1E1, SULT2B1:** Involved in the sulfation of steroids and other molecules, which is another pathway for detoxification and excretion.\n\n6. **Steroid 5\u03b1-Reductases (SRD5A1, SRD5A2, SRD5A3):**\n   - Convert testosterone to dihydrotestosterone (DHT), a more potent androgen.\n\n7. **Catechol-O-Methyltransferase (COMT):**\n   - Involved in the methylation of catecholamines and catechol estrogens, playing a role in the metabolism of neurotransmitters and estrogens.\n\n8. **Steroid Sulfatase (STS):**\n   - Hydrolyzes sulfate esters from steroids, playing a role in the activation of steroid hormones.\n\n### Relationships and Regulatory Elements:\n\nAdditionally, the CYP enzymes often work in concert to metabolize drugs and steroids, with overlapping substrate specificities. HSDs and AKRs are crucial for maintaining the balance between active and inactive steroid forms, influencing physiological processes like reproduction, stress response, and metabolism. UGTs and SULTs provide complementary pathways for the conjugation and elimination of steroids and xenobiotics, enhancing solubility and excretion. Regulatory elements for these genes include hormone response elements, reflecting their regulation by steroid hormones and other signaling molecules.\n\n### Biological Implications:\n\nAll in all, this gene cluster is essential for maintaining homeostasis of steroid hormones, which are critical for numerous physiological processes including growth, reproduction, and stress response. Variations or dysregulation in these genes can lead to disorders such as congenital adrenal hyperplasia, hormone-dependent cancers, and altered drug metabolism, impacting therapeutic efficacy and toxicity. Understanding the interactions and regulation of these genes is crucial for developing targeted therapies for metabolic and endocrine disorders. Overall, this gene cluster represents a complex network of enzymes that are integral to steroid metabolism and detoxification, with significant implications for human health and disease.","The gene cluster responsible for the conversion of inactive steroid hormones into active steroid hormones involves a group of enzymes known as the hydroxysteroid dehydrogenases (HSDs). Some genes in this cluster, identified as 1\u20133, are primarily involved in the interconversion of steroid hormones, including estrone, estradiol, testosterone, and dihydrotestosterone. These genes are part of the short-chain dehydrogenase/reductase (SDR) family, known for their conserved YXXXK motif and NAD(+)/NADP(+) cofactor usage and play roles in the biosynthesis of sex steroids from cholesterol, DHEA, and cortisone in the adrenal gland, and testosterone and estradiol in the testes and adrenal glands. Other genes, named 1\u20132, preferentially act on substrates such as dehydroepiandrosterone (DHEA) and 5-androstenediol, and as members of the aldo-keto reductase (AKR) family, are characterized by their ability to reduce or oxidize a variety of aldehydes, ketones, and aldoses. Additionally, 1\u20133 HSD catalyzes the reduction of ketone groups at the C17 position of the steroid ring to hydroxyl groups, while 1\u20132 HSDs catalyze the reverse oxidation reaction. This structural distinction is reflected in their enzymatic properties, with 1\u20133 HSD existing as a monomeric enzyme with a molecular weight of 34 kDa, whereas 1\u20132 and 1\u20133 HSDs form dimeric structures of approximately 60 kDa. All in all, this gene cluster exemplifies complex enzymatic relationships, contributing to critical biological processes involving steroid hormone functionality and metabolism."
BIOCARTA_LONGEVITY_PATHWAY,"['SOD3', 'PIK3CG', 'HRAS', 'GHR', 'PIK3R1', 'IGF1', 'FOXO3', 'SHC1', 'SOD1', 'SOD2', 'CAT', 'AKT1', 'PIK3CA', 'IGF1R', 'GH1']",The IGF-1 Receptor and Longevity,"A demonstrated means to increase lifespan in a wide range of organisms is through the restriction of caloric intake. Reducing the consumption of calories increases the lifespan of many different organisms, including mice. Although caloric restriction has not been demonstrated experimentally to increase human lifespan, short-term changes in physiological measures like insulin responsiveness have been observed. Caloric restriction not only increases lifespan, but decreases age-related deterioration of systems and physiological responses, reducing age related diseases like cancer and neurodegenerative disease. Caloric restriction in animals reduces the levels of plasma glucose and insulin and reduces inflammatory responses and may reduce oxidative stress through reduced oxidative metabolism, further contributing to the health benefits of reduced calorie intake. The reduction in inflammation may be related to reduces plasma glucose and in humans could reduce an inflammation connection to cancer, heart disease, and Alzheimers disease. Genetic analysis has indicated several genes that influence lifespan, particularly those that alter pituitary development, reduce growth hormone secretion, reduce food intake, and reduce apoptosis (p66 Shc). All of these appear to converge on an IGF-1 receptor pathway and to reproduce many of the effects of caloric restriction. Although dwarf mice with defective growth hormone or IGF-1 signaling also have significantly increased lifespan, humans with defects in growth hormone signaling tend to develop diseases that shorten their lifespan. One of the downstream targets of IGF-1 signaling is to repress stress resistance proteins including antioxidant enzymes like superoxide dismutase, and heat shock proteins, so a reduction in IGF signaling may extend lifespan by increasing the expression of stress resistance genes. The link between caloric restriction and IGF signaling may be that a reduction in food intake reduces the expression of IGF-1, increasing the expression of stress resistance proteins. In addition to the IGF-1R mutation, p66 Shc mutation also increases lifespan without significant aberration of other systems. Shc is a target of IGF-1R phosphorylation, and a major inducer of cellular responses to oxidative stress. Shc increases levels of intracellular reactive oxygen species, repressing the forkhead factor FKHRL1. Alhtough FKHRL1 is also involved in apoptosis, in the absence of Shc, FKHRL1 mediates increased resistance to oxidative stress. Exploration of the genes that induce longevity in animals models may enlighten the role of these genes in human disease and lifespan.","The gene cluster provided is primarily involved in the regulation of growth, metabolism, and oxidative stress response, with significant implications for cellular signaling pathways, particularly those related to the insulin-like growth factor (IGF) and growth hormone (GH) signaling pathways.\n\n1. **Cluster Identification and Biological Function:**\n   - The gene cluster is centered around the IGF and GH signaling pathways, which are crucial for growth, development, and metabolic regulation. The genes in this cluster are involved in signal transduction, oxidative stress response, and cellular growth and survival.\n\n2. **Key Genes and Their Functions:**\n   - Some genes in this cluster include:\n     - **IGF1 (Insulin-like Growth Factor 1):** A hormone similar in molecular structure to insulin, IGF1 plays a critical role in childhood growth and continues to have anabolic effects in adults.\n     - **IGF1R (Insulin-like Growth Factor 1 Receptor):** A receptor that binds IGF1, initiating a signaling cascade that promotes growth and survival.\n     - **GH1 (Growth Hormone 1):** Encodes the growth hormone, which stimulates growth, cell reproduction, and regeneration.\n     - **GHR (Growth Hormone Receptor):** Binds growth hormone, triggering downstream signaling pathways that promote growth and metabolism.\n     - **PIK3CA, PIK3CG, PIK3R1 (Phosphoinositide 3-Kinases):** These genes encode components of the PI3K pathway, which is activated by IGF1R and GHR signaling, leading to cell growth, proliferation, and survival.\n     - **AKT1 (Protein Kinase B):** A key downstream effector in the PI3K pathway, involved in promoting cell survival and growth.\n     - **FOXO3 (Forkhead Box O3):** A transcription factor that is negatively regulated by AKT1, involved in the regulation of oxidative stress response and apoptosis.\n     - **HRAS (Harvey Rat Sarcoma Viral Oncogene Homolog):** A small GTPase involved in transmitting signals within cells, often linked to cell growth and division.\n     - **SHC1 (SHC Adaptor Protein 1):** An adaptor protein that links activated receptors to downstream signaling pathways, including the MAPK and PI3K pathways.\n\n3. **Oxidative Stress Response Genes:**\n   - Other genes include:\n     - **SOD1, SOD2, SOD3 (Superoxide Dismutases):** Enzymes that catalyze the dismutation of superoxide radicals into oxygen and hydrogen peroxide, providing protection against oxidative stress.\n     - **CAT (Catalase):** Breaks down hydrogen peroxide into water and oxygen, further mitigating oxidative damage.\n\n4. **Regulatory Elements and Patterns:**\n   - Additionally, the PI3K/AKT pathway is a central regulatory axis in this cluster, integrating signals from IGF1R and GHR to modulate cellular growth and survival. FOXO3 acts as a critical node, balancing growth signals with oxidative stress responses.\n\n5. **Biological Implications:**\n   - Dysregulation of this gene cluster can lead to various pathologies, including cancer, metabolic disorders, and age-related diseases. The balance between growth signaling and oxidative stress response is crucial for maintaining cellular homeostasis and preventing disease.\n\nAll in all, this gene cluster is integral to growth and metabolic regulation, with significant roles in oxidative stress response and cellular signaling. While much is known about individual gene functions, the precise interactions and regulatory mechanisms within this cluster continue to be an area of active research.","The gene cluster Insulin-like growth factor-1 (IGF-1) plays a crucial role in regulating growth and development. Some genes in this cluster interact with the IGF-1 receptor (IGF-1R), a tyrosine kinase, to stimulate cell proliferation and inhibit apoptosis. Other genes are responsible for mediating the effects of growth hormone (GH), with IGF-1 being produced by various tissues, including the liver, in response to GH. Additionally, IGF-1 functions both endocrinally to stimulate growth in many tissues and in an autocrine/paracrine manner to promote growth in specific tissues. This gene cluster also has significant therapeutic importance, as IGF-1 serves as a treatment for growth failure and offers neuroprotective and cardioprotective benefits. All in all, this gene cluster is not only integral to growth and development but also holds considerable potential in treating neurodegenerative diseases and heart disease."
KEGG_NON_SMALL_CELL_LUNG_CANCER,"['CASP9', 'SOS2', 'E2F1', 'PRKCB', 'RAF1', 'PRKCA', 'RARB', 'BAD', 'PRKCG', 'ERBB2', 'MAP2K2', 'TGFA', 'BRAF', 'MAP2K1', 'RXRB', 'PDPK1', 'RXRG', 'RB1', 'RXRA', 'RASSF1', 'AKT1', 'AKT2', 'NRAS', 'AKT3', 'GRB2', 'MAPK3', 'SOS1', 'MAPK1', 'PIK3R5', 'HRAS', 'EGFR', 'KRAS', 'CDKN2A', 'EGF', 'RASSF5', 'FHIT', 'STK4', 'ARAF', 'CCND1', 'PIK3R3', 'FOXO3', 'CDK4', 'TP53', 'E2F3', 'E2F2', 'PIK3CA', 'PIK3CB', 'CDK6', 'PIK3CD', 'PLCG1', 'PLCG2', 'PIK3CG', 'PIK3R1', 'PIK3R2']",Non-small cell lung cancer,"Non-small-cell lung cancer (NSCLC) accounts for approximately 80% of lung cancer and represents a heterogeneous group of cancers, consisting mainly of squamous cell (SCC), adeno (AC) and large-cell carcinoma. Molecular mechanisms altered in NSCLC include activation of oncogenes, such as K-RAS and c-erbB-2, and inactivation of tumorsuppressor genes, such as p53, p16INK4a, RAR-beta, and RASSF1. Point mutations within the K-RAS gene inactivate GTPase activity and the p21-RAS protein continuously transmits growth signals to the nucleus. Overexpression of c-erbB-2 or EGFR leads to a proliferative advantage. Inactivating mutation of p53 can lead to more rapid proliferation and reduced apoptosis. The protein encoded by the p16INK4a inhibits formation of CDK-cyclin-D complexes by competitive binding of CDK4 and CDK6. Loss of p16INK4a expression is a common feature of NSCLC RAR-beta is a nuclear receptor that bears vitamin-A-dependent transcriptional activity. RASSF1A is able to form heterodimers with Nore-1, an RAS effector.Therefore loss of RASSF1A might shift the balance of RAS activity towards a growth-promoting effect.","The gene cluster provided is primarily involved in the regulation of cell growth, survival, and apoptosis, with significant roles in cancer biology. Some genes in this cluster are part of the PI3K/AKT/mTOR and MAPK/ERK signaling pathways, both of which are critical for cellular responses to growth signals.\n\n### Key Genes and Their Functions:\n\n1. **PI3K/AKT Pathway:**\n   - **PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5:** These genes encode subunits of phosphoinositide 3-kinases (PI3Ks), which are involved in the activation of AKT signaling, promoting cell survival and growth.\n   - **AKT1, AKT2, AKT3:** These serine/threonine kinases are central to the PI3K pathway, mediating downstream effects such as cell proliferation and inhibition of apoptosis.\n   - **PDPK1:** Activates AKT by phosphorylation, further propagating the survival signals.\n\n2. **MAPK/ERK Pathway:**\n   - **RAF1, BRAF, ARAF:** These genes encode RAF kinases, which are upstream activators of the MAPK/ERK pathway, crucial for cell division and differentiation.\n   - **MAP2K1 (MEK1), MAP2K2 (MEK2):** These kinases phosphorylate and activate MAPKs.\n   - **MAPK1 (ERK2), MAPK3 (ERK1):** These are the terminal kinases in the MAPK pathway, executing cellular responses to growth signals.\n\n3. **Growth Factor Receptors and Ligands:**\n   - **EGFR, ERBB2:** Encode receptor tyrosine kinases that, upon binding with ligands like EGF and TGFA, activate downstream signaling pathways including PI3K/AKT and MAPK/ERK.\n   - **EGF, TGFA:** Ligands that bind to EGFR, initiating signaling cascades.\n\n4. **Cell Cycle Regulation:**\n   - **CDK4, CDK6, CCND1 (Cyclin D1):** These genes are involved in cell cycle progression, particularly the transition from G1 to S phase.\n   - **RB1, CDKN2A:** Tumor suppressors that regulate the cell cycle; RB1 inhibits E2F transcription factors, while CDKN2A encodes p16, an inhibitor of CDK4/6.\n\n5. **Apoptosis and Tumor Suppression:**\n   - **CASP9:** Encodes caspase 9, an initiator caspase in the intrinsic apoptosis pathway.\n   - **BAD:** A pro-apoptotic member of the Bcl-2 family, regulated by AKT.\n   - **TP53:** A crucial tumor suppressor gene that regulates the cell cycle and apoptosis.\n\n6. **Transcription Factors:**\n   - **E2F1, E2F2, E2F3:** These transcription factors are involved in the regulation of genes necessary for cell cycle progression.\n   - **FOXO3:** A transcription factor that promotes apoptosis and is negatively regulated by AKT.\n\n### Regulatory Elements and Interactions:\n\nAdditionally, the cluster includes regulatory elements such as RAS genes (HRAS, KRAS, NRAS), which are small GTPases acting as upstream regulators of both the PI3K/AKT and MAPK/ERK pathways, functioning as molecular switches in response to growth signals. GRB2, SOS1, and SOS2 are adaptor proteins that link receptor tyrosine kinases to RAS activation. RASSF1 and RASSF5 are tumor suppressors that interact with RAS proteins and are involved in apoptosis regulation.\n\n### Biological Implications:\n\nAll in all, this gene cluster is heavily implicated in oncogenesis due to its roles in cell proliferation, survival, and apoptosis. Dysregulation of these pathways, through mutations or overexpression, is a hallmark of many cancers. Understanding the interactions and regulatory mechanisms within this cluster is crucial for developing targeted cancer therapies. Despite extensive research, gaps remain in fully elucidating the complex interactions and regulatory networks, highlighting the need for continued investigation.","The gene cluster epidermal growth factor receptor (EGFR) is a cell surface receptor activated by the binding of ligands such as epidermal growth factor (EGF). Some genes in this cluster are frequently over-expressed in human cancers, and their expression is often linked to a more aggressive tumor phenotype and a poorer prognosis. Other genes in this cluster include those from a family of closely related tyrosine kinase receptors, such as neu/HER2, HER3, and HER4. Additionally, ligand binding to the EGFR triggers receptor dimerization and the activation of downstream signaling pathways, including the ras-raf-MEK-MAPK and PI3K-Akt pathways. These pathways ultimately lead to cellular proliferation, inhibition of apoptosis, and enhanced cell motility and metastasis. All in all, this gene cluster plays a crucial role in cancer development and progression."
BIOCARTA_MCALPAIN_PATHWAY,"['ACTA1', 'HRAS', 'MYL2', 'PRKACG', 'CXCR3', 'PRKAR1A', 'CAPN2', 'EGF', 'PRKAR2B', 'TLN1', 'EZR', 'PRKACB', 'EGFR', 'CAPN1', 'CAPNS1', 'PRKAR1B', 'PRKAR2A', 'ITGB1', 'CAPNS2']",mCalpain and friends in Cell motility,"The mammalian calpain gene family currently contains 13 distinct large subunit products most of which complex with one of two smaller 30kDa subunits. ( An excellent introduction to the calpain family can be found on a web site created by Valery Thompson http://ag.arizona.edu/calpains/index.html ) One of the most carefully studied functions of the calpains is the regulation of integrin-mediated cell migration. Calpains digests the links between the actin cytoskeleton and several focal adhesion complex proteins; talin, paxillin and focal adhesion kinase. The release from the focal adhesion complex facilitates migration. Calpestatin is an inhibitor expressed in most cells. Calpestatin binds the four inhibitory domains of calpain. Release from calpestatin does not activate calpain. Activation requires additional signaling, coactivators and an appropriate calcium concentration. During cell migration calpain1 (mu-calpain) acts at the leading edge as a response to integrin signals or calcium fluxuations due to the stretch activated calcium channels. Calpain1 cleaves the target proteins, talin, exzrin, paxillin and the cytoplasmic tail of the integrins B1(a) and B3(b) to release the adhesion and form new adhesions. Calpain2 (M-calpain) is believed to be membrane bound and functions at the trailing edge of the migrating cell to cleave the integrins in response to growth factor receptor signals. PKA functions to down regulate or inhibit calpain2. Disease related notes: In Alzheimers disease, amyloid peptides interfere with calpain activity causing a mislocalization of cdk5. Deregulated cdk5 hyperphosphorylates tau promoting cell death in neurons. Mutations in the muscle specific calpain p94 lead to Limb Girdle muscular dystrophy 2A (LGMD2A). Over activity of calpains due to elevated calcium leads to tissue damage in the heart and brain","The gene cluster provided includes a diverse set of genes involved in various cellular processes, primarily focusing on signal transduction, cytoskeletal dynamics, and cellular adhesion. This cluster does not represent a single, well-defined biological pathway but rather a collection of genes that interact in multiple cellular contexts.\n\n1. **Signal Transduction and Cell Growth:**\n   - Some genes in this cluster, such as **HRAS** and **EGFR** (Epidermal Growth Factor Receptor), are key players in the MAPK/ERK signaling pathway, which regulates cell growth, differentiation, and survival. HRAS functions as a small GTPase acting as a molecular switch, while EGFR is a receptor tyrosine kinase that, upon binding with its ligand EGF (Epidermal Growth Factor), activates downstream signaling cascades.\n   - Other genes, including **PRKACG**, **PRKACB**, **PRKAR1A**, **PRKAR1B**, **PRKAR2A**, and **PRKAR2B**, are components of the cAMP-dependent protein kinase (PKA) complex. These genes encode the catalytic and regulatory subunits of PKA, which is involved in regulating various cellular processes, including metabolism, gene expression, and cell cycle progression.\n\n2. **Cytoskeletal Dynamics and Muscle Function:**\n   - Additionally, **ACTA1** encodes alpha-actin, a fundamental component of the actin cytoskeleton, crucial for muscle contraction and cellular motility.\n   - **MYL2** encodes the regulatory light chain of myosin, essential for muscle contraction and particularly important in cardiac muscle function.\n   - **TLN1** (Talin 1) and **EZR** (Ezrin) are involved in linking the actin cytoskeleton to the plasma membrane, playing critical roles in cell adhesion and migration.\n\n3. **Calcium-Dependent Proteolysis:**\n   - The cluster also includes **CAPN1**, **CAPN2**, **CAPNS1**, and **CAPNS2**, which are part of the calpain family, calcium-dependent cysteine proteases involved in various cellular processes, including cytoskeletal remodeling and signal transduction.\n\n4. **Cell Adhesion and Migration:**\n   - **ITGB1** encodes integrin beta-1, a component of integrin receptors that mediate cell-extracellular matrix adhesion, influencing cell migration and signaling.\n   - **CXCR3** is a chemokine receptor involved in immune cell trafficking and plays a role in inflammatory responses.\n\n5. **Regulatory Elements and Patterns:**\n   - The genes in this cluster are regulated by various signaling pathways, including those mediated by growth factors, cytokines, and second messengers like cAMP and calcium ions. The interplay between these pathways allows for fine-tuned regulation of cellular responses to external stimuli.\n\n6. **Biological Implications:**\n   - Dysregulation of these genes can lead to various pathological conditions, including cancer (e.g., mutations in HRAS and EGFR), cardiovascular diseases (e.g., mutations in MYL2), and muscle disorders (e.g., mutations in ACTA1). Understanding the interactions and regulatory mechanisms of these genes is crucial for developing targeted therapies for these conditions.\n\nAll in all, this gene cluster encompasses a range of genes involved in critical cellular functions, including signal transduction, cytoskeletal organization, and cell adhesion. While each gene has distinct roles, their interactions contribute to the complex regulation of cellular behavior and response to environmental cues.","The gene cluster for cAMP-dependent protein kinase (PKA) encodes a serine/threonine kinase that is activated by the second messenger cAMP. Some genes in this cluster encode the regulatory subunits of PKA: RIalpha and RIIalpha. These subunits are highly similar in sequence and structure but are expressed in different tissues; RIIalpha is highly expressed in the brain, while RIalpha is expressed in most tissues.\n\nOther genes in the cluster encode the PKA catalytic subunit, which is expressed as two isoforms, C\u03b1 and PKCIbeta, in different tissues. Additionally, the PKA holoenzyme structure comprises a tetramer formed by a dimer of regulatory subunits and two dimers of catalytic subunits. The regulatory subunits are encoded by the genes PRKACA, PRKACB, PRKACB, and PRKACG, while the PKA catalytic subunits include PRKACA.\n\nAll in all, this gene cluster illustrates the intricate expression patterns of PKA regulatory and catalytic subunits across different tissues and highlights the dynamic regulation by cAMP binding, which activates the catalytic subunits by releasing them to phosphorylate downstream targets. Furthermore, this activation is transient, as regulatory subunits rebind to reform the inactive PKA holoenzyme once cAMP levels decrease."
KEGG_PARKINSONS_DISEASE,"['UQCR10', 'NDUFA5', 'NDUFA4', 'COX6CP3', 'UBE2L6', 'NDUFS7', 'MT-CYB', 'MT-CO2', 'ATP5PO', 'MT-CO1', 'COX8C', 'MT-CO3', 'VDAC2P5', 'COX5B', 'COX4I1', 'MT-ATP6', 'UCHL1', 'MT-ATP8', 'ATP5PD', 'NDUFA2', 'NDUFA3', 'NDUFA1', 'SNCAIP', 'APAF1', 'SEPTIN5', 'UBE2G2', 'UBE2G1', 'ATP5MC1P5', 'VDAC1', 'VDAC2', 'VDAC3', 'UBE2J2', 'UQCRQ', 'ATP5F1D', 'UBE2L3', 'COX7A2L', 'ATP5MC3', 'ATP5MC2', 'ATP5MC1', 'ATP5PB', 'ATP5F1E', 'COX5A', 'UBA7', 'UBA1', 'SLC25A6', 'UQCRHL', 'SLC25A5', 'ATP5F1A', 'SLC25A4', 'ATP5PF', 'CYCS', 'SDHA', 'SLC18A1', 'SLC18A2', 'NDUFA4L2', 'TH', 'SLC25A31', 'CASP9', 'COX8A', 'COX7C', 'PPID', 'SDHD', 'SDHB', 'SDHC', 'PINK1', 'COX7B', 'COX7A1', 'COX7A2', 'COX6C', 'UBE2J1', 'ATP5F1B', 'COX6B1', 'ATP5F1C', 'UQCR10P1', 'UBB', 'COX7B2', 'PRKN', 'CASP3', 'UQCRB', 'COX6A2', 'COX6A1', 'UQCRH', 'UQCRFS1', 'UQCRC2', 'UQCRC1', 'NDUFB3', 'NDUFB1', 'NDUFB2', 'NDUFA10', 'NDUFAB1', 'MT-ND6', 'NDUFA9', 'MT-ND5', 'NDUFA7', 'NDUFA8', 'UQCR11', 'HTRA2', 'NDUFA6', 'NDUFV3', 'MT-ND4', 'MT-ND4L', 'MT-ND2', 'COX6B2', 'MT-ND3', 'COX4I2', 'MT-ND1', 'SNCA', 'NDUFB10', 'NDUFS8', 'NDUFC1', 'NDUFC2', 'NDUFS1', 'NDUFV2', 'NDUFB6', 'NDUFS4', 'NDUFB7', 'NDUFV1', 'NDUFB8', 'NDUFS6', 'NDUFB9', 'NDUFS5', 'NDUFS2', 'NDUFB4', 'NDUFS3', 'NDUFB5', 'PARK7', 'CYC1', 'GPR37', 'SLC6A3', 'LRRK2']",Parkinson's disease,"Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Mutations in alpha-synuclein, UCHL1 (a ubiquitin carboxy-terminal hydrolase L1), parkin, DJ1 (a parkin-associated protein involved with oxidative stress), and PINK1 (a putative serine threonine kinase) are known to cause early-onset PD. Mutations or altered expression of these proteins contributes to PD pathogenesis through common mechanisms that result in proteasome dysfunction, mitochondrial impairment, and oxidative stress. Point mutations in alpha-synuclein and the recently described Iowan functional duplication of alpha-synuclein lead to excessive intracellular accumulation and protofibril formation. Decrease in the amount of soluble alpha-synuclein tends to increase free cytoplasmic dopamine and the formation of reactive oxygen species (ROS). Indeed, formation of protofibrils or aggregates and Lewy bodies (LBs) diminishes the availability of the physiological forms of alpha-synuclein, favoring an increase in TH (tyrosine hydroxylase) and DAT (dopamine transporter), but diminishes vesicles formation and neuronal plasticity. Modification of parkin and UCHL1 are associated with the ubiquitin-proteasome system pathway and may increase proteotoxic stress. Mutations in parkin, DJ1, and PINK1 may alter mitochondiral activity, potentially impairing proteasomal function. Environmental toxins such as N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and rotenone can cause mitochondrial dysfunction and oxidative stress.","The gene cluster is primarily associated with mitochondrial function and the electron transport chain (ETC), which is crucial for cellular respiration and energy production in eukaryotic cells. Some genes in this cluster encode components of the mitochondrial respiratory complexes I, III, IV, and V, as well as genes involved in mitochondrial transport and regulation.\n\n**Key Genes and Their Functions:**\n\n1. **Complex I (NADH:Ubiquinone Oxidoreductase) Genes:**\n   - **NDUFA1, NDUFA2, NDUFA3, NDUFA4, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFA9, NDUFA10, NDUFA4L2, NDUFAB1, NDUFB1, NDUFB2, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB7, NDUFB8, NDUFB9, NDUFB10, NDUFC1, NDUFC2, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2, NDUFV3**: These genes encode subunits of Complex I, the largest and first enzyme of the ETC, which catalyzes the transfer of electrons from NADH to ubiquinone.\n\n2. **Complex III (Cytochrome bc1 Complex) Genes:**\n   - **UQCR10, UQCRB, UQCRH, UQCRQ, UQCRFS1, UQCRC1, UQCRC2, UQCR11**: These genes encode subunits of Complex III, which transfers electrons from ubiquinol to cytochrome c and contributes to the proton gradient across the mitochondrial membrane.\n\n3. **Complex IV (Cytochrome c Oxidase) Genes:**\n   - **COX4I1, COX4I2, COX5A, COX5B, COX6A1, COX6A2, COX6B1, COX6B2, COX6C, COX7A1, COX7A2, COX7A2L, COX7B, COX7B2, COX7C, COX8A, COX8C**: These genes encode subunits of Complex IV, which catalyzes the reduction of oxygen to water, a critical step in the ETC.\n\n4. **Complex V (ATP Synthase) Genes:**\n   - **ATP5F1A, ATP5F1B, ATP5F1C, ATP5F1D, ATP5F1E, ATP5MC1, ATP5MC2, ATP5MC3, ATP5PB, ATP5PD, ATP5PF, ATP5PO**: These genes encode subunits of ATP synthase, which synthesizes ATP from ADP and inorganic phosphate, utilizing the proton gradient generated by the ETC.\n\n5. **Mitochondrial DNA-encoded Genes:**\n   - **MT-CYB, MT-CO1, MT-CO2, MT-CO3, MT-ATP6, MT-ATP8, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6**: These genes are encoded by mitochondrial DNA and contribute to the structure and function of the ETC complexes.\n\nOther genes in this cluster include:\n\n- **CYCS (Cytochrome c)**: A key component in the electron transport chain and apoptosis.\n- **VDAC1, VDAC2, VDAC3**: Voltage-dependent anion channels involved in metabolite exchange between the mitochondria and cytosol.\n- **PINK1, PARK7, PRKN**: Genes associated with mitochondrial quality control and Parkinson's disease.\n- **CASP3, CASP9, APAF1**: Involved in the apoptotic pathway, linking mitochondrial dysfunction to cell death.\n\nAdditionally, the genes in this cluster are intricately linked through their roles in the ETC and ATP production. Proper function and regulation of these genes are essential for maintaining cellular energy homeostasis. Mutations or dysregulation in these genes can lead to mitochondrial diseases, neurodegenerative disorders, and metabolic syndromes. Regulatory elements include nuclear-encoded transcription factors and mitochondrial transcription factors that ensure coordinated expression of nuclear and mitochondrial genes.\n\nAll in all, this gene cluster is vital for energy metabolism, and its dysfunction can lead to a wide range of diseases, including mitochondrial disorders, neurodegenerative diseases like Parkinson's, and metabolic conditions. Understanding the interactions and regulation of these genes can provide insights into therapeutic targets for diseases associated with mitochondrial dysfunction. Further research is needed to fully elucidate the regulatory mechanisms and interactions within this cluster.","The gene cluster associated with Parkinson's disease (PD) includes key genes such as alpha-synuclein, parkin, PTEN induced kinase 1 (PINK1), and DJ-1. Some genes in this cluster, like parkin and PINK1, are involved in critical processes such as mitochondrial quality control, oxidative stress response, and protein handling. Other genes, including mitofusins (Mfn1 and Mfn2) and optic atrophy 1 (OPA1), facilitate mitochondrial fusion, while Drp1 and Fis1 mediate mitochondrial fission. Additionally, Parkin, PINK1, and the ubiquitin-proteasome system (UPS) are integral to the process of mitophagy, which involves the elimination of damaged mitochondria by PINK1-dependent recruitment of Parkin, leading to ubiquitination and degradation of mitochondrial proteins by the UPS. Notably, impairment in the UPS due to parkin mutations is observed in PD patients, resulting in the accumulation of damaged mitochondria and the death of dopaminergic neurons in the substantia nigra. All in all, this gene cluster underscores the significant role of genetic factors, particularly mitochondrial dysfunction, in the pathogenesis of Parkinson's disease."
BIOCARTA_CDK5_PATHWAY,"['MAPK3', 'NGF', 'HRAS', 'DPM2', 'MAP2K1', 'RAF1', 'EGR1', 'NGFR', 'MAPK1', 'MAP2K2', 'CDK5R1', 'KLK2', 'CDK5']",Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,"Map kinases transduce responses to extracellular signals by a variety of routes, and communicate with other pathways through extensive crosstalk networks. A closely studied Map kinase cascade originates with tyrosine kinase activation, and activation of Ras. Ras activates Raf, Raf activates the Map kinase kinases Mek1 and Mek2 and these kinases activate downstream Map kinases like Erk1 and Erk2. Erk1 and Erk2 in turn activate transgenes like p35 through the Map kinase activated transcription factor EGR-1. Mek1 plays a central role in many different Map kinase pathways. Factors that activate Mek1 include growth factors like NGF, cytokines, chemokines, and phorbol ester, resulting in cellular proliferation and survival. Mek1 activation may also play a role in differentiation in neuronal tissues. In cultured neuronal PC-12 cells, NGF induces neurite outgrowth via Mek1 and the map kinase pathway. Constitutive activation of Mek1 can transform cells and may play a role in cancer. The crucial role of Mek1 in a variety of pathways including cellular transformation suggests that the cell must tightly regulate its activity. Cdk5 is a kinase that regulates the activity of Mek1. Although Cdk5 is a member of the cyclin-dependent kinase gene family, the activity of Cdk5 does not appear to be regulated by cyclins, but is activated by association with p35. Cdk5 does not act as a checkpoint kinase to regulate cell cycle progression, but acts as a regulatory kinase involved in other post-mitotic processes such as neuronal activity such as neuronal migration during development and neurite outgrowth. Mice lacking Cdk5 exhibit defects in neuronal development. One target of Cdk5 is Mek1. Phosphorylation of Mek1 by Cdk5 represses Mek1 activity and blocks downstream cellular responses. The activation of p35 by Map kinase pathways followed by deactivation of Map kinase signaling by the Cdk5/p35 complex completes the loop of a feedback circuit to terminate Map kinase signaling.","The gene cluster provided is primarily involved in the MAPK/ERK signaling pathway, a critical pathway for regulating various cellular processes, including growth, differentiation, and survival. This pathway is essential for transmitting signals from the cell surface to the nucleus in response to extracellular stimuli.\n\nSome genes in this cluster, such as MAPK3 (ERK1) and MAPK1 (ERK2), are central components of the MAPK/ERK pathway. These serine/threonine kinases, once activated, translocate to the nucleus to regulate gene expression by phosphorylating various transcription factors. MAP2K1 (MEK1) and MAP2K2 (MEK2) are dual-specificity kinases that phosphorylate and activate MAPK3 and MAPK1, acting as critical intermediates in the signaling cascade. RAF1 is a serine/threonine kinase that acts upstream of MEK1/2, phosphorylating them in response to signals from RAS proteins. HRAS, a small GTPase, acts as a molecular switch, activating RAF1 upon binding GTP, thus initiating the MAPK/ERK signaling cascade. NGF and NGFR are crucial for initiating this pathway in neuronal contexts, with NGF being a neurotrophin that binds to NGFR, leading to neuronal growth and survival. EGR1 is an early growth response gene rapidly induced by MAPK/ERK signaling, playing a role in cell growth and differentiation. CDK5 and CDK5R1, a cyclin-dependent kinase and its regulatory subunit, are involved in neuronal development and function and can be influenced by MAPK signaling.\n\nOther genes, such as DPM2, are part of the dolichol-phosphate mannose synthase complex, important for glycosylation processes, though not directly involved in the MAPK/ERK pathway. KLK2, a kallikrein-related peptidase, has a less clear role in this cluster but may be involved in proteolytic processes that modulate signaling pathways.\n\nAdditionally, the interaction between HRAS, RAF1, MEK1/2, and ERK1/2 forms the core of the MAPK/ERK signaling cascade. EGR1 is a downstream target of ERK1/2, linking the signaling cascade to changes in gene expression. CDK5 and its activator CDK5R1 can be modulated by MAPK signaling, influencing neuronal cell cycle and differentiation. The MAPK/ERK pathway is tightly regulated by feedback loops and cross-talk with other signaling pathways, ensuring precise control over cellular responses. Phosphorylation and dephosphorylation events are key regulatory mechanisms within this pathway.\n\nAll in all, this gene cluster highlights the complexity and importance of the MAPK/ERK signaling pathway in cellular regulation and its potential implications in health and disease. Dysregulation of the MAPK/ERK pathway is implicated in various diseases, including cancer, due to its role in cell proliferation and survival. In the nervous system, this pathway is crucial for neuronal development, plasticity, and response to injury. Further research is needed to fully elucidate the roles of some genes, such as KLK2 and DPM2, within this context.","The gene cluster known as the mitogen-activated protein kinase (MAPK) pathway is a highly conserved signaling module that transduces extracellular signals to intracellular targets. Some genes in this cluster form a three-tiered kinase cascade, with Raf acting as the MAPKKK at the top, and responsible for phosphorylating and activating the MAPKKs. These MAPKKs, in turn, phosphorylate and activate the MAPKs, a family of kinases involved in various cellular processes such as proliferation, differentiation, and apoptosis. \n\nOther genes within this cluster include those classified into three groups based on their structure and function: extracellular signal-regulated kinases (ERKs), Jun amino-terminal kinases (JNKs), and p38 kinases. The Raf-1 kinase functions as the MAPKKK in the ERK pathway and is activated by the small G-protein Ras. MAPKKs such as MEK1 and MEK2 activate ERK1 and ERK2, while MKK3 and MKK6 activate the JNK and p38 kinases. MKK3 and MKK6 are activated by the MAPKKK ASK1, which itself is activated by the transforming MAPKKK, Tpl-2. JNKs are activated by the MAPKKK MEKK1, and the MAPKK SEK1, which is also activated by ASK1. The ERK5 kinase is activated by MEK5, which is activated by the MAPKKK MEK4, and it plays a role in regulating cell proliferation and survival.\n\nAdditionally, crosstalk between the different MAPK pathways allows for the activation of one pathway to inhibit the other. For example, activation of the JNK pathway can inhibit the ERK pathway by blocking the activation of Raf1.\n\nAll in all, this gene cluster is intricately involved in signaling pathways that regulate key cellular functions and ensures precise communication within cells."
KEGG_LONG_TERM_DEPRESSION,"['GRM5', 'PLCB2', 'RYR1', 'PLCB1', 'RAF1', 'PRKCB', 'PRKCA', 'PLCB3', 'PLCB4', 'IGF1', 'CRHR1', 'GRM1', 'CRH', 'IGF1R', 'PLA2G3', 'GRID2', 'PRKCG', 'JMJD7-PLA2G4B', 'CACNA1A', 'PLA2G6', 'PLA2G2E', 'PLA2G10', 'MAP2K2', 'PLA2G2A', 'BRAF', 'PLA2G4A', 'ITPR3', 'PLA2G5', 'PLA2G12B', 'MAP2K1', 'NOS1', 'GRIA3', 'GRIA2', 'GRIA1', 'PLA2G4B', 'PLA2G2F', 'NRAS', 'MAPK3', 'GUCY1B1', 'GUCY1A1', 'PRKG1', 'PRKG2', 'MAPK1', 'PLA2G1B', 'HRAS', 'ITPR1', 'ITPR2', 'GNA12', 'GNA13', 'GNA11', 'KRAS', 'GNAI1', 'GNAI2', 'GUCY1A2', 'PPP2CB', 'ARAF', 'PPP2CA', 'PPP2R1A', 'PPP2R1B', 'PLA2G4E', 'GNAQ', 'GNAS', 'PPP1R17', 'GNAI3', 'GNAO1', 'GNAZ', 'PLA2G2C', 'PLA2G2D', 'PLA2G12A', 'LYN']",Long-term depression,"Cerebellar long-term depression (LTD), thought to be a molecular and cellular basis for cerebellar learning, is a process involving a decrease in the synaptic strength between parallel fiber (PF) and Purkinje cells (PCs) induced by the conjunctive activation of PFs and climbing fiber (CF). Multiple signal transduction pathways have been shown to be involved in this process. Activation of PFs terminating on spines in dendritic branchlets leads to glutamate release and activation of both AMPA and mGluRs. Activation of CFs, which make multiple synaptic contacts on proximal dendrites, also via AMPA receptors, opens voltage-gated calcium channels (VGCCs) and causes a generalized influx of calcium. These cellular signals, generated from two different synaptic origins, trigger a cascade of events culminating in a phosphorylation-dependent, long-term reduction in AMPA receptor sensitivity at the PF-PC synapse. This may take place either through receptor internalization and/or through receptor desensitization.","The gene cluster provided is primarily involved in signal transduction pathways, particularly those related to G-protein coupled receptor (GPCR) signaling, phospholipase activity, and the MAPK/ERK pathway. This cluster plays a crucial role in cellular communication, growth, and response to external stimuli.\n\nSome genes in this cluster, such as **GRM5** and **GRM1**, encode metabotropic glutamate receptors, which are GPCRs involved in modulating synaptic transmission and neural plasticity, playing a significant role in the central nervous system. **PLCB1, PLCB2, PLCB3,** and **PLCB4** encode phospholipase C beta isoforms, activated by GPCRs to catalyze the hydrolysis of phosphatidylinositol 4,5-bisphosphate, generating inositol trisphosphate (IP3) and diacylglycerol (DAG), leading to calcium release and protein kinase C activation. **RYR1** encodes the ryanodine receptor 1, a calcium release channel in the sarcoplasmic reticulum of skeletal muscle cells, crucial for muscle contraction.\n\nOther genes, such as **RAF1, BRAF,** and **ARAF**, encode RAF kinases, part of the MAPK/ERK signaling pathway involved in cell division, differentiation, and secretion. **PRKCA, PRKCB,** and **PRKCG** encode protein kinase C isoforms, serine/threonine kinases activated by DAG and calcium, playing roles in various cellular processes including proliferation and apoptosis. **IGF1** and **IGF1R** are involved in growth and development, mediating effects through the PI3K/AKT and MAPK pathways. **CRHR1** and **CRH** are involved in the stress response, influencing the hypothalamic-pituitary-adrenal axis. The **PLA2G** family (e.g., **PLA2G1B, PLA2G2A**) encodes phospholipase A2 enzymes, which hydrolyze phospholipids to release arachidonic acid, a precursor for eicosanoids important in inflammation and cell signaling.\n\nAdditionally, **MAP2K1, MAP2K2, MAPK1,** and **MAPK3** are part of the MAPK/ERK pathway, crucial for transmitting signals from the cell surface to the DNA in the cell nucleus, affecting gene expression and cell fate. The **GNA** family (e.g., **GNA12, GNA13**) encodes G-protein subunits involved in transmitting signals from GPCRs to various intracellular pathways. **ITPR1, ITPR2,** and **ITPR3** encode inositol 1,4,5-trisphosphate receptors, mediating calcium release from the endoplasmic reticulum. **NOS1** encodes neuronal nitric oxide synthase, producing nitric oxide, a signaling molecule involved in vasodilation and neurotransmission. **PPP2CA, PPP2CB, PPP2R1A,** and **PPP2R1B** encode subunits of protein phosphatase 2A, a major serine/threonine phosphatase involved in the negative control of cell growth and division. **LYN** encodes a Src family tyrosine kinase involved in the regulation of immune responses.\n\nThe genes in this cluster are interconnected through various signaling pathways, particularly those involving GPCRs, phospholipases, and kinases. The MAPK/ERK pathway is a central node, integrating signals from growth factors (IGF1/IGF1R) and stress responses (CRH/CRHR1). Calcium signaling is a recurring theme, with multiple genes (e.g., RYR1, ITPR family) involved in calcium release and regulation. Phospholipase A2 enzymes link membrane lipid metabolism to inflammatory and signaling pathways.\n\nAll in all, this gene cluster represents a complex network of signaling pathways essential for maintaining cellular homeostasis and responding to environmental changes. Dysregulation of these pathways can lead to various diseases, including cancer, neurological disorders, and inflammatory conditions. Understanding the interactions and regulation of these genes can provide insights into therapeutic targets for modulating these pathways in disease contexts. Further research is needed to elucidate the precise interactions and regulatory mechanisms within this cluster.","The gene cluster responsible for glutamate signaling is significant in the mammalian central nervous system (CNS) as glutamate is the major excitatory neurotransmitter. Some genes in this cluster encode components of ionotropic receptors (AMPA, NMDA, and kainate) and metabotropic receptors (mGlu1-8), where glutamate binds to ligand-gated ion channels (iGluRs) composed of GluR1-4 subunits. NMDA receptors are cation channels activated by glutamate and initially blocked by Mg2+ ions. When glutamate binds to these receptors, it removes the Mg2+ block, enabling Ca2+ to flow into the cell, triggering cellular responses such as the activation of protein kinases and phospholipases.\n\nOther genes encode metabotropic glutamate receptors (mGluRs), which are G-protein-coupled receptors (GPCRs) divided into three groups based on sequence homology, pharmacological properties, and effector coupling. Group I mGluRs (mGluR1 and 5) are linked to Gq/11 proteins and activate phospholipase C (PLC). Group II mGluRs (mGluR2 and 3) and group III mGluRs (mGluR4, 6, 7, and 8) are linked to the inhibition of cAMP formation through Gi/o proteins.\n\nAdditionally, the activation of PLC by Group I mGluRs results in the production of IP3, which prompts the release of Ca2+ from intracellular stores and activates protein kinase C (PKC). The activation through Gq/11 also leads to the activation of the small G protein Rho and its effector kinase, Rho-associated coiled-coil-containing protein kinase (ROCK). This pathway subsequently activates a kinase cascade involving myosin light chain (MLC) phosphorylation, stimulating the formation of actin-myosin filaments for contraction. PKC activation also influences MLC phosphorylation via inhibition of myosin phosphatase (MP). Furthermore, mGluR activation leads to the stimulation of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinases (ERKs), Jun N-terminal kinases (JNKs), and p38 MAPKs, contributing to the regulation of gene expression and various cellular responses.\n\nAll in all, this gene cluster facilitates complex and multifaceted signaling processes essential for excitatory neurotransmission, intracellular signaling cascades, and ultimately, the regulation of various physiological functions within the CNS."
KEGG_ACUTE_MYELOID_LEUKEMIA,"['SOS2', 'CHUK', 'STAT3', 'ZBTB16', 'RAF1', 'RARA', 'PML', 'JUP', 'MTOR', 'CEBPA', 'LEF1', 'EIF4EBP1', 'BAD', 'PIM2', 'MAP2K2', 'BRAF', 'MAP2K1', 'KIT', 'FLT3', 'SPI1', 'IKBKB', 'AKT1', 'AKT2', 'RPS6KB1', 'NRAS', 'AKT3', 'RPS6KB2', 'GRB2', 'STAT5B', 'MAPK3', 'TCF7', 'STAT5A', 'NFKB1', 'MYC', 'SOS1', 'TCF7L2', 'MAPK1', 'RUNX1', 'PIK3R5', 'IKBKG', 'HRAS', 'RUNX1T1', 'RELA', 'KRAS', 'CCNA1', 'ARAF', 'CCND1', 'PIK3R3', 'TCF7L1', 'PPARD', 'PIK3CA', 'PIK3CB', 'PIM1', 'PIK3CD', 'PIK3CG', 'PIK3R1', 'PIK3R2']",Acute myeloid leukemia,"Two major types of genetic events are crucial for the molecular pathogenesis of acute myeloid leukemias (AML) : activating mutations of signal transduction intermediates and alterations in myeloid transcription factors governing hematopoietic differentiation. Both aberrant and constitutive activation of signal transduction molecules are found in about 50% of primary AML bone marrow samples, and seem to contribute to the increased proliferation and apoptosis resistance. The most common of these activating events were observed in the RTK Flt3, in N-Ras and K-Ras, in Kit, and sporadically in other RTKs. Specific haematopoietic transcription factors are crucial for differentiation to particular lineages during normal differentiation, but are frequently disrupted in AML. Some mechanisms of disruption involve the effect of fusion proteins that are generated by chromosomal translocations on haematopoietic transcription factors. In other cases, the transcription factors themselves are mutated.","The gene cluster provided is primarily involved in the regulation of cell growth, survival, proliferation, and differentiation, with significant roles in signal transduction pathways, particularly the PI3K/AKT/mTOR and MAPK/ERK pathways. These pathways are crucial for cellular responses to external stimuli, such as growth factors, and are often implicated in cancer and other diseases when dysregulated.\n\nSome genes in this cluster are part of the PI3K/AKT/mTOR pathway. These include:\n\n- **PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5:** These genes encode subunits of phosphoinositide 3-kinases (PI3Ks), which are involved in the activation of AKT signaling. PI3Ks phosphorylate phosphatidylinositols, leading to the recruitment and activation of AKT.\n- **AKT1, AKT2, AKT3:** These serine/threonine kinases are central to the PI3K pathway, promoting cell survival and growth by phosphorylating a range of downstream targets.\n- **MTOR:** A key regulator of cell growth and metabolism, mTOR integrates signals from nutrients and growth factors to control protein synthesis and autophagy.\n- **RPS6KB1, RPS6KB2, EIF4EBP1:** These are downstream effectors of mTOR, involved in protein synthesis and cell growth.\n\nOther genes are part of the MAPK/ERK pathway, including:\n\n- **RAF1, BRAF, ARAF:** These kinases are part of the RAF family, which activates the MEK/ERK signaling cascade, leading to cell proliferation and differentiation.\n- **MAP2K1 (MEK1), MAP2K2 (MEK2):** These kinases activate ERK1/2, which then translocate to the nucleus to regulate gene expression.\n- **MAPK1 (ERK2), MAPK3 (ERK1):** These are the terminal kinases in the MAPK pathway, involved in the regulation of various cellular activities, including proliferation and differentiation.\n\nAdditionally, the cluster includes transcription factors and regulators such as:\n\n- **STAT3, STAT5A, STAT5B:** Members of the STAT family, these transcription factors are activated by cytokines and growth factors, mediating responses such as cell growth and apoptosis.\n- **MYC:** A well-known oncogene, MYC regulates the expression of numerous genes involved in cell cycle progression and metabolism.\n- **RUNX1, RUNX1T1:** These transcription factors are involved in hematopoiesis and are frequently implicated in leukemia.\n- **CEBPA, SPI1, LEF1, TCF7, TCF7L1, TCF7L2:** These transcription factors play roles in cell differentiation and immune responses.\n\nThe cluster also contains regulatory and adapter proteins:\n\n- **SOS1, SOS2:** These are guanine nucleotide exchange factors that activate RAS proteins, linking receptor tyrosine kinases to the MAPK pathway.\n- **GRB2:** An adapter protein that links receptor tyrosine kinases to the RAS/MAPK pathway.\n- **IKBKB, IKBKG, NFKB1, RELA:** Components of the NF-\u03baB signaling pathway, which is involved in immune responses and cell survival.\n\nReceptors and kinases in the cluster include:\n\n- **KIT, FLT3:** Receptor tyrosine kinases involved in hematopoiesis and implicated in various cancers.\n- **HRAS, KRAS, NRAS:** Members of the RAS family of GTPases, which are critical for transmitting signals from growth factor receptors to intracellular pathways.\n\nThe PI3K/AKT/mTOR and MAPK/ERK pathways are interconnected, with cross-talk that can modulate cellular responses to ensure appropriate growth and survival signals. Dysregulation of these pathways, often through mutations or overexpression of key components like PI3K, AKT, RAS, or RAF, is a hallmark of many cancers. Transcription factors such as MYC and STATs integrate signals from these pathways to regulate gene expression, influencing cell fate decisions.\n\nFeedback loops and cross-talk between the PI3K/AKT/mTOR and MAPK/ERK pathways are critical for maintaining cellular homeostasis. Negative regulators, such as PTEN (not listed here), are crucial for preventing overactivation of these pathways.\n\nAberrations in this gene cluster are associated with oncogenesis, making them targets for cancer therapy. Understanding the precise interactions and regulatory mechanisms within this cluster can lead to the development of targeted therapies, potentially improving treatment outcomes for diseases characterized by pathway dysregulation.\n\nAll in all, this gene cluster represents a complex network of signaling pathways that are essential for normal cellular function and are frequently altered in disease states, particularly cancer. Further research is needed to fully elucidate the intricate regulatory mechanisms and interactions within this cluster.","The gene cluster associated with Acute Myeloid Leukemia (AML) is genetically and clinically heterogeneous. Some genes in this cluster are involved in translocations, such as those involving RUNX1 (also known as AML1), which include t(8;21) (AML-M2), t(15;17) (AML-M3), and inv(16) (AML-M4Eo). Other genes have mutations in NPM1 (AML-M4Eo), C/EBP\u03b1 (AML-M3v), and abnormalities in KIT (AML-mast). Additionally, these molecular abnormalities impact various cellular functions, such as transcription, cell differentiation, signaling, and apoptosis. All in all, this gene cluster highlights the diverse genetic abnormalities that contribute to the complexity of AML."
BIOCARTA_P53HYPOXIA_PATHWAY,"['NFKBIB', 'HIC1', 'GADD45A', 'MAPK8', 'TAF1', 'HSPA1A', 'ATM', 'CDKN1A', 'NQO1', 'TP53', 'FHL2', 'IGFBP3', 'RPA1', 'MDM2', 'ABCB1', 'DNAJB1', 'EP300', 'HSP90AA1', 'AKT1', 'HIF1A', 'BAX']",Hypoxia and p53 in the Cardiovascular system,"Hypoxic stress, like DNA damage, induces p53 protein accumulation and p53-dependent apoptosis in oncogenically transformed cells. Unlike DNA damage, hypoxia does not induce p53-dependent cell cycle arrest, suggesting that p53 activity is differentially regulated by these two stresses. Hypoxia induces p53 protein accumulation, but in contrast to DNA damage, hypoxia fails to induce endogenous downstream p53 effector mRNAs and proteins, such as p21, Bax, CIP1, WAF1 etc. Hypoxia does not inhibit the induction of p53 target genes by ionizing radiation, indicating that p53-dependent transactivation requires a DNA damage-inducible signal that is lacking under hypoxic treatment alone. The phosphatidylinositol 3-OH-kinase-Akt pathway inhibits p53-mediated transcription and apoptosis. Mdm2, a ubiquitin ligase for p53, plays a central role in regulation of the stability of p53 and serves as a good substrate for Akt. Mdm-2 targets the p53 tumor suppressor for ubiquitin-dependent degradation by the proteasome, but, in addition, the p53 transcription factor induces Mdm-2, thus, establishing a feedback loop. Hypoxia or DNA damage by abrogating binding of HIF-1 with VHL and p53 with Mdm-2, respectively, leads to stabilization and accumulation transcriptionally active HIF-1 and p53. At the molecular level, DNA damage induces the interaction of p53 with the transcriptional activator p300 as well as with the transcriptional corepressor mSin3A. In contrast, hypoxia primarily induces an interaction of p53 with mSin3A, but not with p300.","The gene cluster provided is primarily associated with cellular stress responses, particularly those related to DNA damage, apoptosis, and cell cycle regulation. This cluster is centered around the tumor suppressor gene TP53, commonly known as p53, which plays a pivotal role in maintaining genomic stability by regulating the expression of a variety of genes involved in these processes.\n\nSome genes in this cluster include:\n\n1. **TP53 (p53)**: A critical tumor suppressor gene that acts as a transcription factor to regulate the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair. It is often referred to as the \""guardian of the genome\"" due to its role in preventing genomic mutations.\n\n2. **CDKN1A (p21)**: A direct transcriptional target of p53 that encodes a cyclin-dependent kinase inhibitor mediating p53-dependent cell cycle arrest in response to DNA damage.\n\n3. **MDM2**: Encodes a protein that negatively regulates p53 by targeting it for proteasomal degradation. The p53-MDM2 feedback loop is crucial for controlling p53 activity.\n\n4. **GADD45A**: Involved in DNA repair and cell cycle arrest, with expression induced by p53 in response to stress signals.\n\n5. **BAX**: A pro-apoptotic member of the Bcl-2 protein family, upregulated by p53, promoting apoptosis by facilitating the release of cytochrome c from mitochondria.\n\nOther genes include:\n\n6. **ATM**: Encodes a kinase activated by DNA double-strand breaks, phosphorylating p53 to enhance its stability and activity.\n\n7. **HIC1**: A transcriptional repressor that can modulate p53 activity and is involved in tumor suppression.\n\n8. **EP300**: Encodes a histone acetyltransferase acting as a co-activator of p53, enhancing its transcriptional activity.\n\n9. **MAPK8 (JNK1)**: Involved in stress-activated signaling pathways, modulating p53 activity through phosphorylation.\n\n10. **HIF1A**: Encodes a transcription factor responding to hypoxic conditions, interacting with p53 to influence cell survival under low oxygen conditions.\n\n11. **AKT1**: Part of the PI3K/AKT signaling pathway, negatively regulating p53 by promoting MDM2-mediated degradation.\n\n12. **NFKBIB**: Encodes an inhibitor of NF-kB, a transcription factor involved in inflammatory responses and cell survival, interacting with p53 pathways.\n\n13. **HSPA1A and HSP90AA1**: Heat shock proteins involved in protein folding and stress responses, modulating the stability and activity of p53 and other signaling proteins.\n\n14. **RPA1**: Encodes a protein involved in DNA replication and repair, crucial for maintaining genomic integrity.\n\n15. **IGFBP3**: Encodes a protein modulating the activity of insulin-like growth factors, inducing apoptosis in a p53-dependent manner.\n\n16. **NQO1**: Encodes an enzyme involved in detoxification processes, stabilizing p53 by preventing its degradation.\n\n17. **FHL2**: Encodes a protein interacting with various transcription factors, including p53, influencing cell growth and apoptosis.\n\n18. **ABCB1**: Encodes a membrane transporter involved in drug efflux, impacting cellular responses to chemotherapy.\n\n19. **DNAJB1**: Encodes a co-chaperone assisting in protein folding and stress responses, potentially influencing p53 activity.\n\nAdditionally, this gene cluster highlights the intricate network of interactions centered around p53, emphasizing its role in coordinating cellular responses to stress and maintaining genomic integrity. The regulatory elements and feedback loops, such as the p53-MDM2 interaction, are crucial for fine-tuning these responses. Dysregulation of these genes can lead to impaired stress responses and contribute to tumorigenesis, underscoring their biological significance.\n\nAll in all, this gene cluster underscores the critical role of p53 and its associated genes in cellular stress responses, genomic stability, and tumor suppression.","The gene cluster for the heat shock protein Hsp70 (Hsp70) acts as a molecular chaperone, which is induced by various cellular stresses such as heat, heavy metals, and oxidative stress. Some genes in this cluster influence the inhibition of apoptosis triggered by various stimuli, including Fas, TNF-alpha, and heat, through Hsp70's ability to bind and stabilize the pro-apoptotic protein Bax. Other genes in this cluster contribute to Hsp70's capacity to inhibit apoptosis by blocking the Apaf-1-mediated caspase-9 activation pathway.\n\nAdditionally, the anti-apoptotic activity of Hsp70 is reliant on its phosphorylation state. When phosphorylated, Hsp70 is an effective inhibitor of apoptosis, while dephosphorylation permits apoptosis to occur. The phosphorylation process is regulated by the stress-activated protein kinase (SAPK)/Jun N-terminal kinase (JNK) and the protein kinase AKT. Specifically, SAPK/JNK-mediated phosphorylation is stimulated by TNF and inhibits apoptosis, whereas AKT-mediated phosphorylation is promoted by growth factors and also inhibits apoptosis.\n\nMoreover, the presence of co-chaperones, such as AIF (apoptosis-inducing factor) and p400, supports Hsp70's role in apoptosis inhibition. AIF is a mitochondrial protein that translocates to the nucleus to induce chromatin condensation and significant DNA fragmentation in a caspase-independent manner. Hsp70, along with p400, forms a complex that binds to AIF, preventing its nuclear entry and subsequent induction of apoptosis. The presence of Hsp70 in the mitochondria is crucial, as without it, AIF is released and apoptosis is induced.\n\nAll in all, this gene cluster provides Hsp70 with a multifaceted role in cellular protection against apoptosis, mediated through its phosphorylation-dependent regulation and interactions with co-chaperones."
BIOCARTA_LYM_PATHWAY,"['CXCL8', 'IL1A', 'MADCAM1', 'VCAM1', 'ITGAL', 'CD34', 'ITGB2', 'PECAM1', 'ICAM2', 'ITGA4', 'GLYCAM1', 'ICAM1', 'ITGB1', 'SELL']",Adhesion and Diapedesis of Lymphocytes,"Cell adhesion is a fundamental feature of multicellular organisms including their defense mechanisms. In the later case in mammals, leukocytes play central role. They bind bacteria, parasites, viruses, tumor cells etc. Furthermore, their interactions with the endothelium are of special importance. Generally, lymphocyte adhesion and passage from the bloodstream to the lymphatic system occurs in the high endothelial venules of the lymphnodes. This way the lymphocytes can communicate with each other in the lymphatic system and search for foreign compounds after their recirculation to the bloodstream, this fulfilling their role in the immune system. The reaction passes through the following steps: 1. Rolling (the flow of cells is slowed down by first making contacts to the endothelium via P-, E-, and L-selectins and their receptors); 2. Adhesion (After activation of leukocyte integrins, firm contacts are established between them and endothelium molecules of the Ig superfamily - LFA-1, Mac-1, VLA-4 etc.); 3. Flatteningof the cells and diapedesis (Adhering leukocytes crawl to an intercellular junction of the endothelium and then transmigrate to or even through the intercellular matrix. This is mediated by a homophilic interactions of PECAM and CD31.","The gene cluster provided is primarily involved in the regulation of immune responses, inflammation, and cell adhesion processes. Some genes in this cluster include several chemokines, interleukins, and adhesion molecules that play critical roles in leukocyte trafficking, endothelial interactions, and inflammatory signaling.\n\n1. **CXCL8 (Interleukin-8)**: This chemokine is a potent neutrophil chemoattractant and activator, playing a crucial role in the inflammatory response by recruiting immune cells to sites of infection or injury.\n\n2. **IL1A (Interleukin-1 alpha)**: A pro-inflammatory cytokine involved in various immune responses, inflammatory processes, and hematopoiesis. It acts as a mediator in the inflammatory response and can induce the expression of adhesion molecules on endothelial cells.\n\n3. **MADCAM1 (Mucosal Vascular Addressin Cell Adhesion Molecule 1)**: This adhesion molecule is primarily expressed on endothelial cells in the gut and is involved in the homing of lymphocytes to mucosal tissues, playing a key role in gut-associated lymphoid tissue (GALT) immune responses.\n\n4. **VCAM1 (Vascular Cell Adhesion Molecule 1)**: An endothelial protein that mediates the adhesion of lymphocytes, monocytes, eosinophils, and basophils to vascular endothelium. It is upregulated in response to cytokines and is involved in the inflammatory response.\n\nOther genes include:\n\n5. **ITGAL (Integrin Subunit Alpha L)** and **ITGB2 (Integrin Subunit Beta 2)**: These integrins form the LFA-1 complex, which is crucial for leukocyte adhesion and migration through interactions with ICAMs (Intercellular Adhesion Molecules).\n\n6. **CD34**: A cell surface glycoprotein that functions as a cell-cell adhesion factor. It is expressed on early hematopoietic and vascular-associated tissue and is involved in the migration of hematopoietic progenitor cells.\n\n7. **PECAM1 (Platelet and Endothelial Cell Adhesion Molecule 1)**: Involved in leukocyte transmigration, PECAM1 is expressed on endothelial cells and plays a role in the passage of leukocytes through the endothelial barrier.\n\n8. **ICAM1 (Intercellular Adhesion Molecule 1)** and **ICAM2**: These molecules are involved in stabilizing cell-cell interactions and facilitating leukocyte endothelial transmigration. ICAM1 is inducible and plays a significant role in inflammatory responses.\n\n9. **ITGA4 (Integrin Subunit Alpha 4)** and **ITGB1 (Integrin Subunit Beta 1)**: These integrins form the VLA-4 complex, which is important for cell adhesion and migration, particularly in the immune system.\n\n10. **GLYCAM1 (Glycosylation-Dependent Cell Adhesion Molecule 1)**: This molecule is involved in lymphocyte homing and is expressed in high endothelial venules.\n\n11. **SELL (Selectin L)**: Also known as L-selectin, this adhesion molecule is important for the tethering and rolling of leukocytes on endothelial cells, a critical step in leukocyte extravasation.\n\nAdditionally, the interactions among these genes and their products are essential for the regulation of immune cell trafficking and the inflammatory response. The upregulation of adhesion molecules like VCAM1 and ICAM1 in response to cytokines such as IL1A and CXCL8 highlights the coordinated response to inflammatory stimuli.\n\nAll in all, this gene cluster's dysregulation can lead to pathological conditions such as chronic inflammation, autoimmune diseases, and cancer metastasis. Understanding the regulatory elements and signaling pathways involved in this cluster is crucial for developing therapeutic strategies targeting inflammatory and immune-related disorders.","The gene cluster involved in leukocyte trafficking from the bloodstream into tissues is a key component of the inflammatory response. Some genes in this cluster are responsible for the expression of chemokines by endothelial cells in blood vessel walls, which attract leukocytes to inflammation sites. Other genes mediate the interaction of selectins on leukocyte surfaces with their ligands on endothelial cells, initiating the tethering and rolling of leukocytes. Additionally, integrins on the leukocyte surface are activated to bind their ligands on endothelial cells, leading to firm adherence and extravasation into inflamed tissue. The dynamic process of rolling and adhesion is governed by the interaction strength between selectins and their ligands, which is regulated by the enzymatic addition and removal of carbohydrates via glycosyltransferases and glycosidases. Specifically, the enzyme O-GlcNAc transferase (OGT) catalyzes the addition of carbohydrates, whereas O-GlcNAcase (OGA) facilitates their removal. Inhibition of OGT or activation of OGA disrupts selectin-mediated rolling and leukocyte trafficking, and inhibiting OGT in vivo blocks leukocyte recruitment to inflamed tissues. The carbohydrate addition by OGT and its removal by OGA is reversible and crucial for selectin ligand functionality or inactivation. Overall, this gene cluster manages the dynamic process of carbohydrate modulation by OGT and OGA, crucial for the activity of selectin ligands and consequently for the rolling and adhesion of leukocytes."
BIOCARTA_ARF_PATHWAY,"['PIK3CG', 'TWIST1', 'POLR1B', 'PIK3R1', 'MYC', 'RB1', 'RAC1', 'ABL1', 'TP53', 'MDM2', 'POLR1D', 'CDKN2A', 'TBX2', 'POLR1A', 'PIK3CA', 'E2F1', 'POLR1C']",Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,"Cyclin-dependent kinase inhibitor-2A (CDKN2A) goes by the colloquial designation p16, which is sometimes referred to as p16(INK4). The alpha transcript of CDKN2A has been shown to encode p16(INK4a), a recognized tumor suppressor that induces a G1 cell cycle arrest by inhibiting the phosphorylation of the RB protein by the cyclin-dependent kinases CDK4 and CDK6. The beta transcript of CDKN2A encodes p14(ARF). The predicted 132-amino acid p14(ARF) is shorter than the corresponding mouse protein, p19(ARF), and the 2 proteins share only 50% identity. However, both proteins have the ability to elicit a p53 response, manifest in the increased expression of both CDKN1A and MDM2, and resulting in a distinctive cell cycle arrest in both the G1 and G2/M phases. Two unrelated proteins encoded by the INK4A-ARF locus function in tumor suppression. ARF binds to MDM2 and promotes the rapid degradation of MDM2. This interaction is mediated by the E1-beta-encoded N-terminal domain of ARF and a C-terminal region of MDM2. ARF-promoted MDM2 degradation is associated with MDM2 modification and concurrent p53 stabilization and accumulation. The p19(Arf) tumor suppressor inhibits production of ribosomal RNA, retarding processing of 47/45S and 32S precursors. These effects correlate with but do not strictly depend upon inhibition of rRNA biosynthesis or cell cycle arrest, are not mimicked by p53, and require neither p53 nor Mdm2. Arf mutants lacking conserved amino acid residues 2-14 do not block rRNA synthesis and processing or inhibit cell proliferation. Evolution may have linked a primordial nucleolar Arf function to Mdm2 and p53, creating a more efficient checkpoint-signaling pathway for coordinating ribosomal biogenesis and cell cycle progression.","The gene cluster provided includes a diverse set of genes involved in critical cellular processes such as cell cycle regulation, transcription, signal transduction, and oncogenesis. This cluster is significant in understanding cancer biology, as many of these genes are implicated in tumorigenesis and cancer progression.\n\n1. **Cluster Overview and Biological Function:**\n   The gene cluster is primarily associated with cell cycle regulation, transcriptional control, and signal transduction pathways. It plays a crucial role in maintaining cellular homeostasis and responding to extracellular signals, with several genes acting as oncogenes or tumor suppressors.\n\n2. **Key Genes and Their Functions:**\n   Some genes in this cluster include:\n   - **PIK3CG, PIK3R1, PIK3CA:** These genes encode components of the phosphoinositide 3-kinase (PI3K) pathway, which is critical for cell growth, proliferation, and survival. Dysregulation of this pathway is a common feature in many cancers.\n   - **MYC:** A well-known oncogene that regulates gene expression involved in cell growth and proliferation. Overexpression of MYC is linked to numerous cancers.\n   - **TP53:** Encodes the tumor suppressor protein p53, which is crucial for DNA repair, apoptosis, and cell cycle arrest. Mutations in TP53 are among the most common in human cancers.\n   - **RB1:** Another tumor suppressor gene that regulates the cell cycle by controlling the transition from G1 to S phase. Loss of RB1 function can lead to uncontrolled cell proliferation.\n   - **CDKN2A:** Encodes p16^INK4a, a cyclin-dependent kinase inhibitor that regulates the cell cycle. It is frequently mutated or deleted in various cancers.\n   - **MDM2:** Encodes a negative regulator of p53, controlling its degradation. Overexpression of MDM2 can lead to decreased p53 activity, contributing to tumorigenesis.\n   - **E2F1:** A transcription factor that regulates genes essential for cell cycle progression. It is tightly regulated by the RB1 protein.\n   - **TWIST1:** A transcription factor involved in epithelial-mesenchymal transition (EMT), a process important for cancer metastasis.\n   - **RAC1:** A small GTPase involved in cytoskeletal reorganization, cell migration, and growth. It plays a role in cancer cell invasion and metastasis.\n   - **ABL1:** Encodes a tyrosine kinase involved in cell differentiation, division, and adhesion. The BCR-ABL fusion protein is a hallmark of chronic myeloid leukemia.\n   - **TBX2:** A transcription factor involved in developmental processes and has been implicated in cancer cell proliferation and survival.\n\n3. **Relationships and Interactions:**\n   Other genes in this cluster interact in the following ways:\n   - The PI3K pathway (PIK3CG, PIK3R1, PIK3CA) interacts with other signaling pathways, including those involving MYC and TP53, to regulate cell growth and survival.\n   - TP53 and RB1 are central to cell cycle control, with TP53 also interacting with MDM2 to regulate apoptosis.\n   - E2F1 is regulated by RB1, linking cell cycle control to transcriptional regulation.\n   - TWIST1 and RAC1 are involved in processes that facilitate cancer metastasis, such as EMT and cell migration.\n\n4. **Regulatory Elements and Patterns:**\n   Additionally, the interplay between tumor suppressors (TP53, RB1, CDKN2A) and oncogenes (MYC, MDM2, ABL1) highlights the balance between cell proliferation and apoptosis. The PI3K pathway is a major target for cancer therapeutics due to its role in cell survival and growth.\n\n5. **Biological Implications:**\n   Understanding the interactions and regulation of these genes is crucial for developing targeted cancer therapies. Aberrations in this gene cluster can lead to various cancers, making it a focal point for research in oncology.\n\nAll in all, this gene cluster represents a complex network of interactions that are pivotal in maintaining cellular functions and, when dysregulated, contribute to cancer development and progression. Further research is needed to fully elucidate the regulatory mechanisms and potential therapeutic targets within this cluster.","The gene cluster responsible for transcription of rRNA genes by RNA polymerase I plays a critical role as the rate-limiting step in ribosome biogenesis, accounting for up to 60% of all nuclear transcription. Some genes in this cluster are involved in the structure and regulation of RNA polymerase I, which is a multi-subunit enzyme composed of 14 subunits. The activity of these subunits is controlled by various factors.\n\nOther genes are involved in the regulation of the transcription factor UBF, which binds to the core promoter and upstream control region of the rRNA genes, subsequently recruiting the SL1 complex. The SL1 complex consists of the TATA-binding protein (TBP) and TBP-associated factors (TAFs). The activity of UBF is modulated through phosphorylation by cyclin-dependent kinase (CDK)-cyclin complexes, which enhances UBF's affinity for the rRNA promoter, and through acetylation by the histone acetylase PCAF, which further stimulates UBF's activity.\n\nAdditionally, several tumor suppressors interact with components of this transcriptional machinery to regulate rRNA transcription. For example, the tumor suppressor p53 interacts with PCAF, inhibiting its histone acetylase activity, thus repressing rRNA transcription. Similarly, the tumor suppressor RB also interacts with PCAF to repress rRNA transcription by preventing its interaction with UBF. Likewise, the T-box transcription factor TBX2 represses rRNA transcription by interacting with PCAF and blocking its histone acetylase activity. \n\nOther influences include the Myb transcription factor c-Myb, which activates genes involved in the cell cycle and stimulates rRNA transcription. However, its interaction with PCAF can be obstructed by the coactivator CBP and p53, leading to repression of rRNA transcription. Furthermore, the interaction of the basic helix-loop-helix transcription factor Twist with PCAF also results in repression of rRNA transcription, highlighting Twist's role in developmental processes.\n\nAll in all, this gene cluster integrates complex regulatory mechanisms, involving various transcription factors and tumor suppressors, to finely tune the transcription of rRNA genes, thus influencing ribosome biogenesis and cellular function."
BIOCARTA_ATRBRCA_PATHWAY,"['RAD17', 'CHEK1', 'BRCA2', 'RAD1', 'HUS1', 'MRE11', 'BRCA1', 'FANCD2', 'ATR', 'FANCA', 'CHEK2', 'FANCE', 'ATM', 'TP53', 'NBN', 'FANCC', 'FANCG', 'RAD51', 'FANCF', 'RAD50', 'RAD9A', 'TREX1']","Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility","BRCA1 and BRCA2 were identified genetically as breast cancer susceptibility genes when a single copy of the gene is mutated and are involved in the cellular response to DNA damage, including blocking cell cycle progression and inducing DNA repair to preserve the integrity of the genome during cell division. BRCA1 and BRCA2 induce double-stranded repair of breaks using homologous recombination, in part through activation of RAD51. BRCA1 acts as a ubiquitin ligase targeting the protein FancD2 that activates checkpoint control, integrating the ATM response to ionizing radiation and the FA response to cross-linking agents like mitomycin C. Mutation of one of the several components of the FA complex involved in maintaining integrity of the genome leads to the condition Fanconi anemia. One member of the FA complex was recently identified as BRCA2, which leads to Fanconi anemia when both copies of the gene are mutated. Another related factor involved in the response of cells to DNA damage is the kinase ATM. ATM is mutated in patients with AT, a condition with many similar traits to Fanconi anemia. Like ATM, ATR serves as a checkpoint kinase that halts cell cycle progression and induces DNA repair when DNA is damaged. Loss of ATR results in a loss of checkpoint control in response to DNA damage, leading to cell death, and deletion of the ATR gene in mice is embryonic lethal. ATRIP is a protein that interacts with ATR and is a substrate for its kinase activity. ATRIP is required for ATR function, and removal of ATRIP also leads to a loss of checkpoint control of the cell cycle. ATR and ATM kinase targets include repair enzymes like Rad51, and the checkpoint kinases Chk1 and Chk2, as well as BRCA1 and BRCA2. The close relationship of the genes involved in breast cancer and Fanconi anemia has helped illuminate this signaling system, and may help lead to improved understanding and treatment of these conditions.","The gene cluster provided is primarily involved in the DNA damage response (DDR) and repair pathways, which are crucial for maintaining genomic stability and preventing carcinogenesis. This cluster includes genes that participate in various repair mechanisms, such as homologous recombination (HR), checkpoint signaling, and the Fanconi anemia (FA) pathway.\n\nSome genes in this cluster, such as **BRCA1** and **BRCA2**, are central to the homologous recombination repair of double-strand breaks (DSBs). Mutations in these genes are well-known for their association with increased breast and ovarian cancer risk. **RAD51** works closely with BRCA1 and BRCA2 to facilitate the search for homology and strand pairing during HR. **ATM** and **ATR** are key kinases that activate the DNA damage checkpoint, with ATM primarily responding to DSBs and ATR responding to replication stress and single-stranded DNA. **CHEK1** and **CHEK2** are checkpoint kinases downstream of ATM and ATR, helping to propagate the DNA damage signal to halt cell cycle progression, allowing time for repair. **TP53**, known as the \""guardian of the genome,\"" is a tumor suppressor that can induce cell cycle arrest, apoptosis, or senescence in response to DNA damage.\n\nOther genes, such as **MRE11**, **RAD50**, and **NBN (NBS1)**, form the MRN complex, which is crucial for the detection of DSBs and the activation of ATM. **RAD17**, **RAD1**, **HUS1**, and **RAD9A** are part of the 9-1-1 complex, which acts as a sliding clamp to recruit repair proteins to sites of DNA damage. **FANCD2**, **FANCA**, **FANCC**, **FANCG**, **FANCE**, and **FANCF** are part of the Fanconi anemia pathway, involved in the repair of interstrand crosslinks and linked to BRCA1/2 and HR repair. **TREX1** encodes a DNA exonuclease involved in degrading DNA at sites of damage, preventing inappropriate immune activation.\n\nAdditionally, there are important relationships and interactions within this cluster. **BRCA1/2** and **RAD51** collaborate in HR to repair DSBs. **ATM/ATR** and **CHEK1/CHEK2** form a signaling cascade that regulates cell cycle checkpoints. The MRN complex recruits and activates ATM at DSBs, while the 9-1-1 complex is involved in ATR-mediated checkpoint activation. Checkpoint activation is regulated by ATM and ATR, which integrate signals from various DNA damage sensors and transducers. There is significant cross-talk between the FA pathway and HR, particularly through BRCA1/2.\n\nAll in all, this gene cluster is integral to the cellular response to DNA damage, with significant implications for cancer biology and therapy. Mutations in these genes can lead to genomic instability and increased cancer risk, particularly breast, ovarian, and hematological cancers. Many of these genes are targets for cancer therapies, such as PARP inhibitors for BRCA-mutated cancers. Proper functioning of these pathways is essential for preventing mutations and maintaining genomic integrity. While much is known about these pathways, ongoing research continues to uncover new interactions and regulatory mechanisms.","The gene cluster, known as the FA pathway, is crucial for repairing DNA damage caused by crosslinking agents such as cisplatin and mitomycin C. Some genes in this cluster are involved in forming a nuclear complex where the FA-A protein binds to FA-B, -C, -E, -F, and -G proteins. This complex is essential for the ubiquitination of the FANCD2 protein by FA-C, -E, -F, and -G proteins as a response to DNA damage. Additionally, these ubiquitinated FANCD2 proteins associate with BRCA2 and other proteins in chromatin, creating nuclear foci that are important for DNA repair. \n\nOther genes and proteins involved include the checkpoint kinases ATR and ATM, which are required for FANCD2 ubiquitination following DNA damage but not for nuclear foci formation. Furthermore, the checkpoint clamp complex RAD1 7-RAD4-ATAD5 is necessary for the ubiquitination of FANCD2 in response to DNA damage. This complex loads the 9-1-1 complex at DNA damage sites to signal their presence and may recruit the FA complex to these sites. There, the FA complex activates the ubiquitination of FANCD2 via the E3 ubiquitin ligase complex comprised of FANCL, B, C, E, and G proteins.\n\nAdditionally, the deubiquitinating enzyme UAF1 / USP2L3 may be needed to remove ubiquitin groups from FANCD2, facilitating the release of repaired DNA from the repair complex.\n\nAll in all, this gene cluster plays a pivotal role in maintaining genetic stability by repairing DNA and participating in critical ubiquitination processes essential for cellular response to DNA damage. Cells with a defective FA pathway show extreme sensitivity to crosslinking agents and genetic instability."
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,"['DSE', 'B3GALT6', 'CHPF', 'XYLT1', 'CHSY3', 'XYLT2', 'CHST14', 'B3GAT1', 'CHSY1', 'CHST11', 'CHPF2', 'CHST15', 'B4GALT7', 'CHST7', 'UST', 'CHST13', 'CSGALNACT2', 'B3GAT2', 'CSGALNACT1', 'CHST3', 'CHST12', 'B3GAT3']",Glycosaminoglycan biosynthesis - chondroitin sulfate,"Glycosaminoglycans (GAGs) are linear polysaccharide chains consisting of repeating disaccharide units and form proteglycans by covalently attaching to their core proteins. Chondroitin sulfate (CS) is a glycosaminoglycan with the disaccharide unit GalNAc(b1-4)GlcA(b1-3), modified with ester-linked sulfate at certain positions. Dermatan sulfate (DS) is a modified form of CS, in which a portion of D-glucuronate residues is epimerized to L-iduronates. CS and DS are linked to serine residues in core proteins via a linkage tetrasaccharide formed by the transfer of xylose and three more residues. The assembly process of CS is initiated by the transfer of N-acetylgalactosamine to the linkage tetrasaccharide. The polymerization step is catalyzed by bifunctional enzymes (chondroitin synthases) that have both b13 glucuronosyltransferase and b14 N-acetylgalactosaminyltransferase activities. Chondroitin polymerization also requires the action of the chondroitin polymerizing factor. Sulfation of chondroitin in vertebrates is a complex process, with multiple sulfotransferases involved in 4-O sulfation and 6-O sulfation of N-acetylgalactosamine residues. Additional enzymes exist for epimerization of glucuronic acid to iduronic acid in DS, sulfation at the C-2 position of the uronic acids, and other patterns of sulfation found in unusual species of chondroitin.","The gene cluster provided is primarily involved in the biosynthesis and modification of glycosaminoglycans (GAGs), which are essential components of the extracellular matrix and play critical roles in cell signaling, proliferation, and structural integrity of tissues.\n\nSome genes in this cluster, such as **XYLT1** and **XYLT2**, encode xylosyltransferases that initiate GAG biosynthesis by transferring xylose to serine residues on core proteins, forming the linkage region of proteoglycans. **B4GALT7** encodes a galactosyltransferase that adds galactose to the xylose residue, a crucial step in forming the GAG-protein linkage region. **B3GALT6** encodes another galactosyltransferase involved in adding the second galactose to the linkage region, further extending the GAG chain. **B3GAT3** encodes a glucuronosyltransferase that adds glucuronic acid to the growing GAG chain, completing the linkage region.\n\nOther genes, such as **CHSY1**, **CHSY3**, **CHPF**, and **CHPF2**, encode chondroitin synthases and chondroitin polymerizing factors responsible for the polymerization of chondroitin sulfate chains, a type of GAG. **CHST11**, **CHST12**, **CHST13**, **CHST14**, **CHST15**, and **CHST3** encode various sulfotransferases that add sulfate groups to the GAG chains, a modification critical for their function in cell signaling and interaction. **CSGALNACT1** and **CSGALNACT2** encode N-acetylgalactosaminyltransferases involved in the initiation and elongation of chondroitin sulfate chains. **UST** encodes uronyl 2-sulfotransferase, which specifically sulfates the uronic acid residues in GAGs, contributing to their structural diversity and function. **DSE** encodes dermatan sulfate epimerase, which converts glucuronic acid to iduronic acid in dermatan sulfate, altering its physical properties and biological functions. **B3GAT1** and **B3GAT2** encode glucuronosyltransferases involved in the biosynthesis of glycosphingolipids and proteoglycans, contributing to the structural diversity of GAGs.\n\nAdditionally, the genes in this cluster are functionally interconnected, as they sequentially and cooperatively contribute to the biosynthesis and modification of GAGs. Regulatory elements likely coordinate the expression of these genes to ensure the proper synthesis of GAGs, although specific regulatory mechanisms may vary and are not fully understood.\n\nAll in all, this gene cluster is essential for the biosynthesis and functional diversification of glycosaminoglycans, with significant implications for tissue structure and cellular communication. Mutations or dysregulation in these genes can lead to disorders such as Ehlers-Danlos syndrome, spondyloepimetaphyseal dysplasia, and other connective tissue disorders, highlighting their critical role in maintaining tissue integrity. The diversity of sulfation patterns and chain lengths in GAGs, regulated by these genes, is crucial for their interaction with growth factors, cytokines, and other extracellular matrix components, influencing processes like cell migration, wound healing, and inflammation. Further research is needed to fully elucidate the regulatory networks and interactions among these genes.","The gene cluster involves the formation of chondroitin sulfate, a sulfated polysaccharide composed of glucuronic acid and N-acetylgalactosamine. Some genes in this cluster facilitate the attachment of chondroitin sulfate chains to core proteins, forming proteoglycans and initiating chondroitin sulfate biosynthesis. This process begins with the transfer of an N-acetylgalactosamine-glucuronic acid disaccharide repeat unit to a serine residue of a core protein by the enzyme chondroitin synthase. Other genes are responsible for several modifications following the assembly of the disaccharide repeat unit. The first modification involves the addition of a sulfate group to position 6 of the N-acetylgalactosamine, catalyzed by the enzyme chondroitin-6-sulfotransferase. A second modification adds a sulfate group to position 4 of the glucuronic acid, facilitated by chondroitin sulfate N-acetylgalactosaminyltransferase. Additionally, the third modification involves the epimerization of glucuronic acid to iduronic acid, catalyzed by uronyl 2-sulfotransferase. Chondroitin sulfate proteoglycans are found in various tissues, including cartilage, brain, and the eye, and they play roles in numerous biological processes, such as cell adhesion, cell-cell communication, and embryonic development. All in all, this gene cluster is essential for the biosynthesis and function of chondroitin sulfate proteoglycans in diverse biological systems."
BIOCARTA_CHEMICAL_PATHWAY,"['CASP7', 'CASP3', 'BCL2', 'EIF2S1', 'PARP1', 'CASP9', 'ATM', 'BAD', 'TP53', 'PRKCB', 'TLN1', 'AKT1', 'PRKCA', 'APAF1', 'BID', 'BAX', 'CASP6', 'STAT1']",Apoptotic Signaling in Response to DNA Damage,"The cellular activation of the caspase cascade resulting in cell death is triggered by chemical damage to DNA which stimulates a sequence resulting in the cleavage of Bid in a manner similar to the binding of so called death-receptors or directly initiates the permeability transition of the mitochondrial membrane. The permiability transition releases several factors including cytochrome c, AIF and other factors in to the cytoplasm. Cytochrome c, a key protein in electron transport, is released from mitochondria in response to apoptotic signals, and activates Apaf-1, a protease released from mitochondria. Activated Apaf-1 activates caspase-9 and the rest of the caspase cascade. The caspases are a class of cysteine proteases that includes several representatives involved in apoptosis. The caspases convey the apoptotic signal in a proteolytic cascade, with caspases cleaving and activating other caspases that then degrade other cellular targets that lead to cell death.","The gene cluster provided is primarily involved in the regulation of apoptosis, a form of programmed cell death crucial for maintaining cellular homeostasis and development. This cluster includes genes encoding for caspases, BCL2 family proteins, and other regulatory proteins that interact to control the apoptotic pathway.\n\nSome genes in this cluster include:\n\n1. **Caspases (CASP3, CASP6, CASP7, CASP9):** These are cysteine-aspartic proteases that play essential roles in the execution phase of cell apoptosis. CASP9 is an initiator caspase that activates the executioner caspases CASP3, CASP6, and CASP7, leading to the cleavage of cellular components and cell death.\n\n2. **BCL2 Family (BCL2, BAD, BID, BAX):** These proteins regulate mitochondrial outer membrane permeabilization (MOMP), a critical step in apoptosis. BCL2 is anti-apoptotic, preventing the release of cytochrome c from mitochondria, while BAX and BID are pro-apoptotic, promoting cytochrome c release. BAD is a pro-apoptotic member that can bind and inhibit BCL2, tipping the balance towards apoptosis.\n\nOther genes include:\n\n3. **TP53 (p53):** A tumor suppressor gene that plays a pivotal role in DNA damage response and apoptosis. It can induce the expression of pro-apoptotic genes like BAX and BID, and is involved in the transcriptional regulation of several genes in this cluster.\n\n4. **APAF1 (Apoptotic Peptidase Activating Factor 1):** This protein forms the apoptosome in response to cytochrome c release, which then activates CASP9, initiating the caspase cascade.\n\n5. **PARP1 (Poly (ADP-ribose) polymerase 1):** Involved in DNA repair, PARP1 is cleaved by caspases during apoptosis, which serves as a marker of cells undergoing programmed cell death.\n\n6. **AKT1 (Protein Kinase B):** A key player in cell survival signaling, AKT1 can phosphorylate and inactivate components of the apoptotic machinery, such as BAD, thereby promoting cell survival.\n\n7. **ATM (Ataxia Telangiectasia Mutated):** A kinase that responds to DNA damage by phosphorylating several key proteins, including TP53, to initiate DNA repair or apoptosis.\n\n8. **PRKCB and PRKCA (Protein Kinase C Beta and Alpha):** These kinases are involved in various cellular processes, including apoptosis, where they can modulate the activity of BCL2 family proteins and other apoptotic regulators.\n\n9. **TLN1 (Talin 1):** While primarily involved in cell adhesion and migration, TLN1 may have indirect roles in apoptosis through its interactions with the cytoskeleton and signaling pathways.\n\n10. **STAT1 (Signal Transducer and Activator of Transcription 1):** Involved in mediating responses to cytokines and growth factors, STAT1 can influence apoptosis through transcriptional regulation of apoptotic genes.\n\nAdditionally, this gene cluster highlights the intricate network of interactions that govern apoptosis, with implications for cancer research, as dysregulation of these pathways can lead to uncontrolled cell proliferation and tumor development. Understanding these interactions provides insights into potential therapeutic targets for diseases characterized by aberrant apoptosis.\n\nAll in all, this gene cluster is essential for understanding the regulation of apoptosis and its implications in disease, particularly in the context of cancer research.","The gene cluster related to apoptosis, or programmed cell death, is crucial for the development and homeostasis of multicellular organisms. Some genes in this cluster, when defective in regulating apoptosis, are linked to the development of various diseases, including cancer. Other genes in this cluster encode a family of proteases known as caspases, which are responsible for executing apoptosis. Additionally, the activation of caspases leads to the cleavage of several cellular proteins essential for maintaining cellular structure and function. All in all, this gene cluster highlights the various pathways that activate caspases and underscores the key role of caspases in apoptosis."